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Abstract 
Functional food ingredients, with scientifically proven and validated bioactive effects, 
present an effective means of inferring physiological health benefits to consumers to 
reduce the risk of certain diseases. The search for novel bioactive compounds for 
incorporation into functional foods is particularly active, with brewers’ spent grain (BSG, 
a brewing industry co-product) representing a unique source of potentially bioactive 
compounds. 
The DNA protective, antioxidant and immunomodulatory effects of phenolic 
extracts from both pale (P1 - P4) and black (B1 – B4) BSG were examined. Black BSG 
extracts significantly (P < 0.05) protected against DNA damage induced by hydrogen 
peroxide (H2O2) and extracts with the highest total phenolic content (TPC) protected 
against 3-morpholinosydnonimine hydrochloride (SIN-1)-induced oxidative DNA 
damage, measured by the comet assay. Cellular antioxidant activity assays were used to 
measured antioxidant potential in the U937 cell line. Extracts P1 – P3 and B2 - B4 
demonstrated significant (P < 0.05) antioxidant activity, measured by the superoxide 
dismutase (SOD) activity, catalase (CAT) activity and gluatathione (GSH) content 
assays. Phenolic extracts P2 and P3 from pale BSG possess anti-inflammatory activity 
measured in concanavalin-A (conA) stimulated Jurkat T cells by an enzyme-linked 
immunosorbent assay (ELISA); significantly (P < 0.05) reducing production of 
interleukin-2 (IL-2), interleukin-4 (IL-4, P2 only), interleukin-10 (IL-10) and interferon-γ 
(IFN-γ). Black BSG phenolic extracts did not exhibit anti-inflammatory effects in vitro.   
Hydroxycinnamic acids (HA) have previously been shown to be the phenolic 
acids present at highest concentration in BSG; therefore the HA profile of the phenolic 
extracts used in this research, the original barley (before brewing) and whole BSG was 
characterised and quantified using high performance liquid chromatography (HPLC). The 
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concentration of HA present in the samples was in the order of ferulic acid (FA) > p-
coumaric acid (p-CA) derivatives > FA derivatives > p-CA > caffeic acid (CA) > CA 
derivatives. Results suggested that brewing and roasting decreased the HA content. 
Protein hydrolysates from BSG were also screened for their antioxidant and anti-
inflammatory potential. A total of 34 BSG protein samples were tested. Initial analyses of 
samples A – J found the protein samples did not exert DNA protective effects (except 
hydrolysate H) or antioxidant effects by the comet and SOD assays, respectively. 
Samples D, E, F and J selectively reduced IFN-γ production (P < 0.05) in Jurkat T cells, 
measured using enzyme linked immunosorbent assay (ELISA). Further testing of 
hydrolysates K – W, including fractionated hydrolysates with molecular weight < 3, < 5 
and > 5 kDa, found that higher molecular weight (> 5 kDa) and unfractionated 
hydrolysates demonstrate greatest anti-inflammatory effects, while fractionated 
hydrolysates were also shown to have antioxidant activity, by the SOD activity assay. 
A commercially available yogurt drink (Actimel) and snack-bar and chocolate-
drink formulations were fortified with the most bioactive phenolic and protein samples – 
P2, B2, W, W < 3 kDa, W < 5 kDa, W > 5 kDa. All fortified foods were subjected to a 
simulated gastrointestinal in vitro digestion procedure and bioactivity retention in the 
digestates was determined using the comet and ELISA assays. Yogurt fortified with B2 
digestate significantly (P < 0.05) protected against H2O2-induced DNA damage in Caco-2 
cells. Greatest immunomodulatory activity was demonstrated by the snack-bar 
formulation, significantly (P < 0.05) reducing IFN-γ production in con-A stimulated 
Jurkat T cells. Hydrolysate W significantly (P < 0.05) increased the IFN-γ reducing 
capacity of the snack-bar. Addition of fractionated hydrolysate W < 3 kDa and W < 5 
kDa to yogurt also reduced IL-2 production to a greater extent than the unfortified yogurt 
(P < 0.05).  
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1.1.  Introduction 
 
Novel functional food ingredients with proven health benefits are in demand by both the 
food industry and informed modern consumers. Brewers’ spent grain (BSG) is a 
nutritionally valuable co-product of the brewing process and a potential source of 
bioactive ingredients. These ingredients include polyphenols, mainly hydroxycinnamic 
acids, and protein. This literature review aims to evaluate existing knowledge in the area 
of bioactive phenolic compounds and protein hydrolysates and bioactivity retention 
following in vitro digestion of functional food ingredients. Three individual review 
papers entitled “Brewers’ spent grain – bioactivity of phenolic component, its’ role in 
animal nutrition and potential for incorporation in functional foods; a review”, “Protein 
hydrolysates from agricultural crops — bioactivity and potential for functional food 
development” and “Bioaccessibility of functional ingredients” have been published in 
peer-review journals and the literature review will be presented in this format. 
Existing evidence regarding BSG is discussed in section 1.2, with a particular 
focus on the phenolic compounds present in BSG and their extraction, composition and 
bioactivity. The incorporation of BSG into foods for animal and human nutrition is also 
reviewed.   
Due to the lack of information regarding protein hydrolysates from BSG, a broad 
review of the bioactivity of protein hydrolysates from a range of agricultural crops was 
conducted. The bioactive and techno-functional properties associated with protein 
hydrolysates from agricultural crops are examined in section 1.3. 
The ability of a compound to be absorbed across the gastrointestinal tract is 
critical to its bioactivity. Therefore, the bioaccessibility of functional ingredients is 
reviewed in section 1.4, including methods used to simulate in vivo digestion and factors 
affecting bioaccessibility. The bioaccessibility of specific functional food ingredients and 
approaches that can be used to increase bioaccessibility are also discussed.  
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1.2. Brewers’ spent grain – bioactivity of phenolic component, its’ role in animal 
nutrition and potential for incorporation in functional foods; a review. 
Published in: Proceedings of the Nutrition Society (2013) 72, 117-125 
 
1.2.1. Abstract 
Brewers’ spent grain (BSG) is a low-value co-product of the brewing industry produced 
in large quantities annually. This paper reviews existing evidence regarding the phenolic 
component of BSG, focusing on composition, extraction and biofunctions such as 
antioxidant, anti-atherogenic, anti-inflammatory and anti-carcinogenic activities. 
Furthermore, the incorporation of BSG in foodstuffs will be discussed, including the use 
of BSG as an animal feed supplement and the potential of BSG to be incorporated into 
foods for human consumption. BSG contains hydroxycinnamic acids including ferulic 
acid, p-coumaric acid and caffeic acid; which have shown bioactivity in the pure form 
(antioxidant, anti-inflammatory, anti-atherogenic, anti-cancer). Phenolic extracts from 
BSG have also shown antioxidant potential, by protecting against oxidant induced DNA 
damage, possibly by iron chelation. Studies show that BSG has many benefits when used 
as a supplement in animal feed, such as increasing milk yield, milkfat content and in 
providing essential dietary amino acids. The incorporation of BSG in human foods such 
as cookies and ready-to-eat snacks has resulted in increased protein and fibre contents of 
the products, where the changes in organoleptic properties are controllable.  It can be 
concluded that the phenolic component of BSG has potential bioactive effects, which are 
worth pursuing given that the inclusion of BSG into human foodstuffs is viable and 
beneficial.  
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1.2.2. Introduction 
Brewers’ spent grain (BSG) is the solid fraction of barley malt remaining after the 
production of wort. According to Eurostat Data, BSG is the main by-product of the 
brewing industry, with approximately 3.4 million tonnes being produced annually in the 
E.U. (Stojceska et al., 2008), at least 160,000 tonnes of which are produced in Ireland. 
This solid residue contains water insoluble proteins in addition to the husk, 
pericarp and seed coat of the original barley grain (Townsley, 1979). Protein and fibre 
account for 20 % and 70 % of BSG dry matter respectively, while the starch content of 
BSG is insignificant (due to the absence of starchy endosperm). Due to its protein-rich 
composition, BSG has the potential to be utilised in a manner similar to whey protein, 
providing health benefits for consumers. BSG is also rich in phenolic compounds, 
particularly ferulic acid and p-coumaric acid (Bartolome et al., 2002), along with 
oligosaccharides and polysaccharides (Mussatto et al., 2006). Emerging evidence, with 
regard to the ability of dietary phenolic compounds to exhibit anti-carcinogenic, anti-
inflammatory and antioxidant activities (Nagasaka et al., 2007; Yang et al., 2001), has 
led to significant interest in plant phenolic compounds particularly by the food industry, 
scientists and consumers.  
To date, BSG has been widely used as an animal feed, particularly for cattle, to 
provide high amounts of both protein and fibre. BSG is an excellent feed ingredient for 
ruminants, providing all the essential amino acids when combined with inexpensive 
nitrogen sources such as urea (Huige, 1994). However, with the increased cost of disposal 
of the solid fraction, alternative uses are highly sought-after and it has been shown that 
BSG can be effectively integrated into ready-to-eat snacks to increase dietary fibre, crude 
protein and fat levels (Stojceksa et al., 2008). Other areas of successful research include 
the blending of BSG with flour for incorporation into cookies (Prentice et al., 1978) and 
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the addition of BSG to dough to improve the dietary fibre content in bread (Stojceska & 
Ainsworth, 2008). 
This review details existing evidence regarding BSG. A specific focus is placed 
on the potential bioactivities of phenolic compounds (particularly ferulic acid and p-
coumaric acid) present in BSG, and the incorporation of BSG into foodstuffs, for both 
human and animal consumption. 
 
1.2.3. Composition of BSG 
Many studies have reported on the proximate composition of BSG, which contains 
protein, fat, cellulose, hemicelluloses and lignin (Table 1). As shown, there is good 
consistency with regard to the composition of BSG. However, variations can arise due to 
differences in barley variety, harvesting time, characteristics of hops added and brewery 
technology (Santos et al., 2003). BSG predominantly consists of the husk-pericarp-seed 
coat layers that are rich in cellulose, non-cellulosic polysaccharides, lignin, protein and 
fat. This is reflected in the composition of BSG (Table 1), and thus BSG can be regarded 
as a lignocellulosic material (Mussatto et al., 2006). In addition to the components 
detailed in Table 1, it has been shown that BSG is also a valuable source of vitamins, 
minerals and amino acids, particularly for animal feeding. The vitamins present in BSG 
are biotin, folic acid, niacin, choline, riboflavin and thiamine, pantothenic acid, 
pyroxidine (Huige, 1994). BSG is also reported to contain minerals such as calcium, 
copper, iron, manganese, potassium and sodium (Huige, 1994; Pomeranz et al., 1976) 
and both essential (including lysine, histidine, methionine, phenylalanine, tryptophan) 
and non-essential (including alanine, serine, glycine, proline) amino acids (Huige, 1994). 
When combined with inexpensive nitrogen sources, such as urea, BSG can provide all the 
essential amino acids to ruminant animals (Huige, 1994). 
 
 
 
 
a Values expressed as % dry matter, which has been documented in two studies to be 20.4 % (Beldman et al., 1987) 
and 20 % (El-Shafey et al., 2004). 
 
Table 1: The proximate chemical composition of brewers’ spent grain (BSG). 
Study 
Component (as % dry matter a) 
Protein Lipid/Oil Ash Cellulose Hemicelluloses Lignin Starch 
Beldman et al., 1987 23.8 - 3.5 15.1 24.8 - 2.0 
Valverde, 1994 24.0 6.0 - 17.0 39.0 4.0 - 
Kanauchi et al., 2001 24.0 10.6 2.4 25.4 21.8 11.9 - 
Santos et al., 2003 24.2 3.9 3.4 - - - - 
El-Shafey et al., 2004 26.7 8.9 3.9 - - 5.3 - 
Mussatto & Roberto, 2005 15.3 - 4.6 16.8 28.4 27.8 - 
Xiros et al., 2008 14.2 13.3 3.3 12.0 40.2 11.5 - 
Treimo et al., 2009 23.4 - - - - 12.6 7.8 
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1.2.4. Phenolic component of BSG  
1.2.4.1. Phenolics present in BSG 
Phenolic acids, particularly hydroxycinnamic acids and hydroxybenzoic acids are 
secondary plant metabolites found extensively in plant foods. Phenolic acids are 
currently the focus of much attention due to their potential to act as antioxidant, anti-
inflammatory and anti-carcinogenic compounds (Nagasaka et al., 2007; Yang et al., 
2001).  
As previously mentioned, BSG consists predominantly of the husk-pericarp-seed 
coat and is largely made up of cell walls. Since most of the phenolic compounds of the 
barley grain are contained in the husk (Mussatto et al., 2006) and hydroxycinnamic 
acids accumulate in cell walls, BSG is a potentially valuable source of phenolic acids.  
There is evidence to suggest that ferulic acid and p-coumaric acid (as shown in 
Figure 1) are present at relatively high concentrations in BSG (Bartolome et al., 2002). 
Some of the existing literature regarding the presence of ferulic and p-coumaric acid is 
detailed in Table 2. Ferulic acid was found to be the most abundant hydroxycinnamic 
acid being present at concentrations ranging from 1860-1948 µg/g, while the p-
coumaric levels ranged from 565-794 µg/g (Hernanz et al., 2001). More recent evidence 
shows that BSG consists of 1.16 % mono and dimeric phenolic acids, with 53 % of the 
monomeric phenolic acids accounted for by ferulic acid. The vast majority of phenolic 
acids were also found to be in the bound form (Forssell et al., 2008). It has been 
reported that following ferulic and p-coumaric acids, the next most abundant phenolic 
acids in BSG were found to be sinapic, caffeic and syringic acid (Szwajgier et al., 
2010). A summary of the phenolic acids present in BSG is given in Table 3.  
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                   ferulic acid (C10H10O4)           R= OCH3 
                  p-coumaric acid (C9H8O3)        R= H 
 
Figure 1: The general structure of hydroxycinnamic acid and the functional 
groups for ferulic and p-coumaric acids. 
 
 
Table 2: The percentage (% dry weight) of bound phenolics, ferulic acid and 
p-coumaric acid present in brewers’ spent grain (BSG). 
Study Percentage (as % dry matter) 
 
Bound 
Phenolics 
ferulic acid p-coumaric acid 
Bartolome et al., 2002 - ~0.2 ~0.1 
Mandalari et al., 2005 - 0.6 0.3 
Athanasios et al., 2007 - 0.2-0.3 0.1-0.2 
Forrsell et al., 2008 - 0.5 0.5 
Treimo et al., 2009 0.7 - - 
Robertson et al., 2010 0.8 - - 
Szwajgier et al., 2010 - 0.3 0.1 
R 
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Table 3: The most abundant phenolic acids present in brewers’ 
spent grain, modified from Szwajgier et al., (2010) 
Phenolic acid 
Free acid concentration 
 (mg/100g dry matter) 
 Mean ± SE 
Ferulic acid 336.3 ± 16.0 
p-Coumaric acid 64.4 ± 4.6 
Sinapic acid 42.0 ± 1.1 
Caffeic acid 9.9 ± 0.7 
Syringic acid 6.5 ± 0.1 
4-OH-Benzoic acid 1.2 ± 0.6 
Chlorogenic acid 0.6 ± 0.2 
Protocatechuic acid 0.5 ± 0.1 
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1.2.4.2. Extraction of phenolic acids from BSG 
Numerous studies have been conducted to extract phenolic acids from BSG. Novel 
techniques for extraction, such as a rapid microwave-assisted derivatization process 
have been investigated (Athanasios et al., 2007). However, the majority of approaches 
use the basis of either acid hydrolysis or saponification (with 1 - 4 M NaOH) and liquid-
liquid or liquid-solid extraction. A review of methods of extracting, separating and 
detecting phenolic acids in natural plant foods showed that the most frequently used 
methods involve acid hydrolysis and saponification (Stalikas, 2007). Extraction usually 
entails the use of solvents such as methanol and ethyl acetate. Thin layer 
chromatography (TLC) is extensively used for detecting phenolic acids due to its high 
sample throughput. However, using high performance liquid chromatography (HPLC) 
gives a greater degree of separation of compounds and is highly reproducible where 
quantification is possible. Therefore, reverse-phase (RP-) HPLC is predominantly used, 
but HPLC coupled with ultraviolet (UV) or diode array detection (DAD) is also an 
option (Zgórka & Kawka, 2001). A review looking at the extraction and quantification 
of phenolics in foods also reported that methanolic extraction and alkaline hydrolysis 
are commonly used for phenolic acid extraction, while a sequential alkaline hydrolysis 
releases bound phenolics (Naczk & Shahidi, 2004). A new method has recently been 
developed and validated, for the release of phenolic acids (both free and bound) from 
cereals including barley. This method uses solid-phase extraction (SPE) coupled with 
HPLC-DAD analysis and is simple, inexpensive and gives good recoveries and 
precision (Irakli et al., 2012). Recently published results show that exogenous ferulic 
acid esterase (FAE) produced by the probiotic organism Lactobacillus acidophilus K1 
can successfully release the free phenolics from BSG (Szwajgier, 2011). In 2005, a 
study looking at the hydroxycinnamate content of BSG fractions utilized saponification 
with 4 M NaOH. The supernatants were then neutralised and extracted with ethyl 
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acetate, dried and re-suspended in MetOH:H2O (Mandalari et al., 2005). More recent 
research also used this method, giving comparable results (Robertson et al., 2010). 
Using a LUNA C18 RP-HPLC column, both studies found that ferulic acid was the 
phenolic acid in greatest abundance in BSG, with coumaric acid being second highest. 
Saponification (involving the treatment of samples with 1 - 4 M NaOH solution) has 
been widely used to extract hydroxycinnamic acids from BSG (Faulds et al., 2004; 
Bartolome et al., 2002; Hernanz et al., 2001).  
Extraction methods similar to those used for BSG, have also been utilised with 
other materials such as wheat bran extracts (Kim et al., 2006) and apple waste extracts 
(McCann et al., 2007). 
 
1.2.4.3. Potential health benefits of phenolic component of BSG – in vitro evidence 
As previously mentioned, ferulic and p-coumaric acids are the phenolic acids found in 
the highest concentrations in BSG (Table 3). Much research has been conducted looking 
at the in vitro antioxidant activity of hydroxycinnamic acids, particularly ferulic and p-
coumaric acids, however evidence regarding in vivo antioxidant effects are limited to 
date. A commonly used method for quantification of antioxidant activity is the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) assay, which measures the ability of the test 
compound to scavenge the DPPH radical. Chen & Ho (1997) and others have shown the 
antioxidant potential of ferulic acid using the DPPH and Rancimat methods, but ferulic 
acid was a less potent antioxidant than caffeic acid and α-tocopherol (Chen & Ho, 1997; 
Brand-Williams et al., 1995). Caffeic acid has been shown to act as an antioxidant in 
vitro and scavenged radicals including DPPH and the superoxide anion (Gulcin, 2006). 
It has also been shown, using the DPPH assay, that a number of hydroxycinnamic acids 
act as antioxidants, scavenging DPPH in the order caffeic acid > sinapic acid = ferulic 
acid > ferulates > p-coumaric acid (Kikuzaki et al., 2002). Similarly, but using an 
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alternative laboratory method, a study investigating the phenolic compounds in wheat 
bran extract and their antioxidant activity again found that ferulic acid was one of the 
strongest antioxidants using the β-Carotene Linoleic Acid Model System (β-CLAMS). 
The β-CLAMs assay is based on the principle that at high temperature the oxidation of 
linoleic acid produces peroxides that decolourise β-carotene. The wheat bran extracts 
with highest ferulic acid concentrations (following alkaline hydrolysis) also exhibited 
higher antioxidant activity (Kim et al., 2006). Ferulic acid and caffeic acid have been 
reported to have excellent antioxidant potential at low concentrations, with the ability to 
scavenge a range of free radicals. Both phenolic acids scavenge the reactive oxygen 
species (ROS) and reactive nitrogen species (RNS), with concentration dependent 
scavenging of nitric oxide (NO), superoxide and 2,20-azino-bis-3-ethylbenzthiazoline-
6-sulfonic acid radical (ABTS+). In line with previously discussed evidence, caffeic 
acid was a stronger scavenger of the DPPH radical, but ferulic acid was better at 
scavenging ABTS+ and NO (Maurya & Devasagayam, 2010). In a recent study on 
beers, a direct correlation was found between ferric reducing antioxidant power (FRAP) 
and a number of phenolic acids including ferulic, p-coumaric, caffeic, sinapic and 
vanillic acids (Piazzon et al., 2010). A second study also showed that some of the 
phenolic acids present in beer correlate with the antioxidant activity measured by DPPH 
radical and superoxide anion scavenging, metal chelation and reducing power; these 
include syringic and caffeic acids (Zhao et al., 2010). Since ferulic acid is so well 
recognised as an antioxidant, it is approved for use as a food additive in some countries 
to prevent oxidation (Itagaki et al., 2009; Graf, 1992).  In addition, it is important to 
note that while phenolic compounds can have an in vitro antioxidant effect, they have 
also been shown to act as pro-oxidants under certain conditions, thus inducing oxidative 
stress. Recent literature suggests that at low concentrations, many phenolics exhibit pro-
oxidant behaviour, whereas the synthetic antioxidants, including α-tocopherol, do not 
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(Fukumoto & Mazza, 2000). For caffeic acid and ferulic acid to act as pro-oxidants, 
higher concentrations (> 5 µM) are required (Maurya & Devasagayam, 2010). It has 
also been found using the comet assay that at high concentrations p-coumaric acid 
enhanced DNA breakage induced by hydrogen peroxide. This may be due to the 
production of ROS by p-coumaric acid as a result of its pro-oxidant activity (Ferguson 
et al., 2005). It has been suggested that this pro-oxidant effect is related to the presence 
of metal ions in the body (for example due to tissue injury releasing iron and copper) 
and is of relevance for the bioactivity of phenolic compounds in vivo (Morton et al., 
2000). It is clear from a small number of in vivo studies that the hydroxycinnamic acids 
have antioxidant properties. Such studies are essential to understand the biological role 
of these phenolic acids (Shahidi & Chandrasekara, 2010).  
In addition to their in vitro antioxidant activity, there is increasing evidence to 
suggest that phenolic acids can have an anti-carcinogenic effect. Caffeic acid (50 µM) 
exhibits an anti-proliferative effect on several cancer cells including mammary gland, 
adenocarcinoma, lymphoblastic leukaemia (Gomes et al., 2003) and cervical cancer cell 
lines as assessed using the MTT assay (Chang et al., 2010; Gomes et al., 2003). The 
cyclooxygenase-isoform 2 (COX-2) assay has been used for determination of the anti-
cancer potential of these compounds. Over expression of COX-2 increases the 
conversion of arachidonic acid to prostaglandins, which are important mediators of 
inflammation, and are associated with cancer. Phenolic acids including caffeic acid 
(Kang et al., 2009) and vanillic acid (Kim et al., 2011), and polyphenols including 
epigallocatechin-3-gallate (Hussain et al., 2005) and quercetin (Garcia-Mediavilla et al., 
2007), have been shown to inhibit the expression of COX-2, possibly reducing cancer 
risk. Apoptosis in cancer cell lines is also an indicator of anti-carcinogenic potential and 
can be assessed by a number of methods including DNA fragmentation and the Hoechst 
staining assay. Cinnamic acid derivatives induced apoptosis in human leukaemia 
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(HL60) and colon cancer (SW480) cell lines, as measured by the aforementioned 
apoptosis methods (Akao et al., 2003). Additionally, the anti-apoptotic effect of 
phenolic compounds including ferulic acid and caffeic acid on human peripheral blood 
mononuclear cells (PBMCs) was investigated (Khanduja et al., 2006). Caffeic acid 
inhibited externalisation of phosphatidyl serine (PS), which indicates the pre-apoptotic 
stages, and hence it was concluded to have an anti-apoptotic effect. DNA fragmentation 
was analysed using an apoptotic DNA ladder kit. It was shown that pre-treating cells 
with caffeic acid, ferulic acid or ellagic acid before exposure to H2O2 inhibited DNA 
fragmentation. Recently published data adds to the evidence available in the area, by 
measuring the ability of phenolic compounds to modulate nuclear factor kappa B (NF-
κB) activity. In the inflammatory process, NF-κB is a transcription factor, whose 
increased activation has been reported in several human cancers (Escárcega et al., 
2007). Free phenolic acids which can be found in cereal grains (including ferulic, 
caffeic, sinapic and p-coumaric acids) significantly modulate NF-κB activity in 
U9373xκB-LUC cells, with a desired level of modulation being achieved by the 
synergistic action of phenolic acids and other phenolic compounds (Hole et al., 2012). 
Animal studies have also been carried out to determine the anti-carcinogenic potential 
of phenolic acids. An animal study to establish the effect of curcumin, chlorogenic acid, 
ferulic acid and caffeic acid on tumor promotion in the skin of mice showed that 
chlorogenic, ferulic and caffeic acid prevented the number of 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced tumours per mouse by 60, 28 and 35 
%, respectively (Huang et al., 1988). Results of a later animal study suggest that ferulic 
acid not only inhibits the growth of aberrant crypt foci (ACF) in the colon, but also 
prevents the conversion of pre-neoplasia to malignant neoplasia (Kawabata et al., 
2000). A recently published review on plant phenolics reported that natural phenolics, 
including those present in tea and fruit polyphenols, play an antagonistic role in all 
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stages of cancer development and that further study on these compounds will provide 
information regarding their possible future pharmaceutical use (Dai & Mumper, 2010). 
Cytokines are small cell signalling molecules involved in the inflammatory 
response, these include interleukins and interferons (for example interferon-gamma 
(IFN-γ)). The ability of a compound to alter the production of a stimulated cytokine or 
NO indicates the compound’s potential to act as an immune-modulator. Murakami et al. 
(2002) investigated the effect of both ferulic acid (from rice bran) and FA15 (a 
derivative of ferulic acid) on NOS, COX-2 and tumor necrosis factor-α (TNF-α) in the 
RAW264.7 murine macrophage cell line. Unlike the ferulic acid isolated from rice bran, 
the synthesised FA15 derivative was found to inhibit the release of TNF-α and reduce 
the protein expression of both NOS and COX-2 (Murakami et al., 2002). Ferulic acid 
has also been shown to inhibit macrophage inflammatory protein-2 (MIP-2) and TNF-α 
production, induced by lipopolysaccharide (LPS) in a macrophage cell line. The effect, 
although dose-dependent, was very weak compared to the effect of dexmethasone (a 
well known inhibitor of interleukins) (Sakai et al., 1997). In Japanese Oriental 
medicines, Cimicifuga heracleifolia (CH) is often used as an anti-inflammatory drug. 
Ferulic acid has been shown to be among the main phenolic acids in CH (He et al., 
2006). Sakai et al. (1999) showed that ferulic acid and isoferulic acid could reduce 
MIP-2 production in a dose-dependent manner in RAW264.7 cells. It was suggested 
that ferulic acid and isoferulic acid are responsible, at least in part, for the anti-
inflammatory properties of the CH drug (Sakai et al., 1999).  Recently published data 
has shown that ferulic acid and p-coumaric inhibited LPS induced NO production and 
inducible NOS (iNOS) in macrophages (Kim et al., 2012). This supports earlier 
evidence suggesting that these phenolic acids can act as anti-inflammatory agents, by 
reducing TNF-α induced interleukin-6 (IL-6) production in adipocytes. Quercetin, p-
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coumaric acid and reservatrol showed greatest inhibition of IL-6 production (Yen et al., 
2011).  
Oxidised low density lipoprotein (LDL) is a well recognised risk marker of 
cardiovascular disease which is principally caused by atherosclerosis (Yoshida & 
Kisugi, 2010). Evidence exists for the effect of hydroxycinnamic acids on the inhibition 
of low density lipoprotein oxidation. Nardini et al. (1995) demonstrated the antioxidant 
effect of hydroxycinnamic acid derivatives such as caffeic, ferulic and p-coumaric acids 
on LDL oxidation in vitro, with the use of the copper ion Cu2+ as a catalyst. At a 
concentration of 100 μM, all phenolic acids except p-coumaric acid inhibited LDL 
oxidation; at 20 μM, ferulic acid inhibited ~ 92 % of copper-catalysed human LDL 
oxidation; at 5 μM only caffeic acid strongly inhibited the oxidation of LDL (Nardini et 
al., 1995). A second study using similar methodology also found that both ferulic and p-
coumaric acid showed a dose-dependent inhibition of human LDL oxidation in vitro 
when tested at 5, 10 and 20 μM (Meyer et al., 1998). In agreement with these data, 
results of a later study showed sinapic, ferulic and p-coumaric acids inhibited LDL 
oxidation (Andreasen et al., 2001). Other compounds that have shown the ability to 
reduce copper-induced LDL oxidation include catechin (Chen et al., 2011).   
Our research group is the first, to our knowledge, to look specifically at phenolic 
extracts from BSG. Four extracts from pale BSG (P1, P2, P3, P4) and four extracts from 
black BSG (where the grain is roasted to 200 oC before brewing, B1, B2, B3, B4) were 
analysed. Each extract results from a different step in the extraction process and hence 
contains different phenolic acid composition. Extract 1 (P1, B1) contains free phenolics, 
extracts 2 (P2, B2) contains bound phenolics, extract 3 (P3, B3) contains the remainder 
of bound phenolics and extract 4 (P4, B4) contains phenolics extracted with 110 mM 
NaOH (McCarthy et al., 2012). The ability of the phenolic extracts to protect against 
oxidant-induced DNA damage was determined using the comet assay. In the U937 cell 
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line, oxidative DNA damage was induced by a range of oxidants; hydrogen peroxide 
(H2O2), 3-morpholinosydnonimine hydrochloride (SIN-1), 4-nitroquinoline oxide (4-
NQO) and tert-butylhydroperoxide (t-BOOH). Table 4 shows the ability of the extracts 
to protect the cells against DNA damage. There was no protection against DNA damage 
induced by either 4-NQO or t-BOOH. Ferulic acid and the black BSG extracts 
significantly reduce the DNA damage induced by H2O2, while P2, B2, B3, B4 
significantly reduce the percent tail DNA induced by SIN-1 (McCarthy et al., 2012). 
The four oxidants used have different mechanisms of action; damage induced by both 
H2O2 and SIN-1 involve the Fenton reaction and is an iron dependent reaction, 4-NQO 
mimics the action of UV and Cu2+ plays an essential role, while iron does not 
(Yamamoto et al., 1993), t-BOOH causes lipid peroxidation and acts in a Ca2+-
dependent manner and iron plays less of a role than in H2O2-induced damage 
(Kruszewski et al., 2008). Therefore, BSG phenolic extracts may provide protection 
against oxidant-induced DNA damage by Fe chelation (McCarthy et al., 2012).  
In summary, there is increasing evidence to suggest that phenolic acids, 
including those found at highest concentrations in BSG, can confer potential health 
benefits including anti-inflammatory, antioxidant, anti-carcinogenic and anti-
atherogenic effects. Recent data suggest that BSG has antioxidant potential and 
therefore further research on the phenolic compounds extracted from BSG is warranted. 
 
1.2.5. Incorporation of BSG into feed/foodstuffs 
1.2.5.1. Animal food 
As previously mentioned, BSG contains approximately 20 and 70 % protein and 
fibre, respectively and it is due to this favourable chemical composition that it has great 
potential for use as a raw material/food ingredient (Mussatto et al., 2006). BSG is an 
ingredient of significant importance for ruminants. When administered with low-cost 
 
 
a P1 - P4 represent the four pale BSG phenolic extracts, B1 - B4 represent the black BSG phenolic extracts. b Data represents the mean ± 
SE of at least three independent experiments. * Denotes a significant difference in DNA damage (P < 0.05), relative to oxidant control. 
Statistical analysis by ANOVA followed by Dunnett’s test. 
 
Table 4: DNA damage in U937 cells following 24 h incubation with 0.5 % v/v pale (P1 - P4) or black (B1 - B4) BSG phenolic extracts or 
0.1 µg/mL ferulic acid (adapted from McCarthy et al., 2012). 
Samplea 
DNA damage 
(% tail DNA)  
Oxidant –  H2O2 
DNA damage 
(% tail DNA) 
Oxidant – SIN-1 
DNA damage 
(% tail DNA) 
Oxidant – 4-NQO 
DNA damage 
(% tail DNA) 
Oxidant – t-BOOH 
Control 3.2 ± 0.5b 4.3 ± 0.4b 3.1 ± 0.3b 4.7 ± 0.6b 
Oxidant control 40.3 ±0.3b 40.0 ± 3.9b 39.5 ± 1.1b 15.5 ± 0.8b 
P1 30.3 ± 7.3b 32.8 ± 4.9b 39.0 ± 6.8b 14.5 ± 0.8b 
P2 29.0 ± 6.0b 22.7 ± 1.9b* 40.7 ± 4.3b 22.6 ± 3.0b 
P3 39.9 ± 3.9b 33.8 ± 2.9b 37.3 ± 3.2b 22.1 ± 3.1b 
P4 23.1 ± 3.2b 32.2 ± 6.1b 37.8 ± 3.6b 17.4 ± 2.6b 
B1 25.8 ± 7.5b* 33.6 ± 2.9b 36.1 ± 5.7b 13.6 ± 0.9b 
B2 9.6 ± 1.1b* 6.9 ± 1.0b* 31.9 ± 3.2b 18.5 ± 3.3b 
B3 16.0 ± 2.0b* 18.1 ± 0.3b* 33.4 ± 2.4b 16.6 ± 1.8b 
B4 14.0 ± 3.8b* 24.1 ± 2.2b* 33.7 ± 6.8b 14.0 ± 2.7b 
Ferulic acid 17.1 ± 0.8b* 30.8 ± 3.0b 32.6 ± 5.2b 11.0 ± 1.9b 
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nitrogen sources such as urea, BSG can supply all the essential amino acids to 
ruminants. The effect of BSG on milk yield and composition, and the blood components 
of dairy cattle has also been studied (Belibasakia & Tsirgogianni, 1996). The cattle 
received a diet consisting of ground maize, maize silage, soya bean meal and wheat 
bran, with the latter three being substituted with wet brewer’s grain in the treatment 
group. The study showed the treatment group had an increased milk yield, milkfat and 
milk total solids content. Blood components such as glucose, cholesterol, sodium, 
triglycerides were not affected. While the main outlet for BSG is currently as a feedstuff 
for dairy cattle, research has also been conducted looking at the benefits of BSG for use 
as a feed for poultry and fish. The effect of replacing rice bran in a fish diet with 10 - 40 
% brewery waste grains has been investigated (Kaur & Saxena, 2004). The brewery 
waste used contained 19 % crude protein, 18 - 20 % crude fibre and had a good amino 
acid profile. It was found that carp (oily freshwater fish) had better growth performance 
on diets containing brewery waste than the control group. The authors attributed this 
enhanced growth performance to the high-quality protein contained in the waste grains. 
A more recent study showed that biodegraded BSG contained cysteine, lysine and 
methionine in addition to 14 other amino acids (Essien & Udotong, 2008). Depending 
on the microbe used to degrade the BSG, different amino acid concentrations were 
found, with alanine consistently at highest concentrations. This composition was noted 
to be of particular importance for poultry as cysteine, lysine and methionine are the 
main amino acids required in poultry nutrition. For convenience, the possibility of 
producing dry BSG cakes suitable for long term storage was examined using membrane 
filter press technology (El-Shafey et al., 2004). These dry cakes could be used as an 
animal feed at any time, or as a starting material for the production of other products 
using BSG.  
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In summary, evidence suggests that whole BSG, fed as part of a total mixed 
ration, has many nutritional benefits for a range of animals, particularly dairy cattle. 
This has resulted in the routine use of BSG as an animal feed for cattle.  
 
1.2.5.2. Human food 
In addition to its use as an animal feed, BSG has been incorporated into foodstuffs for 
human consumption. Given its low cost and high nutritional value, BSG makes an ideal 
ingredient for human foods such as biscuits and ready-to-eat snacks, particularly where 
there is a need to increase fibre content. In 1978, the possibility of preparing cookies 
with flour containing BSG at levels ranging from 5 - 60 % was examined (Prentice et 
al., 1978). At 40 % BSG addition, the physical qualities of the cookies were sustained. 
This supplementation level gave a 74 % increase in nitrogen and increased crude fibre 
ten-fold. These results were supported by work published in 2002, where the authors 
looked at the effect of BSG (at levels of 5 - 25 %) on the fibre content and quality of 
cookies (Öztürk, 2002). As the level of addition of BSG increased, there was a 
significant increase in dietary fibre content. Another documented foodstuff suitable for 
the inclusion of BSG is ready-to-eat snacks (Stojceska et al., 2008). BSG was added to 
the formulation mix (consisting of ingredients such as corn starch and wheat flour) at 
levels ranging from 10 to 30 %. The incorporation was successful, increasing dietary 
fibre and crude protein levels. Similarly, the addition of BSG into extruded snack food 
has been studied (Ainsworth et al., 2007). The maize flour of the chick pea snacks was 
replaced with BSG at levels of 10, 20, 25 and 30 %. The parameters measured included 
the effect of BSG supplementation on texture, colour, moisture, fat, fibre, starch, 
protein, phenolic compounds and antioxidant capacity. With increasing levels of BSG 
addition, the percent protein, fat and fibre content increased, while starch decreased. It 
was suggested that foods fortified with BSG be considered as functional foods. In a 
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further study by Stojceska and Ainsworth (2008), BSG was incorporated at different 
levels (0 – 30 %) into wheat flour breads treated with 4 different enzymes and the bread 
quality was then evaluated. Similar to the previous study, it was found that the fibre 
content of the breads was significantly increased by BSG addition. The change in fat 
content was significantly linked to the addition of BSG. When addition of BSG is 
combined with the appropriate use of enzymes, the shelf life, texture and loaf volume 
can also be improved. Initially, it was thought that BSG was too granular for direct 
addition to food and that it would have to first be converted to flour before use. 
However, a study in 2009 demonstrated that BSG of various particle sizes could be 
effectively used in the production of frankfurters (Özvural et al., 2009). The control 
frankfurter had the highest score for acceptability, but the other products also had high 
scores, with the score decreasing with increase in particle size and reduction in fat 
levels. The authors suggested that BSG be used to produce low-fat high-fibre meat 
products. In addition to particle size, there are a number of points for consideration with 
the incorporation of BSG into foodstuffs. Firstly, there are concerns about appearance. 
When moist, BSG is brown in colour, thus can only be effectively integrated into off-
white products. Such foods include cookies and cakes. More importantly, it is 
imperative that the organoleptic properties of the foodstuff remain acceptable to 
consumers and are similar to current commercially available products. The study by 
Prentice et al. (1978), demonstrated that BSG addition at a level of 15 % was the upper 
limit for organoleptic acceptability. At this level, the organoleptic quality was lowered 
but still remained acceptable to consumer panels. Similarly, Stojceska et al. (2008) 
found that there was a limit of acceptability. At a level of addition of 30 %, 
physicochemical characteristics (such as texture, colour, and hardness) remained 
acceptable. However, the authors concluded that addition of BSG at 20 % level was 
optimal to maintain properties of commercially available snack foods. Where the 
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protein hydrolysates are to be extracted and incorporated into foodstuffs, there is 
concern over the bitter taste of some peptides, due to the hydrophobic amino acid 
content (Clemente, 2000). 
 
1.2.6. Conclusion 
The literature shows that phenolic compounds including ferulic, caffeic and p-coumaric 
acid can exert antioxidant, anti-cancer, anti-atherogenic and anti-inflammatory effects in 
vitro. Given that these phenolic acids are some of the major phenolics in BSG, it is 
expected that phenolic extracts from spent grain may also exhibit similar properties and 
have the potential to be developed for a range of bioactivities. BSG currently functions 
as an animal feed, having many nutritional benefits. While some attempts have been 
made to incorporate the bioactive components of BSG into foodstuffs, further research 
in this area is needed. Given the potential bioactive nature of the phenolic extracts from 
BSG, and the large amounts of BSG produced annually as a low value co-product, it is 
imperative that an alternative use be explored.  
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1.3. Protein hydrolysates from agricultural crops—bioactivity and potential for 
functional food development. 
Published in: Agriculture (2013) 3, 112-130 
 
1.3.1. Abstract 
There has been an unprecedented demand for inexpensive plant-derived protein 
hydrolysates in recent years, owing to their potential nutritional applications. This review 
examines existing evidence regarding protein hydrolysates from agricultural crops such as 
wheat, soy, rapeseed, sunflower and barley.  The in vitro bioactivity of these protein 
hydrolysates, including antioxidant and anti-hypertensive capabilities are discussed. In 
addition to evidence regarding their potential to enhance human nutrition, the effect of the 
hydrolysates on the techno-functional properties of foods will be reviewed.  
 
1.3.2. Introduction 
Humans require a protein intake sufficient to maintain the body nitrogen balance and allow 
for desirable rates of deposition during growth and pregnancy. Ingestion of protein 
amounts greater than requirements results in the excess being metabolised and excreted. 
Conversely, in the case of inadequate dietary protein intake, the body utilises its own 
proteins as a source of nitrogen; therefore a regular and sufficient intake is essential. 
Protein performs a number of key functions in the body including the building and repair of 
tissues, cell signalling and the provision of energy (4 kcal/g protein). Proteins also perform 
enzymatic and structural functions.  
Protein hydrolysates have been defined as “mixtures of polypeptides, oligopeptides 
and amino acids that are manufactured from protein sources using partial hydrolysis” 
(Schaafsma, 2009). There has been growing interest in these preparations over the last two 
decades, with novel bioactive peptides continually being discovered, as it has been shown 
that short-chain peptides from hydrolysed proteins have a higher nutritive value and may 
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be utilised more efficiently than an equivalent mixture of free amino acids (Grimble et al., 
1986). Milk-based products are the source of the greatest number of bioactive peptides 
isolated to date. Other sources include meat, eggs and fish, in addition to plant sources such 
as soy and wheat (Hartmann & Meisel, 2007). Figure 1 illustrates the effect of bioactive 
peptides on major body systems. It has emerged that protein hydrolysates have many uses 
in human nutrition; ingredients in energy drinks, weight-control and sports nutrition 
products (Clemente, 2000), sources of nutrition for elderly and immuno-compromised 
patients (Nagodawithana et al., 2010). Applications include the incorporation of protein 
hydrolysates into energy drinks, weight-control and sports nutrition products (Frokjaer, 
1994). Clinical applications have also been suggested, for the treatment of Phenylketonuria 
(PKU), liver disease, Crohn’s disease and ulcerative colitis (Clemente, 2000). Other 
functions of plant-derived protein hydrolysates have been discussed in detail elsewhere 
(Pasupuleti et al., 2010). These include use as natural herbicides, particularly corn gluten 
meal and soy and wheat hydrolysates (Christians et al., 1994) and as replacements for 
materials of bovine origin in fermentation media, to reduce risk of Bovine Spongiform 
Encephalopathy (BSE) contamination (Ranganathan  2010). 
In recent years there has been an unprecedented demand by both consumers and 
industry, for inexpensive plant-derived proteins and bioactive peptides for human 
consumption. Additionally, alternative uses for co-products of the plant processing industry 
are highly sought. Such co-products include brewers’ spent grain (BSG), wheat bran and 
okara (a soybean by-product of tofu production), which are excellent sources of both 
protein and fibre (Mandalari et al., 2005; O’Toole, 1999).  
The present review focuses on the in vitro bioactivity of protein hydrolysates from a 
range of agricultural crops, and their potential for inclusion into functional foods.  
 
 
 
 
 
Figure 1: Physiological effects of food derived bioactive proteins on major body systems. 
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1.3.3. Preparation of protein hydrolysates 
1.3.3.1. Protein hydrolysis 
Hydrolysis of proteins involves the cleavage of peptide bonds to give peptides of varying 
sizes and amino acid composition. There are a number of types of hydrolysis; enzymatic, 
acid or alkali hydrolysis. Chemical hydrolysis is difficult to control and reduces the 
nutritional quality of products (Celus et al., 2007), destroying L-form amino acids and 
producing toxic substances such as lysino-alanine (Lahl & Grindstaff, 1989). Enzymatic 
hydrolysis works without destructing amino acids and by avoiding the extreme 
temperatures and pH levels required for chemical hydrolysis, the nutritional properties of 
the protein hydrolysates remain largely unaffected (Celus et al., 2007). Production of 
protein hydrolysates in the food industry involves the use of digestive proteolytic enzymes 
from animals including chymotrypsin, trypsin and pepsin, or food grade enzymes obtained 
from plants and microorganisms which are regarded safe for human nutrition. Following 
protein hydrolysis, fractions can be categorised according to two characteristics. The first 
category consists of fractions with a high amino acid content. The second category consists 
of bioactive peptides with an amino acid sequence which is inactive in the intact protein 
molecule but becomes active in the hydrolysate following exposure to digestive and/or 
proteolytic enzymes (Schaafsma, 2009).  
 
1.3.3.2. Post-hydrolysis treatment 
Following hydrolysis, the ‘crude hydrolysates’ may undergo further processing. Commonly 
used post-hydrolysis processes include heat inactivation, ultrafiltration, hydrolysis by 
exoproteases and treatment with specific enzymes. Table 1 details the main post-hydrolysis 
processes and the function of each of these processes. Control of the molecular size of 
protein hydrolysates is an essential step in the development of protein hydrolysates for  
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Table 1. The main processes used following hydrolysis of protein (post-hydrolysis 
processes). 
Process Function 
Heat inactivation Inactivation of proteolytic enzymes 
Ultrafiltration 
Removal of high molecular weight proteins 
and peptides 
Use of specific enzymes Reduce content of specific amino acids 
Hydrolysis by exoproteases Hydrolysis, reduction of bitterness 
Activated carbon Reduction of bitterness 
Absorption chromatography Reduce content of aromatic amino acids 
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dietary use. Removal of high molecular weight proteins and peptides is primarily carried 
out using ultrafiltration. Protein hydrolysates can have a bitter taste and the elimination or 
reduction of this bitterness is essential to make the hydrolysates acceptable to consumers. 
The bitterness of protein hydrolysates is attributable to their hydrophobic amino acid 
content (Schaafsma, 2009) and the release of these amino acids by exoproteases can reduce 
bitterness (Pedersen, 1994). Post-hydrolysis processes can also be used to produce 
hydrolysates for the treatment of clinical conditions. For example, the use of phenylalanine 
ammonia lyase enzyme can reduce the phenylalanine content in protein hydrolysates, 
producing a hydrolysate suitable for patients with phenylketonuria, a disorder of 
phenylalanine metabolism (Clemente, 2000).  
 
1.3.4. Bioactivity of protein hydrolysates 
1.3.4.1.  Antioxidant  
Protein hydrolysates from agricultural crops including soy, rapeseed, wheat, sunflower and 
barley have been investigated for their antioxidant potential. In 1980, it was reported that 
following proteolysis, soy protein hydrolysates showed antioxidant potential, as measured 
by the thiobarbituric (TBA) assay, which is a measure of lipid peroxidation. It was 
suggested that the release of bound antioxidant phenolics or copper chelating agents was 
responsible for the observed antioxidant activity (Yee et al., 1980). Using similar 
methodology, Peña-Ramos and Xiong (2002) provided comparable results. Soy protein 
hydrolysates prepared with Flavourzyme or chymotrypsin had antioxidant potential greater 
than unhydrolysed soy protein isolate. However, it was found that extensive degradation 
using enzymes such as papain unfavourably altered the antioxidant activity (Yee et al., 
1980). A further study measured the ability of these soy protein hydrolysates, prepared 
with Flavourzyme or chymotrypsin, to inhibit lipid oxidation in cooked pork patties. 
However, in contrast to the initial study, the soy protein hydrolysates did not affect lipid 
- 38 - 
 
oxidation by the TBA assay, but reduced conjugated diene (CD, a marker of free radicals) 
formation in stored pork patties (Peña-Ramos & Xiong, 2003). CD is a secondary product 
of lipid oxidation. Later studies have also reported the antioxidant potential of soy protein 
hydrolysates (Roblet et al., 2012; Xin et al., 2011; Moure et al., 2006; Fan et al., 2005). 
Soy protein hydrolysates post-treated with ultrafiltration, resulting in low molecular weight 
fractions (< 10 kDa) have shown greatest antioxidant potential (Moure et al., 2006).  
Protein hydrolysates from a range of other agricultural crops have been less 
extensively studied in comparison to soy hydrolysates. Rapeseed protein hydrolysates 
exhibited a dose-dependent inhibition of lipid peroxidation by a speculated proton donation 
mechanism (Zhang et al., 2008). Later studies supported these findings, with rapeseed 
hydrolysates showing the ability to act as reducing agents and scavenge hydroxyl radical 
and superoxide anion (Pan et al., 2011; Xue et al., 2009). By employing the post-
hydrolysis process of affinity chromatography, copper chelating peptides were isolated 
from sunflower protein hydrolysates. The ability to chelate copper increased mineral 
bioavailability and exerted antioxidant effects (Megias et al., 2008; Megias et al., 2007). 
Protein hydrolysates isolated from wheat germ also possess radical scavenging abilities, 
with an antioxidant activity close to that of the well known antioxidant α-tocopherol. 
Interestingly, these hydrolysates had low molecular weight < 1500 Da (Zhu et al., 2006). 
Similarly, enzymatic hydrolysates of buckwheat showed excellent antioxidant potential, 
scavenging DPPH radical, inhibiting linoleic acid peroxidation and possessing reducing 
power (Tang et al., 2009).  
Protein hydrolysates isolated from co-products of the plant processing industry 
have also been investigated for antioxidant activity. While BSG protein isolate and 
associated hydrolysates do not possess antioxidant potential (McCarthy et al., 2013), okara 
hydrolysates protect against oxidation of linoleic acid (Yokomizo et al., 2002). 
Furthermore, it has been shown that fermentation of okara using Bacillus subtilis B2 can 
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greatly improve its antioxidant activity, thus adding value to this co-product (Zhu et al., 
2008).  
 
1.3.4.2. Anti-hypertensive 
Normal blood pressure is in the range of 100 - 140 mmHg (systolic) and 60 - 90 mmHg 
(diastolic). Values greater than 140 mmHg (systolic) and 90 mmHg (diastolic) are 
classified as hypertension or high blood pressure. In hypertension, the blood pressure in the 
arteries is elevated and the heart has to work hard to pump blood around the body. 
According to the World Health Organisation (2009), high blood pressure is particularly 
relevant in middle income European countries and African countries. A high percentage of 
stroke (51 %) and ischaemic heart disease (45 %) deaths worldwide are attributable to high 
systolic blood pressure. Dietary and lifestyle changes, including a reduction in salt intake 
and an increase in physical activity levels, can positively influence blood pressure. 
However, in cases where such changes are ineffective or insufficient, drug treatments may 
be prescribed. Angiotensin-converting enzyme (ACE) inhibitors are an example of a drug 
treatment to control blood pressure. ACE reduces the conversion of angiotensin-1 
(vasodilatory) to angiotensin-2 (vasoconstrictory) resulting in a reduced blood pressure. 
Hence, there is great interest in novel compounds that can inhibit ACE. In 2000, wheat 
germ hydrolysate and its dominant peptide significantly reduced mean arterial pressure 
(MAP) in spontaneously hypertensive rats. It was shown that the dominant bioactive 
peptide could be metabolised by an aminopeptidase to form an ACE inhibitory metabolite, 
indicating potential blood pressure lowering effects of the metabolite after absorption 
(Matsui et al., 2000). Similarly, a buckwheat protein hydrolysate was found to reduce 
systolic blood pressure in spontaneously hypertensive rats and also inhibit ACE, 
particularly when hydrolysis was carried out with pepsin followed by chymotrypsin and 
trypsin (Li et al., 2002). More recently, it was found that ultrasonic pre-treatment promotes 
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the release of ACE inhibitory peptides during enzymatic proteolysis of wheat germ (Jia et 
al., 2010). van der Ven et al. (2002) described the processing conditions necessary to 
produce hydrolysates with maximal ACE inhibitory activity. It was suggested that the ACE 
inhibitory activity of protein hydrolysates is due to the synergistic action of the different 
peptides present, thus the isolation of peptides is not justified and optimising the entire 
peptide composition is essential. Response surface modelling (which comprises a body of 
methods to explore optimum operating conditions through experimental methods (Lenth, 
2009)) is effective in the optimisation of a number of parameters simultaneously to produce 
a hydrolysate with maximum ACE inhibitory activity. Similar to the results for antioxidant 
activity of protein hydrolysates, it was found that ACE inhibitory activity of soy protein 
hydrolysates increased with decreasing molecular weight of peptides, hence ACE 
inhibitory peptides have low molecular weight (Wu & Ding, 2002). This study also focused 
on an important consideration for the formulation of anti-hypertensive functional foods, 
that is the digestibility of the protein hydrolysates. Following in vitro gastric digestion, 
which simulates conditions in the human stomach, of the soy protein hydrolysates, the 
ACE inhibitory activity was retained. Stability during processing is another key factor and 
hydrolysates were shown to have sufficient stability to various heat (20 - 100 oC) and pH 
(pH 2- 10) treatments. These findings were supported by a study published in 2006, where 
it was also reported that soy protein hydrolysates possessed ACE inhibitory activity that 
was unaffected by in vitro gastrointestinal proteases (Chaing et al., 2006). Protein 
hydrolysates from a range of other crops including potato (Pihlanto et al., 2008), corn (Kim 
et al., 2004; Suh et al., 1999), spinach (Yang et al., 2003), sunflower (Megias et al., 2004; 
Megias et al., 2009), peanut (Jamdar et al., 2010) and rapeseed (Yoshie-Stark et al., 2006) 
have exhibited high ACE inhibitory activities. Rice-bran, an under-utilized co-product of 
rice milling also has the potential to inhibit ACE activity with high molecular weight 
hydrolysates (10 - 50 and > 50 kDa) resulting in at least 50 % inhibition (Hull et al., 2011). 
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In addition to ACE inhibition, there are a number of other potential mechanisms of 
inhibiting hypertension. These include activation of endothelial nitric oxide synthase 
(NOS), reduction of Ca2+ in vascular smooth muscle cells (VSMC) and rennin inhibition 
(Chen et al., 2009). The ability of a compound to induce nitric oxide (NO) production via 
NOS and increase endothelial cell Ca2+ concentration contributes to vasodilation and 
reduced blood pressure (Chen et al., 2009). Studies utilizing these mechanisms have also 
been carried out; for example soy protein isolate and hydrolysates have been shown to 
increase NO release in human aortic endothelial cells (HaoEC) (Ringseis et al., 2005). 
 
1.3.4.3. Cardiovascular disease 
Cardiovascular diseases (CVD) are the primary cause of death globally, representing 30 % 
of all global deaths in 2008 (World Health Organisation, 2011). Cardiovascular diseases 
are diseases of the heart and blood vessels and include coronary heart disease, 
cerebrovascular disease and peripheral arterial disease (World Health Organisation, 2011). 
An unhealthy diet and physical inactivity are among the two main risk factors for CVD, 
resulting in raised blood pressure, blood lipids and blood glucose, overweight and obesity, 
which are classed as intermediate risk factors for CVD (American Heart Association, 
2009). The consumption of vegetable protein has been associated with a lower risk of 
coronary heart disease, in comparison to consumption of animal protein (Clifton, 2011; 
Terpstra et al., 1983; Hilleboe, 1957). This observed effect may be attributed to decreases 
in serum cholesterol levels (Manson et al., 1992). For more than 100 years, animal studies 
have shown the cholesterol lowering effect of soy protein compared with animal protein 
(Ignatowsky, 1908). Reduced intestinal cholesterol absorption and increased faecal bile 
acid excretion, reduced levels of hepatic lipogenic enzymes such as glucose-6-phosphate 
dehydrogenase (G6PDH) and stimulation of adinopectin (a cytokine involved in adipocyte 
differentiation) and insulin sensitivity are all possible mechanisms for the lipid lowering 
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effect of soy protein (Velasquez & Bhathena, 2007). A meta-analysis of 38 studies 
indicated that soy protein consumption significantly decreased serum cholesterol, low 
density lipoprotein (LDL) cholesterol and triglyceride concentrations; there was also an 
increasing trend in high density lipoprotein (HDL) cholesterol concentrations (Anderson et 
al., 1995). An animal study carried out on genetically obese mice and dietary obese rats 
measured the effect of soy protein isolate and hydrolysate and on the rate of body fat 
disappearance. Feeding with either soy isolate or hydrolysate resulted in a significantly 
reduced body-fat content and plasma glucose levels in comparison with control, casein fed 
rodents. A decrease in the plasma total cholesterol level was also observed (Aoyama et al., 
2000). Soy hydrolysates have also demonstrated effects such as decreased cholesterol 
absorption both in vitro and in rats (Nagaoka et al., 1999), anti-adipogenic in vitro (Tsou et 
al., 2010), reduced fat mass and serum lipid in rats (Park et al., 2010). Sunflower 
hydrolysates produced using alcalase or pepsin inhibited the incorporation of cholesterol 
into bile salts micellar suspensions (Megias et al., 2009b). As mentioned previously, in 
vitro digestion did not decrease ACE inhibitory bioactivity of soy protein hydrolysates. It 
has also been shown that digestion of sunflower protein hydrolysates with simulated 
intestinal fluids produces new peptides that inhibit cholesterol incorporation into micellar 
suspensions (Megias et al., 2009). Protein hydrolysates from crop processing co-products 
have been less extensively studied, but rice bran hydrolysates have demonstrated 
hypocholesterolemic activity, by reducing total cholesterol and increasing HDL cholesterol 
in male Wistar rats (Revilla et al., 2009). 
 
1.3.4.4. Exercise and performance enhancement  
Muscle glycogen is an important fuel during periods of prolonged exercise and a 
relationship between increasing exercise intensity and a reliance on muscle glycogen is 
evident. Fatigue has been directly related to depleting glycogen stores (Bergstrőm & 
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Hultman, 1966, 1967; Bergstrőm et al., 1967). Hence, the post-exercise glycogen synthesis 
rate is essential in determining the time required for recovery. It has been shown that 
carbohydrate and wheat protein hydrolysate combined with an amino acid mixture (0.8 
g/kg/hr and 0.4 g/kg/hr, respectively), administered to cyclists for a five hour period post-
exercise, increases glycogen synthesis rates compared to administration of carbohydrate 
alone (van Loon et al., 2000). Similarly, peak creatine kinase (CK) levels, as a result of 
initial muscle injury, were suppressed by wheat gluten hydrolysate in a dose-dependent 
manner in vivo (Koikawa et al., 2009). Soy protein isolate is beneficial in muscle protein 
synthesis (MPS) following exercise. Consumption of the soy protein isolate was more 
effective than casein isolate but less effective than whey hydrolysate at increasing MPS 
both at rest and following resistance exercise (Tang et al., 2009b). Calbet and MacLean 
(2002) suggested that carbohydrate and protein hydrolysates stimulate a synergistic insulin 
response, regardless of protein source. It was also found that the glucagon response 
depends on the increase in plasma amino acid composition, following protein solution 
ingestions and that pea and whey protein hydrolysates increased insulin to a greater extent 
and increased plasma amino acids more rapidly than cow’s milk solution. It has been 
suggested that hydrolysates, particularly containing di- and tri-peptides, are absorbed more 
rapidly than either intact proteins or free form amino acids (Di Pasquale, 1997) which 
would support the use of protein hydrolysates for post-exercise recovery drinks as this 
would result in a greater increase in plasma amino acid concentration compared with the 
intact protein, over a two hour period (van Loon et al., 2000b). The concentration of amino 
acids present in the blood regulates protein synthesis (Bohè et al., 2003).  
 
1.3.4.5. Other clinical applications  
Protein hydrolysates represent an alternative to intact proteins and elemental (amino-acid 
based) formulas for the treatment of patients with various conditions. Phenylketonuria is a 
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disorder of amino acid metabolism, specifically, absence or deficiency of phenylalanine 
hydroxylase for the conversion of phenylalanine to tyrosine. The lack of this enzyme 
results in phenylpyruvic acid accumulation in the blood which has intellectual and 
neurological implications if left untreated. Protein hydrolysates free of phenylalanine have 
been used for the treatment of phenylketonuric infants, with positive results on physical 
growth and mental development (Acosta et al., 1998; Berry et al., 1976). Hydrolysates 
suitable for the treatment of phenylketonuria have been prepared from animal proteins 
including casein (Bickel et al., 1954) and whey (Delvivo et al., 2006). Plant protein 
hydrolysates low in phenylalanine have been studied to a lesser extent, however the 
potential of a low-phenylalanine soybean hydrolysate for dietetic purposes has been 
investigated (Yamashita et al., 1976). In patients with chronic liver disease, complex 
alterations in the metabolism of proteins occurs and nutritional support is essential in the 
pathogenesis and treatment of this disease (Clemente, 2000). Patients with chronic liver 
failure have high plasma levels of aromatic amino acids (AAA) and methionine and low 
levels of branched-chain amino acids (BCAA) (Schenker & Beer, 1989; Morgan et al., 
1982). While casein hydrolysates are commonly used for nutritional applications in 
patients with chronic liver disease, a protein source with a higher level of BCAA is more 
desirable. Sunflower globulins have been suggested as excellent protein sources for the 
development of protein hydrolysates with high levels of BCAA (Bautista et al., 1996). 
Sunflower protein hydrolysate is recommended for enteral, parenteral and oral nutrition of 
liver disease patients, being hypoallergenic, having low bitterness and providing a high 
Fischer ratio (BCAA:AAA) of approximately 75 (Bautista et al., 2000).  
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1.3.5. Techno-functional properties of protein hydrolysates 
1.3.5.1.  Solubility 
Solubility is the most important and generally the first techno-functional property 
examined during the development of new protein ingredients (Zayas, 1997) due to its 
considerable effect on other techno-functional properties (Vojdani, 1996; Kinsella & 
Melachouris, 1976). It has been proposed that reduction of the secondary structure of a 
protein and the enzymatic release of smaller polypeptide units are responsible for the 
increased solubility of hydrolysates compared to the original intact protein (Chobert et al., 
1988; Adler-Nissen, 1986). The solubility of a number of protein hydrolysates from 
agricultural crops has been studied. Barley protein hydrolysates showed highest solubility 
at strongly basic (pH 10 - pH 12) conditions (Yalcin & Celik, 2007). Similarly, Claver et 
al. (2005) found that the solubility of wheat protein hydrolysates was strongly influenced 
by pH, with lowest and highest solubility at pH 4 and 6, respectively. The use of rapeseed 
and other oilseed protein isolates is restricted due to their low solubility, which is a result 
of protein denaturation during industrial oil extraction (Vioque et al., 2000). To improve 
solubility and functionality, protein isolates from oilseeds can be hydrolysed. It has been 
found that rapeseed hydrolysates exhibit > 90 % solubility at pH 5 - 9 (Yoshie-Stark et al., 
2008). Soy protein hydrolysates were found to be almost completely soluble (> 99 %) in 
the range of pH 2 – 9, whereas the intact protein had highest solubility at pH 9 (Chiang et 
al., 1999). Tsumara et al. (2005) also demonstrated that the solubility of soy protein 
hydrolysates was pH-dependent. The production of hydrolysates that are soluble at acidic 
pH is essential for the supplementation of fruit juices and acidic drinks (Clemente, 2000; 
Mahmoud, 1994). In contrast to soy protein hydrolysates, okara protein isolates showed 
highest solubility at pH 12, with acid modified isolates enhancing solubility, thus 
increasing potential applications of okara protein as a food ingredient (Chan & Ma, 1999). 
Chan and Ma (1999) suggested that the low solubility of okara (a by-product of soymilk 
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manufacture) hydrolysates compared to soy hydrolysates is due to protein denaturation 
caused by severe heat treatments during soymilk manufacture.  
 
1.3.5.2. Emulsifying properties 
The ability of proteins to interact with lipids and form stable emulsions is essential to yield 
a stable food product. Rapeseed protein hydrolysates have higher emulsifying activity (at 
least 20 % greater) and stability than rapeseed protein isolates (Vioque et al., 2000). 
Enzymatic hydrolysates of soy protein resulted in an increased emulsification activity 
(Barca et al., 2000). Studies examining protein hydrolysates from different crop sources 
suggest that the emulsifying capacity of the hydrolysates is related to the degree of 
hydrolysis, with a low degree of hydrolysis (3 - 5%) increasing and a high degree of 
hydrolysis (~ 8 %) decreasing emulsifying capacity (Kong et al., 2007; Vioque et al., 2000; 
Achouri et al., 1999). Ultrafiltered rapeseed protein hydrolysate was demonstrated to have 
greater emulsification stability compared to that of whole egg (Yoshie-Stark et al., 2008) 
and wheat germ protein hydrolysates had higher emulsification capacity, activity and 
stability than bovine casein (Claver & Zhou, 2005). It is generally accepted that limited 
hydrolysis improves the emulsification properties of proteins by exposing hydrophobic 
amino acid residues (which may interact with oil), while the hydrophilic residues interact 
with water (Vioque et al., 2000). Similarly, an increase in hydrophilicity as a result of acid 
modification has been shown to increase the emulsification activity index (EAI) of okara 
protein isolates (Chan & Ma, 1999). 
 
1.3.5.3. Foaming 
Foaming is of special interest in the food industry as it provides a desirable and unique 
texture to a range of aerated foods and beverages including ice-cream, bread, cakes, 
meringues, champagne and beer. It is essential that food foams are stable for consumer 
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acceptability, since consumer perception of quality is influenced by appearance. Wheat 
germ has been shown to have poor foaming properties (German et al., 1985). However 
enzymatic treatment of wheat germ increases foam volume/height but decreases foam 
stability. The trend of increased foam volume being coupled with decreased foam stability 
has been reported in previous studies on rice bran protein hydrolysate and acid 
modification of okara protein hydrolysate (Zhang et al., 2012; Chan & Ma, 1999). The 
absence of large protein components, which function to stabilise the foam, may contribute 
to the observed lack of foam stability (Claver & Zhou, 2005). In a similar study of wheat 
germ hydrolysates it was found that foaming capacity was increased at a degree of 
hydrolysis (DH) of 5 %, resulting in a 74 % increase in foam volume compared to the 
control. The foam was also most stable at DH of 5 %, with 40 % of foam volume sustained 
after 60 min. There was an inverse relationship between DH and foam stability, with 
stability in the order of DH 5 % > DH 10 % > DH 15 %. Similar to suggestions by Claver 
& Zhou (2005), the stability of the foams was attributed to the presence of larger 
component proteins and a partial hydrolysis, whereas a higher DH increases the number of 
polypeptide chains which do not have the ability to stabilise foams (Kong et al., 2007). The 
study of both soy (Tsumara et al., 2005) and rapeseed (Vioque et al., 2000) protein 
hydrolysates produced comparable results. Regarding the effect of pH on foaming, barley 
hydrolysates had greater foam stability at basic pH values and very low stability at acidic 
pH (Yalcin et al., 2008). 
 
1.3.5.4. Gelation 
The ability to manipulate the gel formation properties of a substance is important since 
gelation is desirable for the bakery and meat industries, but not for foods such as beverages 
and frozen deserts (Harper et al., 1992). As a food ingredient, gelation is one of the most 
important techno-functional properties of soy protein, however soy protein hydrolysates 
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possess poor gel-forming ability (Babiker, 2000). Transglutaminase (TGase) is a 
polymeriser shown to be effective in improving gelling of proteins (Sakamoto et al., 2006), 
which improved the gelling ability of soy protein hydrolysates (Fan et al., 2005; Babiker, 
2000) but the gels formed were inferior to the starting soy protein/isolate in terms of gel 
strength. It has been suggested that the reduced ability to form gels may be due to lower 
surface hydrophobicity and short peptide chain length of the hydrolysates (Fan et al., 
2005). Research has been carried out with a focus on manipulating conditions to give 
desired gelation properties. For example, it has been shown that sodium chloride (NaCl) 
concentrations greater than 0.2 M can accelerate gelation by sunflower protein hydrolysates 
but result in a gel of lower strength (Sanchez & Burgos, 1997). Addition of a 
polysaccharide such as guar gum can enhance the gel strength of canola protein isolates 
(Lèger & Arntfield, 1993) and protein concentration and pH have been identified as 
important factors influencing gel formation by canola protein isolate coupled with guar 
gum (Uruakpa & Arntfield, 2005). Hence, while the gel forming ability of protein 
hydrolysates from agricultural crops is not as strong as that from proteins, processes are 
available to improve gelation where necessary.  
 
1.3.6. Safety of protein hydrolysates 
The use of dietary proteins and protein hydrolysates in food products is generally allowed 
in European countries and has the status of ‘generally regarded as safe’ (GRAS) in the 
United States of America (US Food and Drug Administration, online article). In Europe, 
novel foods are defined as foods and food ingredients that have not been used for human 
consumption to a significant degree within the European Community before 15 May 1997 
(Commission of the European Communities, online article). Safety evaluation by external 
independent experts and approval by competent authorities is necessary before a novel 
product is allowed on the market. Schaafsma (2009) proposed a decision tree that should be 
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used for determining the proposed safety assessment of protein hydrolysates and fractions 
thereof. Factors for consideration in deciding if a protein hydrolysate should follow 
procedure for novel foods include documented history of safe use, acceptable food grade 
hydrolysis process and the effect of intake on amino acid levels (Schaafsma, 2009). 
Hydrolysed proteins have a long history of safe use, but it is important to note that the 
majority of studies in this area look at animal-derived protein hydrolysates in infant feeding 
practices (Szajewska et al., 2001; Decsi et al., 1996; Halken et al., 1993). Some evidence 
has been produced regarding the sub-chronic toxicity of plant protein hydrolysates. 
Consumption of potato protein isolates is “well tolerated and without adverse effect” in 
Wistar rats, with parameters including body weight, body weight gain, mortality and organ 
weight remaining unchanged (Lynch et al., 2012). Protein isolates from canola have also 
been reported to be safe, following a 13 week consumption trial in rats, being practically 
devoid of natural toxicants and environmental contaminants. The canola protein isolates 
had no effect on body weight, food consumption, clinical observations, motor activity or 
ophthalmic examinations (Mejia et al., 2009). One particular consideration for the safety of 
protein hydrolysates and bioactive peptides is allergenicity. Most allergenic substances are 
protein-based compounds (Sarmadi & Ismail, 2010), and while hydrolysis breaks down 
proteins into low molecular weight peptides thus lessening the allergenic properties (Moure 
et al., 2005), some hydrolysates may retain their parent protein allergenic effects 
(Hartmann et al., 2007). Therefore, there is a need to further investigate the safety of plant-
derived protein hydrolysates and bioactive peptides.  
 
1.3.7. Conclusion 
Protein hydrolysates derived from agricultural crops have exhibited antioxidant and ACE 
inhibitory potential in vitro, with low molecular weight fractions demonstrating greatest 
effects. There is substantial evidence which supports the ability of soy protein hydrolysates 
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to reduce CVD risk however hydrolysates obtained from other plant sources require further 
investigation. Protein hydrolysates show greater potential than intact protein to increase 
muscle glycogen and muscle protein synthesis and have also demonstrated potential in the 
treatment of clinical conditions, particularly sunflower hydrolysates which may be used in 
cases of chronic liver disease. In terms of techno-functional properties, hydrolysates with a 
low DH have desirable effects on emulsification, foaming and solubility properties. To 
conclude, protein hydrolysates from agricultural crops have demonstrated favourable 
bioactive and techno-functional properties that could be exploited for the development of 
functional foods. For neutraceutical development, clinical trials are necessary to confirm 
biological activity and safety, in addition to addressing issues such as stability during food 
processing, organoleptic issues and identifying the fate of plant-derived hydrolysates 
during passage through the gastrointestinal tract. Furthermore, protein hydrolysates from 
co-products of the plant processing industry should be investigated for their potential 
bioactive and techno-functional properties. 
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1.4. Bioaccessibility of Functional Ingredients 
In press: Current Nutrition and Food Science 
 
1.4.1. Abstract 
Bioaccessibility is defined as the amount of a food constituent transferred to the micelle 
fraction after digestion in the gut, when compared with the original amount of the 
constituent present in the food. Bioaccessible constituents may be able to pass through the 
intestinal barrier and hence become bioavailable within the body. Bioaccessibility is 
commonly determined by in vitro methods simulating the human digestion and is 
assumed to be a good starting point for estimating potential bioavailability of a food 
constituent. The study of bioaccessibility of functional ingredients is necessary in addition 
to studies on their potential beneficial nutritional effects. This review discusses the 
benefits and limitations of methods used to assess bioaccessibility, in addition to factors 
affecting bioaccessiblity, both dietary and physiological. Evidence regarding the 
bioaccessibility of specific functional ingredients, including carotenoids and flavonoids is 
especially highlighted. Potential approaches to enhance bioaccessibility of functional 
ingredients are also discussed. 
 
1.4.2. Introduction 
The amount of a food constituent that is available for absorption, following its release 
from the food matrix into the gastrointestinal (GI) tract, is termed bioaccessibility. 
Therefore, only food constituents that are released from the food matrix by digestive 
enzymes or bacterial microflora are bioaccessible. Bioavailability is linked to 
bioaccessibility, but refers to the fraction of a food constituent that is absorbed and 
available in the bloodstream for utilisation in the body.  
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Functional ingredients are becoming increasingly important in the food industry, 
in response to consumer demand for foods with added benefits to improve health, 
wellness and quality of life (Bleil, 2010). Increased life expectancy, high healthcare costs, 
advances in food science and technology and heightened awareness of health and nutrition 
among the general public are among the reasons why consumers are looking to the food 
industry for healthier versions of their favourite foods. Functional foods, nutraceuticals, 
designer foods and pharma-foods are all synonyms for foods that provide additional 
physiological benefits beyond their basic nutrition (Day et al., 2009). The global 
neutraceutical market is rapidly expanding and set to be worth €23.8 billion in 2015, 
according to market analyst Freedonia (online article).  
Plant extracts represent a unique source of bioactive ingredients, with the ability to 
promote human health benefits, however these effects are dependent on the efficient 
digestion and absorption of functional ingredients. The design of foods to encapsulate, 
protect and release bioactive components at specific locations is an area of increasing 
interest, with accurate methodology to assess bioaccessibility playing a crucial role in the 
development of such foods (Hur et al., 2011) 
Simulation of human digestion in vitro is commonly used as a tool to measure 
bioaccessiblity, in fact in vitro digestion systems model the human stomach and small 
intestine, accounting for parameters such as pH, churning and enzymatic conditions. To 
allow for the complexity of the physiological process in the upper digestive tract more 
advanced models have been developed, that can account for other events such as gastric 
emptying and continuous changes in pH and secretion flow rates (Guerra et al., 2012).   
Assessment of the bioaccessibility of functional ingredients is critical in 
determining potential bioavailability and is essential in the design of foods claiming a 
health benefit due to the presence of bioactive ingredients. In studies where the 
bioaccessibility of functional ingredients is not measured, the significance of the results 
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for health is limited. This review aims to evaluate the methods used to assess 
bioaccessibility and factors that can affect bioaccessibility of functional food ingredients. 
A particular emphasis will be placed on specific functional ingredients such as 
carotenoids, flavonoids and hydroxycinnamic acids. Furthermore, possible means by 
which to enhance bioaccessibility will be detailed.  
 
1.4.3. Bioaccessibility screening methods 
The human digestive system is complex and compromises many processes occurring at 
different stages throughout the gastrointestinal tract, as shown in Figure 1. Briefly, 
mastication and enzymatic degradation (with salivary enzymes amylase, lingual lipase) 
occur in the mouth, producing a food bolus which is transported to the stomach by 
peristalsis (Guerra et al., 2012). In the stomach, the food bolus is exposed to gastric juice 
comprising pepsin, gastric lipase and hydrochloric acid (HCl) and mechanically degraded 
by grinding and mixing. Chyme (small particles) is emptied into the duodenum section of 
the small intestine where it is neutralised with sodium bicarbonate (NaHCO3).  Enzymatic 
(bile and pancreatic enzymes (proteases, lipases, amylases)) and mechanical digestion 
(mixing) act to breakdown food constituents. Peristaltic waves then drive the movement 
of the digesta through the small intestine (Trendelenburg, 2006). Non-absorbed material 
reaches the large intestine, where water and electrolyte absorption occurs, bile salts are 
reabsorbed, faeces are formed, stored and eliminated and polysaccharides and proteins are 
fermented by colonic microbiota (Guerra et al., 2012). 
 
1.4.3.1 In vivo digestion methods   
Measurements in vivo actually determine the amount of a food/nutrient that is absorbed, 
i.e. bioavailability. In vivo approaches are considered the “gold standard” of 
bioavailability assessment, but disadvantages of such approaches include the expense and 
  
- 67 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The main digestive processes in the human gastrointestinal tract. 
 
 
 
 
 
Mouth 
 Mastication 
 Mixing with saliva 
Stomach 
 Mechanical processing (churning, mixing, grinding) 
 Enzymatic processing (pepsin, HCl, lipase) 
Small intestine 
 Chyme from stomach neutralised with NaHCO3 
 Breakdown of food constituents (by proteases, amylases, lipases) 
 Bile aids lipid digestion 
 Mechanical digestion (mixing with digestive enzymes and peristalsis) 
Large intestine 
 Reabsorption of water, electrolytes and bile salts 
 Microbial fermentation of polysaccharides and proteins 
 Formation, storage and elimination of faeces 
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limited throughput (Table 1).  
Digestion in vivo has been carried out for a number of compounds that have 
potential applications as functional food ingredients, including carotenoids and 
tocopherols (Granado et al., 2006), lutein (Granado-Lorencio et al., 2010), naringenin and 
chlorogenic acid (Bugianesi et al., 2004). 
Common in vivo methods to determine the amount of nutrients and bioactive 
compounds absorbed include balance studies and tissue concentration measurements. 
Balance studies measure the absorbed amount of a nutrient or bioactive compound by 
measuring the difference between the consumed and excreted amounts (Fernandez-Garcia 
et al., 2009). Tissue concentration measurements are more frequently used; this method 
involves measuring the change in plasma/serum concentration of the nutrient or bioactive 
compound (Fernandez-Garcia et al., 2009). In vivo bioavailability of a number of 
bioactive ingredients including carotenoids and tocopherols (Granado et al., 2006), lutein 
(Granado-Lorencio et al., 2010) and grape seed procyanidin extract (Serra et al., 2010) 
has been determined by tissue concentration measurements. 
 
1.4.3.2. In vitro gastrointestinal digestion methods 
Various in vitro digestion models have been developed, as a faster, lower-cost alternative 
to in vivo methods (Table 1). While measuring bioaccessibility by in vitro methods has a 
number of advantages, there are also limitations to this approach, which are mainly 
related to the inability to exactly mimic the in vivo digestion process, as highlighted in 
Table 1. In vitro digestion models can be either static or dynamic. Static models do not 
account for the physical processes that occur in vivo, such as mixing, peristalsis and 
changes in conditions over time (Fernandez-Garcia et al., 2009). Contrastingly, dynamic 
models mimic these physical processes and allow for factors including gastric emptying, 
continuous changes in pH and secretion flow rates (Guerra et al., 2012). Static in vitro  
  
Table 1: Benefits and limitations of in vivo and in vitro methods for bioavailability and bioaccessibility measurement.  
 In vivo In vitro 
Benefits  “Gold standard” of assessment (Failla et al., 2008) 
 Allows selection of subjects from target population of 
intended use (Fernandez-Garcia et al., 2009) 
 Provide direct data on bioavailability (Guerra et al., 2012) 
 
 High-throughput (Fernandez-Garcia et al., 2009) 
 Provides information about each digestion step (Fernandez-Garcia et al., 
2009)  
 Lower cost (Fernandez-Garcia et al., 2009) 
 Standard method technically simple (Failla et al., 2008) 
 
Limitations  Lower throughput (Fernandez-Garcia et al., 2009) 
 Ethical considerations (Fernandez-Garcia et al., 2009)   
 Expensive (Fernandez-Garcia et al., 2009) 
 Complex physiology of intestine not fully reproduced (Fernandez-Garcia 
et al., 2009)  
 Do not account for feedback mechanisms, resident microbiota, immune 
system, hormonal controls  (Guerra et al., 2012) 
 Large intestinal phase generally not included (Failla et al., 2008) 
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digestion models (also known as biochemical models) are the most common and usually 
mimic both gastric and intestinal digestion through the use of pepsin and pancreatin and 
bile salts, respectively. Temperature (37 oC), shaking and the chemical and enzymatic 
composition of saliva, gastric juice and bile juice are the key features of the 
gastrointestinal (GI) in vitro digestion model. Investigators may chose to use a two 
(gastric and duodenal) or three (oral, gastric, duodenal) phase digestion system, depending 
on the purpose of the study. For solid foods, oral processing is difficult to simulate and 
methods used include a “chew and spit” process where possible or homogenisation 
(Wickham et al., 2009). For liquid foods, this phase is not necessary, but salivary amylase 
may be added (Wickham et al., 2009). Digestion in the stomach and small intestine is far 
from complete, particularly the digestion of plant foods because plant cell walls are not 
degraded in the upper GI tract. Within static models there can be considerable variations 
in experimental conditions; differences in pH used for gastric and duodenal phases, 
addition of specific enzymes including α-amylase and lipase to digest foods with a high 
starch or fat content, respectively, and addition of antioxidants to limit oxidation (van 
Buggenhout et al., 2010).  At present, no standardised in vitro digestion model exists and 
variations in approaches to in vitro models have been detailed elsewhere (Hur et al., 
2011). Since the luminal (external) environment influences the rate, extent and site where 
a nutrient becomes available for digestion, dynamic models incorporating physical 
conditions and changes in luminal conditions over time have been developed. A dynamic 
GI model was developed by TNO Nutrition and Food Research (The Netherlands), which 
closely mimics the complex in vivo digestion process. On the basis of studies on human 
volunteers, parameters such as pH, temperature, peristaltic mixing and transit, biliary and 
pancreatic secretions are replicated. The TNO system can also account for different life 
stages, different food intakes and physiological and pathological conditions (Blanquet et 
al., 2004), however the high cost associated with this system limits its use. A number of 
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studies have employed this dynamic GI model to determine the bioaccessibility of various 
compounds including xanthophylls and hydroxycinnamic acids (Blanquet-Diot et al., 
2009; Hemery et al., 2010). A study on determining xanthophyll and carotenoid 
bioaccessibility highlighted that the TNO system allowed the identification of parameters 
influencing bioavailability including food matrix, nature, isomeric conformation and the 
digestive compartment (Blanquet-Diot et al., 2009). Hemery et al. (2010) investigated the 
bioaccessibility of hydroxycinnamic acids in breads produced with bran and found that 
the dynamic TNO model provided results comparable with a previous in vivo study 
(Hemery et al., 2010; Kern et al., 2003). Contrastingly, bioaccessibility results obtained 
from studies using static and TNO models have been found to differ. For example, β-
carotene and lycopene from tomato were found to be more bioaccessible using the TNO 
model compared to results of a study using static conditions, suggested to be attributable 
to the degradation of carotenoids in the gastric phase of the static digestion model 
(Blanquet-Diot et al., 2009; Granado-Lorencio et al., 2007). Similarly, discrepancies in 
bioaccessibility of food contaminants, including lead and mercury, measured by static and 
dynamic digestion models have been reported (Torres-Escribano et al., 2011).   
The coupling of in vitro digestion models with experiments in intestinal caco-2 
cells in culture allows host responses to be accurately replicated. Caco-2 cells are a human 
intestinal cell line, which mimic intestinal absorptive epithelium when grown in a 
monolayer and represent the best available cell culture model of absorptive small 
intestinal enterocytes (Feruzza et al., 2012).  Combining the TNO dynamic in vitro 
digestion model with a caco-2 cell model has been shown to produce results consistent 
with in vivo findings on the bioavailability of lycopene and α-tocopherol (Deat et al., 
2009). 
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1.4.3.3. Comparison of in vivo and in vitro digestion methods  
Comparing in vivo and in vitro approaches to measuring bioaccessibility has been studied, 
as detailed in Table 2 (Granado et al., 2006; Granado-Lorencio et al., 2010). A study of 
bioaccessibility of carotenoids and tocopherols from broccoli highlighted that in vivo and 
in vitro approaches can give conflicting results (Granado et al., 2006). High performance 
liquid chromatography (HPLC) of digestates formed by in vitro gastrointestinal digestion 
found that lutein and β-carotene have similar stability, whereas in vivo tissue 
concentration measurements showed that lutein levels significantly increased following 
digestion but β-carotene levels did not (Granado et al., 2006). A similar study of lutein 
ester-fortified fermented milk yielded consistent results in both approaches and the 
importance of in vitro bioaccessibility results as predictors of in vivo bioavailablility was 
noted (Granado-Lorencio et al., 2010). It is essential that both approaches should be 
considered complementary, not inter-changeable, as in vitro methods do not account for 
host-related factors such as biological actions in the body (Granado et al., 2006). 
   
1.4.4. Factors affecting bioaccessibility of functional ingredients 
There are a large number of factors than influence the bioaccessibility/bioavailability of 
functional ingredients, either directly or indirectly (by altering the content of the bioactive 
ingredient). These include dietary, physiological and processing factors, as detailed in 
Table 3.  
 
1.4.4.1. Dietary factors 
Disrupting the food matrix and releasing the constituents is the first step of absorption and 
the influence of food matrix on the bioaccessibility of food components has been well 
documented. It has been reported that β-carotene is less bioavailable from vegetables than 
from a simpler matrix (van het Hof et al., 2000). In addition, lutein and β-carotene are less 
  
 
Table 2: In vivo and in vitro studies measuring the bioaccessibility of potential functional ingredients.  
Study Type Ingredient Aim Study Design Comments Reference 
In vivo & in vitro  Carotenoids  and 
tocopherols from 
broccoli 
To determine bioavailability 
of carotenoids and 
tocopherols from broccoli and 
compare in vivo and in vitro 
approaches 
• In vivo: 7-day intervention trial in healthy 
volunteers. 200 g/day broccoli consumed, blood 
samples taken 
• In vitro : Static gastrointestinal digestion of 
broccoli 
• Followed by HPLC analysis of either blood 
samples or digestates 
• Results showed that in vivo and 
in vitro approaches are  
complementary, not inter-
changeable 
 
Granado et 
al., 2006 
In vivo & in vitro  Lutein To assess bioavailability of 
lutein from lutein ester-
fortified fermented milk 
• In vivo: Healthy volunteers consumed lutein ester-
fortified fermented milk, total dose equalling 8 or 
16 mg lutein (single-dose study) or 60 and 120 mg 
lutein (multiple-dose study). Fasting blood samples 
collected 
• In vitro : Static gastrointestinal digestion of lutein 
ester-fortified fermented milk 
• Followed by HPLC analysis of either blood 
samples or digestates 
• In vitro models useful to predict 
in vivo responses 
Granado-
Lorencio et 
al., 2010 
In vitro Carotenes and 
xanthophylls 
To determine the digestive 
stability of carotenes and 
xanthophylls found in 
tomatoes 
• In vitro: dynamic TNO gastrointestinal tract model 
(TIM) used to digest test meals 
• HPLC analysis of digestates from each digestive 
compartment 
• Use of a dynamic in vitro model 
allowed identification of 
parameters influencing 
bioavailability of carotenoids 
Blanquet-
Diot et al., 
2009 
In vitro Ferulic acid, 
sinapic acid, p-
coumaric acid 
Measurement of 
bioaccessibility of phenolic 
acids in breads made from 
processed bran 
• In vitro: dynamic TNO gastrointestinal tract model 
(TIM) used to digest breads 
• Results correlated well with a 
previous in vivo study 
 
Hemery et 
al., 2010 
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bioaccessible from green leafy vegetables than from other vegetables (van het Hot et al., 
1999). There is mixed evidence regarding the effect of different food matrices on in vivo 
bioavailability; genistein is more bioavailable from a liquid matrix, than a solid matrix 
whereas daidzein bioavailability is not influenced by food matrices including cookies, 
juice and chocolate bars (de Pascual-Teresa et al., 2006).  
In addition to food matrix, dietary components consumed with phenolic 
compounds can greatly affect their bioaccessiblity. It is consistently reported that the 
presence of lipid increases the bioaccessibility of potential functional food ingredients, 
including carotenoids (Hornero-Mendez et al., 2007) and isoflavones (Walsh et al., 2003). 
This is possibly attributable to the ability of foods containing lipids and proteins to 
increase plasma cholecystokinin (CCK) and induce the release of bile into the duodenum 
(Otsuki, 2002), thus increasing bioavailability. It has also been suggested that non-
competitive interactions, where soluble and insoluble complexes are formed, may account 
for this observed effect, with products of fat digestion solubilising fat soluble vitamins 
and carotenoids, thus enhancing absorption (Gibson, 2007). It is important to note that the 
presence of non-absorbable fat soluble compounds such as sucrose polyester (a fat 
replacer) can decrease plasma levels of bioactive compounds like carotenoids (Westrate & 
van het Hof, 1995; Schlagheck et al., 1997). The incorporation of carotenoids released 
from the food matrix into the sucrose polyester rather than the micelles from dietary fat is 
a possible explanation for this. In contrast to the presence of fat and protein, dietary fiber 
can reduce bioavailability of genistein (Tew et al., 1996). There is conflicting evidence 
regarding the relationship between fiber and daidzein bioavailability. Dietary fiber 
consumption has been shown to stimulate equol (daidzein metabolite) production (Lampe 
et al., 1998; Rowland et al., 1999). However, it has also been reported that equol 
producers have lower dietary fiber intake (Gardana et al., 2009). Binding of bile acids by 
lignin and pectin and the retention of water and formation of viscous solutions in the gut 
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by pectins, gums and psyllium both contribute to the reduced absorption of fat-soluble 
vitamins, carotenoids and nutrients (Gibson, 2007).  
 
1.4.4.2. Physiological factors 
Host-related factors that can influence the bioaccessibility of dietary components include 
intestinal (enzyme activity, colonic microflora) and systemic (gender, age, pathologies 
and disorders, genetics) factors (D’Archivio et al., 2010). Intestinal digestion and 
absorption of dietary components is largely influenced by atrophic gastritis and 
hypochlorhydria (decreased secretion of hydrochloric (HCl) acid). The resultant alteration 
in pH levels can impair absorption of vitamins and minerals, including iron, calcium, 
magnesium and vitamin C (Nolan et al., 2012). Bacterial overgrowth is also associated 
with atrophic gastritis and can alter the intestinal mucosal integrity, increasing intestinal 
permeability and reducing nutrient absorption (Gibson, 2007). Infection with salmonella, 
rotavirus, malaria and Giardia lamblia can reduce transit time, decreasing the time for 
extensive solubilisation in the gastrointestinal tract and compromising absorption 
(Gibson, 2007). This phenomenon has been demonstrated in women; following 
consumption of 1.2 mg total isoflavone/kg, a rapid gut transit time coupled with low fecal 
genistein disappearance was associated with greater genistein bioavailability, by urinary 
genistein excretion (Zheng et al., 2003). Furthermore, there was a genetic influence of this 
effect, which was observed in Asian but not Caucasian subjects and daidzein 
disappearance significantly differed between the two ethnic groups. The authors 
suggested this ethnic effect may be due to variation in gut microflora as a result of ethnic 
differences in diet e.g. red meat and soy food (Zheng et al., 2003). 
Potential functional ingredients such as isoflavones and γ-tocopherol are more 
bioavailable in women (Nielsen & Williamson, 2007; Granado et al., 2006). Higher 
urinary excretion of isoflavone conjugates in women was recorded in a long-term feeding 
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study, followed by an increase in urinary excretion of equol, which remained unchanged 
in men (Lu & Anderson, 1998). While serum lutein levels were increased in both male 
and female subjects following broccoli consumption (200 g) for 7 days, serum γ-
tocopherol levels were increased (by ~ 23 %) in women only (Granado et al., 2006). The 
response to xenobiotics, both dietary phytochemicals and drugs, can be influenced by 
genetic variations arising from polymorphisms of genes coding for phase 1 and phase 2 
metabolising enzymes (Holst & Williamson, 2004). Resulting increase or decrease in 
enzyme activity, or the absence of the enzyme, can lead to altered bioavailability (Holst & 
Williamson, 2004). Disease states can also influence bioavailability, particularly of 
minerals, either directly, by increasing or decreasing physiological requirements or 
indirectly, by altering intestinal function and metabolic pathways. Such diseases include 
chronic renal failure, diarrhoea and vomiting, Crohn’s disease, Wilson’s disease (Cu) and 
hyper- and hypo-parathyroidism (Ca) (Fairweather-Tait, 1996).  
   
1.4.4.3. Processing factors 
The most extensively studied processing factors influencing bioaccessibility and 
bioavailability are thermal processing, homogenisation, storage and freezing. These 
factors influence bioaccessibility indirectly, by altering the content of the dietary 
component.  
The effect of domestic cooking on in vivo bioavailability of tomato polyphenols 
was determined by Bugianesi et al. (2004). Plasma naringenin and chlorogenic acid levels 
were increased following consumption of cooked tomatoes. It was suggested that the 
increase in naringenin bioavailability was due to the ability of heat treatments to break 
down interactions between naringenin and insoluble polyesters (constituents of tomato 
fibre) in the ripe tomato fruit (Bugianesi et al., 2004). A more recent study by Mazzeo et 
al. (2011) showed that steaming (for minimum time to reach tenderness for adequate 
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palatability) of frozen vegetables increased bioaccessibility and limited carotenoid 
depletion, whereas boiling of frozen vegetables resulted in a general loss of carotenoids, 
phenolic compounds and total antioxidant capacity (Mazzeo et al., 2011). Severe boiling 
of tomatoes resulted in increased lycopene bioaccessibility, although this increase was 
non-significant (van het Hof et al., 2000b). In the same study, consumption of mildly and 
severely homogenised tomatoes significantly increased plasma lycopene levels by 0.03 
and 0.04 µmol/L, P < 0.05, compared to non-homogenised tomato samples (van het Hof 
et al., 2000b).  
Just as the duration and method of cooking influenced bioaccessibility outcomes, 
the effect of storage on the phenolic content or bioaccessibility of different foods depends 
on the storage conditions, as summarised in Table 3. Storage conditions of red raspberries 
simulating those found in the supermarket (4 oC, 3 days) and in the home (18 oC, 1 day) 
did not effect the anthocyanin content (Mullen et al., 2002). In the same study, it was 
found that freezing red raspberries increased the coumaric acid concentration. Similarly, 
storage of lutein fortified frankfurters for 22 days at 4 oC did not affect lutein content 
(Granado-Lorencio et al., 2010b). However, cold storage of apples increased catechin 
levels (Napolitano et al., 2004). Storage of sweet potato roots in a pit at temperature 17 – 
21 oC and relative humidity (RH) 90 – 100 % had higher β-carotene contents than roots 
stored at ambient conditions (24 - 27 oC, RH 68 – 100 %), with the study providing 
evidence that roots stored in lower temperatures retain β-carotene levels to a greater 
extent and maintains in vitro bioaccessibility (Tumuhimbise et al., 2010). 
In light of this evidence, it is clear that the influence of processing on 
bioaccessibility is complex, with varying results for different functional ingredients. 
Domestic cooking, and steaming rather than boiling to avoid leaching, homogenisation 
and storage at lower temperatures can increase the content and bioaccessibility of certain 
phenolic dietary components.  
  
 
Table 3: Factors influencing bioaccessibility of functional ingredients. 
Factors Functional 
ingredient 
Influence Reference 
Dietary    
Food matrix Carotenoids 
 
Soy isoflavones 
 
Lower bioavailability of β–carotene from vegetables than from a simpler matrix (e.g. 
salad dressing) 
Earlier peak in blood genistein concentrations from liquid matrix (versus solid 
matrix). Daidzein bioaccessibility unaffected by food matrix 
van het Hof et al., 2000 
 
de Pascual-Teresa et al., 2000 
Protein and lipids Isoflavones 
Carotenoids 
 
Carotenoids 
Increased bioavailability from foods containing protein and lipids, 
Unabsorbable fat-soluble compounds (e.g. sucrose polyester) reduced absorption 
 
Addition of cooking oil increased bioaccessibility 
Walsh et al., 2003 
Westrate & van het Hof, 1995; 
Schlagheck et al., 1997 
Hornero-Mendez et al., 2007 
Fibre 
 
Soy isoflavones Decreased bioavailability of daidzein by a fibre rich diet Tumuhimbise et al., 2010 
Physiological    
Gut transit time Isoflavones Bioavailability increased by rapid gut transit time and low faecal digestion rates Nielsen & Williamson, 2007 
Processing 
Thermal Processing 
 
Lycopene 
Naringenin & 
chlorgenic acid  
Polyphenols & 
carotenoids 
 
Severe heat treatment (boiling for 1 hr @ 100 oC) of tomatoes increased bioavailability 
Domestic cooking of tomatoes (15 min @ 100 oC) significantly increased naringenin 
and chlorogenic acid plasma levels 
Steaming increased bioaccessibility of polyphenols & limited depletion of 
caroteonoids. Boiling negatively influenced bioaccessibility of carotenoids and 
phenolic compounds 
 
van het Hof et al., 2000b 
Bugianesi et al., 2004 
 
Mazzeo et al., 2011 
Homogenisation Lycopene Increased bioavailability van het Hof et al., 2000b 
Storage 
 
 
 
 
 
Lutein 
β-carotene 
 
Anthocyanins 
Catechin 
Storage of lutein enriched frankfurters (22 days @ 4 oC) had no effect 
Storage of sweet potato roots in dark, ambient (24-27 oC, RH 68-100 %) conditions 
had lowest bioaccessibility 
Storage of red raspberries (3 days @ 4 oC and 24 h @ 18 oC) had no effect 
Storage (4 months @ 2 oC) increased catechin conc. in apples 
Granado-Lorencio et al., 2010 
Tumuhimbise et al., 2010 
 
Mullen et al., 2002 
Napolitano et al., 2004 
Freezing Coumaric acid Present at higher conc. in frozen fruit Mullen et al., 2002 
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1.4.5. Bioaccessibility of functional food ingredients 
1.4.5.1. Carotenoids 
Carotenoids perform many functions and actions in all living organisms including animals 
and microorganisms, despite being conventionally considered as plant pigments 
responsible for the yellow, orange and red colouration of flowers and fruit. Carotenoids 
are crucial for photosynthesis, but have also been associated with the prevention of human 
diseases including cancer (Britton, 1995). Over 600 carotenoids have been identified, 40 
of which are present in the human diet (Yonekura & Nagao, 2007). However, carotenoids 
cannot be produced by animals, therefore to play a role in human health, they must be 
consumed in the diet, and bioaccessibility is crucial. Only 14 carotenoids and some of 
their metabolites have been identified in blood and tissues, including carotenes (lycopene, 
β-carotene, α-carotene) and xanthophylls (lutein, β-cryptoxanthin, zeaxanthin) (Yonekura 
& Nagao, 2007). Sweet potatoes, tomatoes, bell peppers, carrots, spinach and kale are 
some of the commonly consumed sources of carotenoids. Absorption of carotenoids is 
initiated by disruption of the food matrix to release the carotenoids for incorporation into 
lipid droplets in the stomach. Bile salts, phospholipids, dietary lipids and their hydrolysis 
products produce mixed micelles where the carotenoids are transferred to, from the lipid 
droplets. This step is followed by absorption by the intestinal cells, packing into the 
chylomicrons and secretion to the lymphatic system (Yonekura & Nagao, 2007).  
Much evidence has been carried out investigating the bioaccessibility of 
carotenoids, which has been extensively reviewed elsewhere (Rodriguez-Amaya, 2010),  
and it is generally accepted that in vitro simulated gastric and small intestinal digestion 
coupled with experiments in differentiated caco-2 cells, as previously discussed, 
represents a valid model for the initial screening of the bioaccessibility of carotenoids 
(Rodriguez-Amaya, 2010). This model has been used to measure the carotenoid 
bioaccessibility of bell and chilli peppers and raw and cooked carrots (O’Sullivan et al., 
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2010; Aherne et al., 2010). A study by Goni et al. (2006) details the bioaccessibility of 
carotenoids from fruits and vegetables, through the use of a method incorporating both in 
vitro enzymatic digestion (small intestine bioaccessibility) and colonic fermentation (large 
intestine bioaccessibility) and states the large intestine may be a significant site of 
carotenoid absorption in the gut (Goni et al., 2006). Results found that 91 % of the lutein, 
lycopene and β-carotene found in fruits and vegetables are available in the gut following 
the entire digestion process (Aherne et al., 2010b). Factors affecting the bioaccessibility 
of functional ingredients have been described in the previous section. Briefly, it has been 
shown that the location of carotenoids in the food matrix, carotenoid interactions and 
geographical location of production of vegetables play a role (Aherne et al., 2010b; 
Aherne et al., 2009). Further to this, the factors influencing bioavailability and 
bioconversion of carotenoids have been summarised by the mnemonic “SLAMENGHI”; 
species of carotenoid, molecular linkage, amount of carotenoids consumed in a meal, 
matrix of the food, effectors of absorption and bioconversion, nutrient status of the host, 
genetic factors, host-related factors, mathematical interactions (West & Castenmiller, 
1998).  
It has been repeatedly reported that xanthophylls are more bioaccessible than β-
carotene, assessed by both static in vitro digestion models and the dynamic TNO model 
(Granado-Lorencio et al., 2010; Blanquet-Diot et al., 2009; Kean et al., 2008). Luminal 
stability of carotenoids may be affected by different levels of hydrophobicity influencing 
transfer from lipid droplets to the mixed micelles (Blanquet-Diot et al., 2009). Digestive 
stability and subsequent bioavailability may be explained by differences in localisation in 
the lipid droplets (Borel et al., 1996). It is important to note the methodology used in 
these studies do not incorporate in vitro colonic fermentation to assess large intestine 
bioaccessibility. This is crucial given the findings discussed previously where β-carotene 
was found to be released from the food matrix predominantly in the large intestine (Goni 
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et al., 2006). Thus, the choice of study design and methodology can have a major impact 
on the conclusions made regarding the bioaccessibility of carotenoids.  
 
1.4.5.2. Flavonoids and other secondary plant metabolites 
Secondary plant metabolites are produced from phenylalanine via the phenylpropanoid 
pathway, as shown in Figure 1, and comprise flavonoids, hydroxycinnamic acids, 
coumaroids and stilbenoids. 
There are over 4,000 identified flavonoids of different classes; flavanols, flavones, 
flavanones, isoflavones, catechins and anthocyanins. Flavonoids can be found widely 
dispersed in plant foods, particularly berries, broccoli and kale, and other commonly 
consumed products such as chocolate and green tea. Flavonoids, except flavan-3-ols, in 
plants are bound to sugars, existing as glycosides (Del Rio et al., 2010). The chemical 
structure of the sugar side chains to which the alycones are bound is one of the most 
important factors affecting bioavailability (Koli et al., 2010). During absorption, intestinal 
glycosidases rapidly hydrolyse flavonoid glycosides (Liu & Hu, 2002). This step is 
crucial in determining the intestinal fate of glycosides, as their uptake is limited by slow 
passive diffusion, poor uptake by the glucose transporter SGLT1 and the presence of an 
efflux carrier for glycosides (Liu & Hu, 2002). Contrastingly, flavonoid aglycones are 
rapidly absorbed (Liu & Hu, 2002) and conjugated by phase 2 enzymes, such as UDP-
glucuronyltransferase in the intestine (Crespy et al., 1999). This is followed by excretion 
in the urine or the bile. After biliary excretion, flavonoid conjugates are hydrolysed in the 
lower intestine by bacteria, resulting in flavonoid aglycones reabsorption and 
enterohepatic recirculation (Liu & Hu, 2002; Crespy et al., 1999). Recently, Liang et al. 
(2012) reported only 5 % recovery of the anthocyanin glucosides cyanidin-3-rutinoside 
and cyanidin-3-glucoside following in vitro digestion (Liang et al., 2012). This low 
bioaccessibility was postulated to be due to a few possible mechanisms – high instability 
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Figure 1: The phenylpropanoid pathway for the production of secondary plant metabolites including hydroxycinnamic acids and flavonoids. Enzymes are 
abbreviated as follows: PAL, phenylalanine lyase; C4H, cinnamate-4-hydroxylase; C3H, p-coumaroyl shikimate/quinate 3-hydroxylase; COMT, caffeic acid/5-
hydroxyferulic acid O-methyltransferase; F5H, ferulate-5-hydroxylase; 4CL, 4-coumarate CoA ligase; CHS, chalcone synthase; STS, stilbene synthase.  
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of the compounds in the mildly alkaline conditions of the small intestine and degradation 
of anthocyanins to smaller phenolic compounds, possibly hydroxybenzoic acids (Liang et 
al., 2012). The large change in pH from the acidic gastric environment to the mildly 
alkaline intestinal environment was also considered to be accountable for the 58.1 % loss 
in anthocyanins and overall 56 % loss of total polyphenols during the in vitro digestion of 
grapes (Tagliazucchi et al., 2010). In contrast to anthocyanins, there is a general 
consensus that isoflavones are readily absorbed and reach peak concentrations within a 
few hours of ingestion. Rodriguez-Roque et al. (2013) reported 36 % bioaccessibility of 
total isoflavones from soymilk, with glycosides being more bioaccessible (27 – 42 %) 
than aglycones (15 – 17 %) (Rodriguez-Roque et al., 2013). These values are relatively 
conservative, considering genistein bioaccessibility in the small intestine was found to 
range from 79.55 – 92.11 % depending on fat content in enriched custards (Sanz & 
Luyten, 2007); genistein bioaccessibility was only found to be 17 % by Rodriquez-Roque 
et al. (2013). The in vitro digestion methods used were very similar, however Sanz & 
Luyten (2007) used pH 2.5 and an incubation time of 60 min for gastric digestion, 
whereas Rodriguez-Roque et al. (2013) used a slightly lower pH of 2, with double the 
incubation period (120 min), which may have led to the discrepencies in findings between 
the studies. Further evidence for the high recovery and bioaccessibility of genistein is 
provided by Simmons et al. (2012). The authors formulated soy pretzels using raw soy 
ingredients that demonstrated 133.8 % recovery of genistein (Simmons et al., 2012). 
There is much evidence available detailing the bioaccessibility of flavonoids, with 
isoflavones being the most bioavailable and anthocyanins and flavon-3-ols poorly 
absorbed (Corcoran et al., 2012). Extensive biotransformation by methoxylation, 
glucuronidation and sulfation suggests that bioactivity of flavonoids may be due to these 
metabolites rather than the parent or free forms (Corcoran et al., 2012). Proanthocyanidins 
and other flavonoid polymers must be broken down, primarily in the colon, to monomeric 
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and dimeric units for absorption. Therefore, it has been suggested that in vitro methods to 
assess flavonoid bioaccessibility give limited information, unless they include colonic 
fermentation processes, as in the TNO model (Etcheverry et al., 2012). It has been 
reported that the fermentation of flavonoids from tea with human fecal bacteria results in 
the biotransformation of polyphenols and the production of metabolites that have 
significant bioactive effects (Lee et al., 2006). 
Hydroxycinnamic acids are hydroxy derivatives of cinnamic acid. The most 
common hydroxycinnamic acids are ferulic, coumaric and caffeic acids, present 
predominantly in cereal grains (ferulic, p-coumaric) and coffee (ferulic, caffeic), usually 
in the bound form. Cleavage, release and absorption of hydroxycinnamic acids may occur 
mainly in the small intestine (Kern et al., 2003). Bacterial enzymes in the large intestine 
can further release hydroxycinnamic acids (Lee et al., 2006), but the evidence regarding 
this step is inconclusive with some studies in rats (Adam et al., 2002) and humans (Kern 
et al., 2003) indicating little or no absorption in the large intestine, perhaps due to limited 
access of the digestive enzymes to the phenolic substrate (Adam et al., 2002). Esterified 
hydroxycinnamic acids found in food are metabolised extensively following ingestion. 
Conjugated hydroxycinnamic acids, glucuronidated and predominantly sulphated forms, 
are primarily found in plasma and urine, while free acids are present at low levels (Wong 
et al., 2010). Sulfotransferase 1A1 (SULT1A1) and UDP-glucuronosyltransferase 1A9 
(UDP1A9) are the most active enzymes for hydroxycinnamic acid sulphation and 
glucuronidation, respectively (Wong et al., 2010). Due to the polarity and water solubility 
of hydroxycinnamic acids, these phenolics are readily excreted in the urine and higher 
urinary excretion levels than plasma levels suggests these phenolics, and metabolites, do 
not accumulate in organs and tissues, and are rapidly filtered by the kidneys (Wang et al., 
2012).  
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Ferulic acid has shown low bioaccessibility (< 1 %) from wheat fractions 
(aleurone, bran, flour) and bread in vitro, which increased to ~ 60 % bioaccessibility 
following the addition of free ferulic acid to the flour (Mateo Anson et al., 2009). Using 
the TNO intestinal model, bioaccessibility of ferulic, sinapic and p-coumaric acids was 
measured in white, brown and bran breads. Only the free and conjugated 
hydroxycinnamic acids were bioaccessible. The amount of bioaccessible 
hydroxycinnamic acids was higher in whole-grain and bran bread than in white bread and 
bran dry-fractionation increased the amounts of bioaccessible phenolic acids. Ultra-fine 
grinding of the bran decreased particle size of the cell-wall fragments, increased particle 
surface area and interactions between GI fluids and free and conjugated phenolic acids in 
the cell walls (Hemery et al., 2010). It is generally accepted that the bound forms of 
hydroxycinnamic acids are poorly absorbed. However, these phenolic compounds 
undergo extensive modification during absorption (methylation, sulfation, 
glucuronidation), therefore the forms reaching the blood and tissues differ from those 
present in the food and it is challenging to measure the presence all the metabolites and 
their bioactivities (Pandey & Rizvi, 2009).  
 
1.4.6. Approaches to enhance bioaccessibility of functional ingredients  
The most studied approach to enhance the bioaccessibility of functional ingredients is the 
use of emulsions. Emulsion-based delivery systems, a type of colloidal delivery system, 
can improve the bioavailability of hydrophobic bioactive ingredients. Compounds are 
dissolved in carrier oil, which is emulsified with an aqueous emulsifier solution to form 
an oil-water emulsion and digestion of the carrier oil releases the bioactive compound 
(McClements & Xiao, 2012). A review by McClements (McClements, 2010) detailed the 
necessary characteristics of an edible delivery system to improve bioavailability of 
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lipophilic bioactive ingredients including conjugated linoleic acid (CLA), omega-3 fatty 
acids and carotenoids. These attributes are:  
1. High loading capacity and encapsulation and retention efficiencies 
2. Prevention of chemical degradation of chemically labile bioactive compounds e.g. 
oxidative degradation 
3. Compatability with food/beverage matrix it is to be incorporated into without 
affecting sensory or quality parameters 
4. Resistance to environmental stresses that the food or beverage is exposed to e.g. 
storage, thermal processing 
In addition, the delivery system should be prepared with ingredients generally regarded as 
safe (GRAS) in a facility practising good manufacturing practices (GMP) and the added 
benefit of encapsulating the bioactive lipophilic compounds should outweigh the 
associated costs (McClements, 2010). If multilayer emulsion coatings are used as a 
delivery system, it is imperative that they are broken down in the gastrointestinal tract to 
permit release of the bioactive ingredient and any potential health benefits of absorption 
to occur. Aditya et al. (2013) fabricated nanostructured lipid carriers (NLCs) as a 
potential aid to improve bioaccessibility of genistein and curcumin. These NLCs had 78 – 
79 % entrapment efficiency (EE) and 1.2 - 2 % neutraceutical loading for genistein and 
curcumin, respectively. Encapsulation of genistein and/or curcumin resulted in an 
increased solubility in simulated intestinal medium (SIM) from < 20 % to > 75 % and ≥ 
85 % stability in SIM and simulated gastric medium (SGM) for up to 6 hr. Coloading of 
genistein and curcumin increased loading efficiency and prostate cancer cell growth 
inhibition. Nanoemulsions have also been investigated for their potential to increase β-
carotene bioaccessibility, using medium-chain (MCT) and/or long-chain triglycerides 
(LCT) as the lipid carrier and a static in vitro digestion procedure. Use of either LCT or 
MCT nanoemulsions resulted in significantly higher β-carotene bioaccessibility, 
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compared to nanoemulsions containing LCT-MCT mixtures (Salvia-Trujillo et al., 2013). 
A similar study has been carried out for quercetin bioaccessibility (Pool et al., 2013). The 
small particle size may be responsible for the ability of nanoemulsions to increase 
bioaccessibility of functional ingredients due to increased solubility, greater surface area 
and entrapment in the mucous layer thus increasing retention time (McClements & Xiao, 
2012).  
Proteins play a role in the stabilisation of colloidal delivery systems; hydrolysis of 
these proteins affects their ability to alter droplet charge, droplet aggregation, lipid 
digestion and bioactive release (Pool et al., 2013). It has been shown that when lycopene 
is embedded into whey protein matrices, bioavailability is increased to levels of that for 
tomato paste (Richelle et al., 2002). Other studies also report the use of a protein-
stabilised lipid carrier to increase bioaccessibility of quercetin (Pool et al., 2013) and β-
carotene (Qian et al., 2012). The study by Qian et al. (2012) showed that the presence of 
β-lactoglobulin inhibited the degradation of β-carotene, compared to the use of Tween 20 
to stabilise the nanoemulsion (Qian et al., 2012). The use of colloidal delivery systems is 
well-established in the area of oral drug delivery, however it is still in its infancy in terms 
of functional ingredient bioaccessibility. For this reason, more research regarding the 
development of food-grade colloidal systems to improve bioaccessibility of functional 
ingredients is needed to provide a comprehensive understanding of their effects in vitro 
and in vivo. 
 
1.4.7. Conclusion 
This review discussed bioaccessibility assessment and factors affecting bioaccessibility of 
functional food ingredients, including carotenoids, flavonoids and hydroxycinnamic acids. 
In addition, potential approaches to improve bioacessibility were considered. Assessment 
of the bioaccessibility of functional ingredients is crucial for determining potential 
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bioactivity. The development of advanced in vitro digestion models, particularly dynamic 
models, provides the opportunity to closely mimic in vivo conditions. However, it is 
necessary to validate and standardise existing in vitro procedures for consistency between 
studies. Elucidating bioaccessibility of functional ingredients is extremely challenging, 
with a multitude of factors such as food matrix effect, host-related factors and processing 
affecting the fate of bioactive compounds during digestion. Carotenoids are highly 
bioaccessible, as are isoflavones, with anthocyanins and bound hydroxycinnamic acids 
having limited bioaccessibility. To offset this low bioaccessibility, the use of colloidal 
delivery systems using protein as a stabiliser proves beneficial. Given the increasing 
interest in bioactive functional ingredients and their incorporation into foods for human 
consumption optimisation and standardisation of methods to measure bioaccessibility and 
further research on the development of food-grade colloidal systems are essential.  
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1.5. Literature Review Overall Conclusion  
 The exploitation of BSG as a source of novel bioactive phenolic extracts and 
protein hydrolysates for inclusion into functional foods represents a potential application 
to increase the value of and reduce the waste associated with this brewing industry co-
product. To date, BSG use has been limited to animal nutrition, however given the 
potential health benefits associated with both the phenolic and protein components of 
BSG disccused in this review, its use in human nutrition is favourable.  
Phenolic compounds, including hydroxycinnamic acids, have been shown to 
possess antioxidant, anti-inflammatory, anti-atherogenic and anti-cancer capabilities. 
Protein hydrolysates from a variety of sources have also demonstrated biological activity, 
being antioxidative and blood pressure lowering, while also having potential in sports 
nutrition and the treatment of clinical conditions such as phenylketonuria (PKU) and 
chronic liver disease. It is expected that extracts prepared from BSG would show similar 
bioactivities to those discussed in this review.  
In addition to evaluating the safety, stability and consumer acceptability of 
formulated functional food products, clinical trials are essential to validate claims 
regarding bioactive ingredients. Furthermore, determination of the fate of bioactive 
ingredients during passage through the gastrointestinal tract should be identified using in 
vitro or in vivo gastrointestinal digestion models, to predict bioactive effects in vivo.  
 
 
 
 
  
- 99 - 
 
1.6. Research Objective 
The objective of this thesis was to determine the biological activity of phenolic extracts 
and protein hydrolysates prepared from brewers’ spent grain (BSG) and to determine their 
potential for use as functional food ingredients by measuring bioactivity retention in 
model food systems.  
Antioxidant and immunomodulatory potential of phenolic extracts and protein 
hydrolysates from BSG was measured using in vitro cell culture models. The most 
bioactive samples were chosen for addition into model food systems and subjected to in 
vitro digestion, before determining the biological activity of the digestates. 
Chapters 2, 3 and 4 of this thesis consider phenolic extracts prepared from BSG. 
The ability of phenolic extracts from BSG to protect against oxidant-induced DNA 
damage using the comet assay is examined in Chapter 2. Chapter 3 details the 
hydroxycinnamic acid content of BSG phenolic extracts, determined using high 
performance liquid chromatography (HPLC). In addition, results of preliminary research 
regarding the addition of phenolic extracts into foods, namely fruit juices and smoothies, 
are reported. Chapter 4 studies the antioxidant and anti-inflammatory potential of BSG 
phenolic extracts, measured using cellular antioxidant activity assays and an enzyme-
linked immunosorbent assay (ELISA). 
Chapters 5 and 6 examine protein hydrolysates from BSG. Chapter 5 investigates 
the in vitro antioxidant and anti-inflammatory potential of protein samples A - J, by the 
superoxide dismutase (SOD) and comet assays and ELISA. Using similar methodologies, 
the bioactivity of protein samples K - Y, including fractionated hydrolysates, is studied in 
chapter 6.  
Chapter 7 details the addition of the most bioactive phenolic extracts and protein 
hydrolysates from BSG into model food systems. Fortified foods were subjected to an in 
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vitro digestion procedure, followed by assessment of their bioactivity in cell culture, using 
the comet assay and ELISA.    
 
 
 
Chapter 2 
 
 
Phenolic extracts of Brewers’ Spent Grain (BSG) as 
functional ingredients - assessment of their DNA 
protective effect against oxidant-induced DNA single 
strand breaks in U937 cells. 
 
Published in: Food Chemistry (2012) 134, 641-646 
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2.1. Abstract  
Brewers’ spent grain (BSG), a by-product of the brewing industry, contains high amounts 
of phenolic acids, which have antioxidant effects.  The present study examined the ability 
of BSG extracts to protect against the genotoxic effects of oxidants, hydrogen peroxide 
(H2O2), 3-Morpholinosydnonimine hydrochloride (SIN-1), 4-Nitroquinoline 1-oxide (4-
NQO) and tert-butylhydroperoxide (t-BOOH) in U937 cells.  Four pale (P1-P4) and four 
black (B1-B4) BSG extracts were investigated.  U937 cells were pre-incubated with BSG 
extracts, exposed to the oxidants and the DNA damage was measured by the comet assay.  
The black BSG extracts (B1-B4) significantly protected against H2O2-induced DNA 
damage. Extract B2, which had the highest phenol content, provided the greatest 
protection. Extracts P2, B2, B3 and B4 provided significant protection against SIN-1-
induced DNA damage. None of the extracts protected against DNA damage induced by t-
BOOH and 4-NQO. The DNA protective effects of the BSG phenolic extracts may be 
related to iron chelation. 
 
2.2. Introduction 
Brewers’ spent grain (BSG) is the residual solid fraction of barley malt remaining after 
the production of wort for the brewing industry.  There is approximately 3.4 million tons 
of BSG produced annually in the European Union according to Eurostat Data. Currently, 
BSG is used in animal feed as it is high in protein and fibre (Mussatto et al., 2006) and 
when combined with nitrogen sources, can provide all the essential amino acids (Huige, 
1994). Additional uses for the by-products of the brewing industry would be 
advantageous due to the increasing cost of their disposal.  BSG is a unique source of 
bioactive ingredients including phenolic acids, particularly the hydroxycinnamic acids, 
ferulic acid, p-coumaric acid, sinapic acid and caffeic acid (Szwajgier et al., 2010). 
- 103 - 
 
Plant phenols have been reported to have antioxidant and anti-carcinogenic effects 
(Hollman, 2001). Flavanoids and hydroxycinnamic acids, which are the predominant 
polyphenols in BSG, have antioxidant potential and the in vitro antioxidant effect of plant 
polyphenols was shown to be similar to that of the well-known antioxidants, α-
tocopherol and ascorbic acid (Rice-Evans et al., 1997). There is a large amount of 
information available relating to the health effects of foods rich in phenols such as tea 
(catechins), coffee (chlorogenic acid), wine (resveratrol) and fruit. However, little is 
known regarding the antioxidant potential of BSG. 
Antioxidant activity can be determined by assessing the ability of a compound to 
protect against oxidant-induced DNA damage (Collins, 2004). Oxidants such as hydrogen 
peroxide (H2O2) and tert-butylhydroperoxide (t-BOOH) are known to induce DNA 
damage, such as single strand breaks.  It has been shown that polyphenols, such as 
quercetin and rutin, protect against t-BOOH induced DNA damage (Aherne & O'Brien, 
2000) and H2O2 induced oxidative damage (Musonda & Chipman, 1998). 3-
Morpholinosydnonimine hydrochloride (SIN-1) has been shown to induce DNA damage 
in Jurkat T cells and 4-Nitroquinoline 1-oxide (4-NQO) induced oxidative DNA damage 
in HL-60 cells (Abraham et al., 2007; Johnson & Loo, 2000). 
The aim of the present study was to assess the ability of phenolic rich BSG 
extracts to protect against DNA damage in human lymphocytic U937 cells.  Four extracts 
were prepared from both a pale BSG and a black BSG and the total phenolic content 
(TPC) of the extracts was determined. It was then investigated if the phenolic extracts 
could inhibit oxidative DNA damage induced by either H2O2, SIN-1, 4-NQO or t-BOOH 
using the alkaline single cell gel electrophoresis (Comet) assay.  
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2.3. Materials and methods 
2.3.1. Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich Ireland 
Limited, Co. Wicklow, Ireland.  U937 cells were obtained from the European Collection 
of Animal Cell Cultures (ECACC, Salibury, UK). 
 
2.3.2. Sample preparation 
Pale BSG was the remaining solid fraction obtained following the removal of wort during 
the production of beer in the brewing process. Black BSG was the solid fraction 
remaining following aqueous extraction of barley grains which had been roasted at 200 
°C.  Both BSG types were stored in 1 kg quantities in polyethylene bags which were 
vacuum packed and maintained at -20 oC. The test samples designated P1 - P4 and B1 - 
B4 were obtained from pale (P) and black (B) BSG, respectively. For production of the 
P1 and B1 samples, 15 g BSG (dw) was first sheared for 20 s at 11,000 rpm using an 
Ultra Turrax® T25 basic high performance disperser (IKA® Werke GmbH & Co. KG, 
Janke and Kunkel-Str.10, D-79219 Staufen, Germany) in 300 mL H2O. The sheared 
samples were then allowed to stir gently for 1 hr at room temperature prior to 
centrifugation. The resulting supernatants were designated P1 and B1. The precipitate 
obtained from the above process was subjected to two sequential 1 hr extractions in 300 
mL 110 mM NaOH at room temperature. The combined supernatants from the above 
extractions obtained after centrifugation were adjusted to pH 3.8, stirred gently for 15 
min at room temperature and then centrifuged. The supernatants obtained were 
designated as P4 and B4. The precipitates from above were further extracted in the dark 
with gentle stirring using 200 mL 1 N NaOH at room temperature for 16 hr. The 
supernatants obtained following centrifugation were designated P2 and B2. The 
- 105 - 
 
precipitate was further extracted in the dark for 1 hr with 200 mL H2O by gently stirring 
at room temperature and the resultant supernatants obtained following centrifugation 
were designated P3 and B3 respectively. All centrifugation steps were carried out at 2710 
g for 20 min at 10 oC  using a Hettich Zentrifugen Universal 320R centrifuge (Andreas 
Heittich GmbH & Co. KG, Fohrenstr.12, D-78532 Tuttlingen, Germany) and all 
supernatant samples were adjusted to pH 7.0 using  2 N NaOH or 2 N HCl as required, 
prior to analysis.  
 
2.3.3. Total phenolic content 
The total phenolic content (TPC) of the BSG extracts was determined using the Folin-
Ciocalteau method as described previously (Singleton & Rossi, 1965) . The assay is 
based on the oxidising ability of the Folin-Ciocalteau reagent.  A yellow to blue/green 
colour change is observed and the absorbance is measured spectrophotometrically at 765 
nm. 
 
2.3.4. Quantification of ferulic acid content in BSG samples 
The reverse-phase HPLC method used was according to Tsao and Yang, 2003.  Analysis 
was carried out using a Waters HPLC system (Waters Coprpration, Milford, MA, USA) 
equipped with a Waters 717 Plus autosampler and a dual absorbance detector. Separation 
was carried out with a Jupiter 300 C18 column, 5µm particle size (250  x 4.6, L x ID mm, 
Phenomenex, Cheshire, UK) with a C18 guard column. The mobile phase consisted of 6 
% acetic acid in 2 mM sodium acetate (v/v), final pH 2.55 (solvent A) and acetonitrile 
(solvent B). The flow rate was 1.0 mL per min for a total run time of 70 min and the 
gradient programme was as follows: 0 % B to 15 % B in 40 min, 15 % B to 30 % B in 15 
min, 30 % B to 50 % B in 5 min and 50 % B to 100 % B in 5 min. There was a 70 - 80 
min post-run at initial conditions to equilibrate the column. The injection volume was 20 
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μL and peaks were monitored at 280 nm and 320 nm. All samples were filtered through 
0.45 μm filters prior to injection and peak area was related to concentration using a 
standard curve generated from varying concentrations of ferulic acid.  
 
2.3.4. Ferric Reducing Antioxidant Power (FRAP) Assay 
The in vitro antioxidant activity of test solutions was estimated according to the 
procedure of Benzie and Strain (1996) as modified by Griffin and Bhagooli (2004). 
Solutions of known Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) 
concentration in the range of 50 - 500 μM were used for calibration and the results from 
test extracts were expressed as Trolox Equivalents per mL (TE/mL).     
 
2.3.5. Cell culture  
U937 cells, human histiocytic lymphoma cells, were maintained in antibiotic-free RPMI-
1640 medium supplemented with 10 % (v/v) fetal bovine serum (FBS), at 37 oC in a 5 % 
CO2 atmosphere.  Cells were adjusted to a density of 1 x 105 cells/mL, in reduced serum 
media (2.5 % FBS) for comet experiments. 
 
2.3.6. Preparation of oxidants  
Each of the oxidants (H2O2, SIN-1, 4-NQO and t-BOOH) was dissolved in distilled, 
deionised water. A 20 mM stock solution of H2O2 was prepared and added to 2 mL cells 
to give final concentrations ranging from 50 - 200 µM.  For SIN-1, a 0.1 M stock solution 
was prepared and concentrations of 1, 2 and 4 mM were added to cells. The stock 
solution of 4-NQO was prepared to a concentration of 200 µg/mL and was added to cells 
at final concentrations of 2, 4 and 6 µg/mL. A stock solution (40 mM) of t-BOOH was 
prepared and added to cells at final concentrations of 200, 400 and 800 µM. 
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2.3.7. Comet assay 
U937 cells (2 mL) were seeded in a 6-well plate at a density of 1 x 105 cells/mL in RPMI-
1640 medium supplemented with 2.5 % FBS. Initial cytotoxicity testing with the (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide salt (MTT) assay indicated the 
concentration of BSG phenolic extracts and ferulic acid standard to use for assay, 2.5 % 
(v/v) and 1 µg/mL respectively. Cells were incubated for 24 hr with either 2.5 % (v/v) (50 
µL in 2 mL cells) phenolic extracts from the BSG or 1 µg/mL ferulic acid. Cells were 
subsequently treated with H2O2 (50 µM for 30 min), SIN-1 (4 mM for 90 min), 4-NQO 
(2 µg/mL for 90 min) or t-BOOH (400 µM for 60 min). Following exposure of the cells 
to the various treatments, cell viability was measured using the fluorescein diacetate/ 
ethidium bromide (FDA/EtBr) assay which stains live cells green and dead cells red.  The 
FDA/EtBr assay was conducted simultaneously to each comet assay to ensure cell 
viability did not decrease below 90 %, which could invalidate the results from the comet 
assay. Oxidative DNA damage to the U937 cells was assessed using the comet assay 
adapted from Tice et al. (1991) . Firstly, slides were prepared by coating with 1 % (w/v) 
normal gelling agarose (NGA). Cells (30 µL) were then suspended in 70 µL of 1 % (w/v) 
low melting point agarose (LMP), covered with a coverslip and placed on ice to solidify. 
Slides were submerged in the comet lysing solution at 4 oC for 1 hr, before being placed 
in the comet electrophoresis solution for 40 min. Electrophoresis was carried out at 21 V, 
300 mA for 25 min. Neutralisation of the slides was performed by washing three times 
with 0.4 M Tris for 5 min. Slides were rinsed with distilled H2O and 20 µg/mL EtBr was 
placed on the slides for 5 min.  Following a final rinse with H2O, coverslips were 
replaced and 50 cells were scored for each slide using a fluorescence microscope 
(Optiphot-2, Nikon) at wavelength 510 - 550nm and Komet 5.5 image analysis software. 
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2.3.8. Statistical Analysis 
All data points are the mean and standard error values of at least three independent 
experiments.  Data were analysed by ANOVA followed by Dunnett’s test.  The software 
employed for statistical analysis was GraphPad Prism, version 4.00 for windows 
(GraphPad software, San Diego, California, USA).  
 
2.4. Results and discussion 
2.4.1. Total Phenolic Content of BSG extracts 
Previous studies have extracted phenolic acids from BSG using methods based on acidic 
hydrolysis or saponification. Saponification involves the treatment of samples with 1 - 4 
M NaOH solution, similar to the method used in the present study, and has previously 
been used to extract hydroxycinnamic acids from BSG (Bartolome et al., 2002).  Four 
extracts were prepared from both the pale BSG (P1 - P4) and the black BSG (B1 - B4) as 
outlined in Section 2.3.2.. The total phenolic content of each of the phenolic extracts from 
BSG was measured (Table 1).  Extracts P1 and B1 contain the water soluble or free 
phenolics extracted from BSG and the lower TPC of these samples demonstrates that 
there is a low concentration of free phenolics in BSG.  The second phase of the extraction 
procedure released the bound phenolics as represented by P2 and B2.  P2 and B2 have the 
highest TPC (Table 1) suggesting that it is predominantly bound phenolics that are 
present in BSG.  Extracts P3 and B3 were released at the third step of the extraction and 
contain the remaining bound phenolics from the BSG sample (Table 1). The phenolic 
fractions collected at the final phase of the extraction procedure, P4 and B4, had a lower 
TPC than the two previous phenolic extracts (P2, B2 and P3, B3) obtained using 1M 
NaOH.   It has previously been reported that the majority of the phenolic acids in BSG 
are in the bound form (Forssell et al., 2008). It has also been found that the bound  
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Table 1: Total phenolic content (TPC) of phenolic extracts from Brewer’s Spent Grain 
(BSG). 
BSG Extracta TPC 
(mg gallic acid equivalents (GAE)/mL) 
P1 0.014 ± 0.000b (0.35) 
P2 0.641 ± 0.024b (16.03) 
P3 0.225 ± 0.003b (5.63) 
P4 0.059 ± 0.001b (1.48) 
B1 0.083 ± 0.001b (2.08) 
B2 0.732 ± 0.020b (18.30) 
B3 0.267 ± 0.010b (6.68) 
B4 0.128 ± 0.010 b (3.20) 
a P1 - P4 represent the four pale BSG extracts while B1 - B4 represent the four black BSG 
extracts. b Values are mean ± SE of three independent experiments. Statistical analysis 
was ANOVA followed by Dunnett’s test. Data in brackets represent the total phenolic 
content (µg GAE/mL) of 2.5 % (v/v) extract (used for analysis). 
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phenolics in barley, which is used in the brewing process, are predominantly ferulic and 
p-coumaric acid (Holtekjølen et al., 2006).  Reverse-phase HPLC was used to quantify 
ferulic acid, the principle phenolic acid found in BSG, according to the procedure of Tsao 
and Yang (2003). Ferulic acid could not be detected in the aqueous extracts, P1 and B1. 
Higher levels of ferulic acid were detected in the pale as compared to the black extracts. 
The values obtained for the pale extracts were P2, 113.96 ± 0.88 µg/mL; P3, 33.81 ± 2.42 
µg/mL and P4, 17.59 ± 0.40 µg/mL while those for the black extracts were B2, 27.31 ± 
0.69 µg/mL; B3, 10.70 ± 0.28 µg/mL and B4, 5.48 ± 0.06 µg/mL. A more detailed 
characterisation of other phenolics in the BSG samples is ongoing. 
 
2.4.2. Ferric Reducing Antioxidant Power (FRAP) Assay 
The FRAP assay measures the ability of a compound to reduce Fe3+ (ferric ion) to Fe2+ 
(ferrous ion), thus indicating the antioxidant potential of a compound (Benzie & Strain, 
1996). Extracts B2, P2, B3 and P3 had the highest FRAP activity and the black extracts 
showed best antioxidant potential (Table 2). The FRAP activity correlates with the total 
phenolic content of the BSG extracts (Table 1); extracts with highest TPC showing 
greatest antioxidant effects. Numerous studies have reported a relationship between TPC 
and FRAP activity, with higher TPC resulting in higher ferric reducing antioxidant power 
(Pantelidis et al., 2007; Chu et al., 2002). 
 
2.4.3. Ability of BSG extracts to protect against oxidant-induced DNA damage 
The optimal conditions for the induction of maximal DNA damage without affecting cell 
viability was determined for each of the oxidants in U937 cells.  H2O2, at 50 µM for 30 
min, was found to induce DNA damage with approximately 40 % tail DNA.  t-BOOH 
was not as genotoxic as H2O2 and 400 µM t-BOOH for 60 min resulted in 15.5 % tail  
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Table 2: Antioxidant activity of phenolic BSG extracts, as measured using the Ferric 
Reducing Antioxidant Potential (FRAP) assay. 
BSG Extracta FRAP  
(µM trolox equivalents (TE)/mL) 
P1 0.01 ± 0.00 
P2 0.36 ± 0.01 
P3 0.13 ± 0.00 
P4 0.06 ± 0.00 
B1 0.06 ± 0.00 
B2 0.53 ± 0.02 
B3 0.17 ± 0.00 
B4 0.10 ± 0.01 
a P1 - P4 represent the four pale BSG extracts while B1 - B4 represent the four black BSG 
extracts. b Values are mean ± SD of three independent experiments. Statistical analysis 
was ANOVA followed by Dunnett’s test. 
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DNA.  The selected concentrations of H2O2 and t-BOOH are similar to those previously 
employed by Aherne and O’Brien (2000).  Few studies have examined the genotoxic 
effects of SIN-1 and 4-NQO in U937 cells, as assessed using the comet assay, therefore a 
dose response study for these compounds was carried out.  Increasing concentrations of 
SIN-1 caused a corresponding increase in the percent tail DNA to a maximum of 37.3 % 
at 4 mM SIN-1 following 90 min incubation (Table 3). 4-NQO was incubated for 90 min 
at concentrations ranging from 0 - 8 µg/mL and a concentration of 2 µg/mL was used to 
determine the protective effects of the BSG extracts (Table 3). Each of the oxidants 
ultimately result in the formation of single strand breaks in the DNA, however the 
mechanisms involved differ. H2O2 produces hydroxyl radicals (OH) by means of the 
Fenton reaction in an iron dependent reaction. OH radicals cause single strand breaks by 
attacking the ribose on the DNA backbone (Benhusein et al., 2010).  SIN-1 produces 
nitric oxide (NO) and superoxide anion (O2−), which subsequently form peroxynitrite 
(ONOO−).  O2− is converted to H2O2 which results in DNA damage, by a Fenton type 
reaction. Peroxynitrite can also generate hydroxyl radical in an iron-independent manner 
(Inoue & Kawanishi, 1995). 4-NQO mimics the action of UV and previous studies have 
shown that cell treatment with 4-NQO can lead to the production of H2O2, superoxide 
and hydroxyl radicals and a substantial amount of oxidised DNA bases (Arima et al., 
2006). It has been suggested that Cu2+ has an essential role in DNA damage induced by 4-
NQO, whereas iron does not (Yamamoto et al., 1993). t-BOOH causes lipid peroxidation 
and triggers the Ca2+-dependent formation of H2O2 which results in DNA cleavage. The 
production of additional DNA damaging species by t-BOOH results in DNA lesions 
comparable to those produced by the hydroxyl radical.  DNA single-strand breakage 
induced by t-BOOH has been shown to occur in an iron dependent manner, however 
studies have also demonstrated that t-BOOH-induced DNA damage is less dependent on 
iron than H2O2-induced DNA damage (Kruszewski et al., 2008). 
- 113 - 
 
Table 3: Dose response effects of BSG extracts on oxidative DNA damage induced by 3-
Morpholinosydnonimine hydrochloride (SIN-1) or 4-Nitroquinoline 1-oxide (4-NQO) 
following 90 min incubation, as measured using the Comet assay. 
 DNA damage  
(% Tail DNA) 
Control 3.3 ± 0.4a 
1 mM SIN-1 4.8 ± 0.6a 
2 mM SIN-1 12.0 ± 0.7a * 
4 mM SIN-1 37.3 ± 1.2a * 
2 µg/mL 4-NQO 41.2 ± 4.5a * 
4 µg/mL 4-NQO 51.2 ± 6.7a * 
6 µg/mL 4-NQO 47.9 ± 6.7a * 
8 µg/mL 4-NQO 46.3 ± 3.2a * 
a Values are mean ± SE of three independent experiments. Statistical analysis was 
by ANOVA followed by Dunnett’s test. * Denotes a significant difference (P < 
0.05) in DNA damage, relative to control. 
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To assess the DNA protective effects of the phenolic extracts of pale and black 
BSG, U937 cells were pretreated with the extracts for 24 hr prior to exposing the cells to 
the oxidants. The use of 2.5 % BSG extracts or 1 μg/mL ferulic acid did not affect cell 
viability, with viability > 90 % for all conditions used. Both ferulic acid and the BSG 
extracts alone did not induce DNA damage at the concentrations used in the present study 
(data not shown).  The addition of 50 µM H2O2 to U937 cells for 30 min significantly (P 
< 0.05) increased tail DNA to approximately 40 % (Table 4). The black BSG extracts and 
ferulic acid significantly (P < 0.05) reduced the percentage tail DNA in H2O2 treated 
U937 cells (Table 4). The black BSG extracts have a higher TPC than the corresponding 
pale BSG extracts, thus, a relationship between the TPC of the BSG extracts and 
protection against H2O2 induced DNA damage is evident.  Ferulic acid, p-coumaric acid, 
sinapic acid and caffeic acid are the phenolic acids present at highest concentrations in 
BSG (Szwajgier et al., 2010). Previous studies have demonstrated that pure phenolic 
compounds, ferulic acid and caffeic acid protect against DNA damage caused by H2O2, 
as measured by the comet assay (Wang et al., 2008; Nousis et al., 2005). In a study 
conducted by Wang et al. (2008b) feruloyl oligosaccharides (FOs), the ferulic acid ester 
of oligosaccharides, from wheat bran, protected against H2O2-induced DNA damage in 
lymphocytes, as measured by the comet assay. The authors attributed this protection to 
the antioxidant capacity of the ferulic acid moiety. Olive oil phenolics have also shown a 
protective effect against DNA damage induced by H2O2, as assessed by the comet assay 
(Quiles et al., 2002).  
The exposure of U937 cells to SIN-1 (4 mM) for 90 min resulted in an increase in 
tail DNA from a control, untreated level of 4.3 % to 40 % (Table 5).  The BSG extracts 
which significantly (P < 0.05) protected against SIN-1-induced DNA damage were pale 
BSG extract P2, which is the pale sample with the highest polyphenol content and black 
BSG extracts B2, B3 and B4 (Table 5).  Extract B2 reduced the level of DNA damage to  
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Table 4: DNA damage in U937 cells treated with 50 µM H2O2 for 30 min following 24 h 
incubation with either 2.5 % (v/v) pale (P1 - P4) and black (B1 - B4) brewers’ spent grain 
extracts or ferulic acid (FA, 1 µg/mL). 
Test 
Sample 
DNA damage 
(% Tail DNA) 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Control   3.2 ± 0.5a 
40.3 ± 0.3a 
30.3 ± 7.3a 
29.0 ± 6.0a 
29.9 ± 3.9a 
23.1 ± 3.2a 
 20.3 ± 5.7a * 
Control   2.6 ± 0.3a 
42.1 ± 2.7a 
   25.8 ± 7.5a * 
    9.6 ± 1.1a * 
   16.0 ± 2.0a * 
   14.0 ± 3.8 a * 
    17.1 ± 0.8a * 
H2O2 H2O2 
P1 B1 
P2 B2 
P3 B3 
P4 B4 
FA FA 
a Values are mean ± SE of three independent experiments. Statistical analysis was by 
ANOVA followed by Dunnett’s test. * Denotes a significant difference (P < 0.05) in 
DNA damage, relative to H2O2 control. 
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Table 5: DNA damage in U937 cells treated with 4 mM 3-morpholinosydnonimine 
hydrochloride (SIN-1) for 90 min following 24 hr incubation with either 2.5 % (v/v) pale 
(P1 - P4) and black (B1 - B4) brewers’ spent grain extracts or ferulic acid (FA, 1 µg/mL). 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Control 4.3 ± 0.4a 
40.0 ± 3.9a 
32.8 ± 4.9a 
  22.7 ± 1.9a *  
33.8 ± 2.9a 
32.2 ± 6.1a 
30.8 ± 3.0a 
Control 4.3 ± 0.4a 
40.0 ± 3.9a 
33.6 ± 2.9a 
   6.9 ± 1.0a * 
 18.1 ± 0.3a * 
 24.1 ± 2.2a * 
30.8 ± 3.0a 
SIN-1 SIN-1 
P1 B1 
P2 B2 
P3 B3 
P4 B4 
FA FA 
a Values are mean ± SE of three independent experiments. Statistical analysis was by 
ANOVA followed by Dunnett’s test. * Denotes a significant difference (P < 0.05) in 
DNA damage, relative to SIN-1 control. 
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6.9 %, which is almost a return to control level (4.3 %). Ferulic acid did not significantly 
(P < 0.05) protect against SIN-1 induced DNA damage. Similar to H2O2-induced DNA 
damage, there appeared to be a relationship between the TPC of the extracts and the level 
of protection afforded against SIN-1-induced DNA damage.  Sinapic acid, the third most 
concentrated phenolic acid in BSG (Szwajgier et al., 2010) has been shown to scavenge 
peroxynitrite (ONOO-) induced by SIN-1 (Zou et al., 2002).  Similarly, Johnson and Loo 
(2000) reported that two phenolic compounds, epigallocatechin gallate and quercetin, 
scavenged the free radicals produced by H2O2 and SIN-1 in Jurkat cells.  
Incubation of U937 cells with 4-NQO (2 µg/mL) resulted in a significant increase 
in tail DNA to 39.5 % (Table 6).  Neither the BSG extracts nor the pure ferulic acid 
significantly protected against the DNA damage induced by 4-NQO (Table 6).  Abraham 
et al. (2007) found that the polyphenol, chlorogenic acid, did not significantly reduce 4-
NQO induced DNA damage.  Chlorogenic acid is present at small concentrations in BSG 
(Szwajgier et al., 2010).  Kuroda (1996) also reported that the simultaneous treatment of 
V79 cells with green tea polyphenols (catechins) and 4-NQO did not inhibit mutagenicity 
induced by 4-NQO.  
The incubation of U937 cells with 400 µM t-BOOH for 60 min significantly (P < 
0.05) increased the percent tail DNA to 15.5 % (Table 7).   None of the phenolic BSG 
extracts significantly protected against t-BOOH induced DNA damage.  These results are 
in contrast with previously reported data which found that plant-derived phenolic 
compounds, including quercetin, protected against DNA damage induced by t-BOOH in 
the U937 cell line (Sestili et al., 2002). It has been shown that caffeic acid protected 
against oxidative stress induced by t-BOOH by inhibiting lipid peroxidation (Nardini et 
al., 1998). Phenolic extracts from swallow root also protected against t-BOOH induced 
DNA damage (Harish Nayaka et al., 2010), and it was suggested that p-coumaric acid  
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Table 6: DNA damage in U937 cells treated with 2 µg/mL 4-nitroquinoline 1-oxide (4-
NQO) for 90 min following 24 hr incubation with either 2.5 % (v/v) pale (P1 - P4) and 
black (B1 - B4) brewers’ spent grain extracts or ferulic acid (FA, 1 µg/mL). 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Control 3.1 ± 0.3a  
39.5 ± 1.1a 
39.0 ± 6.8a 
40.7 ± 4.3a 
37.3 ± 3.2a 
37.8 ± 3.6a 
32.6 ± 5.2a 
Control 3.1 ± 0.3a 
39.5 ± 1.1a 
36.1 ± 5.7a  
31.9 ± 3.2a 
33.4 ± 2.4a 
33.7 ± 6.8a 
32.6 ± 5.2a 
4-NQO 4-NQO 
P1 B1 
P2 B2 
P3 B3 
P4 B4 
FA FA 
a Values are mean ± SE of three independent experiments. Statistical analysis by ANOVA 
followed by Dunnett’s test was employed to compare 4-NQO-treated cells with those 
preincubated with BSG extract prior to 4-NQO exposure.  
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Table 7:  DNA damage in U937 cells treated with 400 µM tert-butylhydroperoxide (t-
BOOH) for 60 min following 24 h incubation with either 2.5 % (v/v) pale (P1-P4) and 
black (B1-B4) brewers’ spent grain extracts or ferulic acid (FA, 1 µg/mL). 
Test 
Sample 
DNA damage 
(% Tail DNA) 
Test 
Sample 
DNA damage  
(% Tail DNA) 
Control 4.7 ± 0.6a 
15.5 ± 0.8a 
14.5 ± 0.8a 
22.6 ± 3.0a 
22.1 ± 3.1a 
17.4 ± 2.6a 
11.0 ± 1.9a 
Control 4.7 ± 0.6a 
15.5 ± 0.8a 
13.6 ± 0.9a  
18.5 ± 3.3a 
16.6 ± 1.8a 
14.0 ± 2.7a 
11.0 ± 1.9a 
t-BOOH t-BOOH 
P1 B1 
P2 B2 
P3 B3 
P4 B4 
FA FA 
a Values are mean ± SE of four independent experiments. Statistical analysis by ANOVA 
followed by Dunnett’s test was employed to compare t-BOOH treated cells with those 
preincubated with BSG extract prior to t-BOOH exposure. 
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had a major role in this antioxidant effect and that the bound phenolics were more 
effective than free phenolics.   
The phenolic extracts of BSG protected against the genotoxic effects of H2O2 and 
SIN-1 but not 4-NQO and t-BOOH.  DNA damage induced by H2O2 is more dependent 
on iron than DNA damage induced by t-BOOH (Kruszewski et al., 2008).  Polyphenols 
act as metal chelators and bind Cu and iron (Lopes et al., 1999) and this may be one of 
the mechanisms dictating the genoprotective effects of the phenolic extracts of the BSG.  
Studies carried out by Perron et al. (2008, 2011) demonstrated that selected pure 
polyphenols protected more against the DNA damaging effects of iron than the DNA 
damaging effects of copper, as assessed in plasmid DNA purified from E. coli, using a 
gel electrophoresis method. In addition, results of the FRAP assay support the suggestion 
that the BSG extracts protect against oxidant-induced DNA damage by iron chelation. 
These extracts, particularly the black BSG extracts, showed the ability to reduce the ferric 
oxidant Fe3+ to Fe2+, thus reducing reactive species. The BSG extracts may also act by 
scavenging reactive oxygen species and reducing the resultant DNA damage as has 
previously been demonstrated for pure polyphenols (Bellion et al., 2010). The protective 
effects of the BSG extracts correlated with their total phenolic content for both pale and 
black BSG extracts.  Black BSG extracts were more protective at comparable TPC.  
The black phenolic extracts were found to contain lower ferulic acid levels than 
the pale phenolic extracts, as detailed previously. Since the black phenolic extracts give 
greatest protection against DNA damage induced by H2O2 and SIN-1, it can be deduced 
that ferulic acid is not the principle antioxidant entity in the BSG phenolic extracts. This 
is further evidenced by the fact that B2, B3 and B4 (samples with highest TPC, but lower 
in ferulic acid than pale extracts) significantly protected against SIN-1 induced DNA 
damage, whereas the pale extracts P1, P3, P4 and ferulic acid standard did not (Table 5). 
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Preliminary evidence indicates that high molecular weight phenolic components in the 
black BSG samples may be the main contributors to the observed antioxidant effects.  
In conclusion, the phenolic extracts of BSG protected against the genotoxic 
effects of H2O2 and SIN-1, possibly by chelating iron and or scavenging reactive oxygen 
species (ROS). The BSG phenolic extracts with highest TPC had highest FRAP activity 
and gave greatest protection against oxidant-induced DNA damage. BSG may have the 
potential to be developed as a food additive or dietary supplement with possible health 
promoting properties.   
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3.1. Abstract 
The hydroxycinnamic acid (HA) content of starting barley for brewers’ spent grains 
(BSG), whole BSG and phenolic extracts from BSG was measured using high 
performance liquid chromatography (HPLC) and correlated with in vitro antioxidant 
potential. The effect of BSG phenolic extracts on antioxidant activity of fruit beverages 
was also assessed (using the total phenolic content (TPC), 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) and ferric reducing antioxidant power (FRAP) assays). The concentration of HA 
present in barley extract and BSG was in the order of ferulic acid (FA), p-coumaric acid 
(p-CA) derivatives, FA derivatives, p-CA, caffeic acid (CA) and CA derivatives. Results 
suggested that brewing and roasting decreased the HA content. Antioxidant activity was 
significantly (P < 0.05) correlated with caffeic acid (R2 = 0.8309) and total HA (R2 = 
0.3942) concentrations. Addition of extracts to fruit beverages resulted in a significant (P 
< 0.05) increase in antioxidant activity of cranberry juice, measured by the FRAP assay. 
In vitro digestion significantly (P < 0.05) reduced TPC, DPPH and FRAP activity of the 
fruit beverages. 
 
3.2. Introduction 
Brewers’ spent grain (BSG) is the solid fraction that remains following wort production, 
the first step of the brewing process. The barley used for brewing can be either pale 
(unroasted) or black (roasted to approximately 200 oC prior to use), giving rise to pale 
and black BSG, respectively. BSG is a low-value co-product of the brewing industry 
(Mussatto et al., 2006). According to Eurostat Data, approximately 3.4 million tons of 
BSG are produced annually in the E.U.. Due to its high moisture content (75 - 80 %), wet 
BSG is a perishable product that is difficult to market, therefore some breweries regard 
BSG as a waste rather than a co-product (Valverde, 1994). BSG contains approximately 
20 % protein, 70 % fibre and 1.2 % mono- and di-meric phenolic acids (Mussatto et al., 
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2006) and hence has a high nutritional value. Currently, BSG is used as a feed 
supplement for animals, particularly dairy cattle, however, due to its favourable 
nutritional composition (Mussatto et al., 2006), BSG has the potential to be exploited for 
human nutrition. Barley is beneficial to human health as a source of both fibre and 
phenolic acids and has been reported to reduce plasma levels of low-density lipoprotein 
(LDL) cholesterol and triacylglycerol and also to increase stool volume in healthy women 
(Li et al., 2003). It is possible that BSG may confer health benefits similar to those 
exhibited by barley which would create opportunities to reduce BSG waste, by exploiting 
the nutritional and health protective potential of this co-product (Mussatto et al., 2006).  
Polyphenols are the most abundant antioxidants in the human diet and they may 
support the inherent cellular antioxidant defence system which can become overwhelmed 
during periods of oxidative stress (Sander et al., 2004). The antioxidant properties of 
barley, beer and BSG, measured by the oxidation of methyl linoleate, low density 
lipoprotein (LDL) oxidation and the comet assay, respectively, have been related to their 
total phenolic content (Maillard et al., 1996; Vinson et al., 2003; McCarthy et al., 2012). 
Hydroxycinnamic acids are hydroxy derivatives of cinnamic acid, produced by the 
phenylpropanoid pathway (Figure 1a) and are the primary class of phenolic compounds 
present in barley, beer and BSG. Hydroxycinnamic acids have a C6 - C3 skeleton and 
differences in the substituents of the aromatic ring yield different phenolic acids 
including p-coumaric, caffeic, ferulic and sinapic acid (Figure 1b). Ferulic and p-
coumaric acids are present in barley (Maillard et al., 1996) and beer, which also contains 
syringic, caffeic and vanillic acids (Vinson et al., 2003). Hydroxycinnamic acids have 
demonstrated antioxidant effects (Kikuzaki et al., 2002). A previous study has shown that 
phenolic extracts prepared from BSG have antioxidant activity and the BSG extracts 
prepared from barley which was roasted prior to brewing (black BSG) demonstrated the 
highest antioxidant potential (McCarthy et al., 2012).  
    
  
 
(a)   Phenylalanine     (b)
  
    
PAL    
 
Cinnamate 
 
              C4H 
 
   4-coumarate 
          4CL        C3H 
 
 4-Coumaroyl coA     Caffeic acid 
         COMT 
     
     Ferulic acid 
          
            5-hydroxyferulic acid 
 
       Sinapic acid 
 
Figure 1: (a) Biosynthetic pathway of hydroxycinnamic acids, the phenylpropanoid pathway. PAL, phenylalanine ammonia lyase; C4H, 
cinnamate-4-hydroxylase; 4CL, 4-coumarate-CoA ligase; C3H, coumaroyl-quinate/shikimate 3-hydroxylase; COMT, caffeic acid: 5-
hydroxyferulic acid O-methyltransferase; F5H, ferulate-5-hydroxylase. (b) The general C6 - C3 skeleton structure of hydroxycinnamic 
acids, and the side chains and molecular formula for common hydroxycinnamic acids. 
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caffeic acid (C9H8O4)  R1= OH  
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sinapic acid (C11H12O5) R1= OCH3    R2= OCH3 
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There is a consumer demand for plant-based functional foods that have the 
potential to improve health and well-being. As a consequence functional fruit juices and 
drinks have been developed in a number of countries including Poland, New Zealand and 
the U.S.A. (Sun-Waterhouse, 2011).  
Whole BSG has been added to a range of foods including cookies (Öztürk et al., 
2002), bread (Stojceska & Ainsworth, 2008) and frankfurters (Özvural et al., 2009). The 
addition of BSG to these foods increased the protein and fibre content and consumer 
acceptability was not affected. However, none of these studies investigated the effect of 
BSG extract supplementation on the phenolic content of the foods.       
The stability of polyphenols during digestion and absorption is dependent on the 
compound ingested and the food matrix. Polyphenols from Concord grape juice were 
stable during gastric digestion (pH 2) but significant losses were observed in several of 
the polyphenols during the duodenal phase (pH 7) (Stalmach et al., 2012).  
Hydroxycinnamic acids were found to be relatively stable during the digestion process in 
comparison with anthocyanidins, procyanidins and flavonols.  
The aim of the present study was to characterise and quantify the most abundant 
hydroxycinnamic acids in whole ground barley grain, pale BSG, black BSG and BSG 
phenolic extracts, using high performance liquid chromatography (HPLC), in order to 
determine the potential of BSG phenolic extracts to be exploited for use in functional 
foods. The effect of BSG phenolic extracts on antioxidant activity of fruit juices and 
smoothies was also investigated to give an indication of their potential for use as 
functional food ingredients.   
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3.3. Materials and Methods 
3.3.1. Materials 
Sodium acetate trihydrate, iron sulphate heptahydrate (FeSO4.7H2O) and iron chloride 
hexahydrate (FeCl3.6H2O) were purchased from BDH Laboratory Supplies, Dorset, 
England. Hydrochloric acid and methanol were purchased from Roth (Karlsruhe, 
Germany), acetic acid from Merck (Darmstadt, Germany) and acetonitrile from J. T. 
Baker (Grießheim, Germany). All chemicals and solvents were HPLC grade. All other 
chemicals unless otherwise stated were purchased from Sigma-Aldrich Ireland Limited, 
Co. Wicklow, Ireland.  
 
3.3.2. Barley, whole brewers’ spent grain (BSG) and BSG phenolic extracts  
Barley samples (saffron variety) and wet whole BSG samples were obtained from a local 
brewery. Wet BSG samples were maintained at -20 °C until required for preparation. To 
prepare, all samples were oven-dried at 60 ºC for 18 hr, and subsequently fine-milled 
using a Micromark Minigrinder (Supplier: Des Kavanagh Electrical, Galway, Ireland), 
pulsed for 1 min duration.  Preparation of the phenolic extracts from pale and black BSG 
has been described previously (McCarthy et al., 2012). Samples, designated P1 - P4 and 
B1 - B4 were acquired from pale and black BSG, respectively. Briefly, P1 and B1 were 
the supernatants obtained following shearing in water and centrifugation. P2 and B2 were 
extracted with 110 mM NaOH and subsequently 1 N NaOH. P3 and B3 are aqueous 
washes of sediments obtained during preparation of P2 and B2 extracts. The supernatants 
remaining following acid precipitation at pH 3.8 and centrifugation were designated P4 
and B4. Whole ground barley and whole ground dried BSG are referred to as barley and 
BSG throughout.   
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3.3.3. Sample preparation for HPLC-DAD-MS analysis 
Hydroxycinnamic acids were extracted from barley and BSG samples using a 
modification of the method previously described (Schütz et al., 2004). To analyze the 
hydroxycinnamic acids, sample (2 g) was extracted in duplicate using 60 % aqueous 
methanol on a magnetic stirrer plate for 1.5 hr. The extract was passed through a fluted 
filter and subsequently evaporated to dryness. The residue was dissolved in 5 mL distilled 
water and then passed through a cellulose mixed ether-membrane filter (CME filter) prior 
to HPLC analysis coupled with diode array detection (DAD) and mass spectrometry 
(MS).  
 
3.3.4. Analysis of barley, BSG and BSG phenolic extracts - HPLC-DAD-MS 
The hydroxycinnamic acid derivatives were quantified using a method described 
previously (Neugart et al., 2012). An HPLC series 1100 by Agilent (Waldbronn, 
Germany) consisting of a degasser, binary pump, autosampler, column oven and 
photodiode array detector was used. Extracts were separated at 30 oC on a Phenomenex 
Prodigy column (ODS, 150 X 3.0 mm, 5 µm, 100 Å) using a water/acetonitrile gradient. 
Solvent A consisted of 99.5 % water and 0.5 % acetic acid; solvent B was 100 % 
acetonitrile. The following gradient was used: 5 - 7 % (0 - 12 min), 7 - 9 % (12 - 25 min), 
9 - 12 % (25 - 45 min), 12 - 15 % (45 - 100 min), 15 % isocratic (100 - 150 min), 15 - 50 
% (150 - 155 min), 50 % isocratic (155 - 165 min), 50 - 5 % isocratic (165 - 170 min) and 
5 % isocratic (170 - 175 min). The flow rate used was 0.4 mLmin-1 and the detector 
wavelength was 320 nm. The hydroxycinnamic acid derivatives were identified as 
deprotonated molecular ions and mass fragment ions by HPLC-DAD/ESI-MSn using an 
Agilent series 1100 ion trap mass spectrometer in negative ionization mode. Nitrogen was 
used as the drying gas (12 L min-1, 350 °C) in addition to nebulizer gas (40 psi). Helium 
was used as the collision gas in the ion trap. The standards, ferulic acid and caffeic acid 
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(Roth, Karlsruhe, Germany), were used for external calibration curves at concentrations 
ranging from 0.1 to 10 mg/100 mL. p-Coumaric, sinapic and unknown acid 
concentrations were calculated as ferulic acid equivalents. 
 
3.3.5. Analysis of barley, BSG and BSG phenolic extracts - total phenolic content (TPC)  
For determination of the TPC of barley and BSG an extraction step was necessary, BSG 
phenolic extracts were analysed directly. Extraction was carried out as previously 
described (Sharma & Gujral, 2010). Acidified methanol (HCl/methanol/water, 1:80:10 
v/v/v) was added to 200 mg sample and incubated at room temperature (25 oC) for 2 hr. 
The supernatant was isolated following centrifugation at 3000 g and all experiments were 
carried out within 24 hr. The Folin-Ciocalteu method as described previously (Singleton 
& Rossi, 1965) was used to measure the antioxidant capacity of the barley, BSG and 
BSG phenolic extracts (P1 - P4; B1 - B4). This assay is based on the ability of a 
compound to reduce the Folin-Ciocalteau reagent (FCR), resulting in a yellow to 
blue/green colour change that is measured spectrophotometrically at 765 nm. The TPC 
assay is non-specific to phenols and measures any reducing agent. Results were expressed 
as milligram gallic acid equivalents per gram dry weight (gdw) barley/whole BSG (mg 
GAE/gdw) and milligram gallic acid equivalents per mL phenolic extract (mg GAE/mL). 
 
3.3.6. Analysis of barley, BSG and BSG phenolic extracts - 2,2-Diphenyl-1-
Picrylhydrazyl (DPPH) assay 
Again it was necessary to perform an extraction procedure for barley and BSG samples 
before determining the DPPH radical scavenging potential of the extracts.  For extraction, 
100 mg barley or BSG was added to 1 mL methanol for 2 hr at room temperature (25 oC), 
followed by centrifugation for 10 min at 3000 g (Sharma & Gujral, 2010). The 
supernatant was used for subsequent analysis and all experiments were carried out within 
- 134 - 
 
24 hr of extraction. The DPPH assay was carried out according to the method described 
previously (Brand-Williams et al., 1995). Known concentrations of Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid), ranging from 0.04 to 0.40 µM were used 
to prepare a standard curve for calibration. To account for background colour in the 
samples, colour blanks were prepared with 100 µL sample and 3.9 mL methanol 
(MetOH) where necessary. Absorbance (at 515 nm) of all samples was determined 
following a 30 min incubation with the DPPH reagent (0.0238 µg/mL). This assay gives a 
measure of antioxidant potential, based on the ability of a compound to scavenge the 
DPPH radical by hydrogen donation. Results were expressed as % DPPH inhibition: 
% DPPH inhibition = [(Absblank - Abssample)/Absblank] x 100 
 
3.3.7. Preparation of fruit beverages 
A total of four commercially available fruit juices or smoothies were purchased from a 
local supermarket; Sungrown Pure White Grape Juice (Tesco, UK), OceanSpray 
Cranberry Classic Juice Drink (OceanSpray Cranberries Inc., MA, USA), Innocent 
Strawberry and Banana Smoothie, Innocent Pomegranate, Blueberry and Acai Smoothie 
(Innocent Drinks, Dublin, Ireland). Samples were aliquoted into 25 mL centrifuge tubes 
and stored at -20 oC until analysis. For fortified samples, BSG phenolic extracts, P2 and 
B2, were added at 2.5 and 10 % (v/v) to a final volume of 6 mL prior to freezing. 
Previous research has been carried out using BSG phenolic extracts at a non-toxic 
concentration of 2.5 % (v/v) in cellular bioactivity assays (McCarthy et al., 2012). 
Fortification of foods with whole BSG (ranging from 0 – 30 %) has also been carried out 
(Stojceska & Ainsworth, 2008; Özvural et al., 2009; Öztürk et al., 2002), however due to 
varying effects on consumer acceptability, a maximum level of addition of 10 % BSG 
phenolic extracts was chosen. All samples were analysed before and after in vitro 
digestion.  
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3.3.8. In vitro digestion of fruit beverages 
Fruit beverage samples were subjected to in vitro digestion, using a procedure described 
elsewhere (O'Connell et al., 2007). Briefly, sample (1 mL) was diluted to a volume of 10 
mL with Hank’s balanced salt solution (HBSS) and digested with pepsin (0.04 g/mL) at 
pH 2 and 37 oC for 1 hr in a shaking waterbath. Bile salts, consisting of 
glycodeoxycholate (0.8 mmol/L), taurodeoxycholate (0.45 mmol/L), taurocholate (0.75 
mmol/L), and  pancreatin (0.08 g/ml) were added, followed by a digestion period of 2 hr 
at 37 oC and pH 7.4 in a shaking waterbath. Samples were then ultracentrifuged at 53000 
rpm for 95 min and the aqueous supernatant (digestate) was filtered through a 0.22 µm 
filter, overlaid with a layer of nitrogen and stored at -80 oC until further analysis. The 
TPC, DPPH radical scavenging and FRAP were measured on all beverages prior to and 
following in vitro digestion. 
 
3.3.9. Analysis of the antioxidant potential of fruit beverages 
The TPC and DPPH assays were conducted as detailed above. The ferric reducing 
antioxidant power (FRAP) assay (Benzie & Strain, 1996), which is based on the 
reduction of ferric (Fe3+) to ferrous (Fe2+) was used to determine the reducing power of 
the samples. The reduction of Fe3+ to Fe2+ is measured spectrophotometrically at 593 nm. 
To allow for coloured samples, colour blanks were used consisting of 100 µL sample and 
2.9 mL distilled H2O. For calibration, 0 - 100 µM ferrous sulphate heptahydrate 
(FeSO4.7H2O) was used and results were expressed as µM FRAP.  
 
3.3.10. Statistical Analysis 
Statistical analysis was carried out using GraphPad Prism 4.00 (GraphPad Software, San 
Diego, California, USA). Data were analysed by one-way analysis of variance (ANOVA) 
followed by Dunnett’s test, or Tukey’s test where stated, to determine significant (P < 
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0.05) differences between samples. The paired t-test was used for correlation statistics, 
with P < 0.05 indicating significant correlations. 
 
3.4. Results 
3.4.1. Hydroxycinnamic acid content of barley, BSG and phenolic extracts 
The total hydroxycinnamic acid content was similar for both pale and black barley 
samples; having 1259.04 and 1164.34 µg/gdw, respectively (Table 1). The total 
hydroxycinnamic acid content of barley was higher than its corresponding BSG for pale 
and black barley samples. Of the identified compounds, ferulic acid was consistently 
present in highest amounts, followed by p-coumaric acid derivatives and ferulic acid 
derivatives. Both barley samples contained similar concentrations of the three 
predominant hydroxycinnamic acids. Pale BSG had higher concentrations of individual 
and total hydroxycinnamic acids compared to black BSG.  
The hydroxycinnamic acid contents of BSG phenolic extracts (P1 - P4; B1 - B4) 
were also quantified (Table 2). Caffeic acid derivatives were the only identifiable 
hydroxycinnamic acids present in extract P1 and B1. Extracts P2 - P4 and B2 - B4 all 
contain ferulic acid and its derivatives, and p-coumaric acid derivatives. The pale BSG 
extract P4 also contains sinapic acid (20.78 µg/mL).  Caffeic acid was not detected in any 
of the BSG phenolic extracts, and caffeic acid derivatives, which were present in lowest 
concentrations in barley and BSG samples were not detected in extracts P2 - P4 or B2 - 
B4. Similar to their barley equivalents, the pale BSG phenolic extracts contained higher 
concentrations of individual and total hydroxycinnamic acids, compared to the black 
BSG phenolic extracts. The total hydroxycinnamic acid content of P2 (pale BSG) was 
more than 10 fold higher than that of B2 (black BSG). The hydroxycinnamic acid profile 
was altered in the phenolic extracts in comparison to the parent barley and BSG 
 Table 1: The hydroxycinnamic acid content of whole ground barley and whole brewers’ spent grain (BSG) samples. 
Hydroxycinnamic acid Concentration (µg/gdw)  
Pale Barley Pale BSG Black Barley Black BSG 
Ferulic acid 352.13 ± 51.57 142.29 ± 24.17* 338.05 ± 7.71 62.92 ± 13.46* 
Ferulic acid derivatives 100.40 ± 30.33 66.37 ± 1.75 92.79 ± 4.23 27.56 ± 2.79 
Caffeic acid 8.42 ± 1.02 2.78 ± 0.15* 7.44 ± 0.22 1.33 ± 0.67* 
Caffeic acid derivatives 7.91 ± 0.88 3.64 ± 1.28 4.33 ± 1.88 3.68 ± 1.48 
p-Coumaric acid 67.45 ± 0.97 42.66 ± 0.13*# 66.66 ± 0.79 18.83 ± 0.34* 
p-Coumaric acid derivatives 126.81 ± 1.45 70.90 ± 0.85*# 122.27 ± 2.21 27.98 ± 1.53* 
Unknown 595.92 ± 12.29 226.64 ± 7.72*# 532.79 ± 5.06 95.38 ± 3.29* 
Total 1259.04 ± 69.26 555.29 ± 29.99*# 1164.34 ± 12.36 237.70 ± 23.55* 
Data represents the mean ± SE of two independent experiments. Statistical analysis by ANOVA followed by Tukey’s 
multiple comparison test. * Denotes statistically significant (P < 0.01) difference between value for  whole BSG and 
corresponding barley sample. # Denotes statistically significant (P < 0.05) difference between value for pale BSG and 
corresponding value for black BSG. 
 
 
 
Data represents the mean ± SE of two independent experiments. Statistical analysis by ANOVA followed by Tukey’s multiple comparison test. * Denotes 
statistically (P < 0.01) significant difference between value and corresponding value for black BSG phenolic extracts. CA, caffeic acid; deriv, derivatives; FA, 
ferulic acid;  p-CA, p-coumaric acid; SA, sinapic acid. 
 
 
Table 2: The hydroxycinnamic acid content of BSG phenolic extracts (P1 - P4, B1 - B4). 
Hydroxycinnamic 
acid 
Concentration (µg/mL) 
 P1 P2 P3 P4 B1 B2 B3 B4 
FA - 534.28 ± 9.07* 1306.06 ± 32.25* 563.50 ± 20.89* - 169.62 ± 1.18 176.50 ± 8.59 129.81 ± 26.75 
FA deriv. - 779.90 ± 13.69* 363.05 ± 10.50* 289.25 ± 13.23* - 26.81 ± 1.87 30.55 ± 0.88 26.75 ± 0.32 
CA - - - - - - - - 
CA deriv. 19.04 ± 0.07* - - - 4.27 ± 3.03 - - - 
p-CA - - - - - - - - 
p-CA deriv. - 2977.67 ± 4.77* 845.23 ± 1.68* 96.40 ± 0.26 - 212.63 ± 15.95 256.01 ± 2.60 53.16 ± 0.14 
SA - - - 20.78 ± 0.04 - - - - 
Unknown 11.58 ± 0.32* 723.63 ± 19.01* 270.15 ± 18.54* 121.05 ± 11.52 22.89 ± 1.20 71.48 ± 5.07 42.99 ± 0.61 103.53 ± 6.78 
Total 30.62 ± 0.39 5015.49 ± 19.16* 2784.50 ± 4.90* 1090.98 ± 4.17* 27.16 ± 1.83 480.54 ± 21.72 506.04 ± 9.70 313.25 ± 12.63 
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particularly in samples P2, B2 and B3 and the predominant hydroxycinnamic acids were 
the p-coumaric acid derivatives and not ferulic acid.  
 
3.4.2. TPC and DPPH radical scavenging of barley, BSG and phenolic extracts 
The TPC of the barley and BSG samples ranged from 1.26 - 4.53 mg GAE/g (Table 3). In 
general, the TPC trend as determined by Folin-Ciocalteu was similar to the trend of total 
hydroxycinnamic acid content of the barley and BSG samples as determined by HPLC 
with the exception of the black BSG which had the lowest total hydroxycinnamic acid 
content and the highest TPC. The DPPH scavenging activity ranged from 10.89 % for 
black barley to 17.18 % for pale barley (Table 3). The BSG phenolic rich extracts had 
TPC in the order P2 / B2 > P3 / B3 > P4 / B4 > P1 / B1 (Table 3).  Correlation statistics 
suggest a significant (P < 0.05) correlation between DPPH inhibition and both caffeic 
acid (R2 = 0.8309) and total hydroxycinnamic acid (R2 = 0.3942) concentrations.  
 
3.4.3. Antioxidant potential of fortified fruit beverages before and after digestion  
The TPC of the juices and smoothies ranged from 0.37 to 2.15 mg GAE/mL (Table 4). 
The addition of BSG phenolic extracts P2 and B2 to the juices and smoothies at 
concentrations of 2.5 % and 10 % did not significantly enhance their TPC (Table 4).  The 
addition of 2.5 % and 10 % P2 equates to the addition of 125.39 µg and 501.55 µg 
hydroxycinnamic acids per ml of juice, respectively. The addition of 2.5 % and 10 % B2 
equates to the addition of 12.01 µg and 48.05 µg hydroxycinnamic acids per mL of juice, 
respectively.  The TPC of the pomegranate smoothie was significantly decreased (P < 
0.05) due to dilution with the phenolic extracts which had a lower TPC than the smoothie 
itself. The DPPH scavenging activity of the smoothies (10.95 and 11.11 %) was also 
higher than that of the juices (7.18 and 8.08 %). Addition of the phenolic extracts did not 
significantly alter the scavenging activity of the juices and smoothies (Table 4). 
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Table 3: Total phenolic content (TPC) and DPPH radical scavenging activity of 
whole ground barley, whole brewers’ spent grain (BSG) and phenolic enriched 
extracts of BSG. 
Sample TPC 
(mg GAE/gdw) 
DPPH scavenging 
(%) 
Pale barley 2.08 ± 0.06  17.18 ± 0.69 
Pale BSG    1.26 ± 0.10*# 14.19 ± 0.91 
Black barley 1.88 ± 0.14  10.89 ± 2.64 
Black BSG    4.53 ± 0.16* 17.01 ± 5.11 
 (mg GAE/mL)  
P1 0.01 ± 0.01  14.88 ± 0.06 
P2 0.34 ± 0.01    7.35 ± 1.77  
P3 0.17 ± 0.01     6.78 ± 1.98  
P4 0.05 ± 0.00     5.33 ± 1.42  
B1 0.06 ± 0.00    5.81 ± 0.40 
B2   0.50 ± 0.02† 12.62 ± 1.83 
B3 0.19 ± 0.01  10.17 ± 2.21 
B4   0.14 ± 0.01†  9.10 ± 2.03 
Data represents mean ± SE of four independent experiments. Statistical analysis by 
ANOVA followed by Tukey’s multiple comparison test. * Denotes statistically 
significant (P < 0.01) difference between TPC of whole BSG and corresponding 
barley sample.  # Denotes statistically significant (P < 0.001) difference between 
TPC of pale BSG and black BSG. † Denotes statistically significant (P < 0.001) 
difference between TPC of black BSG extract and corresponding pale BSG extracts. 
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Table 4: Antioxidant activity of fruit beverages supplemented with BSG phenolic extracts. 
Sample TPC 
(mg GAE/mL) 
DPPH scavenging 
(%) 
FRAP 
(µM) 
Grape 
Juice 
Control 0.66 ± 0.07  8.08 ± 1.19  144.87 ± 31.45  
2.5 % (v/v) P2 0.54 ± 0.07 7.77 ± 1.85  130.82 ± 23.13  
 10 % (v/v) P2 0.65 ± 0.09  7.92 ± 1.22  89.05 ± 22.41  
 2.5 % (v/v) B2 0.47 ± 0.06  6.10 ± 1.21  112.12 ± 19.34  
 10 % (v/v) B2 0.91 ± 0.18  6.15 ± 0.12  149.73 ± 16.87 
Cranberry 
Juice 
Control 0.37 ± 0.03  7.18 ± 0.34  118.07 ± 41.72  
2.5 % (v/v) P2 0.54 ± 0.12  9.65 ± 2.03  217.77 ± 34.23*  
 10 % (v/v) P2 0.53 ± 0.05 8.67 ± 1.47    260.57 ± 37.72*  
 2.5 % (v/v) B2 0.41 ± 0.03  7.99 ± 1.48    266.07 ± 34.23*  
 10 % (v/v) B2 0.48 ± 0.01  7.99 ± 1.13   256.21 ± 29.91*    
Strawberry 
Smoothie 
Control 1.24 ± 0.01  10.95 ± 1.20  399.72 ± 35.62  
2.5 % (v/v) P2 1.27 ± 0.03  10.28 ± 1.12   407.48 ± 37.37  
 10 % (v/v) P2 1.43 ± 0.19  8.33 ± 0.93  391.23 ± 42.73  
 2.5 % (v/v) B2 1.33 ± 0.15  9.22 ± 1.69  430.66 ± 48.73  
 10 % (v/v) B2 1.29 ± 0.07  9.22 ± 0.18  439.30 ± 69.00  
Pomegranate 
Smoothie 
Control 2.15 ± 0.15  11.11 ± 0.53  545.15 ± 82.96  
2.5 % (v/v) P2  1.63 ± 0.06*  8.71 ± 2.11   516.64 ± 82.44  
 10 % (v/v) P2  1.66 ± 0.15*  12.15 ± 1.09   512.80 ± 86.18  
 2.5 % (v/v) B2  1.54 ± 0.05*  9.83 ± 0.06   513.27 ± 83.61  
 10 % (v/v) B2  1.49 ± 0.12*  10.87 ± 1.57    506.28 ± 64.08  
Data represents the mean ± SE of at least three independent experiments. Statistical analysis by ANOVA 
followed by Tukey’s multiple comparison test. * Denotes statistically significant (P < 0.05) difference 
between supplemented and unsupplemented beverage. Values in brackets represent the antioxidant 
activity, expressed as % of fruit beverage controls. 
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The FRAP activity of the unsupplemented juices and smoothies ranged from 
118.07 to 545.15 µM FRAP. FRAP activity was significantly increased (P < 0.05) in the 
cranberry juice with added BSG phenolic extracts compared to the unsupplemented 
cranberry juice (Table 4). 
Following in vitro digestion, no significant difference in TPC, DPPH radical 
scavenging or FRAP between the juices or smoothies with or without the addition of 
phenolic extracts was found (Table 5). The DPPH radical scavenging activity was similar 
for both the juices and the smoothies after digestion, however, FRAP values remained 
higher in the smoothies than in the juices following digestion. In vitro digestion resulted 
in significant (P < 0.05) decreases in bioactivity of the juices and smoothies samples.    
 
3.5. Discussion 
The predominant hydroxycinnamic acid found in each of the barley samples was ferulic 
acid and its concentration ranged from 338.05 - 352.13 µg/gdw (Table 1). This 
concentration of ferulic acid was higher than that previously reported for barley (159.70 - 
231.30 µg/gdw) (Dvorakova et al., 2008). Similar to a previous study, the concentration of 
hydroxycinnamic acids present in barley was in the order of ferulic acid > p-coumaric 
acid > caffeic acid (Dvorakova et al., 2008). In addition, greater quantities of derivatives 
of ferulic and p-coumaric acid were found in comparison to caffeic acid derivatives. 
Phenolic acid derivatives present in both barley and BSG seem to be glycosides with 
pentoses and hexoses. While the profile of hydroxycinnamic acids present in barley has 
been found to be similar in a number of studies (Dvorakova et al., 2008; Holtekjølen et 
al., 2006), there was considerable variation in the total quantities measured which could 
result from the difference in barley cultivars (Holtekjølen et al., 2006; Zhao et al., 2008) 
and more importantly the presence or absence of hull (Holtekjølen et al., 2006).  
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Table 5: Antioxidant activity of fruit beverages supplemented with BSG phenolic extracts, following in 
vitro digestion. 
Sample TPC 
(mg GAE/mL) 
DPPH scavenging 
(%) 
FRAP 
(µM) 
Grape 
Juice 
Control 0.21 ± 0.02*  10.06 ± 2.83*  7.35 ± 1.95*  
2.5 % (v/v) P2 0.19 ± 0.02  14.62 ± 3.25*  6.60 ± 2.23* 
 10 % (v/v) P2 0.20 ± 0.01  12.87 ± 2.39*  6.23 ± 1.27*  
 2.5 % (v/v) B2 0.18 ± 0.01  12.79 ± 2.80*  5.88 ± 1.49*  
 10 % (v/v) B2 0.18 ± 0.01*  12.55 ± 3.01*  5.24 ± 1.40*  
Cranberry 
Juice 
Control 0.17 ± 0.03  9.50 ± 1.96  8.18 ± 2.09*  
2.5 % (v/v) P2 0.19 ± 0.00*  9.13 ± 6.94  7.49 ± 2.87*  
 10 % (v/v) P2 0.20 ± 0.01*   14.46 ± 2.39*  7.88 ± 2.06*  
 2.5 % (v/v) B2 0.18 ± 0.02  14.28 ± 3.33  4.41 ± 2.00*  
 10 % (v/v) B2 0.12 ± 0.05 14.48 ± 3.00  3.26 ± 0.92*  
Strawberry 
Smoothie 
Control 0.20 ± 0.02*  11.46 ± 1.87*  13.85 ± 2.32*  
2.5 % (v/v) P2 0.20 ± 0.01*  10.62 ± 3.63*  10.22 ± 1.06*  
 10 % (v/v) P2 0.22 ± 0.01*  8.06 ± 1.70*  12.81 ± 2.44*  
 2.5 % (v/v) B2 0.23 ± 0.02*  11.02 ± 3.79*  10.59 ± 0.47*  
 10 % (v/v) B2 0.22 ± 0.03*  6.91 ± 0.82*  9.77 ± 0.35*  
Pomegranate 
Smoothie 
Control 0.20 ± 0.03*  11.84 ± 2.74*  19.35 ± 2.20*  
2.5 % (v/v) P2 0.20 ± 0.01*  5.50 ± 4.01*  13.97 ± 3.65*  
 10 % (v/v) P2 0.19 ± 0.00*  10.28 ± 2.27*  12.43 ± 0.84*  
 2.5 % (v/v) B2 0.20 ± 0.00* 9.13 ± 2.67*  17.09 ± 2.55*  
 10 % (v/v) B2 0.20 ± 0.00*  10.43 ± 1.60*  15.20 ± 1.76*  
Data represents the mean ± SE of at least three independent experiments. * Denotes statistically 
signficant (P < 0.05) difference between undigested (Table 4) and digested values. 
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Environmental factors, including soil type, sun exposure and climatic conditions, also 
affect polyphenol concentration (Manach et al., 2004). The order of hydroxycinnamic 
acids detected in BSG was in similar order to those present in barley, as outlined above. 
These support previous findings regarding phenolic acids in BSG, where ferulic acid was 
found to be in highest abundance followed by p-coumaric, sinapic and caffeic acids 
(Dvorakova et al., 2008). 
Extracts P1 and B1, which are aqueous extracts of BSG, were the only extracts 
found to contain caffeic acid derivatives (Table 2). This suggests that the polar caffeic 
acid derivatives in BSG are in the free form, since aqueous extraction releases the free, 
water-soluble phenolics. Caffeic acid derivatives present may be isomers esterified with 
syringic acid, a hydroxybenzoic acid, present in BSG (Mussatto et al., 2007). The 
presence of caffeic acid derivatives at higher concentrations in P1 compared to B1 may 
be responsible for the high antioxidant activity shown by extract P1, as caffeic acid has 
previously been shown to have higher antioxidant activity than other hydroxycinnamic 
acids (Kikuzaki et al., 2002). Extracts P2 - P4 and B2 - B4 contain the bound phenolic 
compounds, released with sodium hydroxide (McCarthy et al., 2012). Extraction with 1N 
NaOH resulted in extracts with highest HA concentrations, for example, extracts P2/B2 
and P3/B3. Ferulic acid, ferulic acid derivatives (assuming dehydrodiferulic acid isomers) 
and p-coumaric acid derivatives were the hydroxycinnamic acids present in these 
extracts, suggesting they are present in the bound form in BSG. It has been reported that 
extraction with aqueous HCl alone destroys hydroxycinnamic acids, while ethanol 
extraction can give low yield (Gao & Mazza, 1994).  
It is evident that the brewing process causes a reduction in hydroxycinnamic acid 
concentration as barley had a higher content of hydroxycinnamic acids than BSG (Table 
1). Furthermore, differences in hydroxycinnamic acid content between pale BSG and 
black BSG suggest that roasting of the grain, in the case of black BSG, reduces the 
- 145 - 
 
concentration of hydroxycinnamic acids present. Black BSG had higher TPC and DPPH 
activity than barley and pale BSG samples (Table 3). The Folin-Ciocalteu method is not 
specific to phenolic compounds, but measures any compound which is capable of 
reducing FCR (Huang et al., 2005). Increased antioxidant activity may be attributable to 
non-enzymatic browning Maillard reaction products (MRPs), which can act as 
antioxidants (Samaras et al., 2005). Similarly, the roasting of coffee results in the 
transformation of phenolic compounds to brown high molecular weight MRPs including 
melanoidins (del Castillo et al., 2002). Results of the present study support previous 
findings that although thermal treatments can reduce the concentration of natural 
antioxidants in a product, the overall antioxidant activity of the product is maintained or 
enhanced through production of MRPs (Nicoli et al., 1997). 
Caffeic acid and total hydroxycinnamic acid concentrations of the barley, BSG 
and extracts were correlated with DPPH radical scavenging ability (R2 = 0.86309 and R2 
= 0.3942, respectively, P < 0.05). Evidence in the literature is contradictory regarding the 
phenolic profile of substances and their antioxidant activity. Some studies report close 
correlations between TPC and DPPH scavenging (Lee et al., 2010;  Zhao et al., 2008), 
while others have reported the absence of a correlation between antioxidant capacity and 
hydroxycinnamic acid content (Chinnici et al., 2004) or TPC (Heimler et al., 2006). It has 
been suggested that interference by other substances can affect the correlation between 
radical scavenging activity and phenolic content (Stratil et al., 2006), since the TPC assay 
measures the presence of any reducing agent including inorganic ions, vitamins and 
nitrogen containing compounds and not just phenolic compounds (Huang et al., 2005).  
Phenolic rich extracts P2 and B2 which had the highest hydroxycinnamic acid 
contents of the BSG extracts (Table 2) were selected for addition to fruit juices and 
smoothies in order to determine if the antioxidant potential of the juices could be 
enhanced before and after an in vitro digestion procedure.  
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White grape juice was found to have a higher antioxidant activity than cranberry 
juice (Table 4). The antioxidant activity of the smoothies was higher than that of the fruit 
juices. It has been suggested that combinations of different phenolic compounds, as is the 
case in fruit smoothies, can result in a synergistic antioxidant effect (Cirico & Omaye, 
2006). Results from the present study showed that the addition of the BSG phenolic 
extracts (P2 and B2) did not significantly increase TPC or the DPPH radical scavenging 
activity of the juices and smoothies as the extracts had a similar TPC to the fruit juices 
and a lower TPC than the smoothies (Table 4). However, there was a significant increase 
in the FRAP activity of the cranberry juice with added phenolic extracts, possibly due to 
interactions between different phenolic compounds which can result in a synergistic 
antioxidant effect, as previously mentioned (Cirico & Omaye, 2006).  
The hydroxycinnamic acid in highest concentration in BSG is ferulic acid 
(Dvorakova et al., 2008). Ferulic acid was found in the phenolic extracts used for this 
study, P2 and B2, at levels of 534.28 ± 9.07 and 169.62 ± 1.18 µg/ml, respectively (Table 
2).  It has been shown that ferulic acid can interact synergistically with other antioxidants 
including ascorbic acid, α-tocopherol and β-carotene (Trombino et al., 2004).  
It has been reported that antioxidant activity of selected fruit juices (cranberry, red 
grape, pomegranate and long life orange juices) increases following digestion, possibly 
due to an increase in anthocyanins (Ryan & Prescott, 2010). However, it has also been 
shown that the in vitro digestion of fruit beverages can decrease the phenolic 
concentration, due to alkaline conditions and interactions between polyphenols and 
enzymes (Cilla et al., 2009). Stalmach et al. (2012) showed that hydroxycinnamic acids 
are relatively stable during simulated gastric and duodenal digestion, in comparison with 
other polyphenolic compounds, with an average recovery of 82 % following in vitro 
digestion. Therefore, we postulated that addition of BSG extracts to fruit juices may 
result in an increased antioxidant activity following digestion as the stability of the added 
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BSG phenolics, which have a high content of hydroxycinnamic acids, may be greater 
than that of the polyphenols inherent in the fruit juices during the digestive process. 
However, under the conditions of the present experiment there were no significant 
differences in the antioxidant activity of fruit beverages with or without added BSG 
phenolics following an in vitro digestion procedure. It is noteworthy that the protective 
effects of phenolic compounds, including antioxidant, can occur within the 
gastrointestinal (GI) tract before absorption (Halliwell et al., 2000). This may account for 
the ability of foods rich in phenolic compounds to protect against gastric and oral cancers, 
for example catechins from tea can arrest growth and induce apoptosis in oral cancer 
(Masuda et al., 2001). The benefits of supplementation with BSG may be more apparent 
in a food system with a lower hydroxycinnamic acid or total polyphenol content.  
 
3.6. Conclusion 
This study has shown the main hydroxycinnamic acids in barley and BSG to be ferulic 
and p-coumaric acid and their derivatives. The bound hydroxycinnamic acids in BSG are 
ferulic acid and p-coumaric acid derivatives, which are released by alkaline extraction. 
Caffeic acid was the only free phenolic acid identified and was significantly correlated to 
DPPH scavenging activity, as was total hydroxycinnamic acid content. In addition, it was 
shown that the brewing process decreases the amount of hydroxycinnamic acids present. 
Roasting of the barley grain (to produce black BSG) resulted in a greater decrease in 
hydroxycinnamic acid content, compared to unroasted, while the greater antioxidant 
activity in black BSG may be attributable to MRPs. Furthermore, the present study 
highlights the potential of BSG phenolic extracts to be incorporated as antioxidants into 
functional foods, significantly increasing FRAP activity of cranberry juice. This study 
warrants further investigation of the fortification of foods with BSG phenolic extracts. It 
may be that more beneficial effects may be observed if these extracts are added to foods 
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with a lower antioxidant profile. The application of BSG phenolic extracts in food 
formulation presents a means of utilising this co-product, thus reducing brewery waste, 
while also providing a novel source of functional food ingredients for the food industry. 
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4.1. Abstract 
Large quantities of brewers’ spent grain (BSG), a co-product of the brewing industry, are 
produced annually. BSG contains hydroxycinnamic acids, and phenolic-rich extracts 
from BSG have previously demonstrated the ability to protect against oxidant-induced 
DNA damage. The present study investigated the anti-inflammatory potential of eight 
phenolic extracts from BSG, four pale (P1 - P4) and four black (B1 - B4) extracts.  
BSG extracts were more cytotoxic in Jurkat T than U937 cells, with lower IC50 values in 
Jurkat T cells, measured using the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. Pale BSG extracts P2 and P3 showed the greatest anti-
inflammatory potential; significantly (P < 0.05) reducing interleukin-2 (IL-2), 
interleukin-4 (IL-4, P2 only), interleukin-10 (IL-10) and interferon-γ (IFN-γ) production. 
In addition, extracts P1 - P3 and B2 - B4 showed significant (P < 0.05) antioxidant 
effects, determined by the cellular antioxidant activity assays: superoxide dismutase 
(SOD), catalase (CAT) and glutathione content (GSH).  
Phenolic extracts from BSG, particularly the pale BSG extracts, have the ability to reduce 
a stimulated cytokine production and may also protect against cellular oxidative stress. 
Results of the present study highlight the potential of BSG phenolic extracts to act as 
functional food ingredients, providing an alternative use and improving the value of this 
brewing industry co-product.   
 
4.2. Introduction 
Beer is the fifth most consumed beverage in the world after tea, carbonates, milk and 
coffee (Fillaudeau et al., 2006), with an average consumption in Europe of 72.8 litres per 
capita in 2011 (The Brewers of Europe, online article). Brewers’ spent grain (BSG) is a 
solid co-product of the brewing industry, corresponding to around 85 % of total brewing 
by-products (Reinold, 1997). Currently, the utilisation of BSG is mainly restricted to 
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animal feed, particularly for dairy cattle. However, due to the large quantities produced 
and increasing transport costs, alternative uses are sought. BSG has a number of potential 
applications including energy production (direct combustion or fertilisation to produce a 
biogas), biotechnological processes (substrates for microbial cultivation and enzyme 
production) and human nutrition (Mussatto et al., 2006). Due to its low cost and 
favourable nutritional composition (20 % protein, 70 % fibre; Mussatto et al., 2006), 
BSG has been investigated as a potential ingredient for human nutrition. Both pale and 
black (where barley is roasted to 200 oC prior to brewing) BSG are sources of 
hydroxycinnamic acids, particularly ferulic and p-coumaric acids and their derivatives, 
with total hydroxycinnamic acid contents of 555.29 and 237.70 µg/gdw, respectively 
(McCarthy et al., 2013).   
Immunomodulatory agents have the ability to influence the immune response, 
either positively or negatively (Pragasam et al., 2013). Inflammation has been linked to 
atherosclerosis (Berliner et al., 1995), Alzheimer’s (Salloway et al., 2008) and 
Parkinson’s disease (Hald & Lotharius, 2005), and immunosuppresants are now widely 
used in the treatment of inflammation and autoimmune diseases (Pragasam et al., 2013). 
For this reason, plant-derived bioactive compounds that possess anti-inflammatory 
properties are in demand.  
In addition to their anti-inflammatory potential, the hydroxycinnamic acids 
present in BSG also possess antioxidant capabilities (Nardini et al., 1995; Chen & Ho, 
1997; McCarthy et al., 2012). Cellular antioxidant enzymes, such as catalase (CAT) and 
superoxide dismutase (SOD), neutralise reactive oxygen species (ROS). CAT is found in 
humans at highest levels in the liver, kidney and erythrocytes and detoxifies hydrogen 
peroxide (H2O2) to oxygen and water. SODs are a group of metalloenzymes that catalyse 
the dismutation of the superoxide anion (O2·-) at an extremely fast rate, keeping 
concentrations in cells and tissues very low. SOD forms a crucial part of the cellular 
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antioxidant defence mechanism. Under conditions of oxidative stress the activity of 
antioxidant enzymes can be altered, owing to adaptation of the cellular antioxidant 
system to ROS production (Mansour et al., 2011).   
The ability of phenolic extracts from BSG to protect against oxidant-induced 
DNA damage in vitro has been previously demonstrated (McCarthy et al., 2012). The 
aim of the present study was to determine the immunomodulatory potential of eight 
phenolic extracts from BSG by measuring the production of four cytokines: interleukin-2 
(IL-2), interleukin-4 (IL-4), interleukin-10 (IL-10) and interferon-γ (IFN-γ), using an 
enzyme-linked immunosorbent assay (ELISA) in the Jurkat T cell line (human leukaemic 
T cell line). In addition, the ability of BSG phenolic extracts to protect against oxidation 
induced by H2O2 in a human monocytic blood cell line (U937 cells) was measured using 
the CAT, GSH and SOD assays.  
 
4.3. Materials and Methods 
4.3.1. Materials 
All chemicals and reagents were purchased from Sigma-Aldrich Ireland Limited, Co. 
Wicklow, Ireland, unless otherwise stated. U937 and Jurkat T cells were obtained from 
the European Collection of Animal Cell Cultures (ECACC, Salisbury, Wilts, UK). 
 
4.3.2. Generation of phenolic extracts from BSG 
A total of eight phenolic extracts were prepared from pale (P1 - P4) and black (B1 - B4) 
BSG, as described previously (McCarthy et al., 2012).  Briefly, P1 and B1 were the 
supernatants produced by centrifugation, following shearing in H2O. The precipitate was 
subjected to 110 mM NaOH extraction and following centrifugation, the supernatants 
were designated P4 and B4. Extracts P2 and B2 were the supernatant fractions obtained 
by 110 mM and 1N NaOH extraction followed by centrifugation. Sediment remaining 
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from this step was washed with H2O to yield extracts P3 and B3.  All samples were 
adjusted to pH 7.0 prior to analysis, using either 2 N NaOH or 2 N HCl, as appropriate. 
 
4.3.3. Cell culture 
A leukaemic monocytic lymphoma cell line, U937 cells, and a human leukaemic T cell 
line, Jurkat T cells, were maintained at 37 oC in a 5 % CO2 atmosphere, in antibiotic-free 
medium (RPMI-1640) supplemented with 10 % foetal bovine serum (FBS). For 
experiments, reduced serum media was used (2.5 % FBS). Cells were adjusted to a 
density of either 1 x 105 cells/mL or 2 x 105 cells/mL, as appropriate, for each 
experiment. 
 
4.3.4. Cell viability assay 
Viability of U937 and Jurkat T cell lines was measured by the (3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay to determine subtoxic concentrations 
of the BSG phenolic extracts for subsequent experiments.  U937 or Jurkat T cells (2 x 105 
cells/mL) were exposed to BSG phenolic extracts at concentrations of 0 - 20 % and 0 - 10 
% (v/v), respectively, for 24 hr at 37 oC in a 96 well plate.  Following incubation, an 
MTT assay kit (MTT I proliferation kit, Roche Diagnostics, UK) was used to carry out 
the assay. MTT reagent 1 (10 µL) was added and cells were incubated for a further 4 hr at 
37 oC.  MTT reagent 2 (100 µL) was then added and cells were incubated for 24 hr at 37 
oC. The absorbance was measured on a microplate reader (ThermoScientific Varioskan 
Flash) at 570 nm. A media blank (no cells) was used to correct for the background colour 
of the BSG samples. The half maximal inhibitory concentration (IC50) values were 
determined using GraphPad Prism 4 and expressed as % (v/v). Using data from previous 
work (McCarthy et al., 2012), coupled with results of the MTT assay and IC50 values, a 
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concentration of 2.5 % (v/v) BSG phenolic extracts was selected for further analysis in 
the U937 cells.  A concentration of 5 % (v/v) BSG phenolic extracts was selected for 
addition to the Jurkat T cells stimulated with concanavalin A (which stimulates cell 
proliferation and cytokine production). Cell viability was greater than 90 % for all 
cytokine assay conditions.   
 
4.3.5. Enzyme-linked immunosorbent assay (ELISA)  
Jurkat T cells (2 x 105 cells/mL) were incubated with BSG phenolic extracts (5 % v/v) in 
a 96 well plate for 24 hr at 37 oC, in the presence of Concanavalin A (conA, 50 µg/mL). 
ELISA kits (eBioscience Human Th1/Th2 ELISA Ready-SET-Go kit, Insight 
Biotechnology, UK) were used to determine the production of IL-2, IL-4, IL-10 and IFN-
γ. Sample absorbance was measured at 450 nm on a microplate reader (ThermoScientific 
Varioskan Flash) and data were expressed as a percentage of the ConA stimulated Jurkat 
T cell control.  
 
4.3.6. Antioxidant assays- superoxide dismutase, glutathione, catalase 
U937 cells (1 x 105 cells/mL, 5 mL) were incubated with BSG phenolic extracts (2.5 % 
v/v) for 24 hr at 37 oC. Following incubation, cells were exposed to either 100 µM H2O2 
(superoxide dismutase and glutathione assays) or 200 µM H2O2 (catalase assay) for 60 
min. Cells were harvested, sonicated and centrifuged (800 rpm, 10 min) and the 
supernatant was collected for the determination of antioxidant enzyme activity.  
SOD activity was measured using a Calbiochem SOD Assay Kit II (Merck 
Chemicals Ltd.) according to the protocol provided with the kit and sample absorbance 
was determined at 450 nm using a microplate reader (ThermoScientific Varioskan Flash). 
The GSH content of the cells was measured according to a method described previously 
(Hissin & Hilf, 1976). Briefly, 100 µL sample was mixed with sodium phosphate-
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ethylenediamine tetraacetic acid buffer (1.8 mL) and σ-phthaldialdehyde (0.1 mg). The 
fluorescence intensity of the samples was determined (ThermoScientific Varioskan Flash 
microplate reader) at wavelengths of 350 nm (absorption) and 420 nm (emission). The 
GSH content of the samples was determined from a standard curve (0 - 25 µM GSH). 
CAT activity was measured using a Calbiochem catalase assay kit (Merck Chemicals 
Ltd.). The absorbance was measured at 540 nm using a microplate reader 
(ThermoScientific Varioskan Flash) and a standard curve consisting of formaldehyde (0 - 
75 µM) was used for determining CAT activity. SOD, GSH and CAT activity were 
determined relative to the protein content as SOD units/mg protein in cell homogenate 
(U/mg protein), µM GSH/mg protein and nmol CAT/min/ml, respectively.  The protein 
content of the samples was quantified by the bicinchoninic acid (BCA) protein assay as 
previously described (Smith et al., 1985). Data were expressed as a percentage of 
untreated, control cells. 
 
4.3.7. Statistical analysis 
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was carried out using GraphPad Prism version 4.00 for 
Windows (GraphPad software, San Diego, California, USA). Data was analysed using 
one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.  
Statistical significance was determined at P < 0.01 or P < 0.05. 
 
4.4. Results 
4.4.1. Cell viability 
The IC50 value indicates the concentration of a compound needed to reduce cell viability 
to 50 % of control, untreated cells.  In general, BSG phenolic extracts were more 
cytotoxic in the Jurkat T cell line (Table 2) than in the U937 cell line (Table 1). 
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Therefore, IC50 values were lower in the Jurkat T cells, where determinable; for example 
IC50 values of 8.92 % (U937) versus 3.45 % (Jurkat T) and 5.23 % (U937) versus 2.48 % 
(Jurkat T) for P2 and B3, respectively (Table 3). Extract P4 was the least cytotoxic with 
93 % U937 cell viability at 4 % (v/v) and 91 % Jurkat T cell viability at 8 % (v/v) (Tables 
1 and 2). A non-toxic concentration of 2.5 % (v/v) was selected for analysis of the 
antioxidant activity in U937 cells. The Jurkat T cells were stimulated with conA to 
produce pro-inflammatory cytokines and incubated with 5 % (v/v) BSG phenolic 
extracts. Cell viability in Jurkat T cell co-incubated with ConA and 5 % (v/v) BSG 
phenolic extracts were not lower than 90 % (data not shown).   
 
4.4.2. Immunomodulatory effects of BSG phenolic extracts 
The immunomodulatory potential of phenolic extracts from BSG was determined by 
measuring their effect on the production of cytokines IL-2, IL-4, IL-10, IFN-γ in conA-
stimulated Jurkat T cells (Table 4). Extract P2 significantly (P < 0.05) reduced the 
production of all cytokines investigated in the present study by at least 55.33 %, relative 
to the control cells. IFN-γ production was reduced to the greatest extent, with extract P2 
reducing production to 20.05 % that of control conA-stimulated cells. Pale BSG extract, 
P3, also showed anti-inflammatory effects, significantly (P < 0.05) reducing the 
production of IL-2, IL-10 and IFN-γ to 57.67, 27.57 and 46.62 %, respectively. Extract 
B3 was the only black BSG extract which demonstrated a significant immunomodulatory 
effect, significantly (P < 0.05) reducing IFN-γ production to 55.82 % of the conA-
stimulated, control cells.  
Values represent the mean ± SE of four independent experiments. Statistical analysis by ANOVA followed by Dunnett’s test. * Denotes statistically 
significant difference between sample and untreated cells control, P < 0.05.  
 
Table 1: The effect of brewers’ spent grain (BSG) phenolic extracts (0 – 20 % v/v) on cell proliferation in the U937 cell line.  
Concentration 
       (% v/v) 
Cell Proliferation (% of control) 
          P1            P2             P3            P4            B1           B2            B3            B4 
            0  100.00 ± 0.00  100.00 ± 0.00  100.00 ± 3.81  100.00 ± 0.00 100.00 ± 0.00   100.00 ± 0.00  100.00 ± 0.00 100.00 ± 0.00 
          0.5   96.10 ± 2.02  102.57 ± 4.51 87.09 ± 5.77 100.69 ± 2.92 83.30 ± 8.83  101.23 ± 3.10 82.33 ± 4.25 98.57 ± 7.84 
           1   96.18 ± 1.45  103.53 ± 7.43 64.26 ± 7.45* 102.20 ± 8.31  67.04 ± 11.88* 94.13 ± 9.28 79.52 ± 5.67 89.88 ± 3.67 
           2 87.65 ±  0.72  100.74 ± 6.34 61.04 ± 6.25*  98.61 ± 5.65 53.41 ± 8.10*    68.85 ± 2.87 69.91 ± 2.83* 98.11 ± 4.82 
          2.5 73.28 ± 8.81*  104.54 ± 4.88 50.19 ± 7.47* 104.04 ± 6.04 50.81 ± 8.33*  55.31 ± 10.29* 47.81 ± 6.75* 90.41 ± 3.29 
           4 82.66 ± 1.28* 90.97 ± 2.23 59.04 ± 6.05* 93.08 ± 1.75 48.81 ± 6.12* 54.35 ± 8.84* 49.26 ± 5.59* 94.51 ± 2.92 
           5 84.47 ± 2.35 89.33 ± 6.62 59.44 ± 6.94* 86.84 ± 1.81 47.97 ± 4.49* 57.09 ± 8.50* 47.33 ± 4.89* 97.08 ± 4.56 
           6 76.79 ± 2.63* 61.64 ± 6.10* 54.08 ± 6.70* 79.58 ± 3.93* 40.53 ± 4.38* 49.56 ± 7.66* 34.54 ± 2.38* 89.99 ± 4.83 
           8 65.56 ± 6.37* 30.56 ± 5.88* 54.06 ± 5.71* 73.16 ± 6.63* 39.49 ± 4.17* 23.00 ± 4.78* 20.15 ± 6.46* 87.64 ± 3.02 
          10 64.38 ± 4.86* 2.02 ± 2.03* 56.36 ± 7.75* 69.72 ± 6.94* 34.52 ± 3.23* 23.91 ± 3.61*  1.36 ± 0.96* 76.31 ± 4.74* 
          20 49.58 ± 4.35* 5.50 ± 6.73*  17.42 ± 11.24* 59.56 ± 6.33* 31.29 ± 4.23*   33.12 ± 15.04* 11.33 ± 11.21* 60.20 ± 3.98* 
 Table 2: The effect of brewers’ spent grain (BSG) phenolic extracts (0 – 10 % v/v) on cell proliferation in the Jurkat T cell line.  
   Concentration 
         (% v/v) 
Cell Proliferation (% of control) 
          P1            P2             P3            P4            B1           B2            B3            B4 
              0 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 
             0.5   99.55 ± 5.13   77.68 ± 6.34*   60.12 ± 7.94* 97.80 ± 3.89 73.95 ± 10.61* 95.61 ± 6.20 70.31 ± 8.00* 103.06 ± 6.81 
              1   99.81 ± 3.01   77.55 ± 2.46*  55.97 ± 11.35* 91.82 ± 5.32 67.19 ± 8.99* 89.95 ± 3.30 57.06 ± 8.38*  98.10 ± 7.74 
              2   93.63 ± 9.64   57.04 ± 11.55*  51.20 ± 14.44* 86.25 ± 14.39 54.68 ± 6.11*   77.82 ± 11.97* 52.08 ± 9.71*  83.42 ± 10.08 
             2.5 103.65 ± 10.82   59.42 ± 14.06*  53.00 ± 17.03* 98.90 ± 11.29 59.14 ± 4.06* 79.84 ± 2.53* 48.72 ± 9.17*  87.04 ± 9.83 
              4   99.10 ± 11.53   42.14 ± 14.44*  53.82 ± 15.46* 98.11 ± 15.58 59.68 ± 6.36* 68.54 ± 4.00* 20.21 ± 10.35* 86.16 ± 13.70* 
              5   93.94 ± 6.13   17.56 ± 11.85*  57.34 ± 19.89* 98.04 ± 16.00 59.56 ± 2.36* 73.51 ± 13.32* 9.80 ± 8.99*  84.96 ± 5.52 
              6   92.33 ± 4.35   13.34 ± 10.01*  51.99 ± 18.72* 100.02 ± 14.65 57.69 ± 2.79* 64.21 ± 8.55* 5.43 ± 1.04*  78.51 ± 8.04* 
              8   81.83 ± 8.78*     6.79 ± 2.14*  47.93 ± 11.86* 91.43 ± 17.47 53.56 ± 7.75* 48.69 ± 15.92* 4.81 ± 3.52* 79.14 ± 10.12* 
            10   74.85 ± 6.17*       5.48 ± 0.05*   27.52 ± 6.01* 83.98 ± 12.08 40.55 ± 9.28* 23.78 ± 16.48* 2.68 ± 7.93* 71.50 ± 12.63* 
Values represent the mean ± SE of five independent experiments. Statistical analysis by ANOVA followed by Dunnett’s test. * Denotes statistically 
significant difference between sample and untreated cells control, P < 0.05. 
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Table 3: The half maximal inhibitory concentration (IC50) values of phenolic extracts 
from brewers’ spent grain (BSG), in both the U937 and Jurkat T cell lines. 
Sample IC50 (expressed as % (v/v)) 
U937 cell line Jurkat T cell line 
P1 17.45 n/d 
P2 8.92 3.45 
P3 8.82 5.40 
P4 20.89 n/d 
B1 6.97 7.41 
B2 8.09 7.22 
B3 5.23 2.48 
B4 26.09 n/d 
n/d : IC50 value was not determinable from the range of concentrations tested.  
 
 
 
 
 
 
 
 
 
 
 
 
- 164 - 
 
Table 4: The effect of phenolic extracts from brewer’s spent grain (5 % (v/v)) on cytokine 
production in concanavalin-A stimulated Jurkat T cells. 
BSG sample Cytokine production (% of control) 
 IL-2 IL-4 IL-10 IFN-γ 
control 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 
P1 89.34 ± 3.31 85.90 ± 4.99 72.96 ± 9.13 82.80 ± 10.06 
P2 44.67 ± 16.87# 36.70 ± 11.26* 39.15 ± 16.36* 20.05 ± 2.79# 
P3 57.67 ± 6.25* 66.15 ± 8.39 27.57 ± 5.01# 46.62 ± 10.07# 
P4 90.87 ± 8.71 97.46 ± 8.22 56.60 ± 13.09 60.79 ± 7.55 
B1 95.55 ± 2.79 86.18 ± 5.35 73.42 ± 18.79 64.49 ± 9.64 
B2 92.82 ± 9.64 97.84 ± 3.58 127.20 ± 11.35 76.86 ± 11.36 
B3 78.10 ± 5.91 82.81 ± 4.23 50.70 ± 15.39 55.82 ± 6.89* 
B4 108.15 ± 15.16 101.21 ± 1.66 81.99 ± 6.77 73.45 ± 10.62 
Values are mean ± SE of four independent experiments, expressed as a percentage relative to 
cells treated with conA alone. Statistical analysis by ANOVA followed by Dunnett’s test. * P < 
0.01 # P < 0.05, statistically significant difference in cytokine production between control and 
cells treated with BSG phenolic extract.  
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4.4.3. Antioxidant potential of BSG phenolic extracts 
SOD activity was significantly reduced (P < 0.01) to 55.36 % in U937 cells following the 
addition of 100 µM H2O2 for 60 min (Figure 1).  Extracts P1, B2 and B4 significantly (P 
< 0.05) protected against the reduction in SOD activity which was at levels similar to 
control cells in the presence of P1 (98.92 %). An increase in activity above that of control 
cells was detected in cells treated with B2 and B4 (171.73 and 169.85 %, respectively). 
Similarly, exposure of U937 cells to 100 µM H2O2 for 60 min significantly (P < 0.05) 
reduced GSH content to 51.51 % of the control cells (Figure 2). Extracts from pale BSG 
demonstrated the greatest antioxidant effect and samples P1, P2 and P3 significantly (P < 
0.05) protected against H2O2-induced glutathione depletion. Extract B4 also significantly 
(P < 0.05) protected against glutathione depletion in U937 cells exposed to H2O2. Pale 
BSG extracts (P1 - P3) and black BSG extracts (B2 and B3) also significantly (P < 0.05) 
protected against a H2O2-induced decrease in CAT activity (Figure 3).  
 
4.5. Discussion 
Both pale and black BSG contain the hydroxycinnamic acids, ferulic, p-coumaric and 
caffeic acids, with total hydroxycinnamic acid contents of 555.29 and 237.70 µg/gdw, 
respectively (McCarthy et al., 2013)  and phenolic extracts from BSG have previously 
demonstrated the ability to protect against oxidant-induced DNA damage (McCarthy et 
al., 2012). This study aimed to determine if BSG phenolic extracts possess anti-
inflammatory and antioxidant effects in Jurkat T and U937 cells, respectively.  The MTT 
assay was used to determine the cytotoxicity of the BSG phenolic extracts (P1 - P4 and 
B1 - B4) in both cell lines.  It was found that the samples were more cytotoxic in the  
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Figure 1: The antioxidant potential of pale (P) and black (B) brewers’ spent grain (BSG) 
phenolic extracts, measured by their ability to protect against oxidative stress induced by 
hydrogen peroxide (H2O2) in the U937 cell line, using the superoxide dismutase (SOD) assay. 
Values represent the mean ± SE of three independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s test. * Denotes statistically significant difference in SOD activity 
between control and H2O2 control, P < 0.01. # Denotes statistically significant difference in SOD 
activity between sample and H2O2 control, P < 0.05. 
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Figure 2: The antioxidant potential of pale (P) and black (B) brewers’ spent grain (BSG) 
phenolic extracts, measured by their ability to protect against oxidative stress induced by 
hydrogen peroxide (H2O2) in the U937 cell line, using the glutathione (GSH) assay. Values 
represent the mean ± SE of three independent experiments. Statistical analysis by ANOVA 
followed by Dunnett’s test. * Denotes statistically significant difference in GSH content between 
control and H2O2 control, P < 0.05. # Denotes statistically significant difference in GSH content 
between sample and H2O2 control, P < 0.05. 
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Figure 3: The antioxidant potential of pale (P) and black (B) brewers’ spent grain (BSG) 
phenolic extracts, measured by their ability to protect against oxidative stress induced by 
hydrogen peroxide (H2O2) in the U937 cell line, using the catalase (CAT) assay. Values 
represent the mean ± SE of three independent experiments. Statistical analysis by ANOVA 
followed by Dunnett’s test. * Denotes statistically significant difference in CAT activity 
between control and H2O2 control, P < 0.01. # Denotes statistically significant difference in 
CAT activity between sample and H2O2 control, P < 0.05. 
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Jurkat T cell line, with lower IC50 values in this cell line compared to U937 cells (Table 
3). Similarly, it has been reported that Jurkat T cells are more sensitive to 
epigallocatechin gallate (EGCG), while U937 cells are relatively more resistant to the 
cytotoxic effects of this polyphenol (Nakagawa et al., 2004). 
Inflammation has been associated with numerous human disorders including 
Parkinson’s (Whitton, 2007) and Alzheimer’s disease (Holmes et al., 2009), in addition 
to conditions such as inflammatory bowel disease (Papadakis & Targan, 2000) and 
rheumatoid arthritis (Feldmann et al., 1996). Given the prevalence and severity of these 
conditions, novel anti-inflammatory food-derived compounds could prove immensely 
beneficial.  
Cytokines are cell-signalling molecules involved in the mediation and control of 
inflammatory and immune responses and can be categorised as either T helper 1 (Th1) or 
T helper 2 (Th2) cytokines. Th1 cytokines stimulate Type 1 cellular immunity, whereas 
Th2 cytokines play a role in Type 2 humoral immunity to produce immunoglobulins (Ig) 
(Spellberg & Edwards, 2001; Khajuria et al., 2008). For the purposes of this study, 
cytokines were selected from both the Th1 (IL-2, IFN-γ) and Th2 (IL-4, IL-10) 
categories. BSG contains hydroxycinnamic acids, including ferulic, caffeic and p-
coumaric acids, which have been reported to possess antioxidant (Kikuzaki et al., 2002), 
anti-inflammatory (Hole et al., 2012) and anti-atherogenic activity (Andreasen et al., 
2001). However, the immunomodulatory potential of phenolic extracts from BSG does 
not appear to have been studied.  
This study showed that pale BSG phenolic extracts have greatest anti-
inflammatory potential, with P2 significantly (P < 0.05) reducing IL-2, IL-4, IL-10 and 
IFN-γ production and P3 significantly (P < 0.05) reducing IL-2, IL-10 and IFN-γ 
production in ConA-stimulated Jurkat T cells (Table 4). Of the eight BSG phenolic 
extracts tested, P2 and P3 had highest hydroxycinnamic acid content (McCarthy et al., 
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2013). It has previously been reported that hydroxycinnamic acids have anti-
inflammatory effects, with cranberry and blueberry hydroxycinnamic acids protecting 
against the TNF-α stimulated production of inflammatory markers interleukin-8 (IL-8) 
and intercellular adhesion molecule (ICAM-1) (Youdim et al., 2002). Derivatives of p-
coumaric, ferulic and cinnamic acids isolated from corn bran inhibited nitric oxide (NO) 
production and inducible nitric oxide synthase (iNOS) expression in lipopolysaccharide 
(LPS) induced RAW 264.7 macrophages (Kim et al., 2012). In vivo animal studies also 
support findings for the anti-inflammatory effect of hydroxycinnamic acids, with p-
coumaric acid reducing tumor necrosis factor (TNF-α) expression and circulating 
immune complex levels (Pragasm et al., 2013). This anti-inflammatory potential suggests 
that the hydroxycinnamic acids present in extracts P2 (250.77 µg/mL) and P3 (139.34 
µg/mL) may be responsible for their anti-inflammatory activity, as these are the extracts 
with highest hydroxycinnamic acid content. 
IL-10 is an anti-inflammatory cytokine, which acts as an essential 
immunoregulator during infection (Couper et al., 2008). It has been postulated that the 
strength of the regulatory response by IL-10 reflects the preceding inflammatory response 
(Couper et al., 2008). Therefore, the measured reduction in IL-10 production in this study 
is thought to be indirect, and attributable to the phenolic extract-induced reduction in the 
inflammatory response. 
Reactive oxygen species (ROS) have been linked to inflammation. For example, 
the generation of oxidants by silica results in increased expression of pro-inflammatory 
cytokines including TNF-α (Fubini & Hubbard, 2003). Furthermore, pretreatment of 
macrophages with antioxidants GSH or dimethyl sulfoxide (DMSO) prior to exposure to 
silica significantly decreased TNF-α production (Barrett et al., 1999). Therefore, the 
ability of a compound to exert antioxidant activities could also protect against 
inflammation and have indirect anti-inflammatory effects.  
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In addition to inflammation, oxidative stress has been associated with metabolic 
syndrome and its clinical manifestations including hypertension, atherosclerosis and type 
2 diabetes (Roberts & Sindhu, 2009), Parkinson’s disease (Jenner, 2009) and Alzheimer’s 
disease (Zawia et al., 2009). Therefore, there is a continuing demand for novel anti-
inflammatory compounds, which also possess antioxidant capabilities. This is particularly 
the case in regard to plant-derived compounds, which could be utilised as functional food 
ingredients.  Peanut skin, a by-product of the peanut industry, has a low economic value 
and is mainly use as animal feed, similar to BSG (Yu et al., 2005). Phenolic extracts from 
peanut skin have shown high antioxidant potential, greater than that of green tea infusions 
(Yu et al., 2005). Other agro-industrial by-products such as olive mill waste (Obied et al., 
2007), fruit peel (Gorinstein et al., 2002), potato peel waste (Sotillo et al., 2006) and wine 
industry by-products (Makris et al., 2007) have been suggested as inexpensive sources of 
bioactive compounds. BSG, a co-product of the brewing industry, has been incorporated 
into a range of foods including cookies (Prentice et al., 1978; Ozturk et al., 2002) and 
ready-to-eat snacks (Ainsworth et al., 2007; Stojceska et al., 2008) to increase the protein 
and fibre content.  
Extract P1 had the greatest antioxidant effect and significantly protected against 
the H2O2-induced depletion in CAT and SOD activity and GSH content (Figure 1, 2 & 
3). Extract B1 and P4 did not demonstrate any antioxidant effects under the conditions of 
the present study. The content of caffeic acid derivatives is lower in extract B1 compared 
to extract P1 (4.27 and 19.04 µg/mL, respectively; McCarthy et al., 2013), which may 
account for the difference in antioxidant activity of P1 and B1. Recently, we reported that 
BSG phenolic extracts P2, P3 and B2, B3 have highest total phenolic content (TPC) and 
extract B4 has a higher TPC than extract P4 (McCarthy et al., 2012). Therefore, the 
protection against oxidant-induced depletion of cellular antioxidants is speculated to be 
attributable to the TPC of the extracts, which is a measure of all reducing compounds in 
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the extract and not specifically the phenolic compounds (Huang et al., 2005). Extracts B1 
- B4 also significantly protected against H2O2-induced DNA damage in U937 cells 
(McCarthy et al., 2012). 
To conclude, the pale BSG extracts P2 and P3 possess anti-inflammatory 
properties, reducing stimulated cytokine production, which may be attributed to the 
hydroxycinnamic acid content of BSG extracts. Phenolic extracts P1 - P3 and B2 - B4 
have the potential to protect against cellular oxidative stress induced by H2O2. BSG 
phenolic extracts represent a novel source of natural, plant-derived bioactive components 
with the potential to be exploited for the production of biofunctional foods for human 
consumption.  
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5.1. Abstract 
Brewers’ spent grain (BSG) is a protein-rich by-product of the brewing industry. The 
present study examined the in vitro bioactivity of a BSG protein enriched preparation and 
its associated enzymatic hydrolysates (assigned A - J). Cytotoxicity was measured using 
the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide MTT assay in U937 
and Jurkat T cells. IC50 values were lower in the U937 cell line, ranging from 4.93 to 9.27 
% (v/v) versus a range of 4.11 % (v/v) to undetectable in Jurkat T cells. The superoxide 
dismutase (SOD) and comet assays were performed on U937 cells pre-incubated with test 
samples and subsequently exposed to an oxidant. Hydrogen peroxide (H2O2) 
significantly reduced SOD activity by 37.7 % and none of the test samples provided 
protection. None of the samples protected against DNA damage induced by tert-
butylhydroperoxide (t-BOOH); hydrolysate H, prepared with Alcalase enzyme at 60 oC, 
protected against H2O2-induced DNA damage. The total phenolic content (TPC) was 
found to range from 0.021 to 0.055 mg GAE/mg dry powder.  The effect of the BSG-
derived test samples on cytokine production (IL-2, IL-4, IL-10, IFN-γ) in Concanavalin A 
(conA) stimulated Jurkat T cells was measured using an enzyme linked immunosorbent 
assay (ELISA). Samples had no effect on IL-2 and IL-4 production. The unhydrolysed 
sample C significantly reduced IL-10, while the protein rich isolate, unhydrolysed control 
samples and hydrolysates D, E, F, and J significantly reduced IFN-γ production. The 
BSG preparations possess little antioxidant potential and exhibit selective 
immunomodulatory effects that may be of benefit in the control of inflammatory diseases.  
 
5.2. Introduction 
Brewers’ spent grain (BSG) is the residual solid fraction of barley malt remaining after 
wort is produced in the brewing process. Although BSG is mainly used as an animal feed, 
options for further uses are being explored. In recent years, there has been an 
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unprecedented and extensive demand for inexpensive plant-derived proteins and 
bioactive ingredients for human consumption. The protein content of BSG is 
approximately 20 % (w/dw) (Mussatto et al., 2006), and this has potential to be exploited 
for human nutrition. 
Protein hydrolysates have long been the focus of nutritional research for their 
ability to act as a source of biofunctional agents. Different protein hydrolysates have been 
shown to exert antioxidant and anti-inflammatory effects; these include pea protein 
(Ndiaye et al., 2012), soy protein (Peña-Ramos & Xiong, 2002; Kong et al., 2008), fish 
protein (Harnedy & FitzGerald, 2012) and casein hydrolysates (Phelan et al., 2009; 
Lahart et al., 2011). Protein hydrolysates have numerous uses in human nutrition ranging 
from protein supplementation of geriatric and sports nutrition products, energy drinks and 
weight-loss diets to clinical applications including treatment of Crohn’s disease, liver 
disease and ulcerative colitis (Clemente, 2000). While much evidence exists with regard 
to protein hydrolysates from the aforementioned sources, to our knowledge, this is the 
first study on the bioactivity of protein preparations from BSG. 
The antioxidant activity of a compound can be measured using an array of 
methods, both cellular and non-cellular. Superoxide dismutases are a group of 
metalloenzymes that catalyse the conversion of the superoxide anion (O2.-) to molecular 
oxygen and hydrogen peroxide (H2O2), thus forming an essential part of the cellular 
antioxidant defence system. The single-cell gel electrophoresis assay (comet assay) is 
also used to determine antioxidant potential, through the induction of DNA damage 
(single-strand break) by an oxidant. In these assays, the antioxidant activity is determined 
by the ability of a compound to protect against oxidant-induced damage.  Common 
oxidants employed in cellular antioxidant assays include tert-butylhydroperoxide (t-
BOOH) and H2O2 (Aherne & O’Brien, 2000a; Aherne & O’Brien, 2000b; Alia et al., 
2005; Park et al., 2003).  
- 180 - 
 
Cytokines are low molecular weight cell-signalling protein molecules including 
interleukins, interferons and tumor necrosis factor, which play a role in the inflammatory 
response. The ability of a compound to alter cytokine production may indicate anti-
inflammatory potential and thus it may have beneficial effects for example, in 
inflammatory diseases such as atherosclerosis and rheumatoid arthritis. Jurkat T cells 
have been extensively used as a model for immunomodulatory studies (Phelan et al., 
2009; Benbernou et al., 1997; Grassberger et al., 1999).  
The aims of the present study were: firstly, to assess the potential bioactivity of  a 
protein rich isolate from BSG and its associated hydrolysates by measuring their 
cytotoxic and antioxidant effects in human monocytic blood cells (U937); secondly, to 
measure the ability of the BSG protein rich isolate/ hydrolysates to protect against 
oxidant-induced DNA damage in the U937 cell line; and thirdly, to determine potential 
immunomodulatory effects of the BSG protein isolate/ hydrolysates in concanavalin-A 
(con-A) stimulated human Jurkat T cells. 
 
5.3. Materials and methods 
5.3.1. Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich Ireland 
Limited, Co. Wicklow, Ireland. U937 and Jurkat T cells were obtained from the European 
Collection of Animal Cell Cultures (ECACC). 
 
5.3.2. Generation of protein rich isolate and protein hydrolysates  
For production of the protein rich isolate (49.13 % protein dw), 940 g BSG was first 
sheared for 20 s at 11,000 rpm using an Ultra Turrax® T25 basic high performance 
disperser (IKA® Werke GmbH & Co. KG, Staufen, Germany) in 5.0 L dH2O. The 
sheared samples were then allowed to stir gently for 1 hr at room temperature prior to 
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centrifugation at 2,700 g for 20 min at 10 ºC (Hettich Zentrifugen Universal 320R 
centrifuge, Andreas Heittich GmbH & Co., Tuttlingen, Germany). The precipitate 
obtained from the above process was subjected to two sequential 1 hr extractions in 5.0 L 
110 mM NaOH at 50 oC. The combined supernatants from the above extractions obtained 
after centrifugation were adjusted to pH 3.8, stirred gently for 15 min at room 
temperature and then centrifuged. The precipitated protein obtained was re-suspended in 
dH2O, neutralised to pH 7.0 using 2 N NaOH and freeze-dried. 
The freeze dried protein rich isolate (49.13 % protein dw) was hydrolysed with 
the commercially available enzymes Corolase PP, Flavourzyme and Alcalase 2.4L under 
conditions described in Table 1. The pH was maintained by addition of 0.5 N NaOH 
using a pH-Stat system (Metrohm 718 STAT Titrino, Herisau, Switzerland) and the 
temperature was kept constant using a thermostatically controlled water bath (IKA® 
Werke GmbH & Co. KG, Staufen, Germany). The resulting hydrolysates were each 
adjusted to pH 7.0, heated at 95 oC for 10 min to inactivate the enzyme and were then 
freeze dried. Prior to analysis, freeze-dried samples were made up to 1 % (w/v) solution 
with distilled deionised water, filter sterilised, aliquoted into sterile eppendorphs and 
stored at -20 oC.  
 
5.3.3. Total phenolic content (TPC) 
The total phenolic content (TPC) of the protein rich isolate and its associated 
hydrolysates was measured using the Folin-Ciocalteau method as described previously 
(Singleton & Rossi, 1965). This assay measures the ability of a compound to reduce the 
yellow oxidising Folin-Ciocalteau reagent to a blue/green colour. Absorbance is 
measured spectrophotometrically at 765 nm and results are expressed as mg gallic acid 
equivalents per mg dry powder (mg GAE/mg dry powder). 
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Table 1: Preparation of protein isolate/hydrolysate test samples from brewers’ spent grain (BSG). 
Sample Description Enzyme/water E/S Ratio Temperature (oC) pH Time (h) 
A BSG protein rich isolate - - - - - 
B Control for D, E, F, G, J water - 50 7 4 
C Control for H, I water - 60 9 4 
D BSG protein hydrolysate Corolase PP 1%    (w/w) 50 7 4 
E BSG protein hydrolysate Corolase PP 2.5% (w/w) 50 7 4 
F BSG protein hydrolysate Flavourzyme 1%     (v/w) 50 7 4 
G BSG protein hydrolysate Flavourzyme 2.5%  (v/w) 50 7 4 
H BSG protein hydrolysate Alcalase 2.4L 1%     (v/w) 60 9 4 
I BSG protein hydrolysate Alcalase 2.4L 2.5%  (v/w) 60 9 4 
J BSG protein hydrolysate Alcalase 2.4L 2.5%  (v/w) 50 7 4 
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5.3.4. Cell culture 
U937 cells, a human monocytic blood cell line, and Jurkat T cells, a human leukaemic T 
cell line, were maintained in antibiotic-free RPMI-1640 medium supplemented with 10 % 
(v/v) fetal bovine serum (FBS), at 37 oC in a 5 % CO2 atmosphere.  Cell densities of 1 x 
105 cells/mL (cytotoxicity and superoxide dismutase assays) or 2 x 105 cells/mL (comet 
assay and enzyme-linked immunosorbent assays) were used for experimentation. 
Reduced serum media (2.5 % FBS) was used for all experiments.  
 
5.3.5. Cell proliferation  
To measure cell proliferation the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay was carried out in both the U937 and Jurkat T cell lines. Cells (1 x 
105 cells/mL) were incubated for 24 hr at 37 oC with test samples (A - J) at concentrations 
ranging from 0 - 20 % (v/v). To account for the colour of the samples, a media blank was 
also included (samples and media only, no cells). The MTT assay kit was then used to 
quantify cell proliferation. In this assay, MTT (a yellow tetrazolium salt) is converted to a 
formazan derivative (purple colour), and the absorbance of the converted dye is measured 
at 570 nm.  Briefly, 10 µL MTT reagent 1 and 100 µL RPMI was added to cells and 
incubated for 4 hr at 37 oC. Following incubation, 100 µL was removed from the wells 
and 100 µL MTT reagent 2 was added. A further incubation period of 24 hr at 37 oC 
followed. Absorbance was read at 570 nm using a microplate reader (Spectrafluorplus, 
Tecan). Using cell proliferation data from the MTT assay, IC50 values (the concentration 
of a test sample that induces 50 % cell death) were determined. GraphPad Prism 4 was 
used for analysis and IC50 values are expressed as % (v/v). On the basis of the MTT 
assay and published literature (Cumby et al., 2008; Lahart et al., 2011; Piccolomini et al., 
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2012), a non-toxic concentration of 0.5 % (v/v) BSG protein preparations was used for 
further analyses.  
 
5.3.6. Superoxide dismutase (SOD) assay 
U937 cells (5 mL) were seeded at a density of 1 x 105 cells/mL in T25 flasks. Cells were 
incubated for 24 hr with 0.5 % (v/v) test sample and subsequently treated with 100 µM 
H2O2 for 60 min. SOD activity was measured using a Calbiochem SOD Assay Kit II 
(Merck Chemicals Ltd., Nottingham, U.K.) The protein content of the BSG protein 
samples was measured using the Bicinchoninic acid (BCA) protein assay, as previously 
described (Smith et al., 1985). The SOD activity is expressed relative to the protein 
content, as SOD units/mg protein in cell homogenate (U mg-1 protein). One SOD unit is 
defined as the amount of enzyme needed to exhibit 50 % dismutation of the superoxide 
radical. 
 
5.3.7. Comet assay 
U937 cells (1 x 105cells/mL) were treated with 0.5 % (v/v) protein preparations for 24 hr 
in a 6-well plate (final volume 2 mL) at 37 oC. Following incubation, cells were treated 
with 50 μM H2O2 for 30 min or 400 μM t-BOOH for 60 min. Cell viability was then 
determined using the fluorescein diacetate ethidium bromide (FDA/EtBr) assay. The 
comet assay was used to measure oxidative DNA damage in the U937 cells, as previously 
described by McCarthy et al. (2012). Briefly, cells were harvested and embedded on 
microscope slides using low melting point (LMP) agarose. Lysis was carried out for 1 hr 
at 4 oC, before electrophoresis for 25 min at 21 V, 300 mA. The slides were neutralised 
using 0.4 M Tris and stained with 20 µg/mL EtBr. Komet 5.5 image analysis software 
was used to score 50 cells for each slide using a fluorescence microscope (Optiphot-2, 
Nikon). DNA damage was expressed as percentage tail DNA.  
- 185 - 
 
5.3.8. Cytokine production 
Jurkat cells, at a density of 2 x 105 cells/mL, were seeded in 96-well plates in the presence 
of ConcanavalinA (conA, 50 µg/mL) and treated with 0.5 % (v/v) test samples for 24 hr. 
Production of the cytokines interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-10 (IL-
10) and interferon-γ (IFN-γ) was determined using eBioscience ELISA kits (Human 
Th1/Th2 ELISA Ready-SET-Go kit purchased from Insight Biotechnology, Wembley, 
UK). Absorbance was read at 450 nm using a microplate reader (ThermoScientific 
Varioskan Flash).  
 
5.3.9. Statistical analysis  
All data represents the mean and standard error values of at least three independent 
experiments. Data were analysed by one-way analysis of variance (ANOVA) followed by 
Dunnett’s test (or Tukey’s multiple comparison test, where appropriate), using GraphPad 
Prism 4 (GraphPad software, California, U.S.A.). 
 
5.4. Results   
Ten samples (A - J) were analysed during the course of the study. These included the 
BSG protein rich isolate (A), control at 50 oC (B), control at 60 oC (C) and seven protein 
hydrolysates (D - J).  
Molecular weight distribution profiles (GP-HPLC) of hydrolysates show that up 
to 80 % of the peptides were < 5 kDa when compared to the unhydrolysed BSG protein 
rich isolate which had 32 % of proteins and peptides < 5 kDa. Of the three enzymes, 
hydrolysates generated with Flavourzyme had the lowest percentage of proteins and 
peptides < 5 kDa with values of 64 and 52 % for the high and low E/S ratio, respectively. 
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5.4.1. Total phenolic content (TPC) 
The TPC of the protein/hydrolysate preparations was found to range from 0.021 to 0.055 
mg GAE/mg dry powder (Table 2). Hydrolysate H prepared with Alcalase at 60 oC had a 
significantly (P < 0.01) higher TPC than its corresponding control (C). Compared with 
the protein rich isolate A, hydrolysates H and J (also prepared with Alcalase) had 
significantly (P < 0.05) higher TPC.  
 
5.4.2. Cell proliferation 
A range of concentrations (0 - 20 % v/v) of test samples were incubated at 37 oC for 24 hr 
with either U937 or Jurkat T cells in 96-well plates, the MTT assay was carried out and 
absorbance (which is related to the percentage cell proliferation) was read at 570 nm. As 
shown in Table 3, all samples A - J reduced U937 cell proliferation in a dose-dependent 
manner. Concentrations of 8, 10 and 20 % (v/v) of all samples (except E) signficantly (P 
< 0.05) reduced U937 cell viability. Using GraphPad Prism 4, the IC50 values of each 
sample were computed (Table 3) and found to range from 4.93 to 9.27 % (v/v). For 
further experimentation, a non-toxic concentration of 0.5 % (v/v) protein sample was 
selected. In the Jurkat T cell line, it was found that samples A - H stimulated growth; with 
each of these samples significantly increasing cell viability at 2, 2.5 and 4 % (v/v) 
addition (Table 4). In comparison, hydrolysates I and J, prepared with Alcalase at 60 oC 
and 50 oC, respectively, significantly reduced cell viability in a dose-dependent manner 
(Table 4). Similar to the trend observed in the U937 cell line, sample I significantly (P < 
0.05) reduced cell viability at concentrations greater than 4 % (v/v). The IC50 values in 
the Jurkat T cells for samples I and J were lower than that for the U937 cell line (Table 
4), IC50 values for other samples could not be determined. For immunomodulatory assays 
using the Jurkat T cells, the 0.5 % (v/v) level of addition of BSG test samples was 
chosen, as this level did not cause significant changes in cell viability across all samples. 
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Table 2: Total phenolic content (TPC) of protein isolate and associated hydrolysates 
from brewers’ spent grain (BSG). 
Test samplea TPC content 
(mg gallic acid equivalents (GAE)/mg dry powder) 
A 0.029 ± 0.003 
B 0.043 ± 0.004 
C 0.021 ± 0.002 
D 0.039 ± 0.003 
E 0.034 ± 0.001 
F 0.032 ± 0.001 
G   0.046 ± 0.002 
H     0.049 ± 0.004*# 
I 0.033 ± 0.002 
J   0.055 ± 0.006*  
a A = unhydrolysed starting material, B = control at 50 oC, C = control at 60 oC, D – J = 
protein hydrolysates of BSG. Data represents the mean ± SE of three independent 
experiments. Statistical analysis by ANOVA followed by Tukey’s multiple comparison 
test. * Statistically significant difference between protein rich isolate A and hydrolysate 
(P < 0.05). # Statistically significant difference between relevant control and 
corresponding hydrolysate (P < 0.01). 
 
 
 
 
 
 
Table 3: Effect of BSG protein hydrolysates (0 – 20 % v/v) on cell proliferation in the U937 cell line. 
Samplea Cell proliferation (% of control)b IC50c 
0%  0.5%  1% 2%  2.5% 4%  5% 6%  8% 10%  20% (% v/v) 
A 100.00 83.06 84.35 80.56 78.26 77.94 75.44 67.68 39.78* 9.80* 1.95* 7.80 
B 100.00 76.98 88.22 97.48 97.38 95.74 105.61 81.42 34.21* 23.90* -0.16* 7.43 
C 100.00 72.29 71.68 80.50 98.47 98.03 78.23 77.34 39.45* 47.45* 3.11* 9.27 
D 100.00 96.73 100.38 102.97 101.79 93.18 109.61 99.84 46.84* 8.60* 9.56* 7.92 
E 100.00 80.38 87.55 92.74 93.60 86.10 82.12 46.00 22.13 7.10 11.06 5.95 
F 100.00 87.49 87.90 87.90 93.86 93.94 114.20 89.47 67.23* 18.38* 16.05* 8.31 
G 100.00 95.23 96.06 89.91 94.63 102.66 98.10 91.41 58.44* 10.60* 25.30* 8.01 
H 100.00 53.63 72.63 80.82 90.69 86.40 68.86* 42.11* 4.53* 1.82* 6.36* 6.04 
I 100.00 73.98* 70.94 93.88 90.91 57.58* 41.93* 33.88* 3.80* 6.12* 11.47* 4.93 
J 100.00 77.06* 61.62 88.43 92.07 87.88 85.49 81.04 61.58* 37.39* 33.17* 8.21 
a A = unhydrolysed starting material, B = control at 50 oC, C = control at 60 oC, D – J = protein hydrolysates of BSG  b Values are mean of four 
independent experiments, expressed as a percentage relative to untreated U937 cells. c Data values relate to the amount of protein hydrolysate added 
to cells, expressed as % (v/v). IC50 values were determined using cell proliferation data from the MTT assay and GraphPad Prism, version 4.00.  * 
Denotes statistically significant difference in cell viability, relative to untreated U937 cells (P < 0.05), by ANOVA followed by Dunnett’s Test.  
Table 4: Effect of BSG protein hydrolysates (0 – 20 % v/v) on cell proliferation in the Jurkat T cell line. 
Samplea Cell proliferation (% of control)b IC50c 
0% 0.5% 1%  2%  2.5% 4%  5%  6%  8%  10% 20%  (% v/v) 
A 100.00 95.40 81.40 207.63* 203.86* 189.35* 181.30* 163.25 151.71 139.51 153.92 nd 
B 100.00 82.26 92.20 202.11* 202.50* 188.00* 218.59* 162.62 160.40 139.17 159.30 nd 
C 100.00 90.95 95.73 203.25* 233.40* 195.45* 202.66* 152.11 145.32 139.58 174.33* nd 
D 100.00 94.56 88.46 197.62* 206.29* 210.93* 200.81* 166.80* 154.48 141.80 147.18 nd 
E 100.00 85.59 98.68 224.05* 214.41* 184.61* 165.54* 132.94 132.30 142.09 123.07 nd 
F 100.00 75.17 191.23* 202.93* 217.00* 217.59* 184.56* 175.57* 134.81 140.36 140.28 nd 
G 100.00 95.34 169.61 169.60 217.39* 223.19* 185.43* 186.90* 136.85 151.28 142.66 nd 
H 100.00 82.13 183.29* 182.15* 217.14* 201.52* 152.34 155.24 120.11 114.02 103.30 nd 
I 100.00 74.15 76.31 79.56 75.74 50.05* 16.15* 15.71* 13.53* 26.91* -6.30* 4.11 
J 100.00 83.89 84.79 90.25 88.38 65.66 40.20* 16.29* 34.90* 27.55* 1.00* 4.43 
a A = unhydrolysed starting material, B = control at 50 oC, C = control at 60 oC, D - J= protein hydrolysates of BSG  b Values are mean of four 
independent experiments, expressed as a percentage relative to untreated Jurkat T cells c data values relate to the amount of protein 
hydrolysate added to cells, expressed as % (v/v). IC50 values were determined using cell proliferation data from the MTT assay and GraphPad 
Prism, version 4.00.  * Denotes statistically significant difference in cell viability, relative to untreated Jurkat T cells (P < 0.05), by ANOVA 
followed by Dunnett’s Test.  
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5.4.3. Antioxidant activity  
Two cellular assays were employed to assess the antioxidant potential of the BSG protein 
samples – the SOD assay and the comet assay. For the SOD assay, oxidative stress was 
induced in U937 cells with 100 µM H2O2 and the ability of the test samples to protect 
against this oxidation was measured (Table 5). H2O2 significantly reduced SOD activity 
(expressed as SOD units (U)/mg protein) from 0.20 ± 0.01 to 0.12 ± 0.02. Protein rich 
isolate (A) did not change the % SOD activity, compared to the H2O2 control. Control 
samples B and C increased the % SOD activity by 12.6 and 22.7 %, respectively. None of 
the protein hydrolysates (D - J) provided any significant change from the H2O2 control 
value. Compared to the unhydrolysed starting material (A), hydrolysates D, G, I and J (all 
prepared at 50 oC with Corolase, Flavourzyme or Alcalase, respectively) increased the % 
SOD activity by 14, 13, 9 and 24 %, respectively. Hydrolysate J increased the % SOD 
activity by 12 % compared to its corresponding control preparation B. Hydrolysates H 
and I were less antioxidant than their corresponding control (C) in terms of relative SOD 
activity. The ability of the test samples to protect against oxidant induced DNA damage 
was assessed using the comet assay. Both oxidants (H2O2 and t-BOOH) significantly 
increased the percentage DNA damage (expressed as % tail DNA); none of the test 
samples provided significant protection against these increases in tail DNA, with the 
exception of hydrolysate H which significantly protected against H2O2-induced DNA 
damage (Figure 1a). In cells treated with both H2O2 and hydrolysates E, F, G, H and J 
there was less DNA damage than in cells treated with control preparations A, B and C. 
Hydrolysates G, H, I and J provided greater protection than unhydrolysed protein 
preparations A, B and C against DNA damage induced by t-BOOH (Figure 1b). 
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BSG, brewers’ spent grain; H2O2, hydrogen peroxide; SOD, superoxide dismutase. a A = 
unhydrolysed starting material, B = control at 50 oC, C =control at 60 oC, D – J = protein 
hydrolysates of BSG. Data represents the mean (± SE) of five independent experiments. 
Statistical analysis by ANOVA followed by Dunnett’s test. * Indicates statistically 
significant difference in SOD activity between control and H2O2 control (P < 0.01). 
 
Table 5: Ability of brewers’ spent grain (BSG) protein isolate and associated 
hydrolysates (0.5 % v/v) to protect against oxidative stress induced by hydrogen peroxide 
(H2O2) in the U937 cell line, using the superoxide dismutase (SOD) assay. 
Test samplea SOD activity 
(U mg-1 protein) 
SOD activity 
(% of control) 
Control 0.20 ± 0.01 100.00 
H2O2 control 0.12 ± 0.02* 62.35 * 
A 0.12  ± 0.02 63.04 
B 0.15  ± 0.02 74.92 
C 0.17  ± 0.02 85.00 
D 0.15  ± 0.04 77.20 
E 0.13  ± 0.01 66.25 
F 0.12  ± 0.02 66.22 
G 0.15  ± 0.04 76.71 
H 0.13  ± 0.02 65.87 
I 0.14  ± 0.02 72.03 
J 0.17  ± 0.04 87.20 
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 (b)    
 
  
 
 
Figure 1: The ability of BSG protein hydrolysates to protect against DNA damage 
induced by (a) H2O2 (b) t-BOOH. a A = unhydrolysed starting material, B = control at 50 
oC, C= control at 60 oC, D – J = protein hydrolysates of BSG  Values are mean ± SE of 
five  independent experiments. Statistical analysis by ANOVA followed by Dunnett’s 
test. * Indicates a statistically significant difference in DNA damage between control and 
oxidant control (P < 0.01). # Indicates statistically significant difference in DNA damage,  
relative to H2O2 control (P < 0.01). 
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5.4.4. Immunomodulatory activity 
BSG protein hydrolysates were assessed for their immunomodulatory activity. Following 
stimulation of Jurkat T cells with 50 µg/mL conA, cytokine production was measured 
(IL-2, IL-4, IL-10, IFN-γ), with results shown in Table 6. There was no significant 
change in IL-2 or IL-4 production following supplementation with any of the test 
samples. IL-10 production was unaffected by the hydrolysates. Protein rich isolate control 
sample C significantly reduced IL-10 production (P < 0.05). A more marked effect was 
observed for IFN-γ production, with all unhydrolysed isolates (A, B and C) and all 
hydrolysates except G, H and I significantly reducing IFN-γ production; these samples 
gave a minimum reduction of 20 %. As was also seen in the SOD assay results, 
hydrolysates H and I prepared with Alcalase at 60 oC are less bioactive than their 
unhydrolysed control preparation (C) by the ELISA assay, having no effect on IL-10 
production in conA stimulated Jurkat T cells. It was found that the unhydrolysed starting 
material (A) had more of an anti-inflammatory effect than F, G, H and I for all cytokines 
measured (Table 6). Hydrolysate J, which had the highest TPC and SOD activity reduced 
IL-2 and IL-10 to the greatest extent and was the second most active hydrolysate at 
reducing IL-4 and IFN- γ production. 
 
5.5. Discussion 
Due to its low commercial value and high nutritional value, in addition to the vast 
quantities produced, BSG is an attractive co-product of the brewing industry. Current use 
is limited to animal feed and alternative uses of BSG are highly sought after. The 
antioxidant potential of phenolic extracts from BSG has been previously reported 
(McCarthy et al., 2012); the focus of the present study was on the bioactive potential of a 
BSG protein rich isolate and its associated hydrolysates. As already outlined, the protein 
rich isolate from BSG contained 49.13 % protein as determined by Kjeldahl N 
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Table 6: The effect of protein isolate and hydrolysates from brewer’s spent grain (0.5 % 
v/v) on cytokine production in concanavalin-A stimulated Jurkat T cells. 
BSG samplea Cytokine Production 
(% of control) 
 IL-2 IL-4 IL-10 IFN-γ 
Control 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 
A  87.77 ± 6.87   86.31 ± 3.49 92.02 ± 2.06     73.38 ± 4.59* 
B  78.62 ± 5.40     98.44 ± 10.54 87.57 ± 2.33    67.99 ± 2.17*  
C  84.26 ± 7.56   91.64 ± 3.46 85.21 ± 5.25*    76.31 ± 6.10* 
D  95.11 ± 9.34   95.13 ± 2.82 91.50 ± 2.59    78.98 ± 7.10#  
E  89.74 ± 10.64   89.54 ± 2.18 92.40 ± 4.26    73.22 ± 2.98* 
F 103.97 ± 14.37 102.67 ± 3.88 94.78 ± 3.05    80.16 ± 5.72#  
G  93.73 ± 9.49   99.86 ± 1.33 97.42 ± 3.76   81.89 ± 3.42  
H 107.97 ± 14.75 115.17 ± 7.88 95.61 ± 0.79   85.86 ± 4.26  
I  96.50  ± 10.91   95.62 ± 3.81 103.44 ± 1.64†  84.31 ± 3.27  
J  81.74 ± 1.74   94.80 ± 4.84  88.41 ± 3.33   78.86 ± 5.03# 
BSG, brewers’ spent grain. a A = unhydrolysed starting material, B = control at 50 oC, 
C = control at 60 oC, D – J = protein hydrolysates of BSG  b Values are mean ± SE of 
at least three independent experiments, expressed as a percentage relative to cells 
treated with conA alone. Statistical analysis by ANOVA followed by Dunnett’s test. * 
P < 0.01 # P < 0.05, statistically significant difference in cytokine production between 
control and cells treated with protein hydrolysate. † Denotes statistically significant 
difference (P < 0.05) between hydrolysate I and corresponding control C. 
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determination (Connolly et al., 2013). Interestingly, heat treatment of the unhydrolysed 
BSG protein isolate appeared to differentially affect the TPC. The unhydrolysed sample 
heated at 50 oC had higher mean TPC (0.043) in comparison to the unheated and sample 
heated at 60 oC (0.029 and 0.021 mg GAE/mg dry powder, respectively). Furthermore, 
hydrolysate samples H and J had TPC samples of 0.049 and 0.055 mg GAE/mg dry 
powder, respectively. This would seem to indicate that the specific hydrolysis process 
used to generate those samples enhanced TPC activity. It has been suggested in the 
literature that a number of factors can influence the polyphenol concentration following 
hydrolysis. These include polyphenol-protein interactions and bonding, type of enzyme 
used for extraction and the release of simple sugars and oligosaccharides during cell wall 
polysaccharide degradation, resulting in lower polyphenol content of extracts (Wang et 
al., 2010). 
The effect of the test samples on cell proliferation was assessed using the MTT 
assay. In addition to screening the hydrolysates for their cytotoxic effects, this assay also 
provided information regarding the concentration of test samples to be used for further 
analysis in the antioxidant and immunomodulatory assays. The IC50 values (as % v/v) 
calculated for the BSG test samples I and J were lower than those observed for casein 
hydrolysates in the Jurkat cell line (Phelan et al., 2009). This study also showed that the 
IC50 value of some hydrolysates could not be determined, indicating a high tolerance of 
these cells to supplementation with the test samples.  
SOD represents the first line of enzymatic antioxidant defence in the body, 
catalysing the conversion of the superoxide anion to hydrogen peroxide, which then 
undergoes detoxification by glutathione peroxidise and catalase (Mittler, 2002). H2O2-
induced reduction in SOD activity, as shown here, has also been reported in the literature 
at varying H2O2 concentrations in a range of cell lines (Zhai et al., 2011; O’Sullivan et 
al., 2011; Zhong et al., 2011). It has been proposed that H2O2 exerts its effect on SOD by 
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inactivating the enzyme (Salo et al., 1988). More specifically, H2O2 causes a reduction of 
Cu2+ to Cu+, and subsequently reacts with the Cu+ to form Cu2+OH-, which has the 
potential to oxidatively damage a histidine and thus inactivate the SOD enzyme 
(Hodgson & Fridovich, 1975).  
For this study, two oxidants were utilised to induce DNA damage, H2O2 and t-
BOOH. These oxidants were chosen on the basis that they exert their oxidative effects by 
different mechanisms. While H2O2 induces oxidative stress in an iron-dependent manner, 
by means of the Fenton reaction (Imlay et al., 1988), iron has a minor effect on cell 
susceptibility to t-BOOH induced oxidative stress (Kruszewski et al., 2008). 
In general, test samples from BSG did not exhibit significant antioxidant activity 
by either the SOD activity or the comet assays (except hydrolysate H). Comparing the 
SOD and TPC assay results, hydrolysate J had highest TPC (0.055 mg GAE/mg dry 
powder) and also showed greatest protection against oxidation induced by H2O2. This 
relationship between TPC and antioxidant activity has been previously reported 
(McCarthy et al., 2012).  
The data on these novel BSG-derived samples can be compared to existing 
literature regarding protein hydrolysates from a range of other sources. It has been shown 
that casein hydrolysates do not protect against H2O2-induced DNA damage (Phelan et 
al., 2009). In contrast, there is some evidence to suggest that protein hydrolysates from 
other sources can protect against oxidative stress induced by H2O2, for example, tuna 
liver protein (Je et al., 2009) and algae protein hydrolysates (Sheih et al., 2009).  
Cytokines, cell-signalling protein molecules, are involved in the inflammatory 
response. The excessive production of cytokines has been linked to a number of 
physiological conditions including inflammatory bowel disease (Papadakis & Targan, 
2000) and rheumatoid arthritis (Feldmann et al., 1996). Similarly, insufficient production 
of cytokines can play a role in immunodeficient disease states. Immunity can be classed 
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as either Type 1 or Type 2. Type 1 immunity is stimulated in T helper 1 (Th1) 
lymphocytes by cytokines including IL-2, IFN-γ (Spellberg & Edwards, 2001) and can be 
regarded as cellular immunity (Khajuria et al., 2008). IL-4, IL-5, IL-9, IL-10 play a role 
in type 2 immunity stimulated in T helper 2 (Th2) lymphocytes (Spellberg & Edwards, 
2001). Type 2 immunity is humoral immunity and Th2 cells support the production of 
immunoglobulins (Ig) including IgA and IgM (Khajuria et al., 2008). ConA is a T cell 
lectin mitogen, that stimulates the production of cytokines by activation of the mitogen-
activated protein kinase (MAPK) via the T-cell receptor (Tanaka et al., 2005). Jurkat T 
lymphocytes stimulated with conA have previously been used as a model for assessing 
the immunomodulatory effects of different compounds (Aherne & O’Brien, 2008; 
Verlengia et al., 2004).  
Much evidence exists regarding the immunomodulatory potential of protein 
hydrolysates from a range of sources, although protein hydrolysates from BSG have not 
been studied to date. In 2008, it was reported that a protein hydrolysate from the seaweed, 
Ecklonia cava, reduced the conA stimulated production of IFNγ- and TNF-α in 
splenocytes (Ahn et al., 2008). Hydrolysates from other protein sources also display 
similar immunomodulatory activity. One such source is soy protein, and specifically the 
lunasin peptide isolated from soy. Lunasin has been shown to reduce the production of a 
number of inflammatory markers including TNF-α, IL-6, nitric oxide (NO) and 
prostaglandin E2 (PGE2) (Hernandez-Ledesma et al., 2009; Dia et al., 2009). Protein 
isolated from sources such as whey protein (Cross & Gill, 1999), flaxseed meal 
(Udenigwe et al., 2009) and yak milk casein (Mao et al., 2011) also exhibit anti-
inflammatory potential. Results of the present study suggest that BSG protein isolate and 
associated unhydrolysed samples and hydrolysates selectively reduce production of 
cytokines. Further investigation may yield hydrolysates with greater bioactivity, similar 
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to that observed for the aforementioned hydrolysates from whey (Cross & Gill, 2009), 
flaxseed (Udenigwe et al., 2009) and yak milk casein (Mao et al., 2011).  
IFN-γ is considered a pro-inflammatory cytokine, as it enhances NO production 
and TNF activity and is effective at stimulating pro-inflammatory gene expression such 
as inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) (Dinarello, 2000). IL-
1, TNF-α and IFN-γ can initiate an inflammatory cascade as shown in Figure 2. The 
beneficial effect of the test samples is further supported by the theory that IL-4 and IL-10 
are anti-inflammatory cytokines (Isomaki & Punnonen, 1997). BSG protein hydrolysates 
did not significantly reduce the production of these cytokines, but selectively reduced 
pro-inflammatory IFN-γ production, as did the protein rich isolates from which the 
hydrolysates were prepared. Hydrolysis of the proteins did not enhance their 
immunomodulatory effects. It has been reported that IL-10 acts as a potent inhibitor of 
IL-2 and IFN-γ, making it the most important anti-inflammatory cytokine. This has led to 
its use in clinical trials for the treatment of conditions such as inflammatory bowel 
disease (Opal & DePalo, 2000). Recent treatments for anti-inflammatory diseases such as 
rheumatoid arthritis (Dinarello, 2000), juvenile idiopathic arthritis and Crohn’s disease 
(Nishimoto & Kishimoto, 2004) are centered around increasing anti-inflammatory and 
inhibiting pro-inflammatory cytokines. Therefore, the ability of a compound to 
selectively inhibit pro-inflammatory cytokine production shows great potential for the 
neutraceutical industry, for the treatment of inflammatory diseases. It is important to note 
that while the protein rich isolate contains approximately 50 % protein, there is a 
possibility that components of the remaining 50 % (consisting primarily of carbohydrate) 
may account for the bioactivity of the BSG protein isolate and associated hydrolysates. 
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Figure 2: The inflammatory cascade, as initiated by IL-1, TNF-α and IFN-γ. IL-1: 
interleukin 1, TNF-α: tumor necrosis factor alpha, IFN-γ; interferon gamma, iNOS: 
inducible nitric oxide synthase, COX-2: cyclooxygenase 2, PGE2: prostaglandin E2, NO: 
nitric oxide. IL-1, TNF-α and IFN-γ stimulates increased expression of pro-inflammatory 
genes such as iNOS and COX-2 and synthesis of chemokines. This leads to the 
production of leukotrienes, NO and PGE2 and the activation of neutrophils, resulting in 
inflammation, tissue damage and loss of function. 
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5.6. Conclusion 
The findings of the present study suggest that protein preparations from BSG do not show 
antioxidant potential, but may have selective immunomodulatory effects.  It is possible 
that the presence of phenolic compounds in the preparations plays a role in the observed 
effects. The ability of the BSG protein isolate and associated hydrolysates to significantly 
decrease pro-inflammatory cytokine IFN-γ production may prove useful in the treatment 
of inflammatory diseases.  These data warrant the further investigation of BSG protein 
rich isolate and associated hydrolysates for their immunomodulatory effects. 
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6.1. Abstract 
The present study investigated the bioactivity of protein hydrolysates and fractionated 
hydrolysates prepared from brewers’ spent grain (BSG) using proteases, including 
Alcalase 2.4L, Flavourzyme and Corolase PP. Hydrolysates were designated K-Y, 
including fractionated hydrolysates with molecular weight (m.w.) < 3, < 5 and > 5 kDa. 
Where computable, IC50 values were lower in U937 (1.38 % - 9.78 %) than Jurkat T cells 
(1.15 % - 13.82 %). Hydrolysates L, Q and R and fractionated hydrolysates of U and W 
(< 3, < 5, > 5 kDa) significantly (P < 0.01) protected against hydrogen peroxide (H2O2)-
induced reduction of superoxide dismutase (SOD) activity. A fractionated hydrolysate of 
W (< 5 kDa) protected against H2O2-induced DNA damage, P < 0.01. Hydrolysates K, 
N, P, U, U > 5 kDa, V, V > 5 kDa, W, W > 5 kDa significantly (P < 0.05) reduced a 
concanavalin-A (con-A) stimulated production of interferon-γ (IFN-γ). In conclusion, 
BSG protein hydrolysates demonstrate bioactivity in vitro; lower m.w. hydrolysates (< 3, 
< 5 kDa) show greatest antioxidant activity and unfractionated or higher m.w. 
hydrolysates (> 5 kDa) possess anti-inflammatory effects.  
 
6.2. Introduction 
Brewers’ spent grain (BSG) represents 85 % of the total solid by-products of the brewing 
industry, with 8.5 million tons of dry BSG produced on an annual basis globally (Xiros & 
Christakopoulos, 2012). This lignocellulosic material is an excellent source of protein and 
fibre in addition to polyphenolic compounds (hydroxycinnamic acids), vitamins and 
minerals (Mussatto et al., 2006; McCarthy et al., 2013a). Presently, spent grains are sold 
as livestock feed, particularly for dairy cattle, with a profit in the range of €1 - €6/ton 
(Fillaudeau et al., 2006). Other potential applications have been suggested; energy and 
charcoal production, paper manufacture, use in biotechnological processes and as a 
human food ingredient (Mussatto et al., 2006). 
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Meat, eggs, fish, soy and wheat have been highlighted as sources of bioactive 
peptides (Hartmann & Meisel, 2007; McCarthy et al., 2013b), with protein hydrolysates 
being utilised in many human nutrition products including energy drinks, weight control 
and sports nutrition  products (Clemente, 2000). In addition to antioxidant and anti-
inflammatory potential, protein hydrolysates also possess hypocholesterolemic and anti-
hypertensive properties (Hartmann & Meisel, 2007).   
Phenolic-rich extracts from BSG have previously demonstrated bioactivity, by 
protecting against oxidant-induced DNA damage (McCarthy et al., 2012). We previously 
reported BSG protein isolate and associated hydrolysates possess selective 
immunomodulatory potential, significantly reducing concanavalin-A (conA) stimulated 
interferon-gamma (IFN-γ) production (McCarthy et al., 2013c). As a continuation of this 
research, additional protein hydrolysates were prepared from BSG, with an aim of 
producing a hydrolysate with enhanced bioactivity. Since molecular weight is one of the 
main factors influencing biological properties (Jeon et al., 1999; Park et al., 2001), 
hydrolysates (produced using Alcalase 2.4L, Corolase PP and Flavourzyme) were 
fractionated on the basis of differences in molecular mass for bioactivity analysis. It has 
been reported that membrane separation of protein hydrolysates can result in peptide 
fractions with enriched bioactivity (Korhonen & Pihlanto, 2006). Cellular antioxidant 
activity assays, representing the first line of antioxidant defence in the body, are essential 
to identify the ability of compounds to intercept oxidative stress and prevent or reduce 
oxidation (Sies, 1997). Furthermore, the comet (single cell gel electrophoresis) assay has 
been shown to be a successful means of determining the chemoprotective effects of novel 
functional food ingredients, through antioxidant mechanisms, in cell culture (McCarthy et 
al., 2012; Phelan et al., 2009; Glei et al., 2006). It is hypothesised that fractionation of 
BSG protein hydrolysates will produce peptide fractions with enriched bioactivity, 
measured using common assays of bioactivity in cell culture. 
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The aims of the present study were to assess: firstly, the cytotoxic effects of a 
second set of BSG protein hydrolysates in human monocytic blood cells (U937) and 
human leukaemic T cells (Jurkat T cells); secondly, the cellular antioxidant potential of 
the BSG hydrolysates in the U937 cell line; thirdly, the ability of BSG hydrolysates to 
protect against H2O2-induced DNA damage in U937 cells; and fourthly, the 
immunomodulatory potential of BSG hydrolysates in conA stimulated Jurkat T cells.  
 
6.3. Materials and Methods 
6.3.1. Materials  
All chemicals were purchased from Sigma-Aldrich Ireland Limited, Co. Wicklow, 
Ireland, unless otherwise stated. U937 and Jurkat T cells were obtained from the 
European Collection of Animal Cell Cultures (ECACC). 
 
6.3.2. Generation of protein rich isolate and protein hydrolysates 
The BSG protein rich isolate was obtained by a method previously described (Connolly et 
al., 2013). Samples B - T were generated using a BSG protein rich isolate extracted at 
bench scale whereas samples U - Y were obtained using BSG protein rich isolate 
extracted at semi-pilot scale.  The freeze dried protein rich isolates were then hydrolysed 
by a range of commercially available enzymes under conditions described in Table 1. The 
pH was maintained by addition of 0.5 or 2 N NaOH using a pH-Stat system (Metrohm 
718 STAT Titrino, Herisau, Switzerland) and the temperature was kept constant using a 
thermostatically controlled water bath (IKA® Werke GmbH & Co. KG, Staufen, 
Germany). The resulting hydrolysates were each adjusted to pH 7.0, heated at 95 °C for 
10 min to inactivate the enzyme and were then freeze dried or fractionated using 5 and 3 
kDa molecular weight cut-off membranes (MinimateTM Tangental Flow Filtration 
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Table 1: Summary of methods used to prepare brewers’ spent grain (BSG) protein 
hydrolysates. 
Sample Description Enzyme/water E/S ratio 
(w/w or v/w) % 
B Control for K-Q Water - 
C Control for R-T Water - 
K BSG protein hydrolysate Protamex 1 
L BSG protein hydrolysate Prolyve 1 
M BSG protein hydrolysate Protex 6L 1 
N BSG protein hydrolysate Promod 144MG 1 
O BSG protein hydrolysate Promod 24P 1 
P BSG protein hydrolysate Trypsin 250 1 
Q BSG protein hydrolysate Corolase L10 1 
R BSG protein hydrolysate Alcalase 2.4L 2.5 
S 5 kDa retentate  Alcalase 2.4L 2.5 
T 5 kDa permeate Alcalase 2.4L 2.5 
U BSG protein hydrolysate Alcalase 2.4L 1 
U < 3 3 kDa permeate  Alcalase 2.4L 1 
U < 5 5 kDa permeate Alcalase 2.4L 1 
U > 5 5 kDa retentate Alcalase 2.4L 1 
V BSG protein hydrolysate Corolase PP 1 
V < 3 3 kDa permeate Corolase PP 1 
V < 5 5 kDa permeate Corolase PP 1 
V > 5 5 kDa retentate Corolase PP 1 
W BSG protein hydrolysate Flavourzyme 1 
W < 3 3 kDa permeate Flavourzyme 1 
W < 5 5 kDa permeate Flavourzyme 1 
W > 5 5 kDa retentate Flavourzyme 1 
X Unhydrolysed BSG protein - - 
Y Control for U-W Water - 
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Capsules, Pall Corporation, New York, USA) and then freeze dried. All samples were 
prepared at 50 oC (except R, S and T, 60 oC) and pH 7 (except C, R, S and T, pH 9). 
 
6.3.3. Cell culture 
A human monocytic blood cell line (U937 cells) and human leukaemic T cell line (Jurkat 
T cells) were maintained in antibiotic-free RPMI-1640 medium supplemented with 10 % 
(v/v) foetal bovine serum (FBS), in a 5 % CO2 atmosphere at 37 oC. Cells were adjusted 
to a density of 1 x 105 cells/mL for cell proliferation, superoxide dismutase and comet 
assays and 2 x 105 cells/mL for enzyme-linked immunosorbent assay. Reduced serum 
media (2.5 % FBS) was used for all experiments. 
 
6.3.4. Cell proliferation 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used 
to measure cell proliferation. U937 and Jurkat T cells, at a density of 1 x 105 cells/mL, 
were incubated for 24 hr at 37 oC with protein samples at concentrations of  0 - 10 % 
(v/v) or 0 - 5 % (v/v), respectively, in a 96-well plate. Colour blanks (sample and media 
only, without cells) were used to allow for possible colour interference by samples. The 
MTT assay kit (Roche Diagnostics Limited, West Sussex, England) was used to quantify 
cell proliferation, based on the concept that metabolically active cells convert the yellow 
tetrazolium MTT salt to a purple formazan derivative. In brief, 10 µL MTT reagent 1 and 
100 µL RPMI media were added to each well and incubated for 4 hr at 37 oC. 
Subsequently, 100 µL was then removed and 100 µL MTT reagent 2 added, followed by 
an overnight incubation at 37 oC, before absorbance at 570 nm was measured 
spectrophotometrically using a microplate reader (Spectrafluorplus, Tecan). GraphPad 
Prism 4 was used to calculate the concentration of the samples needed to induce 50 % 
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cell death (IC50 value), expressed as % (v/v). A non-toxic concentration of 0.5 % (v/v) 
was chosen for further analyses.  
 
6.3.5. Superoxide dismutase (SOD) assay 
Using a Calbiochem SOD Assay Kit (Merck Chemicals Ltd., Nottingham, U.K.), SOD 
activity was measured. U937 cells (5 mL, 1 x 105 cells/mL) were incubated for 24 hr with 
0.5 % (v/v) test samples at 37 oC, followed by a 60 min exposure to 100 µM H2O2 at 37 
oC. SOD activity is expressed relative to the protein content of the samples, measured 
using the Bicinchoninic Acid Protein (BCA) assay, previously described (Smith et al., 
1985), as SOD units/mg protein cell homogenate (U mg-1 protein). The amount of SOD 
enzyme needed to dismutate 50 % of the superoxide radical (O2-·) is equivalent to 1 SOD 
unit. 
 
6.3.6. Single cell gel electrophoresis (SCGE) - Comet assay  
U937 cells (2 mL, 1 x 105 cells/mL) were incubated for 24 hr at 37 oC with 0.5 % (v/v) 
test samples and subsequently exposed to 50 µM H2O2 for 30 min. Using the fluorescein 
diacetate ethidium bromide (FDA/EtBr) assay, cell viability was checked and was 
consistently > 90 %.  The comet assay, as previously described (McCarthy et al., 2012), 
was used to determine the effect of the extracts on oxidant-induced DNA damage. 
Briefly, cells were harvested and embedded on microscope slides (prepared with normal 
gelling agarose (NGA)) using low melting point agarose (LMP). Cells were placed in 
lysis solution for 1 hr at 4 oC, followed by electrophoresis at 300 mA, 21V for 25 min. 
Slides were neutralised by using Tris (0.4 M) and stained with EtBr (20 µg/mL). Cells 
were visualised using a fluorescence microscope (Optiphot-2, Nikon) and Komet 5.5 
image analysis software. For each slide, 50 cells were scored and DNA damage expressed 
as percentage tail DNA.  
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6.3.7. Enzyme-linked immunosorbent assay (ELISA) – Interferon-γ production 
Jurkat T cells were treated with concanavalin-A (conA, 50 µg/mL) and incubated for 24 
hr at 37oC with 0.5 % (v/v) test samples. eBioscience ELISA kit (Human IFN-γ ELISA 
Ready-Set-Go) was used to measure the production of interferon-γ (IFN-γ). Absorbance 
was read at 450 nm using a microplate reader (ThermoScientific Varioskan Flash).  
 
6.3.8. Statistical Analysis 
All data points represent the mean ± standard error (SE) of at least 3 independent 
experiments. Statistical analysis was carried out using GraphPad Prism 4.00 (GraphPad 
Software, California, U.S.A.); analysis was by one-way analysis of variance (ANOVA) 
followed by Dunnett’s test (or Tukey’s multiple comparison test, where stated).  
 
6.4. Results  
For hydrolysate samples K-Q and R-T the control protein samples are labelled B and C, 
respectively, as detailed in Table 1. These control samples, B and C, were previously 
studied in our earlier publication (McCarthy et al., 2013c). The control for samples U, V, 
W and associated fractionated hydrolysates is sample Y.   
 
6.4.1. Cell proliferation 
The effect of test samples on cell proliferation in both U937 and Jurkat T cells was 
measured using the MTT assay. Concentrations between 0 - 10 % (v/v) were analysed in 
the U937 cell line, as shown in Table 2. Sample Y was the most cytotoxic, with 0.5 % 
(v/v) significantly (P < 0.05) decreasing cell proliferation, while M was the least toxic 
sample in the U937 cell line. The concentration of each sample needed to induce 50 % 
cell death (IC50 value) was calculated. In the U937 cell line this was found to range from  
 
 
Table 2: Effect of BSG protein hydrolysates (0 - 10 % (v/v)) on cell proliferation in the U937 cell line. 
Samplea Cell proliferation (% of control)b IC50c 
 0 %  0.5 %  1 % 2 %  2.5 % 4 %  5 % 6 %   8 % 10 %  (% (v/v)) 
K 100.00 95.73 89.53 95.15 84.48 80.59 95.85 62.87 31.14* 29.32* 6.02 
L 100.00 96.78 94.24 111.87 99.52 74.98 133.34 73.18 37.20* 40.89* 6.01 
M 100.00 82.93 113.92 104.41 104.80 105.21 114.64 94.67 64.59 64.75 n/d 
N 100.00 96.22 88.21 100.04 100.03 125.80 89.08 75.17 49.97 28.51* 8.13 
O 100.00 83.97 89.82 89.69 105.13 86.77 107.16 65.09 54.07 31.39* 5.98 
P 100.00 93.94 93.63 87.09 112.62 74.10 103.54 88.07 64.07 25.67* 7.84 
Q 100.00 87.43 92.08 70.36 103.53 78.17 87.01 73.79* 52.25* 19.75* 9.07 
R 100.00 88.23 98.34 81.01 88.22* 30.72* 17.92* 13.84* 55.21 37.16* 2.90 
S 100.00 88.42 81.84 68.11 50.58* 20.48* 31.80 29.04* 55.39 74.18 2.01 
T 100.00 82.11 58.56* 43.43* 49.05* 63.81* 43.25* 35.99* 50.55* 33.69* 5.84 
U 100.00 80.01 88.26 40.77* 29.13* 44.77* 46.09* 30.21* 44.36* 26.86* 1.94 
U < 3 100.00 94.42 109.62 99.04 89.10 62.27 88.79 81.67 54.90* 25.29* 9.78 
U < 5 100.00 76.21 103.72 95.68 84.25 86.47 83.97 72.53 53.24 30.04* 9.34 
U > 5 100.00 62.93 89.92 76.59 50.91 39.97* 22.64* 18.17* 9.12* -5.14* 4.27 
V 100.00 45.00 114.60 82.22 84.36 25.39* 26.63* 23.92* 19.22* 15.88* 3.53 
V < 3 100.00 69.94 66.46 77.75 84.42 68.63 63.76 49.07* 34.61* 23.20* 6.33 
V < 5 100.00 60.32* 71.44 73.73 83.21 65.12* 71.20 57.27* 38.03* 25.47* 7.19 
V > 5 100.00 57.32 94.43 60.37 38.48* 31.00* 45.52* 32.53* 5.63* 12.12* 4.64 
W 100.00 79.36 80.68 23.74* 23.58* 17.90* 24.60* 19.20* 14.47* 10.69* 1.57 
W < 3 100.00 74.87 78.81 83.82 71.45 61.35 31.48* 13.66* 16.27* 3.76* 4.59 
W < 5 100.00 76.07 77.60 57.24* 54.91* 55.93* 43.07* 34.37* 24.54* 8.04* 5.87 
W > 5 100.00 66.23 77.95 68.44 20.71* 12.48* 14.66* -1.22* 16.41* -2.31* 2.32 
X 100.00 68.15 38.82* 35.89* 48.32* 34.51* 29.27* 31.82* 38.03* 24.68* 3.56 
Y 100.00 72.63* 58.92* 38.00* 17.74* 17.68* 17.85* 12.62* 25.05* -8.22* 1.38 
a b Values represent the mean ± SE of three independent experiments. c Values relate to the concentration of sample added to the cells, expressed as % 
(v/v) and were computed using GraphPad Prism 4.00. * Denotes statistically significant (P < 0.05) difference in cell proliferation relative to untreated 
control U937 cells. Statistical analysis by ANOVA followed by Dunnett’s test. 
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1.38 % (v/v) to non-determinable (n/d). Therefore, for further analyses using U937 cells, 
a non-toxic concentration of 0.5 % (v/v) was chosen.  
The maximum concentration tested was 5 % (v/v) for the MTT assay in the Jurkat 
T cell line, as results in the U937 cell line suggested that concentrations in excess of 5 % 
(v/v) to be unsuitable for experimentation, having significant (P < 0.05) effects on cell 
proliferation. Results of the MTT assay in the Jurkat T cell line are shown in Table 3. The 
samples tested were less cytotoxic in Jurkat T cells than in U937 cells, with the IC50 
values of 10 samples not determinable. The IC50 values of the remaining samples were in 
the range of 1.15 – 13.82 % (v/v). Similar to the effects in U937 cells, sample Y was the 
most cytotoxic. Therefore, a non-toxic concentration of 0.5 % (v/v) was chosen for 
immunomodulatory analysis of the samples in the Jurkat T cell line. 
Hydrolysates U, V and W and fractionated hydrolysates of U and V had 
significantly (P < 0.01) higher IC50 values than that of control sample Y, in both cell 
lines; indicating that fractionated hydrolysates, particularly with molecular weight (m.w.) 
< 3 and < 5 kDa, are less cytotoxic than the parent hydrolysate samples.   
 
6.4.2. Antioxidant activity 
The antioxidant potential of the samples was measured by their ability to protect against 
H2O2-induced damage in U937 cells using two assays; the SOD and comet assays. 
Exposure of U937 cells to 100 µM H2O2  for 60 min resulted in a significant (P < 0.01) 
decrease in SOD activity to 57.24 % (Table 4). Samples L, Q and R significantly (P < 
0.01) protected against this oxidant-induced reduction in SOD activity. A number of the 
fractionated hydrolysates also provided significant (P < 0.01) protection against H2O2-
induced decrease in SOD activity; U < 3 kDa, U < 5 kDa, U > 5 kDa, V > 5 kDa, W < 3 
kDa, W < 5 kDa, W > 5 kDa. Protection against DNA damage induced by 50 µM H2O2  
for 30 min was measured using the comet assay. H2O2  significantly (P < 0.01) increased
 
 
a b Values represent the mean ± SE of three independent experiments. c Values relate to the concentration of sample added to the cells, 
expressed as % (v/v) and were computed using GraphPad Prism 4.00. * Denotes statistically significant (P < 0.05) difference in cell 
proliferation relative to untreated control Jurkat T cells. Statistical analysis by ANOVA followed by Dunnett’s test. 
Table 3: Effect of BSG protein hydrolysates (0 - 5 % (v/v)) on cell proliferation in the Jurkat T cell line. 
Samplea Cell proliferation (% of control)b IC50c 
0 %  0.5 %  1 % 2 %   2.5 % 4 %  5 % (% v/v) 
K 100.00 78.32 75.55 65.93 78.85 52.44 59.97 n/d 
L 100.00 86.38 80.24 75.17 86.51 53.79* 65.38 n/d 
M 100.00 78.59 84.88 83.78 89.78 52.37* 76.53 n/d 
N 100.00 83.26 87.10 83.96 97.01 65.28 72.88 n/d 
O 100.00 94.31 99.21 84.72 95.50 59.75 83.06 n/d 
P 100.00 88.38 98.29 81.82 100.43 73.10 67.78 12.56 
Q 100.00 89.00 94.09 89.69 109.40 102.77 114.42 n/d 
R 100.00 80.58 85.38 73.63 49.78 49.08 66.36 n/d 
S 100.00 80.23 79.59 70.80 60.99 17.81* 15.32* 5.70 
T 100.00 89.65 85.04 93.08 69.79* 81.69 80.57 6.59 
U 100.00 71.03 69.39 47.85* 16.20* 38.46* 35.80* 1.99 
U < 3 100.00 58.47* 57.22* 64.17 66.51 71.60 69.85 2.08 
U < 5 100.00 79.23 86.17 72.87 73.00 81.38 65.61 11.44 
U > 5 100.00 66.13* 67.39 44.67* 18.13* 21.19* 35.40* 2.00 
V 100.00 71.63* 74.82* 68.00* 51.79* 29.34* 33.76* 2.48 
V < 3 100.00 70.39* 66.20* 62.59* 62.29* 64.55* 51.23* 7.14 
V < 5 100.00 75.49 70.92 64.85* 78.06 70.53 75.72 13.82 
V > 5 100.00 60.90* 63.56* 9.52* 12.90* 13.92* 12.87* 3.25 
W 100.00 63.54 58.09 46.62* 27.75* 27.90* 27.42* 2.02 
W < 3 100.00 67.24 59.24* 65.03 60.78* 68.24 64.55 n/d 
W < 5 100.00 78.41 67.05 71.12 66.13 57.69 76.92 n/d 
W > 5 100.00 55.89 72.16 50.98 39.98 45.22 39.75 n/d 
X 100.00 63.36* 63.65* 19.29* 15.56* 48.11* 73.99 4.12 
Y 100.00 70.12 68.48 27.16* 28.60* 24.14* 40.79* 1.15 
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Data represents the mean ± SE of four independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s test. * Denotes statistically significant difference in SOD 
activity between control and H2O2 control (P < 0.05). # Denotes statistically significant 
difference in SOD activity between H2O2 control and protein hydrolysate (P < 0.01). 
Table 4: Ability of BSG protein hydrolysates (0.5 % (v/v)) to protect against H2O2-
induced oxidative stress in the U937 cell line, measured by superoxide dismutase (SOD) 
activity.  
Sample SOD activity 
(U mg-1 protein) 
SOD activity 
(% of control) 
Control 0.36 ± 0.01 100 ± 0.00 
H2O2 control 0.18 ± 0.00* 57.24 ± 0.70* 
K 0.28 ± 0.06 91.73 ± 16.82 
L 0.57 ± 0.10#  140.47 ± 9.29#  
M 0.32 ± 0.03 94.75 ± 8.22 
N 0.28 ± 0.02 82.21 ± 13.00 
O 0.30 ± 0.04 87.62 ± 10.60 
P 0.34 ± 0.10 94.51 ± 15.53 
Q 0.35 ± 0.06  109.24 ± 25.03# 
R 0.39 ± 0.02 118.93 ± 13.65# 
S 0.32 ± 0.06 91.26 ± 10.44 
T 0.30 ± 0.03 88.16 ± 10.43 
U 0.24 ± 0.12 67.18 ± 5.38 
U < 3 0.36 ± 0.20 101.87 ± 4.86# 
U < 5 0.40 ± 0.12 111.51 ± 3.31# 
U > 5 0.29 ± 0.09 80.53 ± 4.33# 
V 0.22 ± 0.05 62.79 ± 3.53 
V < 3 0.23 ± 0.20 65.94 ± 7.12 
V < 5 0.24 ± 0.09 67.22 ± 4.09 
V > 5 0.33 ± 0.10 91.99 ± 2.81#  
W 0.25 ± 0.06 70.78 ± 4.24 
W < 3 0.44 ± 0.14 124.39 ± 2.89# 
W < 5 0.31 ± 0.22 87.72 ± 3.54# 
W > 5 0.39 ± 0.04 108.44 ± 1.81# 
X 0.21 ± 0.03 58.29 ± 1.95 
Y 0.17 ± 0.03 48.24 ± 3.34 
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the percentage tail DNA to 41.79 % (Figure 1). The fractionated hydrolysate W < 5 kDa 
significantly (P < 0.01) protected against H2O2–induced DNA damage, while other 
samples did not exert significant antioxidant effects (Figure 1). However, a general trend 
was observed indicating that the fractionated hydrolysates reduced the % tail DNA to a 
greater extent than their corresponding unfractionated samples (Figure 1). 
 
6.4.3. Immunomodulatory potential 
ELISA was used to measure the ability of the BSG protein samples to protect against the 
conA stimulated production of IFN-γ in Jurkat T cells; results are shown in Table 5. 
Sample K showed most anti-inflammatory potential, significantly (P < 0.05) reducing 
IFN-γ production to 53.28 %. Other samples also significantly (P < 0.05) reduced IFN-γ 
levels by a minimum of 12 % (W) and maximum of 28 % (P). Unfractionated 
hydrolysates U, V and W significantly (P < 0.001) reduced IFN-γ production to a greater 
extent than the corresponding fractionated samples.  
 
6.5. Discussion  
BSG is a low-value co-product of the brewing industry, with a composition of 20 % 
protein and 70 % fibre (Mussatto et al., 2006). Phenolic extracts of BSG have previously 
demonstrated antioxidant capacity (McCarthy et al., 2012) and BSG protein hydrolysates 
have been shown to possess selective anti-inflammatory effects (McCarthy et al., 2013c). 
The bioactivity of further protein hydrolysates, including fractionated hydrolysates, was 
the focus of the present study.   
 The MTT cell proliferation assay was used to determine the cytotoxicity of the 
samples in both the U937 and Jurkat T cell lines and to indicate an appropriate 
concentration for further analyses. In agreement with previously reported data for BSG 
hydrolysates, the present set of hydrolysates were more cytotoxic in U937 than in 
 
 
 
 
Figure 1: The ability of protein hydrolysates from brewers’ spent grain (BSG) to protect against H2O2-induced DNA damage in the U937 
cell line, measured by the comet assay. Data represents the mean ± SE of three independent experiments. Statistical analysis by ANOVA 
followed by Dunnett’s test. * Denotes statistically significant difference in DNA damage (% tail DNA) between control and H2O2  control (P 
< 0.01). #  Denotes statistically significant difference in DNA damage (% tail DNA) between H2O2  control and BSG protein hydrolysate (P < 
0.01). 
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Data represents the mean ± s.e. of 3 independent experiments. Statistical analysis by 
ANOVA followed by Tukey’s multiple comparison test. * Denotes statistically significant 
reduction in IFN-γ production, relative to conA treated Jurkat T cells control (P < 0.05). # 
Denotes statistically significant difference in IFN-γ production, relative to unfractionated 
parent compound (P < 0.001). 
 
 
 
Table 5: The effect of BSG protein hydrolysates (0.5 % v/v) on IFN-γ production in 
concanavalin-A (conA) stimulated Jurkat T cells. 
BSG hydrolysate IFN-γ production (% of control) 
 IFN-γ 
Control 100.00 ± 0.00 
K 53.28 ± 17.17* 
L 74.28 ± 4.97 
M 76.30 ± 6.29 
N 72.68 ± 6.74* 
O 75.88 ± 3.84 
P 71.16 ± 8.94* 
Q 73.39 ± 12.66 
R 60.67 ± 13.58 
S 58.32 ± 13.46 
T 72.65 ± 13.44 
U 77.70 ± 2.34* 
U < 3 98.19 ± 2.81# 
U < 5 102.56 ± 3.78# 
U > 5 81.95 ± 2.28* 
V 86.86 ± 1.41* 
V < 3 99.55 ± 2.06# 
V < 5 105.57 ± 3.61# 
V > 5 81.32 ± 2.05* 
W 87.27 ± 1.47* 
W < 3 113.47 ± 4.10# 
W < 5 95.15 ± 3.20 
W > 5 78.57 ± 1.56* 
X 83.12 ± 1.68* 
Y 80.88 ± 4.95* 
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Jurkat T cells (McCarthy et al., 2013c).  
Superoxide dismutases (SODs) are a group of three metalloenzymes, copper/zinc 
(Cu/Zn), manganese (Mn) and iron (Fe) SOD, involved in catalysing the dismutation of 
the superoxide anion (O2˙-) to molecular oxygen (O2) and H2O2 in humans. The assay kit 
utilised in this study measures all three SODs generated by xanthine oxidase and 
hypoxanthine. Antioxidant enzymes such as SOD and catalase (CAT) function in 
minimising oxidative stress. However, the oxidant interception and prevention process is 
not always entirely effective and products of damage can be continually formed at low 
levels, leading ultimately to protein and DNA damage, including single-strand breaks 
(Sies, 1997). The comet assay measures the ability of a sample to protect against oxidant-
induced single strand breaks in DNA (DNA damage) in vitro. To determine the 
antioxidant effects of BSG protein hydrolysates, two different antioxidant assays were 
used – SOD and comet assays, to measure both interception and repair of oxidative stress. 
A number of protein hydrolysates demonstrated the ability to protect against the H2O2-
induced reduction in SOD activity in the U937 cell line (Table 4). Interestingly, the 
fractionated hydrolysates of U and W had significant antioxidant effects, by the SOD 
assay (P < 0.01), while the parent hydrolysates did not show significant effects. This 
suggests that the lowest m.w. hydrolysate fractions (< 3 and < 5 kDa) had the greatest 
antioxidant capability of hydrolysates U - Y. Sample W < 5 kDa was the only BSG 
protein fraction to show significant (P < 0.01) ability to repair DNA, protecting against 
oxidant-induced DNA damage as assessed by the comet assay. This hydrolysate fraction 
reduced DNA damage from 41.79 to 21.02 % tail DNA and also increased SOD activity 
from 57.24 to 87.72 %.  The greater antioxidant potential of the lower m.w. (< 5 kDa) 
hydrolysates supports previous findings in the literature for quinoa seed protein 
hydrolysates, < 5 kDa (Aluko & Monu, 2003) and rapeseed protein isolates, < 1 kDa (He 
et al., 2013).  
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Hydrogen peroxide (H2O2) induces oxidative stress in an iron-dependent manner; 
producing hydroxyl radicals (OH·) via the Fenton reaction. The ability of BSG protein 
hydrolysates to protect against H2O2-induced oxidative stress suggests their ability to 
scavenge ferrous iron (Fe2+), thus making it unavailable for reaction. The ability of 
proteins to inhibit oxidation by binding iron has been discussed elsewhere (Elisa et al., 
2008). In accordance with previously reported data (Kissell & Prentice, 1979), the main 
amino acids present in the BSG hydrolysates have been found to be in the order of 
glutamine > proline > leucine (Connolly et al., 2013). Glutamic acid is the amino acid 
most highly correlated with antioxidant activity of Spanish honeys (Perez et al., 2007). 
Similarly, pea seed protein hydrolysates with highest antioxidant activity have highest 
glutamic and aspartic acids contents (Pownall et al., 2010). Hence, the presence of 
glutamine in the BSG protein hydrolysates may be, at least partially, responsible for their 
antioxidant activity.   
The antioxidant activity of food proteins can be attributable to a number of 
characteristics. Peptides with 5 – 16 amino acid residues, particularly tyrosine, 
tryptophan, methionine, lysine, cysteine and histidine are considered to be antioxidant 
peptides (Sarmadi & Ismail, 2010). Peptide linkage, configuration and concentration, 
position of amino acids in the peptide sequence, molecular weight and degree of 
hydrolysis can all contribute to antioxidant activity and the integration of these effects 
determines overall antioxidant potential (Sarmadi & Ismail, 2010). Furthermore, non-
purified food peptides (protein hydrolysates) have higher absorption and antioxidant 
activity than purified peptides (Sarmadi & Ismail, 2010).  
The selective immunomodulatory potential of BSG protein hydrolysates was 
highlighted in a previously published study (McCarthy et al., 2013c). These hydrolysates 
demonstrated the ability to reduce the conA stimulated production of IFN-γ in the Jurkat 
T cells, no effect was seen on interleukins 2 (IL-2), 4 (IL-4) or 10 (IL-10) (McCarthy et 
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al., 2013c). On the basis of these results, it was decided for the purposes of the present 
study that potential modulation of IFN-γ production would be measured in conA 
stimulated Jurkat T cells. Hydrolysates K, N, P, U, V and W showed significant (P < 
0.05) anti-inflammatory activity. Interestingly, hydrolysates U, V and W signficiantly (P 
< 0.01) reduced IFN-γ production to a greater extent than the low m.w. hydrolysate 
fractions < 3 and < 5 kDa (except W < 5 kDa). This suggests that unfractionated 
hydrolysates or fractions with m.w. > 5 kDa possess greatest anti-inflammatory potential. 
This is further supported by the finding that of the fractionated hydrolysates, only 
fractions > 5 kDa significantly (P < 0.05) reduced IFN-γ production. IFN-γ is a type 2 
pro-inflammatory cytokine (Dinarello, 2000) that plays a crucial role in the immune 
system by secreting chemokines, activating immune cells, regulating antigen presentation 
and controlling T-lymphocyte adaptive immune responses (McLaren & Ranji, 2009). 
Hence, the ability to inhibit production of IFN-γ suggests anti-inflammatory activity. 
Events such as tissue injury, microbial invasion and oxidative stress can induce acute 
inflammation (Serhan, 2007) mediated by a number of mediators including cytokines and 
nitric oxide (Feghali & Wright, 1997). A link between antioxidant and anti-inflammatory 
activities has previously been reported for whey protein hydrolysates (Power et al., 2013; 
Iskander et al., 2013), and BSG hydrolysates demonstrating anti-inflammatory potential 
in the present study also significantly increased SOD activity. 
In T lymphocytes, it is thought that conA stimulates cytokine production by 
activating mitogen-activated protein kinase (MAPK) and nuclear factor of activated T 
cell (NFAT) via a T-cell receptor (Tanaka et al., 2005). Compounds with the ability to 
suppress cytokine production induced by conA in T lymphocytes can act by inhibiting 
protein kinase C (PKC) or calcineurin (CN) activity (Tanaka et al., 2005). Hence, BSG 
protein hydrolysates may be exerting anti-inflammatory effects by these mechanisms.  
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Chronic inflammation may occur following acute inflammation and result in 
persistent infection and autoimmune diseases (Serhan, 2007). Such inflammatory and 
autoimmune diseases include rheumatoid arthritis, inflammatory bowel disease and 
psoriasis (Simopoulos, 2002). It has been postulated that IFN-γ plays a role in chronic 
inflammation by acting as a macrophage activating factor (MAF) and a migration 
inhibition factor (MIF), both activating macrophages and retaining them at the 
inflammatory site (Feghali & Wright, 1997). Therefore, the discovery of novel anti-
inflammatory compounds, particularly with the ability to reduce production of IFN-γ, has 
implications for human health.  
The hydrolysates for the present study were produced by a number of enzymes 
including Protamex, Alcalase 2.4L, and Flavourzyme (Table 1). Alcalase is a Bacillus 
licheniformis preparation containing subtilisin and glutamyl endopeptidase activities 
(Spellman et al., 2005). Flavourzyme is from Aspergillus oryzae and contains proteinase 
and exopeptidase activities (Smyth & FitzGerald, 1998). BSG protein hydrolysates M 
and O prepared with Protex 6L and Promod 24P, respectively, did not show antioxidant 
or anti-inflammatory potential. Contrastingly, hydrolysates prepared with Alcalase 2.4L, 
Corolase PP, and Flavouzyme at 50 oC, pH 7 and at an E:S of 1 % (v/v) demonstrated 
greatest bioactivity. It has previously been reported that there is great variation in the 
performance of commercial enzymes, with a wide range of protease variants and 
specificities available (Tavano, 2013; Aspmo et al., 2005). Alcalase has been repeatedly 
documented as being the most effective in terms of degree of hydrolysis (Aspmo et al., 
2005; Kong et al., 2007; Dong et al., 2008) and bioactivity (Dong et al., 2008; Mao et al., 
2011) of resulting hydrolysates. Flavourzyme is also a favourable protease for the 
production of bioactive protein hydrolysates (Peña-Ramos & Xiong, 2002; Torruco-Uco 
et al., 2009).  
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By comparing the results of the current study to those of the previous study of 
BSG protein hydrolysates (McCarthy et al., 2013c), it is evident that the present set of 
protein hydrolysates are more bioactive. While the ability to reduce IFN-γ production is 
demonstrated in the results of both studies, antioxidant activity of BSG protein 
hydrolysates is only evident in the present study. This may be attributed to differences 
arising during scaling-up of the initial protein extraction procedure to semi-pilot scale 
prior to hydrolysis, coupled with the enzymatic conditions (i.e. E/S ratio 1 %, pH 7, 
temperature of 50 oC) and the fractionation of hydrolysates.  
 
6.6. Conclusion 
Results of the present study suggest BSG protein hydrolysates possess antioxidant and 
anti-inflammatory potential. Hydrolysates with lower molecular weight (< 3 and < 5 kDa) 
have greatest antioxidant activity, whereas unfractionated hydrolysates or hydrolysates 
with m.w. > 5 kDa appear to have greater anti-inflammatory effects. These bioactive 
hydrolysates demonstrate potential for incorporation into functional foods, for the 
management of oxidation and inflammation associated diseases.  
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Chapter 7 
 
 
A study of the ability of bioactive extracts from 
brewers’ spent grain to enhance the antioxidant and 
immunomodulatory potential of food formulations 
following in vitro digestion.  
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7.1. Abstract 
The focus of the present study was assessment of the bioactivity of foods fortified with 
brewers’ spent grain (BSG) phenolic extracts or protein hydrolysates, measured following 
a simulated static gastrointestinal in vitro digestion procedure.  Snack-bar and chocolate-
drink formulations and a commercially available yogurt product were fortified with BSG 
phenolic extracts (P2 or B2) or BSG protein hydrolysates (W, W < 3 kDa, W < 5 kDa, W 
> 5 kDa) and subjected to in vitro digestion. Cytotoxicity of the fortified food digestates 
was measured using the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay. Non-toxic concentrations of 0.5 % (v/v) and 0.1 % (v/v) digestates were 
selected for further experiments in Caco-2 and Jurkat T cells, respectively. The comet 
assay was used to measure the antioxidant effect of fortified food digestates; Caco-2 cells 
were exposed to 50 µM hydrogen peroxide (H2O2) for 30 min, following incubation for 
24 hr with digestates. Yogurt supplemented with B2 digestate significantly (P < 0.05) 
protected against H2O2–induced DNA damage. To measure the immunomodulatory 
activity of the digestates, Jurkat T cells were stimulated with concanavalin-A (conA) and 
incubated with digestates for 24 hr prior to determining production of cytokines 
interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-10 (IL-10) and interferon-γ (IFN-γ) 
by enzyme-linked immunosorbent assay (ELISA). Bar digestates possessed significant (P 
< 0.05) immunomodulatory effects. Addition of hydrolysate W significantly (P < 0.05) 
increased the IFN-γ reducing capacity of the snack-bar.  Hydrolysates W < 3 and W < 5 
reduced IL-2 production to a greater extent than the unfortified yogurt (P < 0.05). Select 
BSG extracts possess the ability to enhance the antioxidant and anti-inflammatory 
potential of food formulations.   
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7.2. Introduction 
Functional foods, which have been described as foods that provide physiological benefits 
beyond their basic nutrition (Day et al., 2009), are considered to have originated in Japan 
in the late 1980s (Westrate et al., 2002). Demand by health-conscious consumers has led 
to the growth of the functional food market and the development of novel functional 
foods has become a focus of the food industry. Identification of new bioactive 
compounds increases opportunities for functional food development and provides a 
greater choice of foods with added health benefits to the consumer. It is imperative that 
claims regarding functional foods are regulated to guarantee the efficacy and safety of 
functional foods. In Europe, functional foods are regulated by the Regulation (EC) No. 
1924/2006 on nutrition and health claims made on foods (European Commission, 2006, 
available online). This regulation ensures health claims are supported by scientific data, 
are non-misleading and  pre-approved at the EU level. Additionally, claims should not 
cause doubt about the safety of other foods or encourage excessive consumption of a 
particular food. 
The addition of bioactive compounds to foods for human consumption allows 
compounds found in unusual sources or sources without sensory properties to be 
incorporated into the human diet (Fernandez-Garcia et al., 2009). For a functional food to 
exert a biological effect in vivo, its bioactivity must be retained during digestion. 
Simulating in vitro gastrointestinal digestion is a commonly used technique to mimic 
gastric and duodenal digestion and to aid in determining the metabolic fate and alterations 
in bioactivity of potential functional food ingredients during digestion; a crucial step in 
the development of functional foods.   
Brewers’ spent grain (BSG) is a nutritionally valuable co-product of the brewing 
industry, with phenolic extracts and protein hydrolysates from BSG demonstrating 
antioxidant and anti-inflammatory bioactivities (McCarthy et al., 2012; McCarthy et al., 
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2013; McCarthy et al., 2013b; McCarthy et al., 2013c). To date, whole BSG has been 
incorporated into foods such as ready-to-eat snacks and cookies to increase the fibre 
content (Stojceska et al., 2008; Prentice et al., 1978). However, research regarding the 
addition of extracts prepared from BSG into foods has not been extensively studied to 
date.  We have previously investigated the effect of the addition of BSG phenolic extracts 
to fruit juices and smoothies (McCarthy et al., 2013d), however it was found that the 
initial phenolic content of the beverages was too high for significant increases in 
antioxidant effects to be evident.  
This study aims to incorporate bioactive phenolic extracts and protein 
hydrolysates from BSG into snack-bar and chocolate-drink formulations and a 
commercially available yogurt product. After in vitro gastrointestinal digestion of the 
fortified foods, bioactivity of digestates is measured by assessing the antioxidant and 
immunomodulatory effects using the comet and enzyme-linked immunosorbent (ELISA) 
assays, respectively.  
 
7.3. Materials and methods 
7.3.1. Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich Ireland 
Limited, Co.Wicklow, Ireland. Caco-2 and Jurkat T cells were obtained from the 
European Collection of Animal Cell Cultures (ECACC, Salibury, UK).  
 
7.3.2. Preparation of phenolic extracts and protein hydrolysates 
Phenolic extracts were prepared from pale and black BSG, as described previously 
(McCarthy et al., 2012) and designated P1 - P4 and B1 - B4, respectively. For this study, 
two phenolic extracts were chosen for addition into foods – extract P2 and B2. These 
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extracts are the supernatants produced following the sequential extraction of BSG using 
110 mM NaOH and 1 N NaOH.  
The preparation of fractionated protein hydrolysates from BSG has been 
described previously (McCarthy et al., 2013; McCarthy et al., 2013b). Hydrolysate W, 
was prepared using 1 % (w/w) Flavourzyme at 50 oC and pH 7.0. The resulting 
hydrolysate was heated at 95 °C for 10 min to inactivate the enzyme and then freeze dried 
or fractionated using 5 and 3 kDa molecular weight cut-off membranes (MinimateTM 
Tangental Flow Filtration Capsules, Pall Corporation, New York, USA) and then freeze 
dried. Before addition to foods, a 1 % (w/v) hydrolysate solution was prepared using 
distilled deionised water. Hydrolysates for analysis are labelled W, W < 3 (3 kDa 
permeate), W < 5 (5kDa permeate) and W > 5 (5 kDa retentate). 
 
7.3.3. Preparation of fortified foods 
The snack bar and chocolate drink formulations were obtained from a food company and 
a yogurt product (Actimel Danone Ltd., Co. Dublin) was purchased in a local 
supermarket. Following preliminary experiments concentrations of 10, 20 and 30 % (v/w) 
or (v/v) BSG phenolic extracts were selected for addition to the bar, drink and yogurt, 
respectively. Protein hydrolysates were added to all foods at a concentration of 2.5 % 
(v/v).  
 
7.3.4. In vitro digestion  
A static gastrointestinal digestion model, as previously described (O’Connell et al., 2007; 
McCarthy et al., 2013d) was used to simulate human digestion. Briefly, 4 g / 4 mL 
sample was diluted to a final volume of 8 mL with Hank’s balanced salt solution (HBSS). 
For gastric digestion, pepsin (0.04 g) was added to each sample, followed by a 1 hr 
incubation in a shaking waterbath (95 rpm) at 37 oC, pH 2. To simulate duodenal 
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digestion, pancreatin (8 µg) and bile salts consisting of 8 µg glycodeoxycholate, 5 µg 
taurodeoxycholate and 8 µg taurocholate were added, the pH was adjusted to 7.4 and 
samples were incubated in a shaking waterbath (95 rpm) at 37 oC for 2 hr.  Samples were 
ultracentrifuged at 53000 rpm for 95 min and the supernatant (digestate) was filtered 
through a 0.22 µm filter. Before addition to cells, all digestates were sterile filtered (0.22 
µm filters), aliquoted into sterile eppendorphs and stored at –80 oC. 
 
7.3.5. Cell culture 
Caco-2 cells, human colon adenocarcinoma cells, were maintained in antibiotic-free 
Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 1 % (v/v) non-
essential amino acids and 10 % (v/v) fetal bovine serum (FBS), at 37 oC in a 5 % CO2 
atmosphere.  Caco-2 cells were seeded at density of 0.5 x 105 and 1 x 105 cells/mL for 
cell proliferation and comet assays, respectively. Jurkat T cells, a human leukaemic T cell 
line, were maintained in RPMI-1640 medium supplemented with 10 % (v/v) FBS and 
plated at a seeding density of 1 x 105 and 2 x 105 cells/mL for cell proliferation and 
ELISA assays, respectively. Reduced serum media (2.5 % FBS) was used for all 
experiments.  
 
7.3.6. Cell proliferation 
The (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was 
used to measure the effect of the digestates on cell proliferation in Caco-2 and Jurkat T 
cells. Caco-2 cells were allowed to adhere overnight at 37 oC. Cells were incubated for 24 
hr at 37 oC with 0 - 50 % or 0 - 5 % (v/v) phenolic or protein fortified food digestates, 
respectively, in 96 well plates. The MTT assay kit (MTT I proliferation kit, Roche 
Diagnostics, UK) was then used to measure cell proliferation. MTT reagent 1 (10 µL) 
was added to cells and incubated for 4 hr at 37 oC. After incubation, 100 µL MTT reagent 
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2 was added, followed by a final incubation period of 24 hr at 37 oC. Absorbance was 
determined at 570 nm using a microplate reader (Spectrafluorplus, Tecan) and cell 
proliferation was calculated as a percentage of the control, untreated cells. On the basis of 
the MTT assay results, concentrations of 0.5 % (v/v) and 0.1 % (v/v) digestates were 
selected for further analysis using Caco-2 and Jurkat T cells, respectively.  
 
7.3.7. Comet assay 
Caco-2 cells were incubated for 24 hr at 37 oC in a 6 well plate, prior to the addition of 
digestates (0.5 % (v/v)) and incubation for 24 hr at 37 oC. Following incubation, cells 
were treated with 50 µM H2O2 for 30 min. Cell viability was determined using the 
fluorescein diacetate ethidium bromide assay (FDA/EtBr). The comet assay was then 
used to quantify oxidative DNA damage in Caco-2 cells, as previously described 
(McCarthy et al., 2012; McCarthy et al., 2013; McCarthy et al., 2013b). Briefly, cells 
were harvested and fixed on microscope slides using low melting point (LMP) agarose, 
before lysis for 1 hr at 4 oC and electrophoresis for 25 min at 21 V, 300 mA. Slides were 
neutralised using Tris neutralisation solution, followed by staining with 20 µg/mL 
ethidium bromide (EtBr) and scoring (50 cells) using Komet 5.5 image analysis software 
and a fluorescence microscope (Optiphot-2, Nikon). DNA damage was expressed as 
percentage tail DNA.  
 
7.3.8. Cytokine production 
Jurkat T cells were treated with 50 µg/mL Concanavalin-A (conA) and incubated for 24 
hr at 37 oC with 0.1 % (v/v) food digestates. Production of interleukin-2 (IL-2), 
interleukin-4 (IL-4), interleukin-10 (IL-10) and interferon-γ (IFN-γ) was measured. 
Cytokine production was determined using eBioscience ELISA kits (Human Th1/Th2 
ELISA Ready-SET-Go kit purchased from Insight Biotechnology, Wembley, UK). 
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Absorbance was read at 450 nm on a microplate reader (Spectraflourplus, Tecan) and 
cytokine production expressed as percentage of conA treated Caco-2 cells.  
 
7.3.9. Statistical analysis 
All data represents the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was by one-way analysis of variance (ANOVA) 
followed by Dunnett’s test, analysed using GraphPad Prism 4 (GraphPad software, 
California, U.S.A.). 
 
7.4. Results 
7.4.1. Cell proliferation 
Caco-2 and Jurkat T cells were incubated for 24 hr with digestates and cell proliferation 
was measured using the MTT assay (Tables 1, 2, 3 & 4). Non-toxic concentrations of 0.5 
% (v/v) and 0.1 % (v/v) digestates were selected for further experiments in Caco-2 and 
Jurkat T cells, respectively. 
 
7.4.2. Oxidant-induced DNA damage 
The ability of the fortified food digestates (0.5 % v/v) to protect against H2O2-induced 
DNA damage in Caco-2 cells was measured using the comet assay. Cell viability was 
greater than 90 % for all experimental conditions, as determined by the FDA/EtBr assay. 
Hydrogen peroxide significantly (P < 0.05) increased DNA damage to approximately 30 
% tail DNA (Figures 1 & 2). The digestate prepared from yogurt supplemented with B2 
significantly (P < 0.05) protected against DNA damage induced by H2O2 and reduced tail 
DNA to 18.2 % (Figure 1). None of the hydrolysate-fortified foods protected against 
oxidant-induced DNA damage (Figure 2). 
 
  
 
 
Table 1: Effect of BSG phenolic extract-fortified food digestates on cell proliferation in the Caco-2 cell line. 
Sample Cell proliferation (% of control) 
0 % (v/v) 2.5 % (v/v) 5 % (v/v) 10 % (v/v) 20 % (v/v) 25 % (v/v) 40 % (v/v) 50 % (v/v) 
Digestion blank 100.00 ± 0.00 90.60 ± 7.24 72.49 ± 15.53 68.32 ± 1.24 60.70 ± 15.02 63.93 ± 10.31 21.81 ± 5.47* 0.85 ± 19.19* 
Bar 100.00 ± 0.00 17.55 ± 5.26* 10.68 ± 2.77* 0.0 ± 0.0* 1.88 ± 3.83* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Bar & P2 100.00 ± 0.10 31.05 ± 12.97* 28.26 ± 16.68* 27.88 ± 2.69* 22.88 ± 14.08 21.97 ± 7.08* 17.70 ± 8.95* 0.0 ± 0.0* 
Bar & B2 100.00 ± 0.01 21.11 ± 6.12* 7.76 ± 1.98* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Drink 100.00 ± 0.12 53.98 ± 16.94 61.73 ± 17.43 88.41 ± 26.77 0.0 ± 0.0* 0.0±0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Drink & P2 100.00 ± 0.01 50.50 ± 2.43* 30.48 ± 7.36* 3.95 ± 4.41* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Drink & B2 100.00 ± 0.06 54.10 ± 3.33 56.02 ± 9.82 40.56 ± 4.27 0.33 ± 14.38* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Yogurt 100.00 ± 0.00 43.38 ± 15.41 51.36 ± 22.56 66.47 ± 22.83 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Yogurt & P2 100.00 ± 0.01 58.93 ± 12.93 56.43 ± 13.40 37.32 ± 14.86* 33.45 ± 11.08* 44.37 ± 7.63* 20.90 ± 6.74* 0.0 ± 0.0* 
Yogurt & B2 100.00 ± 0.01 48.84 ± 10.01* 31.43 ± 6.31* 21.65 ± 3.92* 16.47 ± 5.32* 0.0 ± 0.0* 0.0 ± 0.0* 0.0 ± 0.0* 
Values are mean ± SE of four independent experiments, expressed as a percentage relative to untreated Caco-2 cells. Statistical analysis by 
ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell viability, relative to untreated Caco-2 cells (P < 0.05). 
  
 
Table 2: Effect of BSG protein hydrolysate-food digestates on cell proliferation in the Caco-2 cell line. 
Sample Cell proliferation (% of control) 
 0 % (v/v) 0.5 % (v/v) 1 % (v/v) 2 % (v/v) 2.5 % (v/v) 5 % (v/v) 
Digestion Blank 100  ± 0.00 96.72 ± 5.45 94.73 ± 15.81 96.82 ± 4.54 106.90 ± 3.69 118.02 ± 4.14 
Bar 100 ± 0.00 133.41 ± 12.98 112.16 ± 13.91 65.86 ± 12.79 56.41 ± 11.31 51.01 ± 4.99* 
Bar & W 100 ± 0.00 95.71 ± 4.50 80.33 ± 17.76 95.59 ± 0.34 0.0 ± 0.0* 2.98 ± 7.73* 
Bar & W <3 100 ± 0.00 109.65 ± 14.21 84.89 ± 1.04 81.63 ± 9.37 49.04 ± 10.94* 45.35 ± 9.05* 
Bar & W <5 100 ± 0.00 98.24 ± 5.21 100.52 ± 5.35 96.34 ± 3.78 56.34 ± 11.75 46.84 ± 4.17 
Bar & W >5 100 ± 0.00 111.64 ± 17.95 66.06 ± 10.32 24.21 ± 3.85* 28.70 ± 4.11* 34.95 ± 2.89* 
Drink 100 ± 0.00 102.50 ± 7.17 84.30 ± 12.12 83.41 ± 19.90 28.89 ± 13.29* 21.98 ± 4.64* 
Drink & W 100 ± 0.00 95.36 ± 5.61 94.97 ± 8.19 94.67 ± 5.45 69.58 ± 8.13* 31.16 ± 3.42* 
Drink & W < 3 100 ± 0.00 82.35 ± 2.02 85.10 ± 4.95 73.60 ± 11.80 67.43 ± 12.08 67.46 ± 11.13 
Drink & W < 5 100 ± 0.00 99.13 ± 4.44 93.71 ± 2.87 73.93 ± 5.61 76.84 ± 6.29* 60.82 ± 3.65*  
Drink & W > 5 100 ± 0.00 99.68 ± 4.67 88.94 ± 7.76 91.41 ± 6.03 84.27 ± 2.97 82.89 ± 7.79  
Yogurt 100 ± 0.00 137.93 ± 13.10 85.64 ± 9.49 82.90 ± 9.56 52.26 ± 12.41 35.18 ± 9.44*  
Yogurt & W 100 ± 0.00 111.96 ± 6.16 102.60 ± 2.56 79.47 ± 0.88 77.78 ± 8.18* 30.81 ± 2.37*  
Yogurt & W < 3 100 ± 0.00 94.56 ± 7.53 84.64 ± 7.60 77.71 ± 16.32 71.33 ± 16.09 14.51 ± 8.66*  
Yogurt & W < 5 100 ± 0.00 71.98 ± 11.60 79.25 ± 6.65 100.27 ± 3.78 94.91 ± 9.65* 27.78 ± 13.17*  
Yogurt & W > 5 100 ± 0.00 98.60 ± 10.13 105.94 ± 6.74 95.63 ± 14.09 89.15 ± 13.68 28.74 ± 8.10  
Values are mean ± SE of four independent experiments, expressed as a percentage relative to untreated Caco-2 cells. Statistical analysis by 
ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell viability, relative to untreated Caco-2 cells (P < 
0.05).  
  
 
Table 3: Effect of BSG phenolic extract-fortified food digestates on cell proliferation in the Jurkat T cell line. 
Sample Cell proliferation (% of control) 
 0 % (v/v) 0.5 % (v/v) 1 % (v/v) 2 % (v/v) 2.5 % (v/v) 5 % (v/v) 
Digestion blank 100.00  ± 0.00 93.33 ± 2.71 92.33 ± 3.56* 88.95 ± 2.55* 92.71 ± 4.72* 91.33 ± 4.62* 
Bar 100.00 ± 0.00 29.96 ± 3.73* 4.16 ± 2.04* 8.90 ± 0.55* 11.82 ± 1.22* 24.92 ± 1.48* 
Bar & P2 100.00 ± 0.00 41.94 ± 6.04* 3.28 ± 1.74* 6.32 ± 0.96* 8.94 ± 1.46* 23.07 ± 2.03* 
Bar & B2 100.00 ± 0.00 11.91 ± 4.95* 0.0 ± 0.0* 1.73 ± 0.64* 14.64 ± 7.98* 20.15 ± 1.82* 
Drink 100.00 ± 0.00 81.12 ± 2.78* 70.66 ± 3.97* 62.19 ± 2.12* 60.94 ± 3.90* 0.0 ± 0.0* 
Drink & P2 100.00 ± 0.00 68.00 ± 1.37* 61.75 ± 2.43* 45.23 ± 3.56* 36.53 ± 4.40* 0.0 ± 0.0* 
Drink & B2 100.00 ± 0.00 78.11 ± 3.24* 70.43 ± 4.02* 57.75 ± 4.29* 56.35 ± 6.22* 6.76 ± 2.71* 
Yogurt 100.00 ± 0.00 58.86 ± 6.14* 36.04 ± 3.96* 0.0 ± 0.0* 0.0 ± 0.0* 3.15 ± 2.88* 
Yogurt & P2 100.00 ± 0.00 70.47 ± 3.18* 71.50 ± 3.55* 18.32 ± 9.85* 3.29 ± 0.74* 4.85 ± 1.84* 
Yogurt & B2 100.00 ± 0.00 78.31 ± 3.22* 67.43 ± 1.75* 51.99 ± 4.40* 34.69 ± 0.86* 13.49 ± 2.04* 
Values are mean ± SE of four independent experiments, expressed as a percentage relative to untreated Jurkat T cells. Statistical 
analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell viability, relative to untreated 
Jurkat T cells (P < 0.05).  
  
 
Values are mean ± SE of four independent experiments, expressed as a percentage relative to untreated Jurkat T cells. Statistical analysis by 
ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell viability, relative to untreated Jurkat T cells (P < 
0.05).  
 
Table 4: Effect of BSG protein hydrolysate-fortified food digestates on cell proliferation in the Jurkat T cell line. 
Sample Cell proliferation (% of control) 
 0 % (v/v) 0.5 % (v/v) 1 % (v/v) 2 % (v/v) 2.5 % (v/v) 5 % (v/v) 
Digestion blank 100.00 ± 0.00 97.13 ± 2.75 96.39 ± 4.52  95.50 ± 3.98  97.24 ± 8.38 95.61 ± 8.06 
Bar 100.00 ± 0.00 52.70 ± 4.65* 5.55 ± 2.10* 17.68 ± 4.29*  25.39 ± 4.04* 66.28 ± 9.13* 
Bar & W 100.00 ± 0.00 12.13 ± 7.58* 9.24 ± 2.63* 32.27 ± 13.53* 28.01 ±  3.81* 50.33 ± 4.94* 
Bar & W < 3 100.00 ± 0.00 83.31 ± 4.49* 30.91 ± 2.70* 25.09 ± 1.52* 21.26 ± 1.55* 32.45 ± 1.50* 
Bar & W < 5 100.00 ± 0.00 0.0 ± 0.0* 0.0 ± 0.0* 11.48 ± 2.18* 31.59 ± 3.11* 63.46 ± 4.13* 
Bar & W > 5 100.00 ± 0.00 81.93 ± 5.11* 37.70 ± 5.33* 28.40 ± 2.95* 19.36 ± 3.37* 18.65 ± 2.72* 
Drink 100.00 ± 0.00 73.83 ± 4.26 73.45 ± 8.32 50.67 ± 10.93* 54.53 ± 6.25* 19.62 ± 7.61* 
Drink & W 100.00 ± 0.00 110.48 ± 2.64 100.88 ± 5.70 83.36 ± 6.03 58.31 ± 6.25* 0.0 ± 0.0* 
Drink & W < 3 100.00 ± 0.00 80.44 ± 0.96 87.75 ± 9.09 88.50 ± 12.91 85.43 ± 12.63 50.24 ± 7.88* 
Drink & W < 5 100.00 ± 0.00 102.99 ± 3.62 94.59 ± 7.59  83.93 ± 7.36 77.51 ± 6.97* 0.0 ± 0.0* 
Drink & W > 5 100.00 ± 0.00 89.60 ± 4.62 4.81 ± 6.23* 65.13 ± 5.04* 63.64 ± 6.49* 1.65 ± 2.46* 
Yogurt 100.00 ± 0.00 79.68 ± 6.65 44.54 ± 6.48 1.26 ± 0.72* 1.33 ± 1.49* 0.17 ± 1.48* 
Yogurt & W 100.00 ± 0.00 74.98 ± 4.98* 55.44 ± 9.63* 0.0 ± 0.0* 5.20 ± 2.54* 11.70 ± 4.47* 
Yogurt & W < 3 100.00 ± 0.00 88.49 ± 8.06* 92.71 ± 8.28* 34.65 ± 11.84* 0.0 ± 0.0* 0.0 ± 0.0* 
Yogurt & W < 5 100.00 ± 0.00 32.37 ± 2.16 0.0 ± 0.0* 0.0 ± 0.0* 4.28 ± 3.31* 3.65 ±  5.06* 
Y ogurt & W > 5 100.00 ± 0.00 84.67 ± 6.71 76.17 ± 6.08 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
  
 
 
 
 
Figure 1: Ability of BSG phenolic extract-fortified food digestates (0.5 % v/v) to protect against H2O2-induced DNA damage in the Caco-2 
cell line. Data represents the mean ± SE of four independent experiments. Statistical analysis by ANOVA followed by Dunnett’s Test. * 
Denotes statistically significant difference in DNA damage between control and H2O2 control (P < 0.05).  # Denotes statistically significant 
difference in DNA damage, relative to H2O2 control (P < 0.05).  
* 
# 
  
 
 
 
Figure 2: Ability of BSG protein hydrolysate-fortified food digestates (0.5 % v/v) to protect against H2O2-induced DNA damage in the 
Caco-2 cell line. Data represents the mean ± SE of four independent experiments. Statistical analysis by ANOVA followed by Dunnett’s 
Test. * Denotes statistically significant difference in DNA damage between control and H2O2 control (P < 0.05). 
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7.4.3. Cytokine production 
Following stimulation of Jurkat T cells with 50 µg/mL conA in the presence of 0.1 % 
(v/v) digestates, cytokine production (IL-2, IL-4, IL-10 and IFN-γ) was measured using 
ELISA. Digestates prepared from the bar, significantly (P < 0.05) increased the 
production of IL-2 and IL-4 but decreased the production of IL-10 and IFN-γ. Similarly, 
the bar supplemented with P2 increased IL-2 and IL-4 production and decreased IL-10 
and IFN-γ production. The bar supplemented with B2 also decreased IFN-γ production 
but in contrast to the unsupplemented and P2 supplemented bar it decreased the 
production of IL-2 (Table 5). The drink digestates, both unfortified and fortified, did not 
alter cytokine production.  Unfortified, digested yogurt decreased the production of IL-2 
to 66.5 % in Jurkat T cells but this effect was negated by the addition of P2 and B2. There 
was a significant increase in the production of IL-10 and IFN-γ to 108 % in cells exposed 
to the digestates of yogurt supplemented with P2 (Table 5). 
The snack-bar formulation fortified with protein hydrolysates W, W < 3, W < 5 
and W > 5 significantly (P < 0.001) reduced IFN- γ production by at least 70 % (Table 6). 
A number of hydrolysate-fortified digestates also significantly (P < 0.05) reduced IL-2 
production by as much as 65 %; drink & W > 5, yogurt, yogurt & W < 3, yogurt & W < 
5, yogurt & W > 5. IL-4 and IFN-γ production were significantly (P  < 0.05) increased by 
bar & W < 5 and drink & W > 5, respectively. Supplementation of the snack bar with 
hydrolysate W significantly (P < 0.05) increased IFN-γ reduction, compared to the 
unsupplemented snack-bar formulation.  
 
7.5. Discussion 
Research regarding the use of BSG in human nutrition has generally been limited to the 
ability of whole BSG to increase the protein and fibre content of a range of foodstuffs, 
including cookies, frankfurters and bread (Özturk et al., 2002; Özvural et al., 2009; 
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Table 5: Effect of BSG phenolic extract-fortified food digestates (0.1 % v/v) on cytokine 
production in concanavalin-A (conA) stimulated Jurkat T cells. 
Sample Cytokine Production (% of control) 
Interleukin-2 
(IL-2) 
Interleukin-4 
(IL- 4) 
Interleukin-10 
(IL-10) 
Interferon-ã 
(IFN-ã) 
Control 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 
Digestion blank 114.05 ± 4.81 98.18 ± 0.35 107.73 ± 1.01* 101.33 ± 6.60 
Bar 113.17 ± 7.49* 105.36 ± 0.36* 88.46 ± 2.55* 58.09 ± 4.01* 
Bar & P2 114.35 ± 4.77* 103.52 ± 0.21* 92.40 ± 1.58* 64.10 ± 3.84* 
Bar & B2 74.42 ± 1.94* 101.71 ± 0.75 95.85 ± 0.86 63.44 ± 4.97* 
Drink 81.82 ± 14.55 98.74 ± 0.34 98.64 ± 0.24 92.66 ± 5.51 
Drink & P2 103.21 ± 6.14 98.59 ± 0.56 99.79 ± 0.16 114.52 ± 9.34 
Drink & B2 75.11 ± 3.65 98.20 ± 0.78 102.42 ± 0.26 106.37 ± 9.24 
Yogurt 66.15 ± 10.52* 98.18 ± 0.52 99.38 ± 1.66 104.77 ± 5.42 
Yogurt & P2 107.65 ± 4.23 97.87 ± 1.47  108.51 ± 3.19* 108.86 ± 9.20* 
Yogurt & B2 104.93 ± 6.67 98.63 ± 0.30 104.62 ± 1.55 111.63 ± 6.61 
Values are mean ± SE of three independent experiments, expressed as a percentage relative 
to Jurkat T cells treated with conA alone. Statistical analysis by ANOVA followed by 
Dunnett’s Test. * Denotes statistically significant difference in cytokine production, relative 
to control Jurkat T cells (P < 0.05).  
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Table 6: Effect of BSG protein hydrolysate-fortified food digestates (0.1 % v/v) on 
cytokine production in concanavalin-A (conA) stimulated Jurkat T cells. 
Sample Cytokine Production (% of control) 
Interleukin-2 
(IL-2) 
Interleukin-4 
(IL- 4) 
Interleukin-10 
(IL-10) 
Interferon-ã 
(IFN-ã) 
Control 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 
Digestion blank 99.80 ± 3.86 102.95 ± 4.60 108.19 ± 1.25 93.74 ± 8.85 
Bar 95.33 ± 3.89 130.10 ± 4.51* 103.22 ± 2.44 66.10 ± 7.16 
Bar & W 92.68 ± 7.09 108.13 ± 5.02 112.29 ± 9.29 16.83 ± 10.53*# 
Bar & W < 3 90.27 ± 2.01 119.26 ± 1.82 102.31 ± 4.90 29.07 ± 9.46* 
Bar & W < 5 95.75 ± 5.50 127.54 ± 9.63* 98.48 ± 2.83 22.23 ± 11.35* 
Bar & W > 5 83.16 ± 3.26 121.41 ± 3.17 98.55 ± 1.77 22.92 ± 14.65* 
Drink  86.37 ± 1.03 85.17 ± 12.50 104.62 ± 1.24 64.97 ± 11.72 
Drink & W 98.00 ± 7.91 102.86 ± 1.04 104.30 ± 0.09 99.75 ± 7.07 
Drink & W < 3 98.77 ± 5.36  113.04 ± 9.99 114.30 ± 10.90 90.15 ± 10.15 
Drink & W < 5 100.79 ± 5.35 105.95 ± 1.25 107.20 ± 1.05 129.01 ± 10.88 
Drink & W > 5 50.29 ± 2.23* 103.02 ± 1.01 98.39 ± 3.24 137.11 ± 3.94* 
Yogurt  75.50 ± 9.11* 101.79 ± 1.64 104.02 ± 3.61 95.62 ± 9.14  
Yogurt & W 102.46 ± 5.27 98.25 ± 4056 99.61 ± 1.93 102.79 ± 7.67 
Yogurt & W < 3 35.91 ± 9.94*# 94.28 ± 8.10 109.34 ± 8.75 97.39 ± 3.94 
Yogurt & W < 5 66.44 ± 1.70*# 101.57 ± 0.66 103.71 ± 5.40 89.23 ± 2.31 
Yogurt & W >5 76.03 ± 6.82* 98.23 ±2.53 113.72 ± 3.21 92.00 ± 0.96 
Values are mean ± SE of three independent experiments, expressed as a percentage 
relative to Jurkat T cells treated with conA alone. Statistical analysis by ANOVA 
followed by Dunnett’s Test. * Denotes statistically significant difference in cytokine 
production, relative to control Jurkat T cells (P < 0.05). # Denotes statistically significant 
difference in cytokine production, relative to unfortified food (P < 0.05). 
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Stojceska and Ainsworth, 2008). It has previously been shown that phenolic extracts and 
protein hydrolysates from BSG possess antioxidant and anti-inflammatory effects 
(McCarthy et al., 2012; McCarthy et al., 2013c). The present research aimed to determine 
the effectiveness of BSG phenolic extracts and protein hydrolysates as functional 
ingredients by assessing the bioactivity of extract-fortified foods following an in vitro 
digestion procedure.  
The MTT assay was utilised to determine the effect of the food digestates on cell 
proliferation. In general, fortified food digestates demonstrated higher cytotoxicity in 
Jurkat T cells, relative to Caco-2 cells. These data demonstrate the varying degrees of 
sensitivity of different cell lines to cytotoxic compounds. It has been shown that 
naringenin, a flavonoid, is more cytotoxic in leukocytes, including Jurkat T cells, than in 
Caco-2 colon cancer cells and the authors suggested this to be in accordance with the fact 
that anti-cancer drugs are more effective against leukaemia than other cancer types 
(Kanno et al., 2005). Supporting this, Jurkat T leukaemic cells have repeatedly been 
reported to be more sensitive to novel copper complex anti-cancer drugs, compared to 
Caco-2 cells (García-Giménez et al., 2009; Gonzalez-Alvarez et al., 2008).  
To evaluate the antioxidant potential of the fortified food digestates, a single cell 
gel electrophoresis assay was used to measure the ability of the samples to protect against 
oxidant-induced DNA damage. Hydrogen peroxide (H2O2) was used to induce DNA 
damage, as it is effective in the induction of DNA damage (McCarthy et al., 2012; 
McCarthy et al., 2013; McCarthy et al., 2013b) by an iron-dependent mechanism (Imlay 
et al., 1988). Coupling of simulated in vitro digestion procedures with bioactivity 
experiments in intestinal Caco-2 cells, a colon cancer cell line, is a useful model for the 
investigation of host responses (McCarthy et al., in press), therefore Caco-2 cells were 
used for measurement of antioxidant activity after in vitro digestion of the food samples. 
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We have previously reported the ability of BSG phenolic extracts P2 and B2 to reduce 
H2O2-induced DNA damage in U937 lymphocytes (McCarthy et al., 2012).  
The results of the present study show that the addition of BSG phenolic extract B2 
(30 % v/v) to yogurt resulted in a product which significantly (P < 0.05) protected against 
oxidant-induced DNA damage. The unsupplemented yogurt digestate did not demonstrate 
any antioxidant effects. Similarly, the addition of BSG phenolic extracts increased the 
antioxidant activity of a juice with a low initial antioxidant activity, as measured by the 
FRAP assay (McCarthy et al., 2013d). None of the protein hydrolysate fortified foods 
demonstrated antioxidant effects, although it was previously shown that hydrolysate W < 
5 kDa could protect against H2O2-induced DNA damage in the U937 cell line (McCarthy 
et al., 2013b). Antioxidant effects of fortified products may be governed by synergistic 
and antagonistic reactions between the foodstuff and the BSG extract. Interactions that 
occur between different ingredients within foods are not fully understood and further 
investigation is required for the successful development of functional foods.  
Treatment of Jurkat T cells with concanavalin-A (conA) stimulates cytokine 
production in leukocytes, which can be measured by an enzyme-linked immunosorbent 
assay (ELISA). In the foods supplemented with BSG phenolic extracts (P2 or B2), the bar 
digestates demonstrated the greatest immunomodulatory effects. Bar & P2, bar & B2 and 
unfortified bar digestates significantly (P < 0.05) reduced IFN-γ production to 58, 64 and 
63 %, respectively (Table 5). The snack-bar formulation fortified with protein 
hydrolysates also demonstrated anti-inflammatory effects, significantly (P < 0.05) 
reducing IFN-γ production by at least 71 % (Table 6). Many of the hydrolysate fortified 
food digestates also reduced the production of the pro-inflammatory cytokine IL-2; drink 
& W > 5, yogurt & W < 3, yogurt & W < 5, yogurt & W > 5.  
BSG phenolic extract P2 has previously been shown to significantly (P < 0.05) 
reduce production of IL-2, IL-4, IL-10 and IFN-γ, while extract B2 did not demonstrate 
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anti-inflammatory effects prior to in vitro digestion (McCarthy et al., 2013c). Similarly, 
protein hydrolysates W and W > 5 (but not W < 3 or W < 5) significantly reduced IFN-γ 
production in Jurkat T cells (McCarthy et al., 2013b). Therefore, the addition of BSG 
phenolic extracts and protein hydrolysates to foodstuffs, followed by in vitro digestion of 
the foods resulted in greater immunomodulatory effects than was observed for the 
extracts prior to their addition to a foodstuff. 
The addition of bioactive polyphenolic extracts and protein hydrolysates into 
foods has been extensively researched. Grape seed extracts have been incorporated into 
full-fat and non-fat yogurts, resulting in products with higher polyphenol content and 
enhanced anti-radical and antioxidant activities (Chouchouli et al., 2013). Similarly, 
addition of grape seed extract to bread increases antioxidant capacity in a dose-dependent 
manner (Peng et al., 2010). Espresso coffee brew supplemented with hazelnut skin 
extracts possess increased in vitro (DPPH radical scavening) and in vivo (ferric reducing 
antioxidant power (FRAP) of plasma) anti-radical activity (Contini et al., 2012). 
Synergism between coffee brew phenolics and the added hazelnut skin extracts was 
suggested (Contini et al., 2012). Whey hydrolysate beverages have shown the ability to 
decrease low-density lipoprotein (LDL) cholesterol and blood pressure in vivo (Fleugel et 
al., 2010). 
This study has shown that the addition of BSG extracts to foods, in particular the 
snack-bar, can result in a fortified food with selective bioactive potential. Further 
research to determine the mechanisms involved in the bioactive effects of the fortified 
foods would facilitate the selection of ingredients and host foods for optimal bioactivity. 
The fortification of foods with BSG extracts presents a unique opportunity for the 
utilization of this co-product of the brewing industry; producing a nutritionally-enriched 
foodstuff, increasing the commercial value of BSG and reducing waste. 
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Functional foods have the ability to provide consumers with a health benefit 
supplementary to the basic nutrition of the product. There has been considerable 
efforts to search for bioactive ingredients due to health-conscious consumers 
demanding healthier versions of foods. Oxidation and inflammation are associated 
with disease states such as cancer, cardiovascular disease, rheumatoid arthritis and 
Alzheimer’s disease (Valko et al., 2007; Lucas et al., 2006; Chung et al., 2000), hence 
the ability of antioxidant and anti-inflammatory agents to reduce the risk of these 
disease states is of significant public health importance. 
In recent years, there has been an unprecedented demand for plant-derived 
bioactive ingredients for incorporation into foods for human nutrition. Brewers’ spent 
grain (BSG), a nutritious co-product of the brewing industry, represents a unique 
source of novel, potentially bioactive ingredients. Currently, use of BSG is mainly 
restricted to animal feed, although research on the inclusion of whole BSG into foods 
such as cookies, bread and frankfurters has been successfully carried out to improve 
the nutritional profile of these foods (Prentice et al., 1978; Öztürk et al., 2002; 
Stojceska and Ainsworth, 2008; Özvüral et al., 2009).  
The focus of the presented research was to determine the bioactivity of 
extracts from BSG and the retention of bioactivity in fortified food products.  
Phenolic extracts and protein hydrolysates were prepared from BSG and subjected to 
in vitro cellular bioactivity assays. Cell culture models used to assess bioactivity are a 
highly effective, ethical and economical alternative to animal or human trials. 
However, since complex in vivo conditions can not be wholly replicated in vitro, 
human trials are necessary for the substantiation of health claims relating to functional 
foods. A vast range of cell lines are available and for this research U937 (a human 
monocytic blood cell line), Jurkat T (leukaemic T lymphocytes) and Caco-2 
(colorectal adenocarcinoma cell line) cells were chosen for assay.  
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Phenolic extracts from black BSG (barley roasted to 200 oC prior to brewing) 
demonstrated the ability to protect against DNA damage induced by hydrogen 
peroxide (H2O2), measured using the comet assay in U937 cells. By the same assay, 
phenolic extracts with the highest total phenolic content (TPC; P2, P3, B2, B3) 
reduced 3-morpholinosydnonimine hydrochloride (SIN-1) induced DNA damage. The 
failure of the extracts to protect against DNA damage induced by tert-
butylhydroperoxide (t-BOOH) or 4-nitroquinoline oxide (4-NQO), suggests that the 
demonstrated antioxidant effects could possibly be due to iron chelation, since H2O2 
and SIN-1 induce oxidative stress by an iron dependent mechanism, unlike t-BOOH 
(Ca2+-dependent) and 4-NQO (Cu2+-dependent) (Yamamoto et al., 1993; Inoue & 
Kawanishi, 1995; Kruszewski et al., 2008).  
Hydroxycinnamic acids (HA) have previously been shown to be the 
predominant phenolic compounds present in BSG (Szwajgier et al., 2010). High 
performance liquid chromatography (HPLC) coupled with diode array detection 
(DAD) and mass spectrophotometry (MS) was used to determine the phenolic profile 
of starting barley, whole BSG and BSG phenolic extracts. The HA concentrations 
were in the order of ferulic acid > p-coumaric acid derivatives > ferulic acid 
derivatives > p-coumaric acid > caffeic acid > caffeic acid derivatives. Caffeic acid 
was the only free phenolic acid (present in aqueous extract P1), while other HA acids 
were present in the bound form. Comparison of the phenolic profiles of barley versus 
BSG and pale versus black BSG suggests that both brewing and roasting decreased 
the HA concentration. In the same study, the 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) 
scavenging activity and TPC of all samples was measured. While black BSG had a 
lower HA concentration, a higher DPPH activity and TPC was recorded, suggesting 
antioxidant activity by a compound other than HA, since the Folin-Ciocalteau method 
of TPC determination measures any reducing compounds (Huang et al., 2005). The 
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greater antioxidant activity recorded for black BSG extracts may be attributable to 
Maillard reaction products (MRPs) formed from non-enzymatic browning during the 
roasting of barley.  
The most bioactive hydrolysates, P2 and B2, were chosen for addition into 
fruit juices and smoothies and the fortified foods were subjected to in vitro digestion, 
before bioactivity analysis of digestates. Addition of the extracts significantly 
increased the ferric reducing antioxidant power (FRAP) of cranberry juice, the sample 
with lowest TPC prior to fortification. There was significantly decreased TPC and 
antioxidant activity after in vitro digestion, however it is important to note that 
phenolic compounds can exert protective effects in the gastrointestinal tract, before 
absorption (Halliwell et al., 2000). 
Using an enzyme-linked immunosorbent assay (ELISA), phenolic extracts P2 
and P3 demonstrated anti-inflammatory potential that may be related to the HA 
content. P2 and P3 have highest HA concentration, which have previously been 
reported to have anti-inflammatory effects (Youdim et al., 2002). Six of the studied 
phenolic extracts (P1 - P3, B2 - B4) were found to possess antioxidant capabilities, 
measured by cellular antioxidant activity assays – superoxide dismutase (SOD) 
activity, catalase (CAT) activity and gluathione (GSH) content. While anti-
inflammatory potential of the BSG phenolic extracts may be attributable to the HA 
content, it is speculated that the antioxidant activity is related to the TPC of the 
extracts.  
Protein samples from BSG, including protein isolate (A), protein hydrolysates 
(D – W) and fractionated protein hydrolysates (U, V and W, < 3, < 5 and > 5 kDa) 
were screened for their antioxidant and anti-inflammatory effects. Initial analysis of 
hydrolysates A – J found that BSG hydrolysates did not possess antioxidant activity 
or inhibit production of the cytokines interleukin 2 (IL-2), 4 (IL-4) or 10 (IL-10). The 
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ability of the BSG protein samples to selectively reduce production of pro-
inflammatory IFN-γ, but not anti-inflammatory IL-4 or IL-10, is an attractive property 
for neutraceutical development. Fractionated protein hydrolysates demonstrated 
greatest antioxidant activity with fractionated hydrolysates of U and W providing 
protection against H2O2-induced reduction in SOD activity, while hydrolysate W < 5 
kDa reduced H2O2-induced DNA damage. Unfractionated U, V and W inhibited 
concanavalin-A (conA) stimulated interferon-γ (IFN-γ) production to a greater extent 
than fractionated hydrolysates. It is important to note that the fractionated 
hydrolysates found to possess anti-inflammatory activity, also demonstrated 
antioxidant activity by the SOD assay. Oxidative stress has been linked to acute 
inflammation mediated by cytokines (Serhan, 2007; Feghali and Wright, 1997) and a 
link between antioxidant and anti-inflammatory capabilities has also been reported for 
whey protein hydrolysates (Power et al., 2013; Iskander et al., 2013). 
On the basis of cellular bioactivity assay results, bioactive phenolic extracts 
(P2 and B2) and protein hydrolysates (W, W < 3 kDa, W < 5 kDa, W > 5 kDa) were 
chosen for incorporation into snack-bar and chocolate-drink formulations and a 
commercially available yogurt product. Black BSG extract B2 increased the 
antioxidant capacity of the formulation with lowest initial antioxidant activity; a result 
similar to that reported for inclusion of BSG extracts into fruit beverages (Chapter 3). 
Snack-bar digestates showed greatest immunomodulatory potential and addition of 
BSG protein hydrolysate W significantly (P < 0.05) enhanced the IFN-γ reducing 
capability of the snack-bar formulation. Interestingly, addition of hydrolysates W < 3 
or W < 5 to yogurt, followed by in vitro digestion, significantly (P < 0.05) increased 
the IL-2 reducing ability of the yogurt, despite W < 3 and W < 5 demonstrating no 
anti-inflammatory effects prior to the fortification study (Chapter 6). This suggests 
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either a synergistic effect between the yogurt and W < 3 and W < 5 or an increase in 
bioactivity following in vitro digestion.   
This evidence contributes to existing research regarding the use of BSG as a 
functional food ingredient. To date, research on BSG for human nutrition has been 
focused on whole BSG and this novel data on the in vitro bioactivity of phenolic 
extracts and protein hydrolysates progresses this area of research.   
The present thesis has shown the bioactive potential of BSG phenolic extracts 
and protein hydrolysates in cell culture model systems. This in vitro approach has 
both strengths and limitations. Cell culture model systems are economical, ethical, 
highly effective and allow a high throughput and reproducibility. A vast selection of 
cell lines are available for experimentation, conditions are well defined and in vitro 
studies give reliable data on initial efficacy and mechanisms of action. Limitations of 
in vitro studies include the use of homogenous cell lines (heterogenous in vivo), lack 
of circulating factors including hormones and signalling molecules and the use of 
concentrations in excess of levels in systemic circulation. In vivo studies are 
considered the “gold standard” and are essential for accurately determining bioactive 
effects in the body, using concentrations of biological relevance and accounting for 
bioavailability and metabolism.  
 The incorporation of these preparations into formulated foods shows selective 
bioactivity retention following in vitro digestion. These novel preparations possess 
characteristics that favours their incorporation into functional foods for human 
consumption. Since phenolic extracts and protein hydrolysates demonstrated varying 
degrees of antioxidant and anti-inflammatory potential, future research should focus 
on the formulation of a combined phenolic and protein ingredient blend for human 
ingestion. A further 3 years of research funding has been granted to continue the 
research in this area. This work will optimise the extraction of phenolic extracts and 
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protein hydrolysates and determine their bioactivity in vitro. The technofunctional, 
bitterness, physicochemical and proteomic characteristics of ingredients will be 
determined and beverages containing phenolic and protein extracts will be formulated 
and flavoured for a human intervention trial and biomarkers of antioxidant and anti-
inflammatory activity assessed. 
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(a)
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Figure 1: HPLC chromatogram of phenolic extracts from pale brewers’ spent grain (BSG); 
(a) P1 (b) P2 (c) P3 (d) P4. Conditions of HPLC analysis are described in Chapter 3. 
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(b) 
 
 
Figure 2: HPLC chromatogram of phenolic extracts from black brewers’ spent grain (BSG); 
(a) B1 (b) B2 (c) B3 (d) B4. Conditions of HPLC analysis are described in Chapter 3. 
 
 
 
- 266 - 
 
 
 
 
(c)  
 
 
(d) 
 
 
 
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
The Summer meeting of the Nutrition Society hosted by the Irish Section was held at Queen’s University, Belfast on 16–19 July 2012
Conference on ‘Translating nutrition: integrating research, practice and policy’
Postgraduate Symposium
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Brewers’ spent grain (BSG) is a low-value co-product of the brewing industry produced in
large quantities annually. This paper reviews the existing evidence regarding the phenolic
component of BSG, focusing on composition, extraction and biofunctions such as antioxidant,
anti-atherogenic, anti-inflammatory and anti-carcinogenic activities. Furthermore, the incor-
poration of BSG in foodstuffs will be discussed, including the use of BSG as an animal feed
supplement and the potential of BSG to be incorporated into foods for human consumption.
BSG contains hydroxycinnamic acids including ferulic acid, p-coumaric acid and caffeic
acid; which have shown bioactivity in the pure form (antioxidant, anti-inflammatory, anti-
atherogenic and anti-cancer). Phenolic extracts from BSG have also shown antioxidant poten-
tial, by protecting against oxidant-induced DNA damage, possibly by Fe chelation. Studies
show that BSG has many benefits when used as a supplement in animal feed, such as increasing
milk yield, milkfat content and in providing essential dietary amino acids. The incorporation
of BSG in human foods such as cookies and ready-to-eat snacks has resulted in increased
protein and fibre contents of the products, where the changes in organoleptic properties are
controllable. It can be concluded that the phenolic component of BSG has potential bioactive
effects, which are worth pursuing given that the inclusion of BSG into human foodstuffs is
viable and beneficial.
Brewers’ spent grain: Phenolic acids: Animal nutrition: Functional foods: Bioactivity
Brewers’ spent grain (BSG) is the solid fraction of barley
malt remaining after the production of wort. According
to the Eurostat Data, BSG is the main by-product of the
brewing industry, with approximately 3.4 million tonnes
being produced annually in the EU(1), at least 160 000
tonnes of which are produced in Ireland.
This solid residue contains water insoluble proteins in
addition to the husk, pericarp and seed coat of the original
barley grain(2). Protein and fibre account for 20 and 70%
of BSG dry matter, respectively, while the starch content
of BSG is insignificant (due to the absence of starchy
endosperm). Owing to its protein-rich composition, BSG
has the potential to be utilised in a manner similar to
whey protein, providing health benefits for consumers.
BSG is also rich in phenolic compounds, particularly
ferulic acid and p-coumaric acid(3), along with oligo-
saccharides and polysaccharides(4). Emerging evidence,
with regard to the ability of dietary phenolic compounds
to exhibit anti-carcinogenic, anti-inflammatory and anti-
oxidant activities(5,6) has led to significant interest in plant
phenolic compounds particularly by the food industry,
scientists and consumers.
To date, BSG has been widely used as an animal
feed, particularly for cattle, to provide high amounts
Abbreviations: BSG, brewers’ spent grain; COX-2, cyclooxygenase-isoform 2; DPPH, 1,1-diphenyl-2-picrylhydrazyl.
*Corresponding author: Professor Nora M. O’Brien, fax + 353 21 4270244, email nob@ucc.ie
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g The Authors 2012 First published online 9 November 2012
P
ro
ce
ed
in
gs
o
f
th
e
N
u
tr
it
io
n
So
ci
et
y
of both protein and fibre. BSG is an excellent feed
ingredient for ruminants, providing all the essential
amino acids when combined with inexpensive N sources
such as urea(7). However, with the increased cost of dis-
posal of the solid fraction, alternative uses are highly
sought-after and it has been shown that BSG can be
effectively integrated into ready-to-eat snacks to increase
dietary fibre, crude protein and fat levels(1). Other areas of
successful research include the blending of BSG with
flour for incorporation into cookies(8) and the addition of
BSG to dough to improve the dietary fibre content in
bread(1).
This review details the existing evidence regarding
BSG. A specific focus is placed on the potential bioactiv-
ities of phenolic compounds (particularly ferulic acid and
p-coumaric acid) present in BSG, and the incorporation
of BSG into foodstuffs, for both human and animal con-
sumption.
Composition of brewers’ spent grain
Many studies have reported on the approximate composi-
tion of BSG, which contains protein, fat, cellulose, hemi-
cellulose and lignin (Table 1). As shown, there is good
consistency with regard to the composition of BSG.
However, variations can arise due to differences in barley
variety, harvesting time, characteristics of hops added and
brewery technology(12). BSG predominantly consists of
the husk-pericarp-seed coat layers that are rich in cellu-
lose, non-cellulosic polysaccharides, lignin, protein and
fat. This is reflected in the composition of BSG (Table 1),
and thus BSG can be regarded as a lignocellulosic mate-
rial(4). In addition to the components detailed in Table 1,
it has been shown that BSG is also a valuable source of
vitamins, minerals and amino acids, particularly for ani-
mal feeding. The vitamins present in BSG are biotin, folic
acid, niacin, choline, riboflavin and thiamine, pantothenic
acid and pyroxidine(7). BSG is also reported to contain
minerals such as Ca, Cu, Fe, Mn, K and Na(7,17) and both
essential (including lysine, histidine, methionine, phenyl-
alanine, tryptophan) and non-essential (including alanine,
serine, glycine, proline) amino acids(7). When combined
with inexpensive N sources, such as urea, BSG
can provide all the essential amino acids to ruminant
animals(7).
Phenolic component of brewers’ spent grain
Phenolics present in brewers’ spent grain
Phenolic acids, particularly hydroxycinnamic acids and
hydroxybenzoic acids are secondary plant metabolites
found extensively in plant foods. Phenolic acids are cur-
rently the focus of much attention due to their potential to
act as antioxidant, anti-inflammatory and anti-carcinogenic
compounds(5,6).
As previously mentioned, BSG consists predominantly
of the husk-pericarp-seed coat and is largely made up
of cell walls. Since most of the phenolic compounds of
the barley grain are contained in the husk(4) and hydroxy-
cinnamic acids accumulate in the cell walls, BSG is a
potentially valuable source of phenolic acids.
There is evidence to suggest that ferulic acid and
p-coumaric acid (as shown in Fig. 1) are present at rela-
tively high concentrations in BSG(3). Some of the existing
literature regarding the presence of ferulic and p-coumaric
acid is detailed in Table 2. Ferulic acid was found to be the
most abundant hydroxycinnamic acid being present at
concentrations ranging from 1860 to 1948mg/g, while the
p-coumaric levels ranged from 565 to 794mg/g(23). More
recent evidence shows that BSG consists of 1.16% mono
and dimeric phenolic acids, with 53% of the monomeric
phenolic acids accounted for by ferulic acid. The vast
majority of phenolic acids were also found to be in
the bound form(20). It has been reported that following
ferulic and p-coumaric acids, the next most abundant phe-
nolic acids in BSG were found to be sinapic, caffeic and
Table 1. The approximate chemical composition of brewers’ spent grain
Study
Component (as % dry matter*)
Protein Lipid/Oil Ash Cellulose Hemicellulose Lignin Starch
Beldman et al.(9) 23.8 – 3.5 15.1 24.8 – 2.0
Valverde(10) 24.0 6.0 – 17.0 39.0 4.0 –
Kanauchi et al.(11) 24.0 10.6 2.4 25.4 21.8 11.9 –
Santos et al.(12) 24.2 3.9 3.4 – – – –
El-Shafey(13) 26.7 8.9 3.9 – – 5.3 –
Mussatto & Roberto(14) 15.3 – 4.6 16.8 28.4 27.8 –
Xiros(15) 14.2 13.3 3.3 12.0 40.2 11.5 –
Treimo(16) 23.4 – – – – 12.6 7.8
*Values expressed as % dry matter, which has been documented in two studies to be 20.4(9) and 20%(13).
Fig. 1. The general structure of hydroxycinnamic acid and the
functional groups for ferulic and p-coumaric acids.
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syringic acids(22). A summary of the phenolic acids present
in BSG is given in Table 3.
Extraction of phenolic acids from brewers’ spent grain
Numerous studies have been conducted to extract phenolic
acids from BSG. Novel techniques for extraction, such as a
rapid microwave-assisted derivatisation process have been
investigated(19). However, the majority of approaches use
the basis of either acid hydrolysis or saponification (with
1–4 M NaOH) and liquid–liquid or liquid–solid extraction.
A review of methods of extracting, separating and detect-
ing phenolic acids in natural plant foods showed that the
most frequently used methods involve acid hydrolysis
and saponification(24). Extraction usually entails the use
of solvents such as methanol and ethyl acetate. TLC is
extensively used for detecting phenolic acids due to its
high sample throughput. However, using HPLC gives a
greater degree of separation of compounds and is highly
reproducible where quantification is possible. Therefore,
reverse phase-HPLC is predominantly used, but HPLC
coupled with UV or diode array detection is also an
option(25). A review looking at the extraction and quanti-
fication of phenolics in foods also reported that methanolic
extraction and alkaline hydrolysis are commonly used
for phenolic acid extraction, while a sequential alkaline
hydrolysis releases bound phenolics(26). A new method has
recently been developed and validated, for the release of
phenolic acids (both free and bound) from cereals includ-
ing barley. This method uses solid-phase extraction
coupled with HPLC-diode array detection analysis and is
simple, inexpensive and gives good recoveries and preci-
sion(27). Recently published results show that exogenous
ferulic acid esterase produced by the probiotic organism
Lactobacillus acidophilus K1 can successfully release the
free phenolics from BSG(28). In 2005, a study looking at
the hydroxycinnamate content of BSG fractions utilised
saponification with 4 M NaOH. The supernatants were then
neutralised and extracted with ethyl acetate, dried and re-
suspended in MetOH:H2O
(18). More recent research also
used this method, giving comparable results(21). Using a
LUNA C18 reverse phase-HPLC column, both studies
found that ferulic acid was the phenolic acid in greatest
abundance in BSG, with coumaric acid being second
highest. Saponification (involving the treatment of samples
with 1–4 M NaOH solution) has been widely used to extract
hydroxycinnamic acids from BSG(3,23,29).
Extraction methods similar to those used for BSG, have
also been utilised with other materials such as wheat bran
extracts(30) and apple waste extracts(31).
Potential health benefits of phenolic component of
brewers’ spent grain
As previously mentioned, ferulic and p-coumaric acids are the
phenolic acids at highest concentrations in BSG (Table 3).
A lot of research has been conducted looking at the anti-
oxidant activity of hydroxycinnamic acids, particularly
ferulic and p-coumaric acids. A commonly used method
for quantification of antioxidant activity is the 1,1-diphe-
nyl-2-picrylhydrazyl (DPPH) assay, which measures the
ability of the test compound to scavenge the DPPH radical.
Chen and Ho(32) have shown the antioxidant potential of
ferulic acid using the DPPH and Rancimat methods, but
ferulic acid was a less potent antioxidant than caffeic acid
and a-tocopherol(33). Caffeic acid has been shown to act as
an antioxidant in vitro and scavenged radicals including
DPPH and the superoxide anion(34). It has also been
shown, using the DPPH assay, that a number of hydroxy-
cinnamic acids act as antioxidants, scavenging DPPH
in the order caffeic acid>sinapic acid = ferulic acid-
> ferulates>p-coumaric acid(35). Similarly, but using an
alternative method, a study investigating the phenolic
compounds in wheat bran extract and their antioxidant
activity again found that ferulic acid was one of the
strongest antioxidants using the b-carotene linoleic acid
model system. The b-carotene linoleic acid model system
assay is based on the principle that at a high temperature
the oxidation of linoleic acid produces peroxides that
decolourise b-carotene. The wheat bran extracts with
highest ferulic acid concentrations (following alkaline
hydrolysis) also exhibited higher antioxidant activity(30).
Ferulic acid and caffeic acid have been reported to have
excellent antioxidant potential at low concentrations, with
the ability to scavenge a range of free radicals. Both phe-
nolic acids scavenge the reactive oxygen species and
reactive nitrogen species, with concentration-dependent
scavenging of NO, superoxide and 2,20-azino-bis-3-ethyl-
benzthiazoline-6-sulfonic acid radical. In line with the
previously discussed evidence, caffeic acid was a stronger
scavenger of the DPPH radical, but ferulic acid was better
Table 2. The percentage (% dry weight) of bound phenolics, ferulic
acid and p-coumaric acid present in brewers’ spent grain
Study
Percentage (as % dry matter)
Bound
phenolics
Ferulic
acid
p-Coumaric
acid
Bartolome(3) – 0.2 0.1
Mandalari(18) – 0.6 0.3
Athanasios(19) – 0.2–0.3 0.1–0.2
Forrsell(20) – 0.5 0.5
Treimo(16) 0.7 – –
Robertson(21) 0.8 – –
Szwajgier(22) – 0.3 0.1
Table 3. The most abundant phenolic acids present in brewers’
spent grain modified from Szwajgier et al.(22)
Phenolic acid
Free acid concentration (mg/100 g dry matter)
Mean SE
Ferulic acid 336.3 16.0
p-Coumaric acid 64.4 4.6
Sinapic acid 42.0 1.1
Caffeic acid 9.9 0.7
Syringic acid 6.5 0.1
4-OH-benzoic acid 1.2 0.6
Chlorogenic acid 0.6 0.2
Protocatechuic acid 0.5 0.1
Bioactivity of phenolic component of BSG 119
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at scavenging 2,20-azino-bis-3-ethylbenzthiazoline-6-
sulfonic acid radical and NO(36). In a recent study on beers,
a direct correlation was found between ferric-reducing
antioxidant power and a number of phenolic acids in-
cluding ferulic, p-coumaric, caffeic, sinapic and vanillic
acids(37). A second study also showed that some of
the phenolic acids present in beer correlate with the
antioxidant activity measured by the DPPH radical and
superoxide anion scavenging, metal chelation and reducing
power; these include syringic and caffeic acids(38). Since
ferulic acid is so well recognised as an antioxidant, it is
approved for use as a food additive in some countries to
prevent oxidation(39,40). In addition, it is important to note
that while phenolic compounds can have an antioxidant
effect, they have also been shown to act as pro-oxidants
under certain conditions, thus inducing oxidative stress.
Recent literature suggests that at low concentrations, many
phenolics exhibit pro-oxidant behaviour, whereas the syn-
thetic antioxidants, including a-tocopherol, do not(41). For
caffeic acid and ferulic acid to act as pro-oxidants, higher
concentrations are required(36). It has also been found
by using the comet assay that at high concentrations
p-coumaric acid enhanced DNA breakage induced by
H2O2. This may be due to the production of reactive
oxygen species by p-coumaric acid as a result of its
pro-oxidant activity(42). It has been suggested that this pro-
oxidant effect is related to the presence of metal ions in
the body (for example due to tissue injury releasing Fe
and Cu) and is of relevance for the bioactivity of phenolic
compounds in vivo(43). It is clear from a small number
of in vivo studies that the hydroxycinnamic acids have
antioxidant properties. Such studies are essential to under-
stand the biological role of these phenolic acids(44).
In addition to their antioxidant potential, there is
increasing evidence to suggest that phenolic acids can
have an anti-carcinogenic effect. Caffeic acid exhibits an
anti-proliferative effect on several cancer cells including
mammary gland, adenocarcinoma, lymphoblastic leukae-
mia(45) and cervical cancer cell lines as assessed using the
MTT assay(45,46). The cyclooxygenase-isoform 2 (COX-2)
assay has been used for determination of the anti-cancer
potential of these compounds. Overexpression of COX-2
increases the conversion of arachidonic acid to pros-
taglandins, which are important mediators of inflammation,
and are associated with cancer. Phenolic acids including
caffeic acid(47) and vanillic acid(48), and polyphenols
including epigallocatechin-3-gallate(49) and quercetin(50),
have been shown to inhibit the expression of COX-2,
possibly reducing cancer risk. Apoptosis in cancer cell
lines is also an indicator of anti-carcinogenic potential and
can be assessed by a number of methods including DNA
fragmentation and the Hoechst staining assay. Cinnamic
acid derivatives induced apoptosis in human leukaemia
(HL60) and colon cancer (SW480) cell lines, as measured
by the aforementioned apoptosis methods(51). In addition,
the anti-apoptotic effect of phenolic compounds includ-
ing ferulic acid and caffeic acid on human peripheral
blood mononuclear cells was investigated(52). Caffeic
acid inhibited externalisation of phosphatidyl serine,
which indicates the pre-apoptotic stages, and hence it
was concluded to have an anti-apoptotic effect. DNA
fragmentation was analysed using an apoptotic DNA lad-
der kit. It was shown that pre-treating cells with caffeic
acid, ferulic acid or ellagic acid before exposure to H2O2
inhibited DNA fragmentation. Recently published data add
to the evidence available in the area, by measuring the
ability of phenolic compounds to modulate NF-kB activity.
In the inflammatory process, NF-kB is a transcription fac-
tor, whose increased activation has been reported in several
human cancers(53). Free phenolic acids that can be found
in cereal grains (including ferulic, caffeic, sinapic and
p-coumaric acids) significantly modulate NF-kB activity in
U9373xkB-LUC cells, with a desired level of modulation
being achieved by the synergistic action of phenolic acids
and other phenolic compounds(54). Animal studies have
also been carried out to determine the anti-carcinogenic
potential of phenolic acids. An animal study to establish
the effect of curcumin, chlorogenic acid, ferulic acid and
caffeic acid on tumour promotion in the skin of mice
showed that chlorogenic, ferulic and caffeic acid prevented
the number of 12-O-tetradecanoylphorbol-13-acetate-
induced tumours per mouse by 60, 28 and 35%, respec-
tively(55). Results of a later animal study suggest that
ferulic acid not only inhibits the growth of aberrant crypt
foci in the colon but also prevents the conversion of pre-
neoplasia to malignant neoplasia(56). A recently published
review on plant phenolics reported that natural phenolics,
including tea and fruit polyphenols, play an antagonistic
role in all stages of cancer development and that further
study on these compounds will provide information
regarding their possible future pharmaceutical use(57).
Cytokines are small cell signalling molecules involved
in the inflammatory response, these include interleukins
and interferons (for example interferon-g). The ability of a
compound to alter the production of a stimulated cytokine
or NO indicates the compound’s potential to act as an
immune-modulator. Murakami et al.(58) investigated the
effect of both ferulic acid (from rice bran) and FA15
(a derivative of ferulic acid) on NO synthase, COX-2
and TNFa in the RAW264.7 murine macrophage cell
line. Unlike the ferulic acid isolated from rice bran, the
synthesised FA15 derivative was found to inhibit the
release of TNFa and reduce the protein expression of both
nitric oxide synthase and COX-2(58). Ferulic acid has also
been shown to inhibit macrophage inflammatory protein-2
and TNFa production, induced by lipopolysaccharide in a
macrophage cell line. The effect, although dose-dependent,
was very weak compared with the effect of dexamethasone
(a well-known inhibitor of interleukins)(59). In Japanese
Oriental medicines, Cimicifuga heracleifolia is often used
as an anti-inflammatory drug. Ferulic acid has been shown
to be among the main phenolic acids in C. heracleifolia(60).
Sakai et al.(61) showed that ferulic acid and isoferulic acid
could reduce macrophage inflammatory protein-2 produc-
tion in a dose-dependent manner in RAW264.7 cells. It
was suggested that ferulic acid and isoferulic acid are
responsible, at least in part, for the anti-inflammatory
properties of the C. heracleifolia drug(61). Recently pub-
lished data have shown that ferulic acid and p-coumaric
acid inhibited lipopolysaccharide-induced NO production
and inducible NO synthase in macrophages(62). This
supports earlier evidence suggesting that these phenolic
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acids can act as anti-inflammatory agents, by reducing
TNFa induced IL-6 production in adipocytes. Quercetin,
p-coumaric acid and reservatrol showed greatest inhibition
of IL-6 production(63).
Oxidised LDL is a well-recognised risk marker of CVD
which is principally caused by atherosclerosis(64). Evidence
exists for the effect of hydroxycinnamic acids on the
inhibition of LDL oxidation. Nardini et al.(65) demon-
strated the antioxidant effect of hydroxycinnamic acid
derivatives such as caffeic, ferulic and p-coumaric acids
on LDL oxidation in vitro, with the use of the copper
ion Cu2 + as a catalyst. At a concentration of 100mM,
all phenolic acids except p-coumaric acid inhibited
LDL oxidation; at 20mM, ferulic acid inhibited about 92%
of Cu-catalysed human LDL oxidation; at 5mM only caf-
feic acid strongly inhibited the oxidation of LDL(65). A
second study using similar methodology also found that
both ferulic and p-coumaric acid showed a dose-dependent
inhibition of human LDL oxidation in vitro when tested at
5, 10 and 20mM(66). In agreement with these data, results of
a later study showed sinapic, ferulic and p-coumaric acids
inhibited LDL oxidation(67). Other compounds that have
shown the ability to reduce Cu-induced LDL oxidation
include catechin(68).
Our research group is the first, to our knowledge, to look
specifically at phenolic extracts from BSG. Four extracts
from pale BSG (P1, P2, P3 and P4) and four extracts from
black BSG (where the grain is roasted to 200C before
brewing; B1, B2, B3 and B4) were analysed. Each extract
results from a different step in the extraction process and
hence contains different phenolic acid compositions.
Extract 1 (P1, B1) contains free phenolics, extract 2 (P2,
B2) contains bound phenolics, extract 3 (P3, B3) contains
the remainder of bound phenolics and extract 4 (P4, B4)
contains phenolics extracted with 110 mM NaOH(69). The
ability of the phenolic extracts to protect against oxidant-
induced DNA damage was determined using the comet
assay. In the U937 cell line, oxidative DNA damage was
induced by a range of oxidants; H2O2, 3-morpholino-
sydnonimine hydrochloride, 4-nitroquinoline oxide and
tert-butylhydroperoxide. Table 4 shows the ability of the
extracts to protect the cells against DNA damage. There
was no protection against DNA damage induced by either
4-nitroquinoline oxide or tert-butylhydroperoxide. Ferulic
acid and the black BSG extracts significantly reduced the
DNA damage induced by H2O2, while P2, B2, B3 and
B4 significantly reduced the percent tail DNA induced
by 3-morpholinosydnonimine hydrochloride(69). The four
oxidants used have different mechanisms of action;
damage induced by both H2O2 and 3-morpholinosydnoni-
mine hydrochloride involve the Fenton reaction which is
an Fe-dependent reaction, 4-nitroquinoline oxide mimics
the action of UV and Cu2 + plays an essential role, whereas
Fe does not(70), tert-butylhydroperoxide causes lipid per-
oxidation and acts in a Ca2 + -dependent manner and Fe
plays less of a role than in H2O2-induced damage
(71).
Therefore, BSG phenolic extracts may provide protection
against oxidant-induced DNA damage by Fe chelation(69).
In summary, there is increasing evidence to suggest
that phenolic acids, including those found at highest con-
centrations in BSG, can confer potential health benefits
including anti-inflammatory, antioxidant, anti-carcinogenic
and anti-atherogenic effects. Recent data suggest that BSG
has antioxidant potential and therefore further research on
the phenolic compounds extracted from BSG is warranted.
Incorporation of brewers’ spent grain into
feed/foodstuffs
Animal food
As previously mentioned, BSG contains approximately 20
and 70% protein and fibre, respectively, and it is due to
this favourable chemical composition that it has great
potential for use as a raw material/food ingredient(4). BSG
is an ingredient of significant importance for ruminants.
Table 4. DNA damage in U937 cells following 24 h incubation with 0.5% (v/v) pale (P1–P4) or black (B1–B4) brewers’ spent grain phenolic
extracts or 0.1mg/ml ferulic acid (adapted from McCarthy et al.(69))
Sample
DNA damage
(% tail DNA)
oxidant – H2O2
DNA damage
(% tail DNA)
oxidant – SIN-1
DNA damage
(% tail DNA)
oxidant – 4-NQO
DNA damage
(% tail DNA)
oxidant – t-BOOH
Mean SE Mean SE Mean SE Mean SE
Control 3.2† 0.5 4.3† 0.4 3.1† 0.3 4.7† 0.6
Oxidant control 40.3† 0.3 40.0† 3.9 39.5† 1.1 15.5† 0.8
P1 30.3† 7.3 32.8† 4.9 39.0† 6.8 14.5† 0.8
P2 29.0† 6.0 22.7*† 1.9 40.7† 4.3 22.6† 3.0
P3 39.9† 3.9 33.8† 2.9 37.3† 3.2 22.1† 3.1
P4 23.1† 3.2 32.2† 6.1 37.8† 3.6 17.4† 2.6
B1 25.8*† 7.5 33.6† 2.9 36.1† 5.7 13.6† 0.9
B2 9.6*† 1.1 6.9*† 1.0 31.9† 3.2 18.5† 3.3
B3 16.0*† 2.0 18.1*† 0.3 33.4† 2.4 16.6† 1.8
B4 14.0*† 3.8 24.1*† 2.2 33.7† 6.8 14.0† 2.7
Ferulic acid 17.1*† 0.8 30.8† 3.0 32.6† 5.2 11.0† 1.9
SIN-1, 3-morpholinosydnonimine hydrochloride; 4-NQO, 4-nitroquinoline oxide; t-BOOH, tert-butylhydroperoxide.
*Data represent the mean of at least three independent experiments.
†Denotes a significant difference in DNA damage (P<0.05), relative to oxidant control. Statistical analysis by ANOVA followed by Dunnett’s test.
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When administered with low-cost N sources such as
urea, BSG can supply all the essential amino acids to the
ruminants. The effect of BSG on milk yield and composi-
tion and the blood components of dairy cattle has also been
studied(72). The cattle received a diet consisting of ground
maize, maize silage, soya bean meal and wheat bran, with
the latter three being substituted with wet brewer’s grain in
the treatment group. The study showed the treatment group
had an increased milk yield, milkfat and milk total solids
content. Blood components such as glucose, cholesterol,
Na and TAG were not affected. While the main outlet for
BSG is currently as a feedstuff for dairy cattle, research
has also been conducted looking at the benefits of BSG for
use as a feed for poultry and fish. The effect of replacing
rice bran in a fish diet with 10–40% brewery waste grains
has been investigated(73). The brewery waste used con-
tained 19% crude protein, 18–20% crude fibre and had
a good amino acid profile. It was found that carp (oily
freshwater fish) had better growth performance on diets
containing brewery waste than the control group. The
authors attributed this enhanced growth performance to
the high-quality protein contained in the waste grains. A
more recent study showed that biodegraded BSG contained
cysteine, lysine and methionine in addition to fourteen
other amino acids(74). Depending on the microbe used to
degrade the BSG, different amino acid concentrations were
found, with alanine consistently at highest concentrations.
This composition was noted to be of particular importance
for poultry as cysteine, lysine and methionine are the main
amino acids required in poultry nutrition. For convenience,
the possibility of producing dry BSG cakes suitable for
long-term storage was examined using membrane filter
press technology(13). These dry cakes could be used as an
animal feed at any time, or as a starting material for the
production of other products using BSG.
In summary, evidence suggests that whole BSG, fed as
part of a total mixed ration, has many nutritional benefits for
a range of animals, particularly dairy cattle. This has resulted
in the routine use of BSG as an animal feed for cattle.
Human food
In addition to its use as an animal feed, BSG has been
incorporated into foodstuffs for human consumption.
Given its low cost and high nutritional value, BSG makes
an ideal ingredient for human foods such as biscuits and
ready-to-eat snacks, particularly where there is a need to
increase fibre content. In 1978, the possibility of preparing
cookies with flour containing BSG at levels ranging
from 5 to 60% was examined(8). At 40% BSG addition,
the physical qualities of the cookies were sustained.
This supplementation level gave a 74% increase in N
and increased crude fibre ten-fold. These results were
supported by work published in 2002, where the authors
looked at the effect of BSG (at levels of 5–25%) on the
fibre content and quality of cookies(75). As the level of
addition of BSG increased, there was a significant increase
in dietary fibre content. Another documented foodstuff
suitable for the inclusion of BSG is ready-to-eat snacks(1).
BSG was added to the formulation mix (consisting of
ingredients such as corn starch and wheat flour) at levels
ranging from 10 to 30%. The incorporation was successful,
increasing dietary fibre and crude protein levels. Similarly,
the addition of BSG into extruded snack food has been
studied(76). The maize flour of chickpea snacks was
replaced with BSG at levels of 10, 20, 25 and 30%. The
parameters measured included the effect of BSG supple-
mentation on texture, colour, moisture, fat, fibre, starch,
protein, phenolic compounds and antioxidant capacity.
With increasing levels of BSG addition, the percent pro-
tein, fat and fibre content increased, while starch
decreased. It was suggested that foods fortified with BSG
be considered as functional foods. In a further study by
Stojceska and Ainsworth(77), BSG was incorporated at
different levels (0–30%) into wheat flour breads treated
with four different enzymes and the bread quality was then
evaluated(77). Similar to the previous study, it was found
that the fibre content of the breads was significantly
increased by BSG addition. The change in fat content was
significantly linked to the addition of BSG. When addition
of BSG is combined with the appropriate use of enzymes,
the shelf life, texture and loaf volume can also be
improved. Initially, it was thought that BSG was too
granular for direct addition to food and that it would have
to first be converted to flour before use. However, a study
in 2009 demonstrated that BSG of various particle sizes
could be effectively used in the production of frankfur-
ters(78). The control frankfurter had the highest score for
acceptability, but the other products also had high scores,
with the score decreasing with increase in particle size and
reduction in fat levels. The authors suggested that BSG be
used to produce low-fat high-fibre meat products. In addi-
tion to particle size, there are a number of points for con-
sideration with the incorporation of BSG into foodstuffs.
Firstly, there are concerns about appearance. When moist,
BSG is brown in colour, thus it can only be effectively
integrated into off-white products. Such foods include
cookies and cakes. More importantly, it is imperative that
the organoleptic properties of the foodstuff remain accep-
table to consumers and are similar to the current commer-
cially available products. The study by Prentice et al.(8),
demonstrated that BSG addition at a level of 15% was the
upper limit for organoleptic acceptability(8). At this level,
the organoleptic quality was lowered but still remained
acceptable to consumer panels. Similarly, Stojceska
et al.(1) found that there was a limit to acceptability(1). At a
level of addition of 30%, physicochemical characteristics
(such as texture, colour and hardness) remained acceptable.
However, the authors concluded that addition of BSG at
20% level was optimal to maintain properties of commer-
cially available snack foods. Where the protein hydro-
lysates are to be extracted and incorporated into foodstuffs,
there is concern over the bitter taste of some peptides, due
to the hydrophobic amino acid content(79).
Conclusion
The literature shows that phenolic compounds including
ferulic, caffeic and p-coumaric acid can have antioxidant,
anti-cancer, anti-atherogenic and anti-inflammatory effects.
Given that these phenolic acids are some of the major
phenolics in BSG, it is expected that phenolic extracts
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from spent grain may also exhibit similar properties and
have the potential to be developed for a range of bioac-
tivities. BSG currently functions as an animal feed, having
many nutritional benefits. While some attempts have been
made to incorporate the bioactive components of BSG into
foodstuffs, further research in this area is needed. Given
the potential bioactive nature of the phenolic extracts from
BSG, and the large amounts of BSG produced annually as
a low value co-product, it is imperative that an alternative
use be explored.
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Abstract: There has been an unprecedented demand for inexpensive plant-derived protein 
hydrolysates in recent years, owing to their potential nutritional applications. This review 
examines existing evidence regarding protein hydrolysates from agricultural crops such as 
wheat, soy, rapeseed, sunflower and barley. The bioactivity of these protein hydrolysates, 
including antioxidant and anti-inflammatory capabilities are discussed. In addition to 
evidence regarding their potential to enhance human nutrition, the effect of the 
hydrolysates on the techno-functional properties of foods will be reviewed.  
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1. Introduction 
Humans require a protein intake sufficient to maintain the body nitrogen balance and allow for 
desirable rates of deposition during growth and pregnancy. Ingestion of protein amounts greater than 
requirements results in the excess being metabolised and excreted. Conversely, in the case of 
inadequate dietary protein intake, the body utilizes its own proteins as a source of nitrogen; therefore a 
regular and sufficient intake is essential. Protein performs a number of key functions in the body 
including the building and repair of tissues, cell signalling and the provision of energy (4 kcal/g 
protein). Proteins also perform enzymatic and structural functions.  
Protein hydrolysates have been defined as “mixtures of polypeptides, oligopeptides and amino acids 
that are manufactured from protein sources using partial hydrolysis” [1]. There has been growing 
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interest in these preparations over the last two decades, with novel bioactive peptides continually being 
discovered, as it has been shown that short-chain peptides from hydrolyzed proteins have a higher 
nutritive value and may be utilized more efficiently than an equivalent mixture of free amino acids [2]. 
Milk-based products are the source of the greatest number of bioactive peptides isolated to date. Other 
sources include meat, eggs and fish, in addition to plant sources such as soy and wheat [3]. Figure 1 
illustrates the effect of bioactive peptides on major body systems. It has emerged that protein 
hydrolysates have many uses in human nutrition; ingredients in energy drinks, weight-control and 
sports nutrition products [4], sources of nutrition for elderly and immuno-compromised  
patients [5]. Clinical applications have also been suggested, including treatment of Phenylketonuria 
(PKU), liver disease, Crohn’s disease and ulcerative colitis [6]. Other functions of plant-derived 
protein hydrolysates have been discussed in detail elsewhere [7]. These include use as natural 
herbicides, particularly corn gluten meal and soy and wheat hydrolysates [8] and as replacements for 
materials of bovine origin in fermentation media, to reduce risk of Bovine Spongiform Encephalopathy 
(BSE) contamination [9].  
In recent years there has been an unprecedented demand by both consumers and industry, for 
inexpensive plant-derived proteins and bioactive peptides for human consumption. Additionally, 
alternative uses for co-products of the plant processing industry are highly sought. Such co-products 
include brewers’ spent grain (BSG), wheat bran and okara (a soybean by-product of tofu production), 
which are excellent sources of both protein and fibre [10,11].  
The present review focuses on the bioactivity of protein hydrolysates from a range of agricultural 
crops, and their potential for inclusion into functional foods.  
Figure 1. Physiological effects of food derived bioactive proteins on major body systems. 
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2. Preparation of Protein Hydrolysates 
2.1. Protein Hydrolysis 
Hydrolysis of proteins involves the cleavage of peptide bonds to give peptides of varying sizes and 
amino acid composition. There are a number of types of hydrolysis; enzymatic, acid or alkali 
hydrolysis. Chemical hydrolysis is difficult to control and reduces the nutritional quality of  
products [12], destroying L-form amino acids and producing toxic substances such as  
lysino-alanine [13]. Enzymatic hydrolysis works without destructing amino acids and by avoiding the 
extreme temperatures and pH levels required for chemical hydrolysis, the nutritional properties of the 
protein hydrolysates remain largely unaffected [12]. Production of protein hydrolysates in the food 
industry involves the use of digestive proteolytic enzymes from animals including chymotrypsin, 
trypsin and pepsin, or food grade enzymes obtained from plants and microorganisms which are 
regarded safe for human nutrition. Following protein hydrolysis, fractions can be categorised 
according to two characteristics. The first category consists of fractions with a high amino acid 
content. The second category consists of bioactive peptides with an amino acid sequence which is 
inactive in the intact protein molecule but becomes active in the hydrolysate following exposure to 
digestive and/or proteolytic enzymes [1]. It is worthy to note that the process of manufacturing protein 
hydrolysates has essentially remained the same since its emergence several decades ago and is still in 
its infancy [14]. Co-operation between manufacturers and end-users is necessary to develop optimum 
hydrolysates for specific functions [14].  
2.2. Post-Hydrolysis Treatment 
Following hydrolysis, the “crude hydrolysates” may undergo further processing. Commonly used 
post-hydrolysis processes include heat inactivation, ultrafiltration, hydrolysis by exoproteases and 
treatment with specific enzymes. Table 1 details the main post-hydrolysis processes and the function 
of each of these processes. Control of the molecular size of protein hydrolysates is an essential step in 
the development of protein hydrolysates for dietary use. Removal of high molecular weight proteins 
and peptides is primarily carried out using ultrafiltration. Protein hydrolysates can have a bitter taste 
and the elimination or reduction of this bitterness is essential to make the hydrolysates acceptable to 
consumers. The bitterness of protein hydrolysates is attribuatable to their hydrophobic amino acid 
content [1] and the release of these amino acids by exoproteases can reduce bitterness [15].  
Post-hydrolysis processes can also be used to produce hydrolysates for the treatment of clinical 
conditions. For example, the use of phenylalanine ammonia lyase enzyme can reduce the 
phenylalanine content in protein hydrolysates, producing a hydrolysate suitable for patients with 
phenylketonuria, a disorder of phenylalanine metabolism [6].  
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Table 1. The main processes used following hydrolysis of protein (post-hydrolysis processes). 
Process Function 
Heat inactivation Inactivation of proteolytic enzymes 
Ultrafiltration 
Removal of high molecular weight proteins 
and peptides 
Use of specific enzymes Reduce content of specific amino acids 
Hydrolysis by exoproteases Hydrolysis, reduction of bitterness 
Activated carbon Reduction of bitterness 
Absorption chromatography Reduce content of aromatic amino acids 
3. Bioactivity of Protein Hydrolysates 
3.1. Antioxidant  
Protein hydrolysates from agricultural crops including soy, rapeseed, wheat, sunflower and barley 
have been investigated for their antioxidant potential. In 1980, it was reported that following 
proteolysis, soy protein hydrolysates showed antioxidant potential, as measured by the thiobarbituric 
(TBA) assay, which is a measure of lipid peroxidation. It was suggested that the release of bound 
antioxidant phenolics or copper chelating agents was responsible for the observed antioxidant  
activity [16]. Using similar methodology, Peña-Ramos and Xiong [17] provided comparable results. 
Soy protein hydrolysates prepared with Flavourzyme or chymotrypsin had antioxidant potential greater 
than unhydrolysed soy protein isolate. However, it was found that extensive degradation using 
enzymes such as papain unfavourably altered the antioxidant activity [17]. A further study  
measured the ability of these soy protein hydrolysates, prepared with Flavourzyme or chymotrypsin, to 
inhibit lipid oxidation in corked pork patties. However, in contrast to the initial study, the soy  
protein hydrolysates did not affect lipid oxidation by the TBA assay, but reduced conjugated  
diene (CD, a marker of free radicals) formation in stored pork patties [18]. CD is a secondary  
product of lipid oxidation. Later studies have also reported the antioxidant potential of soy protein 
hydrolysates [19–22]. Soy protein hydrolysates post-treated with ultrafiltration, resulting in low 
molecular weight fractions (<10 kDa) have shown greatest antioxidant potential [20].  
Protein hydrolysates from a range of other agricultural crops have been less extensively studied in 
comparison to soy hydrolysates. Rapeseed protein hydrolysates exhibited a dose-dependent inhibition 
of lipid peroxidation by a speculated proton donation mechanism [23]. Later studies supported these 
findings, with rapeseed hydrolysates showing the ability to act as reducing agents and scavenge 
hydroxyl radical and superoxide anion [24,25]. By employing the post-hydrolysis process of affinity 
chromatography, copper chelating peptides were isolated from sunflower protein hydrolysates. The 
ability to chelate copper increased mineral bioavailability and exerted antioxidant effects [26,27]. 
Protein hydrolysates isolated from wheat germ also possess radical scavenging abilities, with an 
antioxidant activity close to that of the well known, antioxidant α-tocopherol. Interestingly, these 
hydrolysates had low molecular weight <1500 Da [28]. Similarly, enzymatic hydrolysates of 
buckwheat showed excellent antioxidant potential, scavenging (DPPH) radical, inhibiting linoleic acid 
peroxidation and possessing reducing power [29].  
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Protein hydrolysates isolated from co-products of the plant processing industry have also been 
investigated for antioxidant activity. While BSG protein isolate and associated hydrolysates do not 
possess antioxidant potential [30], okara hydrolysates protect against oxidation of linoleic acid [31]. 
Furthermore, it has been shown that fermentation of okara using Bacillus subtilis B2 can greatly 
improve its antioxidant activity, thus adding value to this co-product [32].  
3.2. Anti-hypertensive 
Normal blood pressure is in the range of 100–140 mmHg (systolic) and 60–90 mmHg (diastolic). 
Values greater than 140 mmHg (systolic) and 90 mmHg (diastolic) are classified as hypertension or 
high blood pressure. In hypertension, the blood pressure in the arteries is elevated and the heart has to 
work hard to pump blood around the body. According to the World Health Organisation, high blood 
pressure is particularly relevant in middle income European countries and African countries. A high 
percentage of stroke (51%) and ischaemic heart disease (45%) deaths worldwide are attributable to 
high systolic blood pressure [33]. Dietary and lifestyle changes, including a reduction in salt intake and 
an increase in physical activity levels, can positively influence blood pressure. However, in cases 
where such changes are ineffective or insufficient, drug treatments may be prescribed.  
Angiotensin-converting enzyme (ACE) inhibitors are an example of a drug treatment to control blood 
pressure. ACE reduces the conversion of angiotensin-1 (vasodilatory) to angiotensin-2 
(vasoconstrictory) resulting in a reduced blood pressure. Hence, there is great interest in novel 
compounds that can inhibit ACE. In 2000, wheat germ hydrolysate and its dominant peptide 
significantly reduced mean arterial pressure (MAP) in spontaneously hypertensive rats. It was shown 
that the dominant bioactive peptide could be metabolised by an aminopeptidase to form an ACE 
inhibitory metabolite, indicating potential blood pressure lowering effects of the metabolite after 
absorption [34]. Similarly, a buckwheat protein hydrolysate was found to reduce systolic blood 
pressure in spontaneously hypertensive rats and also inhibit ACE, particularly when hydrolysis was 
carried out with pepsin followed by chymotrypsin and trypsin [35]. More recently, it was found that 
ultrasonic pre-treatment promotes the release of ACE inhibitory peptides during enzymatic proteolysis 
of wheat germ [36]. van der Ven et al. [37] described the processing conditions necessary to produce 
hydrolysates with maximal ACE inhibitory activity. It was suggested that the ACE inhibitory activity 
of protein hydrolysates is due to the synergistic action of the different peptides present, thus the 
isolation of peptides is not justified and optimising the entire peptide composition is essential. 
Response surface modelling (which comprises a body of methods to explore optimum operating 
conditions through experimental methods [38]) is effective in the optimisation of a number of 
parameters simultaneously to produce a hydrolysate with maximum ACE inhibitory activity. Similar to 
the results for antioxidant activity of protein hydrolysates, it was found that ACE inhibitory activity of 
soy protein hydrolysates increased with decreasing molecular weight of peptides; hence ACE 
inhibitory peptides have low molecular weight [39]. This study also focused on an important 
consideration for the formulation of anti-hypertensive functional foods, that is, the digestibility of the 
protein hydrolysates. Following in vitro gastric digestion, which simulates conditions in the human 
stomach, of the soy protein hydrolysates, the ACE inhibitory activity was retained. Stability during 
processing is another key factor and hydrolysates were shown to have sufficient stability to various 
heat (20–100 °C) and pH (pH 2–10) treatments. These findings were supported by a study published in 
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2006, where it was also reported that soy protein hydrolysates possessed ACE inhibitory activity that 
was unaffected by in vitro gastrointestinal proteases [40]. Protein hydrolysates from a range of other 
crops including potato [41], corn [42,43], spinach [44], sunflower [45,46], peanut [47] and  
rapeseed [48] have exhibited high ACE inhibitory activities. Rice-bran, an under-utilized co-product of 
rice milling also has the potential to inhibit ACE activity, high molecular weight hydrolysates (10–50 
and >50 kDa) resulting in at least 50% inhibition [49]. In addition to ACE inhibition, there are a 
number of other potential mechanisms of inhibiting hypertension. These include activation of 
endothelial nitric oxide synthase (NOS), reduction of Ca2+ in vascular smooth muscle cells (VSMC) 
and rennin inhibition [50]. The ability of a compound to induce nitric oxide (NO) production via NOS 
and increase endothelial cell Ca2+ concentration contributes to vasodilation and reduced blood  
pressure [50]. Studies utilizing these mechanisms have also been carried out; for example soy protein 
isolate and hydrolysates have been shown to increase NO release in human aortic endothelial cells 
(HaoEC) [51]. 
3.3. Cardiovascular Disease 
Cardiovascular diseases (CVD) are the primary cause of death globally, representing 30% of all 
global deaths in 2008 [52]. Cardiovascular diseases are diseases of the heart and blood vessels and 
include coronary heart disease, cerebrovascular disease and peripheral arterial disease [52]. An 
unhealthy diet and physical inactivity are among the two main risk factors for CVD, resulting in raised 
blood pressure, blood lipids and blood glucose, overweight and obesity, which are classed as 
intermediate risk factors for CVD. The consumption of vegetable protein has been associated with a 
lower risk of coronary heart disease, in comparison to consumption of animal protein [53–55]. This 
observed effect may be attributed to decreases in serum cholesterol levels [56]. For more than  
100 years, animal studies have shown the cholesterol lowering effect of soy protein compared with 
animal protein [57]. Reduced intestinal cholesterol absorption and increased faecal bile acid excretion, 
reduced levels of hepatic lipogenic enzymes such as glucose-6-phosphate dehydrogenase (G6PDH) 
and stimulation of adinopection, a cytokine involved in adipocyte differentiation and insulin sensitivity 
are all possible mechanisms for the lipid lowering effect of soy protein [58]. A meta-analysis of  
38 studies indicated that soy protein consumption significantly decreased serum cholesterol, low 
density lipoprotein (LDL) cholesterol and triglyceride concentrations; there was also an increasing 
trend in high density lipoprotein (HDL) cholesterol concentrations [59]. An animal study carried out 
on genetically obese mice and dietary obese rats measured the effect of soy protein isolate and 
hydrolysate and on the rate of body fat disappearance. Feeding with either soy isolate or hydrolysate 
resulted in a significantly reduced body-fat content and plasma glucose levels in comparison with 
control, casein fed rodents. A decrease in the plasma total cholesterol level was also observed [60]. 
Soy hydrolysates have also demonstrated effects such as decreased cholesterol absorption both in vitro 
and in rats [61], anti-adipogenic in vitro [62], reduced fat mass and serum lipid in rats [63]. Sunflower 
hydrolysates produced using alcalase or pepsin inhibited the incorporation of cholesterol into bile salts 
micellar suspensions [64]. As mentioned in section 3.2 in vitro digestion did not decrease ACE 
inhibitory bioactivity of soy protein hydrolysates. It has also been shown that digestion of sunflower 
protein hydrolysates with simulated intestinal fluids produces new peptides that inhibit cholesterol 
incorporation into micellar suspensions [64]. Protein hydrolysates from crop processing co-products 
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have been less extensively studied, but rice bran hydrolysates have demonstrated hypocholesterolemic 
activity, by reducing total cholesterol and increasing HDL cholesterol in male Wistar rats [65]. 
3.4. Exercise and Performance Enhancement  
Muscle glycogen is an important fuel during periods of prolonged exercise and a relationship 
between increasing exercise intensity and a reliance on muscle glycogen is evident. Fatigue has been 
directly related to depleting glycogen stores [66–68]. Hence, the post-exercise glycogen synthesis rate 
is essential in determining the time required for recovery. It has been shown that carbohydrate and 
wheat protein hydrolysate combined with an amino acid mixture (0.8 g/kg/hr and 0.4 g/kg/hr, 
respectively), administered to cyclists for a five hour period post-exercise, increases glycogen 
synthesis rates compared to administration of carbohydrate alone [69]. Similarly, peak creatine kinase 
(CK) levels, as a result of initial muscle injury, were suppressed by wheat gluten hydrolysate in a  
dose-dependent manner in vivo [70]. Soy protein isolate is beneficial in muscle protein synthesis 
(MPS) following exercise. Consumption of the soy protein isolate was more effective than casein 
isolate but less effective than whey hydrolysate at increasing MPS both at rest and following resistance 
exercise [71]. Calbet and MacLean [72] suggested that carbohydrate and protein hydrolysates 
stimulate a synergistic insulin response, regardless of protein source. It was also found that the 
glucagon response depends on the increase in plasma amino acid composition, following protein 
solution ingestions and that pea and whey protein hydrolysates increased insulin to a greater extent and 
increased plasma amino acids more rapidly than cow’s milk solution. It has been suggested that 
hydrolysates, particularly containing di- and tri-peptides, are absorbed more rapidly than either intact 
proteins or free form amino acids [73] which would support the use of protein hydrolysates for  
post-exercise recovery drinks as this would result in a greater increase in plasma amino acid 
concentration compared with the intact protein, over a two hour period [74]. The concentration of 
amino acids present in the blood regulates protein synthesis [75].  
3.5. Other Clinical Applications  
Protein hydrolysates represent an alternative to intact proteins and elemental (amino-acid based) 
formulas for the treatment of patients with various conditions. Phenylketonuria is a disorder of amino 
acid metabolism, specifically, absence or deficiency of phenylalanine hydroxylase for the conversion 
of phenylalanine to tyrosine. The lack of this enzyme results in phenylpyruvic acid accumulation in the 
blood which has intellectual and neurological implications if left untreated. Protein hydrolysates free 
of phenylalanine have been used for the treatment of phenylketonuric infants, with positive results on 
physical growth and mental development [76,77]. Hydrolysates suitable for the treatment of 
phenylketonuria have been prepared from animal proteins including casein [78] and whey [79]. Plant 
protein hydrolysates low in phenylalanine have been studied to a lesser extent;, however the potential 
of a low-phenylalanine soybean hydrolysate for dietetic purposes has been investigated [80]. In 
patients with chronic liver disease, complex alterations in the metabolism of proteins occurs and 
nutritional support is essential in the pathogenesis and treatment of this disease [6]. Patients with 
chronic liver failure have high plasma levels of aromatic amino acids (AAA) and methionine and low 
levels of branched-chain amino acids (BCAA) [81,82]. While casein hydrolysates are commonly used 
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for nutritional applications in patients with chronic liver disease, a protein source with a higher level of 
BCAA is more desirable. Sunflower globulins have been suggested as excellent protein sources for the 
development of protein hydrolysates with high levels of BCAA [83]. Sunflower protein hydrolysate is 
recommended for enteral, parenteral and oral nutrition of liver disease patients, being hypoallergenic, 
having low bitterness and providing a high Fischer ratio (BCAA:AAA) of approximately 75 [84].  
3.6. Further Uses  
Advances in the understanding of protein hydrolysates have resulted in their use in biotechnology 
and fermentation. Hydrolysates have the ability to increase both production of monoclonal antibodies 
and productivity of therapeutic drugs produced by microorganisms and animal cells [7]. However, the 
most basic function of protein hydrolysates in biotechnology is as a source of nitrogen in industrial 
fermentation, cell culture and microbiological media [14]. As a protective mechanism against the 
spread of BSE from bovine animals to humans, plant materials have been recommended as an 
alternative for inclusion into fermentation media. Tryptone (a digest of casein) in Luria-Bertani broth 
supplies essential growth factors for Escherichia coli (E. coli). It has been shown that non-bovine and 
plant hydrolysates are efficient replacements for tryptone, measured by growth rate and growth yield 
of E. coli [9]. Furthermore, an animal-free cell culture medium supplement has been developed that 
can improve the bio-performance of the culture medium by providing peptides, carbohydrates, lipids, 
vitamins and minerals. [85]. Plant protein hydrolysates have also proved useful in the area of weed 
control. Corn gluten meal is commercially available as a natural pesticide, with corn gluten 
hydrolysate being suggested for similar results with easier application as a spray [86]. Corn, soybean 
and wheat protein hydrolysates have also been developed as herbicides [8].  
4. Techno-Functional Properties of Protein Hydrolysates 
4.1. Solubility 
Solubility is the most important and generally the first techno-functional property examined during 
the development of new protein ingredients [87] due to its considerable effect on other  
techno-functional properties [88,89]. It has been proposed that reduction of the secondary structure of 
a protein and the enzymatic release of smaller polypeptide units are responsible for the increased 
solubility of hydrolysates compared to the original intact protein [90,91]. The solubility of a number of 
protein hydrolysates from agricultural crops has been studied. Barley protein hydrolysates showed 
highest solubility at strongly basic (pH 10–pH 12) conditions [92]. Similarly, Claver et al. [93] found 
that the solubility of wheat protein hydrolysates was strongly influenced by pH, with lowest and 
highest solubility at pH 4 and 6, respectively. The use of rapeseed and other oilseed protein isolates is 
restricted due to their low solubility, which is a result of protein denaturation during industrial oil 
extraction [94]. To improve solubility and functionality, protein isolates from oilseeds can be 
hydrolysed. It has been found that rapeseed hydrolysates exhibit >90% solubility at pH 5–9 [95]. Soy 
protein hydrolysates were found to be almost completely soluble (>99%) in the range of pH 2–9, 
whereas the intact protein had highest solubility at pH 9 [96]. Tsumara et al. [97] also demonstrated 
that the solubility of soy protein hydrolysates was pH-dependent. The production of hydrolysates that 
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are soluble at acidic pH is essential for the supplementation of fruit juices and acidic drinks [6,98]. In 
contrast to soy protein hydrolysates, okara protein isolates showed highest solubility at pH 12, with 
acid modified isolates enhancing solubility, thus increasing potential applications of okara protein as a 
food ingredient [99]. Chan and Ma [99] suggested that the low solubility of okara (a by-product of 
soymilk manufacture) hydrolysates compared to soy hydrolysates is due to protein denaturation caused 
by severe heat treatments during soymilk manufacture.  
4.2. Emulsifying Properties 
The ability of proteins to interact with lipids and form stable emulsions is essential to yield a stable 
food product. Rapeseed protein hydrolysates have higher emulsifying activity (at least 20% greater) 
and stability than rapeseed protein isolates [94]. Enzymatic hydrolysates of soy protein resulted in an 
increased emulsification activity [100]. Studies examining protein hydrolysates from different crop 
sources suggest that the emulsifying capacity of the hydrolysates is related to the degree of hydrolysis, 
with a low degree of hydrolysis (3%–5%) increasing and a high degree of hydrolysis (~8%) decreasing 
emulsifying capacity [94,101,102]. Ultrafiltered rapeseed protein hydrolysate was demonstrated to 
have greater emulsification stability compared to that of whole egg [95] and wheat germ protein 
hydrolysates had higher emulsification capacity, activity and stability than bovine casein [91]. It is 
generally accepted that limited hydrolysis improves the emulsification properties of proteins by 
exposing hydrophobic amino acid residues (which may interact with oil), while the hydrophilic 
residues interact with water [94]. Similarly, an increase in hydrophilicity as a result of acid 
modification has been shown to increase the emulsification activity index (EAI) of okara protein 
isolates [99]. 
4.3. Foaming 
Foaming is of special interest in the food industry as it provides a desirable and unique texture to a 
range of aerated foods and beverages including ice-cream, bread, cakes, meringues, champagne and 
beer. It is essential that food foams are stable for consumer acceptability, since consumer perception of 
quality is influenced by appearance. Wheat germ has been shown to have poor foaming  
properties [103]. However enzymatic treatment of wheat germ increases foam volume/height but 
decreases foam stability. The trend of increased foam volume being coupled with decreased foam 
stability has been reported in previous studies on rice bran protein hydrolysate and acid modification 
of okara protein hydrolysate [99,104]. The absence of large protein components, which function to 
stabilise the foam, may contribute to the observed lack of foam stability [93]. In a similar study of 
wheat germ hydrolysates it was found that foaming capacity was increased at a degree of hydrolysis 
(DH) of 5%, resulting in a 74% increase in foam volume compared to the control. The foam was also 
most stable at DH of 5%, with 40% of foam volume sustained after 60 minutes. There was an inverse 
relationship between DH and foam stability, with stability in the order of DH 5% >  
DH 10% > DH 15%. Similar to suggestions by Claver et al. [93], the stability of the foams was 
attributed to the presence of larger component proteins and a partial hydrolysis, whereas a higher DH 
increases the number of polypeptide chains which do not have the ability to stabilise foams [102]. The 
study of both soy [97] and rapeseed [94] protein hydrolysates produced comparable results. Regarding 
Agriculture 2013, 3 121 
 
the effect of pH on foaming, barley hydrolysates had greater foam stability at basic pH values and very 
low stability at acidic pH [105]. 
4.4. Gelation 
The ability to manipulate the gel formation properties of a substance is important since gelation is 
desirable for the bakery and meat industries, but not for foods such as beverages and frozen  
deserts [106]. As a food ingredient, gelation is one of the most important techno-functional properties 
of soy protein, however soy protein hydrolysates possess poor gel-forming ability [107]. 
Transglutaminase (TGase) is a polymeriser shown to be effective in improving gelling of  
proteins [108], which improved the gelling ability of soy protein hydrolysates [107,109] but the gels 
formed were inferior to the starting soy protein/isolate in terms of gel strength. It has been suggested 
that the reduced ability to form gels may be due to lower surface hydrophobicity and short peptide 
chain length of the hydrolysates [109]. Research has been carried out with a focus on manipulating 
conditions to give desired gelation properties. For example, it has been shown that sodium chloride 
(NaCl) concentrations greater than 0.2M can accelerate gelation by sunflower protein hydrolysates but 
result in a gel of lower strength [110]. Addition of a polysaccharide such as guar gum can enhance the 
gel strength of canola protein isolates [111] and protein concentration and pH have been identified as 
important factors influencing gel formation by canola protein isolate coupled with guar gum [112]. 
Hence, while the gel forming ability of protein hydrolysates from agricultural crops is not as strong as 
that from proteins, processes are available to improve gelation where necessary.  
5. Safety of Protein Hydrolysates 
The use of dietary proteins and protein hydrolysates in food products is generally allowed in 
European countries and has the status of “generally regarded as safe” (GRAS) in the United States of 
America [113]. In Europe, novel foods are defined as foods and food ingredients that have not been 
used for human consumption to a significant degree within the European Community before 15 May 
1997 [114]. Safety evaluation by external independent experts and approval by competent authorities 
is necessary before a novel product is allowed on the market. Schaafsma [1] proposed a decision tree 
that should be used for determining the proposed safety assessment of protein hydrolysates and 
fractions thereof. Factors for consideration in deciding if a protein hydrolysate should follow 
procedure for novel foods include documented history of safe use, acceptable food grade hydrolysis 
process and the effect of intake on amino acid levels [1]. Hydrolysed proteins have a long history of 
safe use, but it is important to note that the majority of studies in this area look at animal-derived 
protein hydrolysates in infant feeding practices [114–117]. Some evidence has been produced 
regarding the sub-chronic toxicity of plant protein hydrolysates. Consumption of potato protein 
isolates is “well tolerated and without adverse effect” in Wistar rats, with parameters including body 
weight, body weight gain, mortality and organ weight remaining unchanged [118]. Protein isolates 
from canola have also been reported to be safe, following a 13 week consumption trial in rats, being 
practically devoid of natural toxicants and environmental contaminants. The canola protein isolates 
had no effect on body weight, food consumption, clinical observations, motor activity or ophthalmic 
examinations [119]. One particular consideration for the safety of protein hydrolysates and bioactive 
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peptides is their allergenicity. Most allergenic substances are protein-based compounds [120] and 
peptides in the range of 800–1500 Da are considered non-allergenic [5]. While hydrolysis breaks down 
proteins into low molecular weight peptides thus lessening the allergenic properties [121], some 
hydrolysates may retain their parent protein allergenic effects [122]. Therefore, there is a need to 
further investigate the safety of plant-derived protein hydrolysates and bioactive peptides.  
6. Conclusions 
Protein hydrolysates derived from agricultural crops have exhibited antioxidant and ACE inhibitory 
potential, with low molecular weight fractions demonstrating greatest effects. There is substantial 
evidence which supports the ability of soy protein hydrolysates to reduce CVD risk however 
hydrolysates obtained from other plant sources require further investigation. Protein hydrolysates show 
greater potential than intact protein to increase muscle glycogen and muscle protein synthesis and have 
also demonstrated potential in the treatment of clinical conditions, particularly sunflower hydrolysates 
which may be used in cases of chronic liver disease. In terms of techno-functional properties, 
hydrolysates with a low DH have desirable effects on emulsification, foaming and solubility 
properties. To conclude, protein hydrolysates from agricultural crops have demonstrated favourable 
bioactive and techno-functional properties that could be exploited for the development of functional 
foods. For neutraceutical development, clinical trials are necessary to confirm biological activity and 
safety, in addition to addressing issues such as stability during food processing, organoleptic issues 
and identifying the fate of plant-derived hydrolysates during passage through the gastrointestinal tract. 
Furthermore, protein hydrolysates from co-products of the plant processing industry should be 
investigated for their potential bioactive and techno-functional properties. 
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Brewers' spent grain (BSG) protein hydrolysates
decrease hydrogen peroxide (H2O2)-induced oxidative
stress and concanavalin-A (con-A) stimulated IFN-g
production in cell culture
Aoife L. McCarthy,a Yvonne C. O'Callaghan,a Alan Connolly,b Charles O. Piggott,b
Richard J. FitzGeraldb and Nora M. O'Brien*a
The present study investigated the bioactivity of protein hydrolysates and fractionated hydrolysates
prepared from brewers' spent grain (BSG) using proteases, including Alcalase 2.4L, Flavourzyme and
Corolase PP. Hydrolysates were designated K–Y, including fractionated hydrolysates with molecular
weight (m.w.) < 3, <5 and >5 kDa. Where computable, IC50 values were lower in U937 (1.38–9.78%)
than Jurkat T cells (1.15–13.82%). Hydrolysates L, Q and R and fractionated hydrolysates of U and W
(<3, <5, >5 kDa) signiﬁcantly (P < 0.01) protected against hydrogen peroxide (H2O2)-induced reduction
of superoxide dismutase (SOD) activity. A fractionated hydrolysate of W (<5 kDa) protected against
H2O2-induced DNA damage, P < 0.01. Hydrolysates K, N, P, U, U > 5 kDa, V, V > 5 kDa, W, W > 5 kDa
signiﬁcantly (P < 0.05) reduced a concanavlin-A (con-A) stimulated production of interferon-g (IFN-g). In
conclusion, BSG protein hydrolysates demonstrate bioactivity in vitro; lower m.w. hydrolysates (<3, <5
kDa) show greatest antioxidant activity and unfractionated or higher m.w. hydrolysates (>5 kDa) possess
anti-inﬂammatory eﬀects.
1. Introduction
Brewers' spent grain (BSG) represents 85% of the total solid by-
products of the brewing industry, with 8.5 million tons of dry
BSG produced on an annual basis globally.1 This lignocellulosic
material is an excellent source of protein and bre in addition to
polyphenolic compounds (hydroxycinnamic acids), vitamins
and minerals.2,3 Presently, spent grains are sold as livestock
feed, particularly for dairy cattle, with a prot in the range of
V1–V6 ton1.4 Other potential applications have been sug-
gested; energy and charcoal production, paper manufacture, use
in biotechnological processes and as a human food ingredient.2
Meat, eggs, sh, soy and wheat have been highlighted as
sources of bioactive peptides,5,6 with protein hydrolysates being
utilised in many human nutrition products including energy
drinks, weight control and sports nutrition products.7 In addi-
tion to antioxidant and anti-inammatory potential, protein
hydrolysates also possess hypocholesterolemic and anti-hyper-
tensive properties.5
Phenolic-rich extracts from BSG have previously demon-
strated bioactivity, by protecting against oxidant induced DNA
damage.8 We previously reported BSG protein isolate and
associated hydrolysates possess selective immunomodulatory
potential, signicantly reducing Concanavalin-A (con-A) stim-
ulated interferon-gamma (IFN-g) production.9 As a continua-
tion of this research, additional protein hydrolysates were
prepared from BSG, with an aim of producing a hydrolysate
with enhanced bioactivity. Since molecular weight is one of the
main factors inuencing biological properties,10,11 hydrolysates
(produced using Alcalase 2.4L, Corolase PP and Flavourzyme)
were fractionated on the basis of diﬀerences in molecular mass
for bioactivity analysis. It has been reported that membrane
separation of protein hydrolysates can result in peptide frac-
tions with enriched bioactivity.12 Cellular antioxidant activity
assays, representing the rst line of antioxidant defence in the
body, are essential to identify the ability of compounds to
intercept oxidative stress and prevent or reduce oxidation.13
Furthermore, the comet (single cell gel electrophoresis) assay
has been shown to be a successful means of determining the
chemoprotective eﬀects of novel functional food ingredients,
through antioxidant mechanisms, in cell culture.8,14,15 It is
hypothesised that fractionation of BSG protein hydrolysates will
produce peptide fractions with enriched bioactivity, measured
using common assays of bioactivity in cell culture.
The aims of the present study were to assess: rstly, the
cytotoxic eﬀects of a second set of BSG protein hydrolysates in
human monocytic blood cells (U937) and human leukaemic T
cells (Jurkat T); secondly, the cellular antioxidant potential of
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the BSG hydrolysates in the U937 cell line; thirdly, the ability of
BSG hydrolysates to protect against H2O2-induced DNA damage
in U937 cells; and fourthly, the immunomodulatory potential of
BSG hydrolysates in con-A stimulated Jurkat T cells.
2. Materials and methods
2.1. Materials
All chemicals were purchased from Sigma-Aldrich Ireland
Limited, Co. Wicklow, Ireland, unless otherwise stated. U937
and Jurkat T cells were obtained from the European Collection
of Animal Cell Cultures (ECACC).
2.2. Generation of protein rich isolate and protein
hydrolysates
The BSG protein rich isolate was obtained by a method previ-
ously described.16 Samples B–T were generated using a BSG
protein rich isolate extracted at bench scale whereas samples
U–Y were obtained using BSG protein rich isolate extracted at
semi-pilot scale. The freeze dried protein rich isolates were then
hydrolysed by a range of commercially available enzymes under
conditions described in Table 1. The pH was maintained by
addition of 0.5 or 2 N NaOH using a pH-Stat system (Metrohm
718 STAT Titrino, Herisau, Switzerland) and the temperature
was kept constant using a thermostatically controlled water
bath (IKA Werke GmbH & Co. KG, Staufen, Germany). The
resulting hydrolysates were each adjusted to pH 7.0, heated at
95 C for 10 min to inactivate the enzyme and were then freeze
dried or fractionated using 5 and 3 kDamolecular weight cut-oﬀ
membranes (Minimate Tangental Flow Filtration Capsules,
Pall Corporation, New York, USA) and then freeze dried. All
samples were prepared at 50 C (except R, S and T, 60 C) and
pH 7 (except C, R, S and T, pH 9).
2.3. Cell culture
A human monocytic blood cell line (U937 cells) and human
leukaemic T cell line (Jurkat T cells) were maintained in anti-
biotic-free RPMI-1640 medium supplemented with 10% v/v
foetal bovine serum (FBS), in a 5% CO2 atmosphere at 37 C.
Cells were adjusted to a density of 1  105 cells per ml for cell
proliferation and superoxide dismutase assays and 2  105 cells
per ml for comet and enzyme-linked immunosorbent assays.
Reduced serum media (2.5% FBS) was used for all experiments.
2.4. Cell proliferation
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay was used to measure cell proliferation. U937 and
Jurkat T cells, at a density of 1  105 cells per ml, were incu-
bated for 24 h at 37 C with protein samples at concentrations of
0–10% (v/v) or 0–5% (v/v), respectively, in a 96-well plate. Colour
blanks (sample and media only, without cells) were used to
allow for possible colour interference by samples. The MTT
assay kit (Roche Diagnostics Limited, West Sussex, England)
was used to quantify cell proliferation, based on the concept
that metabolically active cells convert the yellow tetrazolium
MTT salt to a purple formazan derivative. In brief, 10 ml MTT
reagent 1 and 100 ml RPMI media were added to each well and
incubated for 4 h at 37 C. Subsequently, 100 ml was then
removed and 100 ml MTT reagent 2 added, followed by an
overnight incubation at 37 C, before absorbance at 570 nm was
measured spectrophotometrically using a microplate reader
(Spectrauorplus, Tecan). GraphPad Prism 4 was used to
calculate the concentration of the samples needed to induce
50% cell death (IC50 value), expressed as % (v/v). A non-toxic
concentration of 0.5% (v/v) was chosen for further analyses.
2.5. Superoxide dismutase (SOD) assay
Using a Calbiochem SOD Assay Kit (Merck Chemicals Ltd,
Nottingham, UK), SOD activity was measured. U937 cells (5 ml,
1  105 cells per ml) were incubated for 24 h with 0.5% (v/v) test
samples at 37 C, followed by a 60 min exposure to 100 mMH2O2
at 37 C. SOD activity is expressed relative to the protein content
of the samples, measured using the Bicinchoninic Acid Protein
(BCA) assay (previously described17), as SOD units per mg
protein cell homogenate (U mg1 protein). The amount of SOD
enzyme needed to dismutate 50% of the superoxide radical
(O2_
) is equivalent to 1 SOD unit.
2.6. Single cell gel electrophoresis (SCGE) – comet assay
U937 cells (2 ml, 1  105 cells per ml) were incubated for 24 h at
37 C with 0.5% (v/v) test samples and subsequently exposed to
50 mM H2O2 for 30 min. Using the uorescein diacetate
ethidium bromide (FDA/EtBr) assay, cell viability was checked
Table 1 Summary of methods used to prepare brewers' spent grain (BSG)
protein hydrolysates
Sample Description Enzyme/water
E/S ratio (w/w
or v/w) %
B Control for K–Q Water —
C Control for R–T Water —
K BSG protein hydrolysate Protamex 1
L BSG protein hydrolysate Prolyve 1
M BSG protein hydrolysate Protex 6L 1
N BSG protein hydrolysate Promod 144 MG 1
O BSG protein hydrolysate Promod 24P 1
P BSG protein hydrolysate Trypsin 250 1
Q BSG protein hydrolysate Corolase L10 1
R BSG protein hydrolysate Alcalase 2.4L 2.5
S 5 kDa retentate Alcalase 2.4L 2.5
T 5 kDa permeate Alcalase 2.4L 2.5
U BSG protein hydrolysate Alcalase 2.4L 1
U < 3 3 kDa permeate Alcalase 2.4L 1
U < 5 5 kDa permeate Alcalase 2.4L 1
U > 5 5 kDa retentate Alcalase 2.4L 1
V BSG protein hydrolysate Corolase PP 1
V < 3 3 kDa permeate Corolase PP 1
V < 5 5 kDa permeate Corolase PP 1
V > 5 5 kDa retentate Corolase PP 1
W BSG protein hydrolysate Flavourzyme 1
W < 3 3 kDa permeate Flavourzyme 1
W < 5 5 kDa permeate Flavourzyme 1
W > 5 5 kDa retentate Flavourzyme 1
X Unhydrolysed BSG protein — —
Y Control for U–W Water —
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and was consistently >90%. The comet assay, as previously
described,8 was used to determine the eﬀect of the extracts on
oxidant-induced DNA damage. Briey, cells were harvested and
embedded on microscope slides (prepared with normal gelling
agarose (NGA)) using low melting point agarose (LMP). Cells
were placed in lysis solution for 1 h at 4 C, followed by elec-
trophoresis at 300 mA, 21 V for 25 min. Slides were neutralised
by using Tris (0.4 M) and stained with EtBr (20 mg ml1). Cells
were visualised using a uorescence microscope (Optiphot-2,
Nikon) and Komet 5.5 image analysis soware. For each slide,
50 cells were scored and DNA damage expressed as percentage
tail DNA.
2.7. Enzyme-linked immunosorbent assay (ELISA) –
interferon-g production
Jurkat T cells were treated with concanavalin-A (con-A, 50 mg
ml1) and incubated for 24 h at 37 C with 0.5% (v/v) test
samples. eBioscience ELISA kit (Human IFN-g ELISA Ready-Set-
Go) was used to measure the production of interferon-g (IFN-g).
Absorbance was read at 450 nm using a microplate reader
(ThermoScientic Varioskan Flash).
2.8. Statistical analysis
All data points represent the mean  standard error (s.e.) of at
least 3 independent experiments. Statistical analysis was carried
out using GraphPad Prism 4.00 (GraphPad Soware, California,
USA); analysis was by one-way analysis of variance (ANOVA)
followed by Dunnett's test (or Tukey's multiple comparison test,
where stated).
3. Results
For hydrolysate samples K–Q and R–T the control protein
samples are labelled B and C, respectively, as detailed in
Table 1. These control samples, B and C, were previously
studied in our earlier publication.9 The control for samples U,V,
W and associated fractionated hydrolysates is sample Y.
3.1. Cell proliferation
The eﬀect of test samples on cell proliferation in both U937 and
Jurkat T cells was measured using the MTT assay. Concentra-
tions between 0 and 10% (v/v) were analysed in the U937 cell
line, as shown in Table 2 and Fig. 1. Sample Y was the most
cytotoxic, with 0.5% (v/v) signicantly (P < 0.05) decreasing cell
proliferation, while M was the least toxic sample in the U937 cell
line. The concentration of each sample needed to induce 50%
cell death (IC50 value) was calculated. In the U937 cell line this
was found to range from 1.38% (v/v) to non-determinable (n/d).
Therefore, for further analyses using U937 cells, a non-toxic
concentration of 0.5% (v/v) was chosen.
Themaximum concentration tested was 5% (v/v) for the MTT
assay in the Jurkat T cell line, as results in the U937 cell line
suggested that concentrations in excess of 5% (v/v) to be
Table 2 Eﬀect of BSG protein hydrolysates (0–10% (v/v)) on cell proliferation in the U937 cell line
Sample
Cell proliferation (% of control)a
IC50
b (% (v/v))0% 0.5% 1% 2% 2.5% 4% 5% 6% 8% 10%
K 100.00 95.73 89.53 95.15 84.48 80.59 95.85 62.87 31.14* 29.32* 6.02
L 100.00 96.78 94.24 111.87 99.52 74.98 133.34 73.18 37.20* 40.89* 6.01
M 100.00 82.93 113.92 104.41 104.80 105.21 114.64 94.67 64.59 64.75 n/d
N 100.00 96.22 88.21 100.04 100.03 125.80 89.08 75.17 49.97 28.51* 8.13
O 100.00 83.97 89.82 89.69 105.13 86.77 107.16 65.09 54.07 31.39* 5.98
P 100.00 93.94 93.63 87.09 112.62 74.10 103.54 88.07 64.07 25.67* 7.84
Q 100.00 87.43 92.08 70.36 103.53 78.17 87.01 73.79* 52.25* 19.75* 9.07
R 100.00 88.23 98.34 81.01 88.22* 30.72* 17.92* 13.84* 55.21 37.16* 2.90
S 100.00 88.42 81.84 68.11 50.58* 20.48* 31.80 29.04* 55.39 74.18 2.01
T 100.00 82.11 58.56* 43.43* 49.05* 63.81* 43.25* 35.99* 50.55* 33.69* 5.84
U 100.00 80.01 88.26 40.77* 29.13* 44.77* 46.09* 30.21* 44.36* 26.86* 1.94
U < 3 100.00 94.42 109.62 99.04 89.10 62.27 88.79 81.67 54.90* 25.29* 9.78
U < 5 100.00 76.21 103.72 95.68 84.25 86.47 83.97 72.53 53.24 30.04* 9.34
U > 5 100.00 62.93 89.92 76.59 50.91 39.97* 22.64* 18.17* 9.12* 5.14* 4.27
V 100.00 45.00 114.60 82.22 84.36 25.39* 26.63* 23.92* 19.22* 15.88* 3.53
V < 3 100.00 69.94 66.46 77.75 84.42 68.63 63.76 49.07* 34.61* 23.20* 6.33
V < 5 100.00 60.32* 71.44 73.73 83.21 65.12* 71.20 57.27* 38.03* 25.47* 7.19
V > 5 100.00 57.32 94.43 60.37 38.48* 31.00* 45.52* 32.53* 5.63* 12.12* 4.64
W 100.00 79.36 80.68 23.74* 23.58* 17.90* 24.60* 19.20* 14.47* 10.69* 1.57
W < 3 100.00 74.87 78.81 83.82 71.45 61.35 31.48* 13.66* 16.27* 3.76* 4.59
W < 5 100.00 76.07 77.60 57.24* 54.91* 55.93* 43.07* 34.37* 24.54* 8.04* 5.87
W > 5 100.00 66.23 77.95 68.44 20.71* 12.48* 14.66* 1.22* 16.41* 2.31* 2.32
X 100.00 68.15 38.82* 35.89* 48.32* 34.51* 29.27* 31.82* 38.03* 24.68* 3.56
Y 100.00 72.63* 58.92* 38.00* 17.74* 17.68* 17.85* 12.62* 25.05* 8.22* 1.38
a Values represent the mean  s.e. of 3 independent experiments. b Values relate to the concentration of sample added to the cells, expressed as %
(v/v) and were computed using GraphPad Prism 4.00. * Denotes statistically signicant (P < 0.05) diﬀerence in cell proliferation relative to untreated
control U937 cells. Statistical analysis by ANOVA followed by Dunnett's test.
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unsuitable for experimentation, having signicant (P < 0.05)
eﬀects on cell proliferation. Results of the MTT assay in the
Jurkat T cell line are shown in Table 3 and Fig. 2. The samples
tested were less cytotoxic in Jurkat T cells than in U937 cells,
with the IC50 values of 10 samples not determinable. The IC50
values of the remaining samples were in the range of 1.15–
13.82% (v/v). Similar to the eﬀects in U937 cells, sample Y was
the most cytotoxic. Therefore, a non-toxic concentration of 0.5%
(v/v) was chosen for immunomodulatory analysis of the samples
in the Jurkat T cell line.
Fig. 1 Eﬀect of BSG protein hydrolysates (0–10% v/v) on cell proliferation in the U937 cell line. Values represent the mean of 3 independent experiments.
Table 3 Eﬀect of BSG protein hydrolysates (0–5% (v/v)) on cell proliferation in the Jurkat T cell line
Sample
Cell proliferation (% of control)a
IC50
b (% v/v)0% 0.5% 1% 2% 2.5% 4% 5%
K 100.00 78.32 75.55 65.93 78.85 52.44 59.97 n/d
L 100.00 86.38 80.24 75.17 86.51 53.79* 65.38 n/d
M 100.00 78.59 84.88 83.78 89.78 52.37* 76.53 n/d
N 100.00 83.26 87.10 83.96 97.01 65.28 72.88 n/d
O 100.00 94.31 99.21 84.72 95.50 59.75 83.06 n/d
P 100.00 88.38 98.29 81.82 100.43 73.10 67.78 12.56
Q 100.00 89.00 94.09 89.69 109.40 102.77 114.42 n/d
R 100.00 80.58 85.38 73.63 49.78 49.08 66.36 n/d
S 100.00 80.23 79.59 70.80 60.99 17.81* 15.32* 5.70
T 100.00 89.65 85.04 93.08 69.79* 81.69 80.57 6.59
U 100.00 71.03 69.39 47.85* 16.20* 38.46* 35.80* 1.99
U < 3 100.00 58.47* 57.22* 64.17 66.51 71.60 69.85 2.08
U < 5 100.00 79.23 86.17 72.87 73.00 81.38 65.61 11.44
U > 5 100.00 66.13* 67.39 44.67* 18.13* 21.19* 35.40* 2.00
V 100.00 71.63* 74.82* 68.00* 51.79* 29.34* 33.76* 2.48
V < 3 100.00 70.39* 66.20* 62.59* 62.29* 64.55* 51.23* 7.14
V < 5 100.00 75.49 70.92 64.85* 78.06 70.53 75.72 13.82
V > 5 100.00 60.90* 63.56* 9.52* 12.90* 13.92* 12.87* 3.25
W 100.00 63.54 58.09 46.62* 27.75* 27.90* 27.42* 2.02
W < 3 100.00 67.24 59.24* 65.03 60.78* 68.24 64.55 n/d
W < 5 100.00 78.41 67.05 71.12 66.13 57.69 76.92 n/d
W > 5 100.00 55.89 72.16 50.98 39.98 45.22 39.75 n/d
X 100.00 63.36* 63.65* 19.29* 15.56* 48.11* 73.99 4.12
Y 100.00 70.12 68.48 27.16* 28.60* 24.14* 40.79* 1.15
a Values represent the mean  s.e. of 3 independent experiments. b Values relate to the concentration of sample added to the cells, expressed as %
(v/v) and were computed using GraphPad Prism 4.00. * Denotes statistically signicant (P < 0.05) diﬀerence in cell proliferation relative to untreated
control U937 cells. Statistical analysis by ANOVA followed by Dunnett's test.
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Hydrolysates U, V and W and fractionated hydrolysates of U
and V had signicantly (P < 0.01) higher IC50 values than that of
control sample Y, in both cell lines; indicating that fractionated
hydrolysates, particularly with molecular weight (m.w.) < 3 and
<5 kDa, are less cytotoxic than the parent hydrolysate samples.
3.2. Antioxidant activity
The antioxidant potential of the samples was measured by their
ability to protect against H2O2-induced damage in U937 cells
using two assays; SOD and comet assays. Exposure of U937 cells
to 100 mM H2O2 for 60 min resulted in a signicant (P < 0.01)
decrease in SOD activity to 57.24% (Table 4). Samples L, Q and R
signicantly (P < 0.01) protected against this oxidant-induced
reduction in SOD activity. A number of the fractionated hydro-
lysates also provided signicant (P < 0.01) protection against
H2O2 induced decrease in SOD activity; U < 3 kDa, U < 5 kDa, U >
5 kDa, V > 5 kDa, W < 3 kDa, W < 5 kDa, W > 5 kDa.
Protection against DNA damage induced by 50 mM H2O2 for
30 min was measured using the comet assay. Examples of the
cell-images scored using image analysis soware are shown in
Fig. 3. H2O2 signicantly (P < 0.01) increased the percentage tail
DNA to 41.79% (Fig. 4). The fractionated hydrolysate W < 5 kDa
signicantly (P < 0.01) protected against H2O2-induced DNA
damage, while other samples did not exert signicant antioxi-
dant eﬀects (Fig. 4). However, a general trend was observed
indicating that the fractionated hydrolysates reduced the % tail
DNA to a greater extent than their corresponding unfractio-
nated samples (Fig. 4).
3.3. Immunomodulatory potential
ELISA was used to measure the ability of the BSG protein
samples to protect against the con-A stimulated production of
IFN-g in Jurkat T cells; results are shown in Table 5. Sample K
showed most anti-inammatory potential, signicantly (P <
0.05) reducing IFN-g production to 53.28%. Other samples also
signicantly (P < 0.05) reduced IFN-g levels by a minimum of
12% (W) andmaximum of 28% (P). Unfractionated hydrolysates
U, V andW signicantly (P < 0.001) reduced IFN-g production to
a greater extent than the corresponding fractionated samples.
Fig. 2 Eﬀect of BSG protein hydrolysates (0–5% v/v) on cell proliferation in the Jurkat T cell line. Values represent the mean of 3 independent experiments.
Table 4 Ability of BSG protein hydrolysates (0.5% (v/v)) to protect against H2O2-
induced oxidative stress in the U937 cell line, measured by superoxide dismutase
(SOD) activitya
Sample
SOD activity
(U mg1 protein) SOD activity (% of control)
Control 0.36  0.01 100  0.00
H2O2 control 0.18  0.00* 57.24  0.70*
K 0.28  0.06 91.73  16.82
L 0.57  0.10# 140.47  9.29#
M 0.32  0.03 94.75  8.22
N 0.28  0.02 82.21  13.00
O 0.30  0.04 87.62  10.60
P 0.34  0.10 94.51  15.53
Q 0.35  0.06 109.24  25.03#
R 0.39  0.02 118.93  13.65#
S 0.32  0.06 91.26  10.44
T 0.30  0.03 88.16  10.43
U 0.24  0.12 67.18  5.38
U < 3 0.36  0.20 101.87  4.86#
U < 5 0.40  0.12 111.51  3.31#
U > 5 0.29  0.09 80.53  4.33#
V 0.22  0.05 62.79  3.53
V < 3 0.23  0.20 65.94  7.12
V < 5 0.24  0.09 67.22  4.09
V > 5 0.33  0.10 91.99  2.81#
W 0.25  0.06 70.78  4.24
W < 3 0.44  0.14 124.39  2.89#
W < 5 0.31  0.22 87.72  3.54#
W > 5 0.39  0.04 108.44  1.81#
X 0.21  0.03 58.29  1.95
Y 0.17  0.03 48.24  3.34
a Data represents the mean  s.e. of 4 independent experiments.
Statistical analysis by ANOVA followed by Dunnett's test. * Denotes
statistically signicant diﬀerence in SOD activity between control and
H2O2 control (P < 0.05). # Denotes statistically signicant diﬀerence in
SOD activity between H2O2 control and protein hydrolysate (P < 0.01).
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4. Discussion
BSG is a low-value co-product of the brewing industry, with a
composition of 20% protein and 70% bre.2 Phenolic extracts of
BSG have previously demonstrated antioxidant capacity8 and
BSG protein hydrolysates have been shown to possess selective
anti-inammatory eﬀects.9 The bioactivity of further protein
hydrolysates, including fractionated hydrolysates, was the focus
of the present study.
The MTT cell proliferation assay was used to determine the
cytotoxicity of the samples in both the U937 and Jurkat T cell
lines and to indicate an appropriate concentration for further
analyses. In agreement with previously reported data for BSG
hydrolysates, the present set of hydrolysates were more cyto-
toxic in U937 than in Jurkat T cells.9
Superoxide dismutases (SODs) are a group of three metal-
loenzymes, copper/zinc (Cu/Zn), manganese (Mn) and iron (Fe)
SOD, involved in catalysing the dismutation of the superoxide
anion (O2_
) to molecular oxygen (O2) and H2O2 in humans. The
assay kit utilised in this study measures all three SODs gener-
ated by xanthine oxidase and hypoxanthine. Antioxidant
enzymes such as SOD and catalase (CAT) function in minimis-
ing oxidative stress. However, the oxidant interception and
prevention process is not always entirely eﬀective and products
of damage can be continually formed at low levels, leading
ultimately to protein and DNA damage (including single-strand
breaks).13 The comet assay measures the ability of a sample to
protect against oxidant-induced single strand breaks in DNA
(DNA damage) in vitro. To determine the antioxidant eﬀects of
BSG protein hydrolysates, two diﬀerent antioxidant assays were
used – SOD and comet assays, to measure both interception and
repair of oxidative stress. A number of protein hydrolysates
demonstrated the ability to protect against the H2O2-induced
reduction in SOD activity in the U937 cell line (Table 4). Inter-
estingly, the fractionated hydrolysates of U and W had signi-
cant antioxidant eﬀects, by the SOD assay (P < 0.01), while
the parent hydrolysates did not show signicant eﬀects. This
suggests that the lowest m.w. hydrolysate fractions (<3 and <5
kDa) had the greatest antioxidant capability of hydrolysates
U–Y. Sample W < 5 kDa was the only BSG protein fraction to
show signicant (P < 0.01) ability to repair DNA, protecting
against oxidant-induced DNA damage as assessed by the comet
assay. This hydrolysate fraction reduced DNA damage from
41.79 to 21.02% tail DNA and also increased SOD activity from
57.24 to 87.72%. The greater antioxidant potential of the lower
m.w. (<5 kDa) hydrolysates supports previous ndings in the
literature for quinoa seed protein hydrolysates, <5 kDa18 and
rapeseed protein isolates, <1 kDa.19
Hydrogen peroxide (H2O2) induces oxidative stress in an
iron-dependent manner; producing hydroxyl radicals (OH_) via
the Fenton reaction. The ability of BSG protein hydrolysates to
protect against H2O2-induced oxidative stress suggests their
ability to scavenge ferrous iron (Fe2+), thus making it unavail-
able for reaction. The ability of proteins to inhibit oxidation by
binding iron has been discussed elsewhere.20 In accordance
with previous reports,21 the main amino acids present in the
BSG hydrolysates have been found to be in the order of gluta-
mine > proline > leucine.16Glutamic acid is the amino acidmost
highly correlated with antioxidant activity of Spanish honeys.22
Similarly, pea seed protein hydrolysates with highest antioxi-
dant activity have highest glutamic and aspartic acids
contents.23 Hence, the presence of glutamine in the BSG protein
Fig. 3 Cellular DNA damage induced by H2O2, as measured by the comet (single cell gel electrophoresis) assay in U937 cells and visualised using Komet 5.5 image
analysis software. (a) Control, untreated U937 cell (b–e) U937 cells with increasing degrees of DNA damage.
Fig. 4 The ability of protein hydrolysates from brewers' spent grain (BSG) to protect against H2O2-induced DNA damage in the U937 cell line, measured by the comet
assay. Data represents the mean  s.e. of 3 independent experiments. Statistical analysis by ANOVA followed by Dunnett's test. * Denotes statistically signiﬁcant
diﬀerence in DNA damage (% tail DNA) between control and H2O2 control (P < 0.01). # Denotes statistically signiﬁcant diﬀerence in DNA damage (% tail DNA) between
H2O2 control and BSG protein hydrolysate (P < 0.01).
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hydrolysates may be, at least partially, responsible for their
antioxidant activity.
The antioxidant activity of food proteins can be attributable
to a number of characteristics. Peptides with 5–16 amino acid
residues, particularly tyrosine, tryptophan, methionine, lysine,
cysteine and histidine are considered to be antioxidant
peptides.24 Peptide linkage, conguration and concentration,
position of amino acids in the peptide sequence, molecular
weight and degree of hydrolysis can all contribute to antioxi-
dant activity and the integration of these eﬀects determines
overall antioxidant potential.24 Furthermore, non-puried food
peptides (protein hydrolysates) have higher absorption and
antioxidant activity than puried peptides.24
The selective immunomodulatory potential of BSG protein
hydrolysates was highlighted in a previously published study.9
These hydrolysates demonstrated the ability to reduce the con-A
stimulated production of IFN-g in the Jurkat T cell, no eﬀect was
seen on interleukins 2 (IL-2), 4 (IL-4) or 10 (IL-10).9 On the basis
of these results, it was decided for the purposes of the present
study that potential modulation of IFN-g production would be
measured in con-A stimulated Jurkat T cells. Hydrolysates K, N,
P, U, V and W showed signicant (P < 0.05) anti-inammatory
activity. Interestingly, hydrolysates U, V and W signicantly (P <
0.01) reduced IFN-g production to a greater extent than the low
m.w. hydrolysate fractions <3 and <5 kDa (except W < 5 kDa).
This suggests that unfractionated hydrolysates or fractions with
m.w. > 5 kDa possess greatest anti-inammatory potential. This
is further supported by the nding that of the fractionated
hydrolysates, only fractions >5 kDa signicantly (P < 0.05)
reduced IFN-g production. IFN-g is a type 2 pro-inammatory
cytokine25 that plays a crucial role in the immune system by
secreting chemokines, activating immune cells, regulating
antigen presentation and controlling T-lymphocyte adaptive
immune responses.26 Hence, the ability to inhibit production of
IFN-g suggests anti-inammatory activity. Events such as tissue
injury, microbial invasion and oxidative stress can induce acute
inammation27 mediated by a number of mediators including
cytokines and nitric oxide.28 A link between antioxidant and
anti-inammatory activities has previously been reported for
whey protein hydrolysates,29,30 and BSG hydrolysates demon-
strating anti-inammatory potential in the present study also
signicantly increased SOD activity.
In T lymphocytes, it is thought that con-A stimulates cyto-
kine production by activating mitogen-activated protein kinase
(MAPK) and nuclear factor of activated T cell (NFAT) via a T-cell
receptor.31 Compounds with the ability to suppress cytokine
production induced by con-A in T lymphocytes can act by
inhibiting protein kinase C (PKC) or calcineurin (CN) activity.31
Hence, BSG protein hydrolysates may be exerting anti-inam-
matory eﬀects by these mechanisms.
Chronic inammation may occur following acute inam-
mation and result in persistent infection and autoimmune
diseases.27 Such inammatory and autoimmune diseases
include rheumatoid arthritis, inammatory bowel disease and
psoriasis.32 It has been postulated that IFN-g plays a role in
chronic inammation by acting as a macrophage activating
factor (MAF) and a migration inhibition factor (MIF), both
activating macrophages and retaining them at the inamma-
tory site.28 Therefore, the discovery of novel anti-inammatory
compounds, particularly with the ability to reduce production
of IFN-g, has implications for human health.
The hydrolysates for the present study were produced by a
number of enzymes including Protamex, Alcalase 2.4L, and
Flavourzyme (Table 1). Alcalase is a Bacillus licheniformis prep-
aration containing subtilisin and glutamyl endopeptidase
activities.33 Flavourzyme is from Aspergillus oryzae and contains
proteinase and exopeptidase activities.34 BSG protein hydroly-
sates M and O prepared with Protex 6L and Promod 24P,
respectively, did not show antioxidant or anti-inammatory
potential. Contrastingly, hydrolysates prepared with Alcalase
2.4L, CorolasePP, and Flavouzyme at 50 C, pH 7 and at an E/S
of 1% (v/v) demonstrated greatest bioactivity. It has previously
been reported that there is great variation in the performance of
commercial enzymes, with a wide range of protease variants
and specicities available.35,36 Alcalase has been repeatedly
documented as being the most eﬀective in terms of degree of
hydrolysis36–38 and bioactivity38,39 of resulting hydrolysates. Fla-
vourzyme is also a favourable protease for the production of
bioactive protein hydrolysates.40,41
Table 5 The eﬀect of BSG protein hydrolysates (0.5% (v/v)) on IFN-g production
in concanavalin-A (con-A) stimulated Jurkat T cellsa
BSG hydrolysate
IFN-g production
(% of control)
IFN-g
Control 100.00  0.00
K 53.28  17.17*
L 74.28  4.97
M 76.30  6.29
N 72.68  6.74*
O 75.88  3.84
P 71.16  8.94*
Q 73.39  12.66
R 60.67  13.58
S 58.32  13.46
T 72.65  13.44
U 77.70  2.34*
U < 3 98.19  2.81#
U < 5 102.56  3.78#
U > 5 81.95  2.28*
V 86.86  1.41*
V < 3 99.55  2.06#
V < 5 105.57  3.61#
V > 5 81.32  2.05*
W 87.27  1.47*
W < 3 113.47  4.10#
W < 5 95.15  3.20
W > 5 78.57  1.56*
X 83.12  1.68*
Y 80.88  4.95*
a Data represents the mean  s.e. of 3 independent experiments.
Statistical analysis by ANOVA followed by Tukey's multiple
comparison test. * Denotes statistically signicant reduction in IFN-g
production, relative to con-A treated Jurkat T cells control (P < 0.05). #
Denotes statistically signicant diﬀerence in IFN-g production,
relative to unfractionated parent compound (P < 0.001).
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By comparing the results of the current study to those of the
previous study of BSG protein hydrolysates,9 it is evident that
the present set of protein hydrolysates are more bioactive. While
the ability to reduce IFN-g production is demonstrated in the
results of both studies, antioxidant activity of BSG protein
hydrolysates is only evident in the present study. This may be
attributable to diﬀerences arising during scaling-up of the initial
protein extraction procedure to semi-pilot scale prior to hydro-
lysis, coupled with the enzymatic conditions (i.e. E/S ratio 1%, pH
7, temperature of 50 C) and the fractionation of hydrolysates.
5. Conclusion
Results of the present study suggest BSG protein hydrolysates
possess antioxidant and anti-inammatory potential. Hydroly-
sates with lower molecular weight (<3 and <5 kDa) have greatest
antioxidant activity, whereas unfractionated hydrolysates or
hydrolysates with m.w. > 5 kDa appear to have greater anti-
inammatory eﬀects. These bioactive hydrolysates demonstrate
potential for incorporation into functional foods, for the
management of oxidation and inammation associated
diseases.
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